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Abstract 
The construction of carbon-carbon bonds has played and will play a central role in the development of 
future organic chemistry, as carbon frameworks represent vital motifs in natural and material sciences. 
For this reason, the field of synthetic organic chemistry is under constant pressure to produce novel 
methods that outcompete previous generations in terms of cost, atom-economy and sustainability. While 
this area of research is currently dominated by indispensable transition-metal catalyzed cross-coupling 
methods, there will always be demand for the development of complementary approaches and alterna-
tives, which embodies the main objective of this thesis. Therefore, this work outlines transition-metal 
free C-C coupling reactions bearing tetrahedrally coordinated boron species at their reaction core. In a 
first step, the access toward those species as well as their robustness and usefulness in transition-metal 
free reactions is displayed and generalized. Novel organometallic species based on the earth-abundant 
lanthanide metal cerium are then established and their reactivity and advantages over other organome-
tallics in organic transformations are explored. Lastly, the gained knowledge is translated to electro-
chemical processes, in which tetrahedrally coordinated boron salts enable versatile C-C bond forming 
reactions through oxidative electrocoupling chemistry. 
Kurzfassung 
Der Aufbau von Kohlenstoff-Kohlenstoff-Bindungen hat und wird eine zentrale Rolle in der zukünfti-
gen Entwicklung der organischen Chemie spielen, da Kohlenstoff-Gerüste elementare Strukturmotive 
in Natur- und Materialwissenschaften darstellen. Aus diesem Grund ist das Gebiet der synthetischen 
organischen Chemie unter ständigem Druck, neue Methoden zu entwickeln, die vorangegangene Sys-
teme in Bezug auf Kosten, Atomökonomie und Nachhaltigkeit übertreffen. Obwohl dieses Forschungs-
gebiet derzeit von unverzichtbaren Übergangsmetall-katalysierten Kreuzkupplungsmethoden dominiert 
ist, wird es immer erforderlich sein, komplementäre Ansätze und Alternativen zu entwickeln, welches 
das Hauptziel dieser Arbeit darstellt. In dieser Arbeit werden daher übergangsmetallfreie C-C-Kupp-
lungsreaktionen vorgestellt, deren Reaktionszentrum tetraedrisch koordinierte Borspezies darstellen. In 
einem ersten Schritt wird der synthetische Zugang zu diesen Spezies sowie ihre Robustheit und Nutz-
barkeit in übergangsmetallfreien Reaktionen vorgestellt und verallgemeinert. Anschließend werden neu-
artige metallorganische Spezies auf Basis des am häufigsten vorkommenden Lanthanoids Cer hergestellt 
und ihre Reaktivität und Vorteile gegenüber anderen metallorganischen Verbindungen in organischen 
Reaktionen untersucht. Schließlich wird das gewonnene Wissen auf elektrochemische Prozesse übertra-
gen, bei denen tetraedrisch koordinierte Borsalze vielseitige Reaktionen zur Bildung von C-C-Bindun-
gen durch oxidative Elektrokupplungschemie ermöglichen. 
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A. INTRODUCTION 
  
2      A. INTRODUCTION 
1 General Introduction 
"One thing appears to be unmistakably certain. Namely, we will always need, perhaps increasingly so 
with time, the uniquely creative field of synthetic organic and organometallic chemistry to prepare both 
new and existing organic compounds for the benefit and well-being of mankind."1 (Ei-ichi Negishi, 
Nobel Lecture, 08.12.2010) 
 
Over the last century, organic synthesis has – driven by tremendous efforts and creativity – flourished 
from a primitive and limited field to an area of research that allows chemists with sufficient resources 
and patience to synthesize virtually any conceivable molecule. Especially the ground-breaking discov-
ery of transition-metal catalyzed cross-coupling reactions in the 1970s,2 which was awarded with the 
Nobel Prize in Chemistry in 2010, has changed the way chemists think about synthesis in general, as 
they allow for the simple – yet essential – formation of carbon-carbon bonds. The development of reli-
able, efficient, economical and eco-compatible methods for those C-C bond formations is of utmost 
importance to humankind, as they represent key steps in the synthesis of bioactive, highly complex 
molecules developed as pharmaceutically active ingredients and agrochemicals as well as in the build-
ing of novel optoelectronic materials and devices.3 
Since our globalized society is growing rapidly and is forecast to peak at around 11 billion people in 
21004, recent studies suggest that agricultural production has to increase by 1.1 percent every year to 
meet the rising food demand.5 As food consumption is in addition expected to increase by up to 80% in 
underdeveloped countries by 2100, as we are facing challenges like global warming6 and pandemic 
outbreaks such as most recently COVID-197, there is extreme political and societal pressure on agricul-
tural and pharmaceutical chemistry to provide solutions to those threats.8 Hence, the main goal of mod-
ern organic chemistry is to build upon the countless discoveries from the past and come up with fast 
synthetic answers that meet ecological and economical restrictions. In modern 21st century organic 
chemistry, it will therefore no longer be sufficient to simply be “the first” to synthesize the desired 
needed compound; the success of a methodology will largely depend on how efficiently and straight-
forward a compound can be prepared to ultimately find the “flawless” synthesis.1,9  
 
1 E. Negishi, Angew. Chem. Int. Ed. 2011, 50, 6738–6764. 
2 a) N. Miyaura, A. Suzuki, J. Chem. Soc., Chem. Commun. 1979, 866–867; b) N. Miyaura, K. Yamada, A. Suzuki, 
Tetrahedron Letters 1979, 20, 3437–3440; c) A. O. King, N. Okukado, E.-i. Negishi, J. Chem. Soc., Chem. Com-
mun. 1977, 683–684; d) R. F. Heck, J. P. Nolley, J. Org. Chem. 1972, 37, 2320–2322. 
3 A. Suzuki, Angew. Chem. Int. Ed. 2011, 50, 6722–6737. 
4 United Nations, Dept of Economic and Social Affairs, “World Population Prospects”, 2019. 
5 N. Alexandratos, J. Bruinsma, ESA Working Paper 2012, 12-03. 
6 J. Cook, et al., Environ. Res. Lett. 2016, 11, 048002. 
7 R. Li, S. Pei, B. Chen, Y. Song, T. Zhang, W. Yang, J. Shaman, Science 2020, 368, 489–493. 
8 a) P. S. Baran, J. Am. Chem. Soc. 2018, 140, 4751–4755; b) L. Depenbusch, S. Klasen, PLOS ONE 2019, 14, 
e0223188; c) W. Willett, et al., The Lancet 2019, 393, 447–492. 
9 J. M. Smith, S. J. Harwood, P. S. Baran, Acc. Chem. Res. 2018, 51, 1807–1817. 
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2 Organometallic Chemistry 
2.1 Overview 
Organometallic compounds are molecules with at least one carbon-metal (C-M) or carbon-metalloid 
bond, therefore including elements such as boron (C-B). Even though the first syntheses of organome-
tallic compounds trace back to the 18th century10, their use was popularized by the pioneering work on 
organomagnesium compounds by Victor Grignard in 190011, which was awarded with the Nobel Prize 
in 1912. More than a hundred years later, countless compounds containing C-M bonds have been pro-
duced and studied, including a wide range of alkaline, earth alkaline and transition metals and great 
structural diversity on the organic counterpart.12 
What makes organometallic compounds appealing is the inherent polarization of the C-M bond, which 
can be best described by the difference in electronegativity between the two atoms. With an electroneg-
ativity of 2.55 on the Pauling scale13, the carbon atom is more electronegative than any known metal or 
metalloid, thereby generally acting as a nucleophile when bound to a metal (Figure 1). The greater the 
difference between the two atoms, the higher the ionic character of the C-M bond, resulting in a more 
reactive species. For this reason, organolithium compounds are highly reactive species that even act as 
nucleophiles toward ethereal solvents at ambient temperature and lack functional group tolerance.14 In 
contrast, Grignard reagents show lower reactivity than organolithium compounds and can be stored in 
ethereal solvents at room temperature but are in return more tolerant for functional groups.15 Lastly, 
organoboron compounds have a strong covalent character, showcasing exceptional functional group 
tolerance. However, their limited reactivity often requires additional activation.16 
Further tendencies for reactivity and tolerance are observed when altering the hybridization of the or-
ganometallic species. In general, the reactivity of organometallics increases from Csp-M to Csp2-M to 
Csp3-M species, as stabilization of the nucleophilic carbon atom from the nuclei is reduced with increas-
ing p-orbital character.17 
 
10 a) D. Seyferth, Organometallics 2001, 20, 1488–1498; b) K. C. Nicolaou, Angew. Chem. Int. Ed. 2013, 52, 
131–146. 
11 V. Grignard, Compt. Rend. Acad. Sci. Paris 1900, 130, 1322–1324.  
12a) K. C. Nicolaou, D. Vourloumis, N. Winssinger, P. S. Baran, Angew. Chem. Int. Ed. 2000, 39, 44–122; b) A. 
Boudier, L. O. Bromm, M. Lotz, P. Knochel, Angew. Chem. Int. Ed. 2000, 39, 4414–4435; c) K. C. Nicolaou, P. 
G. Bulger, D. Sarlah, Angew. Chem. Int. Ed. 2005, 44, 4442–4489; d) S. D. Robertson, M. Uzelac, R. E. Mulvey, 
Chem. Rev. 2019, 119, 8332–8405. 
13 a) L. Pauling, J. Am. Chem. Soc. 1932, 9, 3570–3582; b) A. L. Allred, J. Inorg. Nucl. Chem. 1961, 17, 215–
221. 
14 P. Stanetty, M. D. Mihovilovic, J. Org. Chem. 1997, 62, 1514–1515. 
15 D. Seyferth, Organometallics 2009, 28, 1598–1605. 
16 a) N. Miyaura, A. Suzuki, Chem. Rev. 1995, 95, 2457–2483; b) A. F. Littke, G. C. Fu, Angew. Chem. Int. Ed. 
2002, 41, 4176–4211. 
17 a) D. Hauk, S. Lang, A. Murso, Org. Process Res. Dev. 2006, 10, 733–738. 
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Figure 1: Comparison of electronegativity, reactivity and functional group (FG) tolerance of various organome-
tallics on the Pauling scale.18 
The first general route toward organometallic reagents was established by Frankland19 and Grignard11 
in the second half of the 19th century and involves the oxidative insertion of a metal such as zinc19, 
lithium20 and magnesium11 into a carbon-halogen bond, which in case of magnesium is widely believed 
to follow a radical SET mechanism.21 However, most recent quantum-chemical calculations have 
shown that several processes are of importance, including a nucleophilic pathway.22 In order to facilitate 
the reaction progress, the usually oxidized and therefore passivated magnesium turnings or powder has 
to be activated, e.g. with iodine or 1,2-dibromoethane.23 While the original procedure with 1 in diethyl 
ether is performed in refluxing solvent, a stronger activation by reduction of magnesium salt (e.g. 
MgCl2) with an alkaline metal (e.g. Li, K) results in the much more reactive Rieke-Magnesium (Mg*), 
enabling the insertion at cryogenic temperatures and allowing for the tolerance of a wider range of 
functional groups, such as ester-substituted arene 3 (Scheme 1).24 Lastly, the presence of equimolar 
amount of LiCl in THF greatly enhances the oxidative insertion of magnesium, presumably due to sol-
ubilization and coordination effects at the heterogenic reaction surface.25 This mild LiCl mediated mag-
nesium insertion by Knochel and co-workers therefore conveniently allows for the preparation of Gri-
gnard reagents at ambient temperature, resulting in a high functional group tolerance exemplified in 5.26 
 
18 Figure adapted from: A. Music, D. Didier, Synlett 2019, 30, 1843–1849. 
19 E. Frankland, Liebigs Ann. Chem. 1849, 71, 171–213.  
20 M. Schlosser, Organometallics in Organic Synthesis, 2nd Ed., 2002, Wiley, New York. 
21 a) H. R. Rogers, C. L. Hill, Y. Fujiwara, R. J. Rogers, H. L. Mitchell, G. M. Whitesides, J. Am. Chem. Soc. 
1980, 102, 217–226; b) H. M. Walborsky, J. Rachon, J. Am. Chem. Soc. 1989, 111, 1897–1900; c) Z.-N. Chen, 
G. Fu, X. Xu, Org. Biomol. Chem. 2012, 10, 9491–9500.  
22 R. M. Peltzer, J. Gauss, O. Eisenstein, M. Cascella, J. Am. Chem. Soc. 2020, 142, 2984–2994. 
23 a) H. Gilman, R. H. Kirby, Rec. Trav. Chim. Pays-Bas 1935, 54, 577–582; b) D. E. Pearson, D. Cowan, J. D. 
Beckler, J. Org. Chem. 1959, 24, 504–509; c) U. Tilstam, H. Weinmann, Org. Proc. Res. Dev. 2002, 6, 906–910. 
24 a) T. P. Burns, R. D. Rieke, J. Org. Chem. 1987, 52, 3674–3680; b) R. D. Rieke, Science 1989, 246, 1260–
1264; c) J.-S. Lee, R. Velarde-Ortiz, A. Guijarro, J. R. Wurst, R. D. Rieke, J. Org. Chem. 2000, 65, 5428–5430.  
25 a) C. Reichardt, Solvents and Solvent Effects in Organic Chemistry, 2003, Wiley-VCH, Weinheim; b) C. Feng, 
D. W. Cunningham, Q. T. Easter, S. A. Blum, J. Am. Chem. Soc. 2016, 138, 11156–11159. 
26 F. M. Piller, P. Appukkuttan, A. Gavryushin, M. Helm, P. Knochel, Angew. Chem. Int. Ed. 2008, 47, 6802–
6806. 
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Scheme 1: Different methods for the oxidative addition of magnesium into carbon-halogen bonds.27 
A complementary approach is the directed metalation originating from the pioneering work of Schlenk 
in 1928, in which alkyl metal or metal amide bases cleave a C-H bond heterolytically.28 The deproto-
nation step is hereby usually controlled by a directing metalation group (DMG), resulting in selective 
C-H metalation adjacent to the DMG.29 This directed ortho-metalation (DoM) can either be enabled by 
kinetic effects, in which the Lewis basic DMG acts as coordination anchor for the organometallic base, 
or by electronic effects of the then electron-withdrawing DMG itself.30 Importantly, the concept of di-
rected metalation can be applied to heterocycles. For instance, the coordinative influence of heteroatoms 
in furans 7, thiophenes 8 and pyrroles 9 enables smooth ortho-metalation.20 As an example, the McMil-
lan group exploited this property to synthesize the naturally occurring (+)-minfiensine 14 (Scheme 2) 
by direct ortho-metalation of the corresponding protected indole moiety 12.31 In addition, non-aromatic 
surrogates such as vinyl ethers 10 and 11 can be readily metalated in the respective ortho-position of 
the DMG with simple alkylmetal bases such as n-BuLi.32 
The last two major methods for the preparation of organometallics, the halogen-metal exchange and the 
transmetalation, will be discussed in detail as they are the most frequently used methods for the prepa-
ration of organometallics in this work. 
 
27 Scheme adapted from: M. A. Ganiek, Dissertation, LMU Munich, 2018. 
28 W. Schlenk, E. Bergmann, Justus Liebigs Ann. Chem. 1928, 463, 98–227.   
29 a) E. J.-G. Anctil, V. Sniekus, J. Organomet. Chem. 2002, 653, 150–160; b) F. F. Wagner, D. L. Comins Eur. 
J. Org. Chem. 2006, 3562–3565.  
30 a) V. Sniekus, Chem. Rev. 1990, 90, 879–933; b) M. C. Whisler, S. MacNeil, V. Snieckus, P. Beak, Angew. 
Chem. Int. Ed. 2004, 43, 2206–2225. 
31 S. B. Jones, B. Simmons, D. W. C. MacMillan, J. Am. Chem. Soc. 2009, 131, 13606–13607. 
32 V. Hornillos, M. Giannerini, C. Vila, M. Fananas-Mastral, B. Feringa, Chem. Sci. 2015, 6, 1394–1398. 
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Scheme 2: Preferred metalation sites on heterocycles and non-aromatic systems (top) and synthetic application to 
minfiensine (bottom). 
2.2 Halogen-Metal Exchange Reactions33 
The halogen-metal exchange is one of the most convenient and fastest routes toward organometallic 
reagents. Since the discovery of bromine-magnesium exchange reactions by Prevost in 193134, numer-
ous other metals including transition metals and lanthanides have shown to partake in metal-exchange 
chemistry. Hereby, a halogen-metal exchange is a reaction in equilibrium between an organometallic 
species and an organic halide (Scheme 3). The direction of this equilibrium is displaced with respect to 
the relative stability of the different carbon-metal bonds, favoring the formation of the most stable or-
ganometallic reagent.35 As already described, the stability of the formed organometallic strongly de-
pends on the hybridization of the carbon atom and additional stabilizing mesomeric and inductive ef-
fects (sp > sp2vinyl > sp2aryl > sp3prim > sp3sec > sp3tert).17 Although the direction of the exchange is mainly 
controlled by the nature of the organic part, its rate strongly depends on the electronegativity of the 
metal, so that a halogen-lithium exchange proceeds faster than the corresponding halogen-magnesium 
exchange.36 
 
Scheme 3: A typical halogen-metal exchange reaction. 
Among all metal-halogen exchange reactions, the lithium-halogen exchange discovered by Wittig37 and 
Gilman38 in 1938/39 is one of the most utilized, since the fast reaction rate allows for the rapid formation 
of organolithium compounds. As organolithium reagents rank among the most reactive organometallic 
 
33 This chapter has been adapted from: A. Music, D. Didier, Synlett 2019, 30, 1843–1849. 
34 C. Prévost, Bull. Soc. Chim. Fr. 1931, 49, 1372–1381. 
35 a) H. J. S. Winkler, H. Winkler, J. Am. Chem. Soc. 1966, 88, 964969; b) H. J. S. Winkler, H. Winkler, J. Am. 
Chem. Soc. 1966, 88, 969–974.   
36 L. Anthore-Dalion, A. D. Benischke, B. Wei, G. Berionni, P. Knochel, Angew. Chem. Int. Ed. 2019, 58, 
4046–4050. 
37 G. Wittig, U. Pockels, H. Dröge, Chem. Ber. 1938, 71, 1903–1912.   
38 a) H. Gilman, W. Langham, A. L. Jacoby, J. Am. Chem. Soc. 1939, 61, 106109; b) R. G. Jones, H. Gilman, Org. 
React. 1951, 6, 339–366. 
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species and functional group tolerance can be problematic, transmetalation of the generated organolith-
ium toward smoother and more stable reagents is usually privileged for further applications (see chap-
ter 2.3).39 Nevertheless, this type of exchange was used in some total syntheses40 and several exchange 
reactions featuring diverse Csp2- and Csp3-halides (15, 16) are reported, which can even tolerate nitro- 
(17) and ester-substituted arenes (18) at very low reaction temperatures (Scheme 4).41  
 
Scheme 4: Examples for halogen-lithium exchange reactions. 
In contrast to lithium-halogen exchange chemistry, organomagnesium compounds are – due to their 
well-balanced reactivity and functional group tolerance – the most represented organometallics gener-
ated from halogen-metal exchange.42 As demonstrated by the groups of Cahiez and Knochel, iodine-
magnesium exchange reactions with i-PrMgBr or (i-Pr)2Mg on sensitive arenes bearing nitrile, ethyl 
ester and amide functionalities proceed smoothly at –40 °C.43 However, those exchange-reagents strug-
gle with the replacement of bromides, if the system is not activated by additional electron-deficient 
groups. While other exchange reagents such as aryl magnesium bromides44 and mixed metal species 
like (n-Bu)3MgLi45 have to be mentioned, the introduction of the “Turbo-Grignard” i-PrMgCl•LiCl 
 
39 L. E. Overmann, D. J. Ricca, V. D. Tran, J. Am. Chem. Soc. 1997, 119, 12031–12040. 
40 a) J. E. Toth, P. L. Fuchs, J. Org. Chem. 1986, 52, 473–475; b) M. Bogenstatter, A. Limberg, L. E. Overman, 
A. L. Tomasi, J. Am. Chem. Soc. 1999, 121, 12206–12207; c) A. G. Myers, S. D. Goldberg, Angew. Chem. Int. 
Ed. 2000, 39, 2732–2735. 
41 a) G. Köbrich, P. Buck, Chem. Ber. 1970, 103, 1412–1419; b) W. E. Parham, L. D. Jones, J. Org. Chem. 1976, 
41, 2704–2706; c) H. Neumann, D. Seebach, Tetrahedron Lett. 1976, 17, 4839–4842; d) W. F. Bailey, E. R. 
Punzalan, J. Org. Chem. 1990, 55, 5404–5406.  
42 a) P. Knochel, W. Dohle, N. Gommermann, F. F. Kneisel, F. Kopp, T. Korn, I. Sapoutnis, V. A. Vu, Angew. 
Chem. Int. Ed. 2003, 42, 4302–4320; b) N. M. Barl, V. Werner, C. Sämann, P. Knochel, Heterocycles 2014, 88, 
827–844; c) D. S. Ziegler, B. Wei, P. Knochel, Chem. Eur. J. 2019, 25, 2695–2703. 
43 a) L. Boymond, M. Rottländer, G. Cahiez, P. Knochel, Angew. Chem. Int. Ed. 1998, 37, 1701–1703; b) M. 
Abarbri, F. Dehmel, P. Knochel, Tetrahedron Lett. 1999, 40, 7449–7453; c) G. Varchi, A. Ricci, G. Cahiez, P. 
Knochel, Tetrahedron 2000, 56, 2727–2731; d) G. Varchi, A. E. Jensen, W. Dohle, A. Ricci, G. Cahiez, P. 
Knochel, Synlett 2001, 4, 477–480. 
44 a) I. Sapountzis, P. Knochel, Angew. Chem. Int. Ed. 2002, 41, 1610–1611; b) I. Sapountzis, H. Dube, R. Lewis, 
P. Knochel, J. Org. Chem. 2005, 70, 2445–2454.   
45 a) K. Kitagawa, A. Inoue, H. Shinokubo, K. Oshima, Angew. Chem. Int. Ed. 2000, 39, 2481–2483; b) A. Inoue, 
K. Kitagawa, H. Shinokubo, K. Oshima, J. Org. Chem. 2001, 66, 4333–4339. 
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popularized magnesium-bromine exchanges.46 Similar to the use of LiCl in Grignard reactions, the ad-
ditional salt helps breaking aggregates in solution, allowing for a consequent decrease in reaction times 
and higher yields compared to i-PrMgCl itself.  
 
Scheme 5: Overview of halogen-magnesium exchange chemistry. 
As depicted in Scheme 5, the formed organomagnesium species can be trapped with various electro-
philes, showcasing good functional group tolerance for compounds 19, 21, 22. In addition, these rea-
gents proved to preferably perform 1,2-addition over 1,4-addition, resulting in 20 employing a Michael 
acceptor electrophile. More recently, the group of Knochel reported a novel halogen-magnesium ex-
change in toluene rather than commonly used THF, employing the exchange-reagents 
s-BuMgOR•LiOR (R = 2-ethylhexyl) and s-Bu2Mg•2LiOR, respectively. The exchange rates for these 
transformations are very high and the reactions completed within a few minutes, even when using chal-
lenging electron-rich arenes. Notably, the addition of the additive PMDTA allowed for the first chlo-
rine-magnesium exchange on electron-rich substrates.47 
Other than the two presented and well-established classes of metal-exchange reagents, more exotic 
metal-exchange reagents have been designed. For example, the iodine-calcium exchange was recently 
described by the group of Westerhausen (Scheme 6).48 (Trimethylsilyl)methylcalcium iodide was iden-
tified as a privileged exchange reagent for aryl-, alkenyl- (23), and cyclopropyl iodide substrates. The 
nucleophilic addition of the reactive intermediate organocalcium reagent 24 was performed on Me3SiCl, 
furnishing corresponding organosilicon compounds such as 25 in excellent yields. With calcium having 
 
46 a) A. Krasovskiy, P. Knochel, Angew. Chem. Int. Ed. 2004, 43, 3333–3336; b) A. Krasovskiy, B. F. Straub, P. 
Knochel, Angew. Chem. Int. Ed. 2006, 45, 159–162; c) L. Shit, Y. Chu, P. Knochel, H. Mayr, Angew. Chem. Int. 
Ed. 2008, 47, 202–204; d) C. Sämann, B. Haag, P. Knochel, Chem. Eur. J. 2012, 18, 16145–16152. 
47 D. S. Ziegler, K. Karaghiosoff, P. Knochel, Angew. Chem. Int. Ed. 2018, 57, 6701–6704.   
48 A. Koch, M. Wirgenings, S. Krieck, H. Görls, G. Pohnert, M. Westerhausen, Organometallics 2017, 36, 3981–
3986. 
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a low electronegativity – very close to lithium – organocalcium reagents are expected to be very reac-
tive, hence the limited number of examples described until now. 
 
Scheme 6: Generation and trapping reaction of organocalcium species with TMSCl. 
As another example, Knochel and co-workers developed the first halogen-lanthanide exchange reagent, 
(n-Bu)2LaMe•5LiCl. In a double halogen-lanthanide exchange, aryl- and heteroaryl iodides and bro-
mides were employed furnishing organolanthanides that were previously only accessible via transmeta-
lation of organolithium compounds with the appropriate lanthanide salt (see chapter 2.3).49 Since all 
known lanthanides display electronegativities in the range between lithium ( = ) and magnesium 
( = ),13 a fast exchange within 5 minutes at –50 °C was observed. Remarkably, not only trapping 
reactions with ketones (26), but also sequences with Weinreb amides (27) and cross-coupling proce-
dures (28) were tolerated (Scheme 7).  
(n-Bu)2LaMe•5LiCl was also used to promote exchanges on 2-bromobiaryls. Interestingly, a C-H met-
alation of the formed 2-biaryllanthanum compound onto the other arene was observed and the resulting 
organometallic was trapped with various electrophiles yielding polyfunctional biaryls such as 29.50 In 
addition, the 2nd generation exchange reagents Ph3La•5LiCl and (m-xylyl)3La•5LiCl were developed, 
exhibiting greater functional group tolerance and thermal properties than the previously described rea-
gent as well as enabling a triple halogen-lanthanide exchange.51 
Most recently, the same group subsequently proposed the alternative oligoalkyl samarium reagents 
(n- Bu)2SmCl•4LiCl and (n-Bu)3Sm•5LiCl to perform double or triple halogen-samarium exchanges 
giving products 30–32. Similar to their results on organolanthanum chemistry, the exchanges occurred 
at high rates and could be performed at slightly elevated temperatures. The authors proposed that tuning 
the electronegativity of the chosen metal greatly influences the rate of the exchange, but also the reac-
tivity and stability of the corresponding organometallic species. Importantly, they demonstrated the 
synthetic utility of their approach by highlighting that product 31 was not accessible employing organ-
olithium reagents under identical conditions (Scheme 8).36 
  
 
49 A. D. Benischke, L. Anthore-Dalion, G. Berionni, P. Knochel, Angew. Chem. Int. Ed. 2017, 56, 16390–16394.  
50 B. Wei, D. Zhang, Y.-H. Chen, A. Lei, P. Knochel, Angew. Chem. Int. Ed. 2019, 58, 15631–15635. 
51 A. D. Benischke, L. Anthore-Dalion, F. Kohl, P. Knochel, Chem. Eur. J. 2018, 24, 11103–11109. 
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Scheme 7: Halogen-lanthanum exchange and following transformations. 
 
Scheme 8: Halogen-samarium exchange and following trapping sequence. 
In contrast to these novel organolanthanide exchange reagents, the field of halogen-zinc exchange 
chemistry is well-established and was pioneered by Oku in 1989,52 even though earlier reports by Fu-
rukawa et al. on improved Simmons-Smith reaction53 conditions in 1966 might be considered the first 
example of an iodine-zinc exchange.54 While the group of Oku mainly demonstrated the reaction to be 
useful for generating stable carbenoid derivatives for further functionalization,52,55 the group of Knochel 
was able to perform the exchange with similar zincate reagents on functionalized alkyl groups, showing 
the high tolerance of such organozinc species.56 Again, this tolerance stems from the relatively weak 
 
52 T. Harada, K. Hattori, T. Katsuhira, A. Oku, Tetrahedron Lett. 1989, 30, 6035–6038. 
53 H. E. Simmons, R. D. Smith, J. Am. Chem. Soc. 1959, 81, 4256–4264. 
54 a) J. Furukawa, N. Kawabata, J. Nishimura, Tetrahedron Lett. 1966, 28, 3353–3354; b) J. Furukawa, N. Kawa-
bata, J. Nishimura, Tetrahedron 1968, 24, 53–58. 
55 T. Harada, Y. Kotani, T. Katsuhira, A. Oku, Tetrahedron Lett. 1991, 32, 1573–1576. 
56 a) I. Klement, P. Knochel, K. Chau, G. Cahiez Tetrahedron Lett. 1994, 35, 1177–1180; b) L. Micouin, P. 
Knochel, Synlett 1997, 327–328. 
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polarization of the C-Zn bond as a result of zinc’s inherently high electronegativity and enables ambient 
temperature exchange chemistry. 
 
Scheme 9: Iodine-zinc exchange reactions and following transformations. 
In 1994, Uchiyama and co-workers described the first iodine-zinc exchange of aryl iodides (33) with 
lithium trimethylzincate species. In the following two decades, organozinc derivatives (34) proved to 
be reactive toward the addition of allyl halides giving products such as 35 (Scheme 9A) and to be 
efficient in Negishi cross-coupling reactions.57 Later, the group of Knochel elaborated a strategy for 
iodine-zinc exchange using diisopropylzinc reagents and catalytic amounts of Li(acac) in a solvent mix-
ture containing NMP at room temperature. Allylation- and cross-coupling reactions were performed on 
various substrates possessing sensitive groups such as aldehydes and esters (38) with good yields 
(Scheme 9B).58 More recent contributions from the groups of Gros, Mongin, Fort, and Uchiyama 
demonstrated the usefulness of homoleptic lithium polyalkyl zincates for halogen-metal exchanges on 
bromopyridine derivatives.59 Lastly, the group of Hevia showed the applicability of structurally defined 
magnesium-zincates for iodine-zinc exchanges.60 
 
57 a) Y. Kondo, N. Takazawa, C. Yamazaki, T. Sakamoto, J. Org. Chem. 1994, 59, 4717–4718; b) M. Uchiyama, 
T. Miyoshi, Y. Kajihara, T. Sakamoto, Y. Otani, T. Ohwada, Y. Kondo, J. Am. Chem. Soc. 2002, 124, 8514–8515; 
c) M. Uchiyama, T. Furuyama, M. Kobayashi, Y. Matsumoto, K. Tanaka, J. Am. Chem. Soc. 2006, 128, 8404–
8405; d) M. Uchiyama, Y. Kobayashi, T. Furuyama, S. Nakamura, Y. Kajihara, T. Miyoshi, T. Sakamoto, Y. 
Kondo, K. Morokuma, J. Am. Chem. Soc. 2008, 130, 472–480; e) S. Nakamura, C.-Y. Liu, A. Muranaka, M. 
Uchiyama, Chem. Eur. J. 2009, 15, 5686–5694. 
58 a) F. F. Kneisel, M. Dochnahl, P. Knochel, Angew. Chem. Int. Ed. 2004, 43, 1017–1021; b) L.-Z. Gong, P. 
Knochel, Synlett 2005, 267–270. 
59 N. T. T. Chau, M. Meyer, S. Komagawa, F. Chevallier, Y. Fort, M. Uchiyama, F. Mongin, P. C. Gros, Chem. 
Eur. J. 2010, 16, 12425–12433. 
60 a) E. Hevia, J. Z. Chua, P. García-Álvarez, A. R. Kennedy, M. D. McCall, Proc. Natl. Acad. Sci. U.S.A. 2010, 
107, 5294–5299; b) T. D. Bluemke, W. Clegg, P. García-Alvarez, A. R. Kennedy, K. Koszinowski, M. D. McCall, 
L. Russo, E. Hevia, Chem. Sci. 2014, 5, 3552–3562. 
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Scheme 10: Halogen-copper exchange and following trapping sequence. 
The last major transition metal that partakes in halogen-metal exchange reactions is copper. In 1968, 
Corey et al. described the first example of halogen-copper exchange using dialkyl cuprates.61 In this 
report, alkyl-, alkenyl-, allyl-, and aryl iodides, bromides, and even chlorides were shown to proceed 
through halogen-copper permutations. Organocuprates are known to be reactive nucleophiles toward 
alkyl halides through nucleophilic substitutions. As primary alkyl halides are produced during the reac-
tion of exchange, a major drawback happens to be the alkylation of the generated organocopper species 
with this alkyl halide. To tackle this problem, Knochel and co-workers later used bulkier alkyl copper 
species to avoid the parasitic alkylation reaction. Dineopentylcuprate species were used on olefinic, 
aromatic and heteroaromatic bromides and iodides. Interestingly, besides exhibiting excellent func-
tional group tolerance, dineopentylcuprate reagents showed exceptional regioselectivitiy in case of pol-
yhalogenated compounds (39), which was attributed to the presence of a coordinating group such as an 
ester or a sulfone, directing the exchange to the favorable ortho-position (40) and yielding the desired 
compound 41 in high yield (Scheme 10).62 
2.3 Transmetalation 
Since many organometallic compounds cannot be prepared by either oxidative insertion, directed met-
alation or halogen-metal exchange reactions, transmetalation proved to be a convenient alternative. In 
principle, every organometallic reagent that is generated by one of the methods mentioned above can 
be transmetalated to another organometallic compound by treatment with the desired metal salt, as long 
as the cation in the salt has a higher electronegativity than the metal in the starting organometallic 
reagent. This process is thermodynamically favored and therefore usually irreversible, as the more co-
valent C-M bond in addition to the more ionic and thus stable metal salt is formed (Scheme 11). 63 
 
61 a) E. J. Corey, G. H. Posner, J. Am. Chem. Soc. 1968, 90, 5615–5616; b) Y. Kondo, T. Matsudaira, J. Sato, N. 
Maruka, T. Sakamoto, Angew. Chem. Int. Ed. Engl. 1996, 35, 736–738. 
62 a) C. Piazza, P. Knochel, Angew. Chem. Int. Ed. 2002, 41, 3263–3265; b) X. Yang, T. Rotter, C. Piazza, P. 
Knochel, Org. Lett. 2003, 5, 1229–1231; c) X. Yang, A. Althammer, P. Knochel, Org. Lett. 2004, 6, 1665–1667. 
63 a) G. O. Spessard, G. L. Miessler, Organometallic Chemistry 2010, Oxford University Press, New York; b) C. 
Elschenbroich, Organometallchemie 6. Auflage 2008, Teubner, Wiesbaden.   
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Scheme 11: The general mechanism of transmetalation reactions. 
Transmetalations have two main purposes: First, otherwise unstable organometallic reagents can be 
transformed to more stable, functional group tolerant species with altered reactivity.64 Frequent metal 
salts used are LiCl complexed MgCl2, ZnCl2 or CuCN. Upon transmetalation, the resulting organome-
tallic species enable specific reactions such as Negishi cross-coupling reactions or copper-catalyzed 
allylations,65 in which transmetalation reactions also play an important role for the catalytic cycle (see 
chapter 3.3).66 Second, rapid formation of organolithium or organomagnesium compounds followed by 
transmetalation is usually much faster than other preparative methods for the synthesis of more covalent 
organometallic species such as organo-boron, -silicon or -tin compounds and is also popular in organ-
olanthanide chemistry.67 A common example was developed within the pioneering work of Imamoto, 
in which transmetalation of n-BuLi with CeCl3 (43) enabled the selective 1,2-addition to easily enoliz-
able ketones such as -tetralone in up to 97% yield (Scheme 12). Importantly, the absence of CeCl3 
resulted in a significantly lower yield of 26% for tertiary alcohol 44, as – due to enolization – significant 
amounts of the starting ketone were recovered. However, premixing of the ketone with CeCl3 also 
proved to be feasible and the corresponding alcohol was isolated in 80%, since coordination of the 
Lewis acidic cerium salt to the ketone favors 1,2-addition.68 
 
Scheme 12: Transmetalation of n-BuLi with CeCl3 and 1,2-addition to -tetralone. 
 
64 K. Osakada, Fundamentals of Molecular Catalysis 2003, Elsevier, Amsterdam. 
65 a) A. Metzger, F. M. Piller, P. Knochel, Chem. Commun. 2008, 5824–5826; b) F. M. Piller, A. Metzger, M. A. 
Schade, B. A. Haag, A. Gavryushin, P. Knochel, Chem. Eur. J. 2009, 15, 7192–7202; c) A. Frischmuth, M. 
Fernández, N. M. Barl, F. Achrainer, H. Zipse, G. Berionni, H. Mayr, K. Karaghiosoff, P. Knochel, Angew. Chem. 
Int. Ed. 2014, 53, 7928–7932. 
66 a) E. Negishi, Acc. Chem. Res. 1982, 15, 340–348; b) A. J. J. Lennox, G. C. Lloyd-Jones, Chem. Soc. Rev. 2014, 
43, 412–443. 
67 a) T. Imamoto, T. Kusumoto, M. Yokoyama, J. Chem. Soc. Chem. Commun. 1982, 1042–1044; b) T. Imamoto, 
Y. Sugiura, J. Phys. Org. Chem. 1989, 2, 93–102; c) G. A. Molander, Chem. Rev. 1992, 92, 29–68; d) V. Alexan-
der, Chem. Rev. 1995, 95, 273–342. 
68 N. Takeda, T. Imamoto, Org. Synth. 1999, 76, 228. 
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While transmetalation reactions of organolithium species with cerium salts are believed to yield the 
desired organocerium compound with a real carbon-cerium bond (43), there is still debate and uncer-
tainty about the true nature of organocerium compounds transmetalated from organomagnesium com-
pounds.69 First, the transmetalation process in case of magnesium is not favored, as it shows a higher 
electronegativity than cerium, making it the more stable organometallic species.13,18 Second, the two 
organocerium species generated from different organometallics strongly vary in their chemical proper-
ties, as the latter usually exhibit higher thermal stability, lower nucleophilicity and stronger basicity 
than the former organocerium species prepared via transmetalation of organolithium reagents.69b Based 
on those observations, the currently most prominent assumption is the formation of bimetallic cerium-
ate complexes 49 when employing organomagnesium compounds, even though Imamoto and co-work-
ers suggested the presence of Ce-C bonds from allylmagnesium species via IR spectroscopy.70 There-
fore, the formation of those species should be described as a coordination of organomagnesium species 
toward CeCl3 rather than a transmetalation process. (Scheme 13).69 
 
Scheme 13: Preparation of organocerium reagents via transmetalation and coordination of anhydrous CeCl3. 
An example of the varying reactivity from the two different preparation methods was given by Reetz et 
al. in competitive additions of organocerium species toward aldehydes and ketones. While 
PhMgBr/CeCl3 combinations gave exclusive and therefore chemoselective additions to the more elec-
trophilic benzaldehyde 50, PhLi/CeCl3 mixtures reacted chemorandomly with 50 and acetophenone 51, 
giving products 54 and 55 in a 1:1 ratio (Scheme 14).71 
 
Scheme 14: Different reactivity of organocerium reagents. 
 
69 a) H.-J. Liu, K.-S. Shia, X. Shang, B.-Y. Zhu, Tetrahedron 1999, 55, 3803–3830; b) G. Bartoli, E. Marcantoni, 
M. Marcolini, L. Sambri, Chem. Rev. 2010, 110, 6104–6143. 
70 S. Matsukawa, Y. Funabashi, T. Imamoto, Tetrahedron Lett. 2003, 44, 1007–1010. 
71 M. T. Reetz, H. Haning, S. Stanchev, Tetrahedron Lett. 1992, 33, 6963–6966. 
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3 Organoboron Chemistry 
3.1 Overview 
Throughout the majority of the last century, organoboron chemistry was almost irrelevant to the scien-
tific community. However, the ground-breaking work by Brown and co-workers in the early 1960s on 
hydroboration of alkynes and alkenes,72 which was awarded the Nobel Prize in Chemistry in 1979, 
completely revolutionized the field as organoboranes were readily accessible and demonstrated to fur-
nish synthetically useful intermediates. In analogy to this pioneering work, transition-metal catalyzed 
carboborations and haloborations as well as borylations for the preparation of bench-stable boronic 
acids and related compounds such as pinacol boronic esters were developed in the last decades, since 
traditional organoboranes usually exhibit pyrophoricity.73 The growth in the field was even more accel-
erated, when – amongst others – Suzuki and Miyaura developed their cross-coupling protocol allowing 
for the formation of ubiquitous C-C bonds.2,3 
 
Figure 2: Examples of drugs either synthesized by Suzuki-Miyaura coupling or bearing an organoboron moiety.74  
Nowadays, organoboron reagents are essential and indispensable tools in any organic chemist’s toolbox. 
Arguably, they are the most studied and applied class of reagents in organic synthesis and represent a 
rapidly expanding field, since they do not only offer a wide reactivity profile but are in addition popular 
due to their non-toxic nature and excellent functional group tolerance.16a,75 Moreover, boronic and bo-
rinic acids and esters thereof have shown their potential beyond acting as substrates in C-C bond form-
ing reactions and are regularly used in catalysis, e.g. Corey’s CBS reduction76, or in drug discovery and 
material science.3,77 In combination with the importance of the Suzuki-Miyaura cross-coupling in those 
fields (Figure 2), there is an ever-growing importance for the straightforward and elegant preparation 
of organoboron compounds. 
 
72 a) H. C. Brown, G. Zweifel, J. Am. Chem. Soc. 1961, 83, 3834–3840; b) H. C. Brown, S. K. Gupta, J. Am. 
Chem. Soc. 1971, 93, 1816–1818; c) K. Burgess, M. J. Ohlmeyer, Chem. Rev. 1991, 91, 1179–1191. 
73 a) A. Suzuki, Heterocycles 2010, 80, 15–43; b) E. Negishi, G. Wang, H. Rao, Z. Xu, J. Org. Chem. 2010, 75, 
3151–3182; c) M. Suginome, Chem. Rec. 2010, 10, 348–358; d) J. R. Lawson, R. L. Melen, Inorg. Chem. 2017, 
56, 8627–8643. 
74 P. Schäfer, T. Palacin, M. Sidera, S. P. Fletcher, Nat. Commun. 2017, 8, 15762. 
75 J. W. B. Fyfe, A. J. B. Watson, Chem 2017, 3, 31–55. 
76 a) E. J. Corey, R. K. Bakshi, S. Shibata, J. Am. Chem. Soc. 1987, 109, 5551–5553; b) L. Deloux, M. Srebnik, 
Chem. Rev. 1993, 93, 763–784; c) E. J. Corey. C. J. Helal, Angew. Chem. Int. Ed. 1998, 37, 1986–2012. 
77 D. G. Brown, J. Boström, J. Med. Chem. 2016, 59, 4443–4458. 
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3.2 Tetracoordinated Organoboron Salts 
Debatably the most classical synthesis of organoboron compounds lies in the addition of organolithium 
and organomagnesium reagents to trialkylborates, which generates a tetracoordinated boron center.78 
Even though traditional organoboron chemistry disregarded those species and routinely converted them 
into the corresponding boronic acids by acid hydrolysis, more recent studies by the groups of Mayr, 
Aggarwal, Morken and many more have shown the importance of such tetracoordinated boron centers.79 
As trivalent organoboron species – due to their electronic structure and trigonal planar geometry – act 
as electrophiles in chemical transformations, their tetrahedral equivalents exhibit nucleophilic charac-
ter, fundamentally changing their properties and reactivity.80 The influence on the nucleophilic charac-
ter of the ligands surrounding the boron core was thoroughly described by Mayr and his group on their 
nucleophilicity scale. The authors investigated furyl boronic acid derivatives and engaged those with 
different benzhydrylium cations, while carefully measuring the kinetics. From this data, respective nu-
cleophilicities (N) were derived, which are summarized in Figure 3.81 
 
Figure 3: Selection of furyl boronic acid derivates by Mayr et al. and their calculated nucleophilicities.  
As seen above, the pinacol boronic ester 57 is less reactive toward carbocations than the unsubstituted 
2-methylfuran 58 itself. Moreover, intramolecular coordination of an additional alkoxide (63) or amino 
group in 59 drastically increases the nucleophilicity of the compound. This general trend of increasing 
nucleophilicity by tetrahedral assembly onto the boron center holds true for potassium trifluoroborate 
60 as well as bisorganoborinate 61 and tetraorganoborate 62 and has its sole exception in MIDA 
 
78 a) H. C. Brown, T. E. Cole, Organometallics 1983, 2, 1316–1319; b) H. C. Brown, N. Bhat, M. Srebnik, Tet-
rahedron Lett. 1988, 29, 2631–2634; c) H. C. Brown, M. V. Rangaishenvi, Tetrahedron Lett. 1990, 31, 7113–
7114; d) H. C. Brown, M. V. Rangaishenvi, Tetrahedron Lett. 1990, 31, 7115–7118. 
79 a) K. Feeney, G. Berionni, H. Mayr, V. K. Aggarwal, Org. Lett. 2015, 17, 2614–2617; b) C. García-Ruiz, J. L.-
Y. Chen, C. Sandford, K. Feeney, P. Lorenzo, G. Berionni, H. Mayr, V. K. Aggarwal, J. Am. Chem. Soc. 2017, 
139, 15324–15327; c) C. Shu, A. Noble, V. K. Aggarwal, Angew. Chem. Int. Ed. 2019, 58, 3870–3874; d) A. 
Fawcett, T. Biberger, V. K. Aggarwal, Nat. Chem. 2019, 11, 117–122; e) S. Namirembe, J. P. Morken, Chem. 
Soc. Rev. 2019, 48, 3464–3474. 
80 R. N. Dhital, H. Sakurai, Asian J. Org. Chem. 2014, 3, 668–684. 
81 a) G. Berionni, B. Maji, P. Knochel, H. Mayr, Chem. Sci. 2012, 3, 878–882; b) G. Berionni, A. I. Leonov, P. 
Mayer, A. R. Ofial, H. Mayr, Angew. Chem. Int. Ed. 2015, 54, 2780–2783. 
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boronate 56, as the electron-withdrawing effect of the carbonyl groups outcompetes the coordination 
effect and results in an attenuated nucleophilicity.81 
As a recent example for the addition of organolithium reagents to trialkylborates like B(Oi-Pr)3, Didier 
and co-workers, amongst others, showed that a highly reactive Boc-protected azetinyllithium compound 
64 – generated and only stable at cryogenic temperatures – can be transmetalated to the corresponding 
4-azetinylboronate 65, which is stable at room temperature. These compounds were for instance en-
gaged in Suzuki-Miyaura cross-couplings (chapter 3.3), yielding compounds such as 66 in high yields 
(Scheme 15).82 
 
Scheme 15: Reaction of 53 with B(Oi-Pr)3 and subsequent Suzuki-Miyaura cross-coupling. 
Contrary to the reaction in Scheme 15, in which the transmetalating agent is added after completed 
formation of the organometallic species, the group of Buchwald presented an in situ transmetalation 
process.83 Hereby, 2-bromopyridines (67) and B(Oi-Pr)3 were dissolved in THF/toluene mixtures and 
n-BuLi was added slowly over the course of 30 min. Due to kinetic effects, the bromine-lithium ex-
change is favored over the competing nucleophilic attack onto the borate (Scheme 16A). The resulting 
triisopropyl 2-pyridylborate 68 was then submitted to a Suzuki-Miyaura cross-coupling yielding com-
pound 70 in 91%. As other typical boron-based esters failed to perform the desired cross-coupling, this 
report highlights the importance of tetracoordinated boron species. In a similar fashion, Knochel and 
co-workers demonstrated that in situ transmetalation of Grignard reagents toward organozinc com-
pounds was feasible.65 The same group showed furthermore, that B(On-Bu)3 greatly enhanced the in-
sertion process, enabling a fast transmetalation toward the organoborate 72 within 1 h (Scheme 16B). 
A comparable transmetalation with ZnCl2 was only completed after 3 h and other borate sources such 
as B(OEt)3 or B(OMe)3 gave worse results, as transesterification with sensitive substrates such as ester 
71 were observed. The cross-coupled product 73 was isolated in 65% yield.84 
 
82 a) Y. Yamamoto, M. Takizawa, X.-Q. Yu, N. Miyaura, Angew. Chem. Int. Ed. 2008, 47, 928−931; b) M. A. 
Oberli, S. L. Buchwald, Org. Lett. 2012, 14, 4606−4609; c) A. N. Baumann, M. Eisold, A. Music, G. Haas, Y. M. 
Kiw, D. Didier, Org. Lett. 2017, 19, 5681–5684; d) A. Music, A. N. Baumann, M. Eisold, D. Didier, J. Org. 
Chem. 2018, 83, 783–792. 
83 a) W. Li, D. P. Nelson, M. S. Jensen, R. S. Hoerrner, D. Cai, R. D. Larsen, P. J. Reider, J. Org. Chem. 2002, 
67, 5394–5397; b) Billingsley, K. L.; Buchwald, S. L. Angew. Chem., Int. Ed. 2008, 47, 4695−4698. 
84 a) B. A. Haag, C. Sämann, A. Jana, P. Knochel, Angew. Chem. Int. Ed. 2011, 50, 7290−7294; b) E. Demory, 
V. Blandin, J. Einhorn, P. Y. Chavant, Org. Process Res. Dev. 2011, 15, 710–716. 
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Scheme 16: Buchwald’s and Knochel’s approaches toward in situ transmetalated organoborates. 
Coming back from those more elaborate structures, one of the earliest reports of an addition reaction to 
a tricoordinated boron species was reported by Wittig and co-workers in 1949.85 In their study, tri-
phenylborane 74 was treated with phenyllithium 75 at ambient temperature, generating lithium tetra-
phenylborate 77 for the first time (Scheme 17). Two years later, the same group demonstrated that the 
methodology was applicable to synthesize mixed tetraorganoborate 78 utilizing lithium phenylacetylide 
76.86 
 
Scheme 17: First synthesis of symmetrical and mixed lithium tetraorganoborates. 
Exploiting this methodology, Hirao and co-workers later showed that tetraorganoborates 77 and 78 
were prone to oxidation by organovanadium compounds.87 Hereby, the strong oxidant VO(OEt)Cl2 is 
reduced from vanadium(V) to vanadium(III), oxidizing the tetraorganoborate and ultimately furnishing 
biphenyl and diphenylacetylene in a selective intramolecular oxidative coupling reaction, a process also 
enabled by other molecular oxidants.88 Based on this concept, Hirao’s group extended their work to 
 
85 G. Wittig, G. Keicher, A. Rückert, P. Raff, Liebigs Ann. Chem. 1949, 563, 110–126. 
86 G. Wittig, P. Raff, Liebigs Ann. Chem. 1951, 573, 195–209. 
87 a) H. Mizuno, H. Sakurai, T. Amaya, T. Hirao, Chem. Commun. 2006, 48, 5042–5044; b) M. Asay, B. Don-
nadieu, T. Amaya, Y. Tsukamura, T. Hirao, Adv. Synth. Catal. 2009, 351, 1025–1028. 
88 a) P. Abley, J. Halpern, J. Chem. Soc. D 1971, 1237–1238; b) H. Sakurai, C. Morimoto, T. Hirao, Chem. Lett. 
2001, 30, 1084–1085; c) Z. Lu, R. Lavendomme, O. Burghaus, J. R. Nitschke, Angew. Chem. Int. Ed. 2019, 58, 
9073–9077. 
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olefinations and showed that organoborane 79, prepared by hydroboration of dicycloborane and phe-
nylacetylene, could be treated with n-BuLi to synthesize the tetracoordinated organoborate salt 80, fol-
lowed by stereoselective oxidation with VO(OEt)Cl2 to yield olefin 81 in good yield (Scheme 18A).89 
Most recently, Studer and co-workers showcased the selective cross-coupling of tetraarylborates. The 
highly reactive and unstable triarylborane could be prepared in situ from the ammonium protected salt 
82 by treatment with hydrochloric acid (Scheme 18B). After addition of an aromatic organolithium or 
organomagnesium species, the desired mixed tetraorganoborate 83 was prepared. Interestingly, an or-
ganic oxoammonium salt (Bobbitt’s salt)90 could either be used as a stoichiometric oxidant or employed 
catalytically with NO2/O2 as additional oxidants to yield (hetero)biaryls like 84.91 
 
Scheme 18: Hirao’s and Studer’s methods for the oxidation of tetraorganoborates. 
A complementary pathway for the synthesis of tetrahedral organoborates, which enjoyed great popu-
larity in cross-coupling chemistry over the last decades,92 stems from direct ligand-exchange on already 
 
89 T. Ishikawa, S. Nonaka, A. Ogawa, T. Hirao, Chem. Commun. 1998, 1209–1210. 
90 a) J. M. Bobbitt, J. Org. Chem. 1998, 63, 9367–9374; b) N. Merbouh, J. M. Bobbitt, C. Brückner, Org. Prep. 
Proced. Int. 2004, 36, 1–31; c) M. A. Mercadante, C. B. Kelly, J. M. Bobbitt, L. J. Tilley, N. E. Leadbeater, Nat. 
Protoc. 2013, 8, 666–676. 
91 C. Gerleve, A. Studer, Angew. Chem. Int. Ed. 2020, accepted manuscript, doi.org/10.1002/ange.202002595. 
92 a) K. Siegmann, P. S. Pregosin, L. M. Venanzi, Organometallics 1989, 8, 2659–2664; b) P. G. Ciattini, E. 
Morera, G. Ortar, Tetrahedron Lett. 1992, 33, 4815–4818; c) N. A. Bumagin, V. V. Bykov, Tetrahedron 1997, 
53, 14437–14450; d) D. Villemin, M. J. Gómez-Escalonilla, J.-F. Saint-Clair, Tetrahedron Lett. 2001, 42, 635–
637; e) T. Ohe, S. Uemura, Bull. Chem. Soc. Jpn. 2003, 76, 1423–1431; f) J. R. Gardinier, P. J. Pellechia, M. D. 
Smith, J. Am. Chem. Soc. 2005, 127, 12448–12449; g) J. Yan, W. Hu, G. Rao, Synthesis 2006, 6, 943–945; h) L. 
Bai, J.-X. Wang, Adv. Synth. Catal. 2008, 350, 315–320; i) H. Zeng; R. Hua, J. Org. Chem. 2008, 73, 558–562; 
j) W. W. Schoeller, G. Bertrand, Angew. Chem. Int. Ed. 2009, 48, 4796–4799; k) W.-J. Zhou, K.-H. Wang, J.-X. 
Wang, Z.-R. Gao, Tetrahedron 2010, 66, 7633–7641; l) N. Ishida, W. Ikemoto, M. Narumi, M. Murakami, Org. 
Lett. 2011, 13, 3008–3011; m) R. B. Bedford, P. B. Brenner, E. Carter, J. Clifton, P. M. Cogswell, N. J. Gower, 
M. F. Haddow, J. N. Harvey, J. A. Kehl, D. M. Murphy, E. C. Neeve, M. L. Neidig, J. Nunn, B. E. R. Snyder, J. 
Taylor, Organometallics 2014, 33, 5767–5780.  
20      A. INTRODUCTION 
tetracoordinated potassium trifluoroborate salts. The discovery of this reactivity again dates back to 
Wittig and co-workers in 1951, who demonstrated that up to four consecutive transmetalations with 
phenyllithium could be performed on BF3•Et2O to yield lithiumtetraphenylborate 77.86 Adapting this 
method and using pentafluorophenyllithium, Massey and Park prepared the first BARF-anion (nick-
name for polyfluorinated tetraarylborate anions) lithium tetra(pentafluorophenyl)borate,93 followed by 
Kobayashi and co-workers in 1984 who synthesized a variety of BARF-anions from Grignard reagents 
(86), including compound 87 (Scheme 19).94 These anions are particularly useful as they exhibit a very 
low nucleophilicity and therefore reformed the class of weakly coordinating anions. The four aromatic 
rings in addition to the fluorine substituents effectively shield the borate anion, therefore allowing for 
the study of highly electrophilic cations.95 
 
Scheme 19: Synthesis of BARF-anion 73 by magnesium insertion and following transmetalation sequence. 
More recent procedures employing potassium trifluoroborate salts are focused on the synthesis of so-
phisticated organoboron complexes.96 Interestingly, the work of Soós and others showed that treatment 
of the initial tetrahedral trifluoroborate salt 88 results in the corresponding triarylborane 90, since the 
di-ortho substituted arylmagnesium reagent 89 is not able to perform three consecutive transmeta-
lations. Thus, a halogenated and sterically interlocked organoborane is obtained, that can be further 
used in frustrated Lewis pair chemistry (Scheme 20).97 
 
93 A. G. Massey; A. J. Park, J. Organometal. Chem. 1964, 2, 245. 
94 a) H. Nishida, N. Takada, M. Yoshimura, T. Sonoda, H. Kobayashi, Bull. Chem. Soc. Jpn. 1984, 57, 2600–
2604; b) N. A. Yakelis, R. G. Bergman, Organometallics 2005, 24, 3579–3581. 
95 a) S. G. Weber, D. Zahner, F. Rominger, B. F. Staub, Chem. Comm. 2012, 48, 11325–11327; b) N. Hafezi, J. 
M. Holcroft, K. J. Hartlieb, E. J. Dale, N. A. Vermeulen, C. L. Stern, A. A. Sarjeant, J. F. Stoddard, Angew. Chem. 
Int. Ed. 2015, 54, 456–461; c) P. Pommerening, J. Mohr, J. Friebel, M. Oestreich, Eur. J. Org. Chem. 2017, 2312–
2316; d) L. Carreras, L. Rovira, M. Vaquero, I. Mon, E. Martin, J. Benet-Buchholz, A. Vidal-Ferran, RSC Adv. 
2017, 7, 32833–32841. 
96 a) K. Schickedanz, J. Radkte, M. Bolte, H.-W. Lernern, M. Wagner, J. Am. Chem. Soc. 2017, 139, 2841–2851; 
b) S. Konishi, T. Iwai, M. Sawamura, Organometallics 2018, 37, 1876–1883; c) A. B. Saida, A. Chardon, A. Osi, 
N. Tumanov, J. Wouters, A. I. Adjieufack, B. Champagne, G. Berionni, Angew. Chem. Int. Ed. 2019, 58, 16889–
16893; d) S. Atsushi, JP2016150925, 2016. 
97 a) À. Gyömöre, M. Bakos, T. Földes, I. Pápai, A. Domján, T. Soós, ACS Catal. 2015, 5, 5366–5372; b) É. 
Dorkó, M. Szabó, B. Kótai, I. Pápai, A. Domján, T. Soós, Angew. Chem. Int. Ed. 2017, 56, 9512–9516. 
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Scheme 20: Formation of triarylborane 90 by Soós. 
3.3 The Suzuki-Miyaura Cross-Coupling 
In the history of organic synthesis, only a few reactions can compete with the novelty and importance 
of C-C cross-coupling chemistry. These schematically simple reactions, which enable the formation of 
diversely hybridized carbon-carbon bonds by coupling of organometallic reagents with organic 
(pseudo)halides under transition-metal catalysis, enjoy great popularity due to their broad applicability 
and generality (Scheme 21).1,3,16,66,73 
 
Scheme 21: Schematic representation of a C-C cross-coupling. 
Even though several organometallic reagents have proven to participate in these transformations, in-
cluding exceptional contributions by Negishi (Zn, Al, Zr), Stille (Sn), Hiyama (Si), Corriu and Kumada 
(Mg), the Suzuki-Miyaura coupling utilizing organoboron compounds is arguably the most-sought-af-
ter.75,98 The main reasons for this are the high availability, water and air stability of the used organoboron 
compounds in addition to mild and non-inert reaction conditions, resulting in exceptional functional 
group tolerance, regio- and stereoselectivity as well as high yields.3,16 
Traditionally, the Suzuki-Miyaura coupling is performed using boronic acids or esters thereof, which 
are coupled to organohalides via palladium catalysis under basic conditions. From a mechanistic per-
spective, a Pd0 catalyst 91 – either prepared in situ from the corresponding metal salt and a ligand or 
directly used as Pd0, e.g. Pd(PPh3)4 – undergoes oxidative insertion to the organohalide 92, forming 
palladium(II) complex 93, which then performs a reversible ligand exchange with the base to provide 
94, thus enhancing the electrophilicity of the complex. In the next crucial and rate-determining 
transmetalation step, the somewhat nucleophilic boronic acid 95 and the electrophilic palladium com-
plex 94 react to furnish palladium(II) complex 98 and boric acid 97 as a side product. Importantly, the 
tetracoordinated boronate 96 generated from 95 and base was found to be inactive in the catalytic cycle, 
even though it exhibits a much higher nucleophilicity than the boronic acid 95. As this process is 
 
98 C. C. C. Johansson Seechurn, M. O. Kitching, T. J. Colacot, V. Snieckus, Angew. Chem. Int. Ed. 2012, 51, 
5062–5085. 
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reversible, a careful balance between base, catalyst and substrate loading is required to maximize the 
turnover of the desired cycle.99 Lastly, base-assisted reductive elimination yields the desired cross-cou-
pled compound 99 and recovers the initial catalyst for another cycle (Scheme 22).66b,99 
 
Scheme 22: The catalytic cycle of a Suzuki-Miyaura cross-coupling. 
While boronic acids perform well in the Suzuki-Miyaura couplings, their use has fallen out of favor in 
the cross-coupling community, because they are difficult to purify and tend to form trimeric anhydrides, 
which makes it hard to estimate exact stoichiometries.100 Moreover, boronic acids suffer from proto-
deborylation in aqueous solutions, rendering them useless in the catalytic process.99 Therefore, pinacol 
boronic esters serve today as the preferred boron source and are readily available. However, the inher-
ently lower reactivity of boronic esters (see Figure 3), coupled with a lack of atom-economy, motivated 
researchers to find alternative solutions. In the early 2000s, the group of Molander started engaging 
potassium trifluoroborate salts in Pd-catalyzed cross-coupling reactions.100,101 These salts can be con-
veniently prepared from boronic acids or esters in a one-pot procedure, which was first described by 
Vedejs et al.,102 and are exceptionally stable toward air, moisture and oxidation. In addition, they relia-
bly form crystalline monomeric materials and can be seen as precursors to boronic acids, as they were 
found to slowly hydrolyze under Suzuki-Miyaura reaction conditions.99e,103 From this perspective, 
 
99 a) C. Amatore, A. Jutand, G. Le Duc, Chem. Eur. J. 2011, 17, 2492–2503; b) B. P. Carrow, J. F. Hartwig, J. 
Am. Chem. Soc. 2011, 133, 2116–2119; c) C. Amatore, G. Le Duc, A. Jutand, Chem. Eur. J. 2013, 19, 10082–
10093; d) A. J. J. Lennox, G. C. Lloyd-Jones, Angew. Chem., Int. Ed. 2013, 52, 7362–7370; e) G. A. Molander, 
J. Org. Chem. 2015, 80, 7837–7848; f) A. A. Thomas, S. E. Denmark, Science 2016, 352, 329–332. 
100 G. A. Molander, N. Ellis, Acc. Chem. Res. 2007, 40, 275–286. 
101 G. A. Molander, T. Ito, Org. Lett. 2001, 3, 393–396. 
102 E. Vedejs, R. W. Chapman, S. C. Fields, S. Lin, M. R. Schrimpf, J. Org. Chem. 1995, 60, 3020–3027. 
103 a) G. A. Molander, B. Biolatto, J. Org. Chem. 2003, 68, 4302–4312; b) R. Ting, C. W. Harwig, J. Lo, Y. Li, 
M. J. Adam, T. J. Ruth, D. M. Perrin, J. Org. Chem. 2008, 73, 4662–4670; c) Z. Liu, D. Chao, Y. Li, R. Ting, J. 
Oh, D. M. Perrin, Chem. Eur. J. 2015, 21, 3924–3928; d) A. J. J. Lennox, G. C. Lloyd-Jones, J. Am. Chem. Soc. 
2012, 134, 7431–7441. 
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potassium trifluoroborate salts combine the advantages of pinacol boronic esters and boronic acids,104 
which was for instance experimentally demonstrated in the synthesis of trityrosine by Hutton and co-
workers (Scheme 23).105 While the Suzuki-Miyaura reaction of the potassium tyrosine-3-trifluoroborate 
100 enabled a double cross-coupling on the diiodotyrosine derivate 101 and furnished the expected 
trityrosine 102 in 74% overall yield, the same reaction with the analogous pinacol boronic ester did not 
result in any product formation. Since then, potassium trifluoroborate salts have demonstrated to re-
semble versatile substrates in Suzuki-Miyaura couplings.106 
 
Scheme 23: Double Suzuki-Miyaura coupling for the formation of trityrosine 87. 
More recent advances in the field focus on the relative reactivity of the used substrates, enabling selec-
tivity in iterative and tandem cross-coupling reactions.75 For instance, Watson and co-workers107 
demonstrated that conjunctive dihalide components in combination with an aryl pinacol boronic ester 
and aryl MIDA (methyliminodiacetic acid) boronate allow for the chemoselective formation of two C-C 
bonds in one operation.108 While electrophile selectivity for the oxidative addition is well-defined 
(I>Br>Cl) and the bromide on quinoline 104 reacts faster than the chloride, MIDA-substituted organo-
boron compounds are usually not nucleophilic enough (see Figure 3) to perform in Suzuki-Miyaura 
couplings and therefore serve as protecting groups. As boric acid pinacol ester is released in the first 
cross-coupling cycle with pyridyl boron pinacol ester 103, a rapid transesterification takes place, acti-
vating the other MIDA substrate 105 for the second cross-coupling cycle (Scheme 24A).107 A similar 
protection/deprotection strategy for the activation of MIDA-substituted organoboron compounds was 
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107 C. P. Seath, J. W. B. Fyfe, J. J. Molloy, A. J. B. Watson, Angew. Chem. Int. Ed. 2015, 54, 9976–9979. 
108 a) E. P. Gillis, M. D. Burke, J. Am. Chem. Soc. 2007, 129, 6714–6717; b) E. P. Gillis, M. D. Burke, J. Am. 
Chem. Soc. 2008, 130, 14084–14085; c) S. J. Lee, K. C. Gray, J. S. Paek, M. D. Burke, J. Am. Chem. Soc. 2008, 
130, 466–468; d) J. Li, M. D. Burke, J. Am. Chem. Soc. 2011, 133, 13774–13777; e) J. P. G. Rygus, C. M. Crudden 
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showcased by Burke and co-workers, who designed an automated process allowing for several selective 
C-C bond formations in one operation.109 Lastly, Crudden et al. displayed that exploiting simple nucle-
ophilicity trends of carbon hybridization (Csp2>Csp3>Csp3benz) in substrate 107 allowed for the selective 
formation of highly functionalized carbogenic frameworks such as 111 without protection of the or-
ganoboron species (Scheme 24B).110 
 
Scheme 24: Modern approaches to Suzuki-Miyaura cross-couplings. 
Even if palladium-catalyzed Suzuki-Miyaura couplings are among the most elaborate and utilized trans-
formations, there are significant drawbacks with the metal itself: palladium is not only very rare and 
thus expensive, it is also subject of strict regulations in the pharmaceutical industry due to potential 
health risks.111,112 Although significant improvements in catalyst loadings down to the lower ppm level 
have been achieved, more environmentally benign metals are of interest.113 Nickel as a replacement 
metal for palladium solves the problem of price, but its use is limited due to severe toxicity issues.114 
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112 a) Á. Molnár, Chem. Rev. 2011, 111, 2251–2320; b) A. Biffis, P. Centomo, A. Del Zotto, M. Zecca, Chem. 
Rev. 2018, 118, 2249–2295. 
113 a) A. Piontek, E. Bisz, M. Szostak, Angew. Chem. Int. Ed. 2018, 57, 11116–11128; b) S. E. Hooshmand, B. 
Heidari, R. Sedghi, R. S. Varma, Green Chem. 2019, 21, 381–405. 
114 a) T. Clarkson, G. F. Nordberg, P. R. Sager, Reproductive and Developmental Toxicity of Metals 1983, 
Springer, Berlin; b) F.-S. Han, Chem. Soc. Rev. 2013, 42, 5270–5298. 
A. INTRODUCTION      25 
More abundant and less toxic metals such as iron115, copper116 or cobalt117 have shown catalytic activity 
in Suzuki-Miyaura couplings, but they cannot keep up with the versatility and applicability of their 
palladium-based competitors. For example, Bedford and co-workers reported a cobalt-catalyzed Suzuki 
biaryl coupling in which the initial boron pinacol ester had to be activated with n-BuLi to generate a 
much more nucleophilic tetracoordinated boron salt 113. This system provided relatively simple biaryl 
products such as 115 in good yields using aryl chlorides (112) and bromides, which significantly low-
ered when heterocycles were employed. In addition, the system required sophisticated NHC-ligand sys-
tems (114) to provide useful yields, whereas simple phosphine ligands did not result in satisfying results 
(Scheme 25).111 In a similar approach, the same group was able to use activated boronate salts and N-
pyrrole amide directing groups on aryl chlorides to facilitate iron-catalyzed Suzuki-Miyaura cou-
plings.118 
 
Scheme 25: Cobalt-catalyzed Suzuki biaryl coupling by Bedford and co-workers. 
3.4 Transition-metal free C-C bond formations – Zweifel Olefination 
In an idealized organic chemist’s world, purely organic molecules would mimic the unique properties 
of transition metals to perform the same operations in the same efficiency. Although this is certainly 
not possible, organocatalysis is a growing field with transformations such as proline-enabled asymmet-
rical aldol reactions119 as well as more recent contributions by Nicewicz and others in the area of or-
ganophotocatalysis.120 Outside catalysis, nucleophilic and electrophilic substitutions such as the famous 
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Friedel-Crafts reaction are well-described,121 but also oxidative coupling reactions instancing hyperva-
lent-iodine species or DDQ are worthy of note.122 
 
Scheme 26: General mechanism of the Zweifel olefination.18 
In the field of olefination reactions, those that create a carbon-carbon double bond or introduce it into a 
target molecule, Wittig’s outstanding work from 1954 has to be mentioned.123 Awarded the Nobel Prize 
in Chemistry in 1979, this reaction named after him allows for the transformation of a carbonyl moiety 
into the desired olefin using phosphonium ylides, giving triphenylphosphine oxide as the side prod-
uct.124 In addition to several more contributions by others in the next decades,125 the Zweifel olefination 
represents a powerful and often times overlooked method for the stereoselective formation of alkenes.126 
Pioneered by Zweifel and co-workers, only iodine and a base are required for this olefination to occur.127 
Mechanistically, the iodine coordinates to the pre-existing C-C double bond of a preactivated tetracoor-
dinated organoboron species 116, thus forming the iodonium intermediate 117, which provokes the 
formation of 118 via a stereospecific 1,2-metalate rearrangement. Lastly, the so-formed -iodo organo-
boron species undergoes antiperiplanar -elimination promoted by the base, resulting in the desired 
olefin 119 (Scheme 26). Importantly, this transformation is stereospecific, meaning that initial (E)-al-
kenes are transferred to (Z)-olefins and vice versa.18,126 Notably, Zweifel later also showed that by re-
placement of iodine with cyanogen bromide the selectivity is switched as syn-periplanar elimination 
was observed.128 
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Scheme 27: Zweifel olefination within the synthesis of bombykol by Negishi and co-workers. 
The Zweifel olefination was picked up early by Negishi et al. for the total synthesis of bombykol.129 As 
at that time vinyl borane intermediates were only accessible by Brown’s hydroboration method, the 
sequence toward bombykol starts with the reaction of alkyne 121 with borane 120, followed by addition 
of alkynyllithium species 122, generating the tetracoordinated organoborane salt 123, which after 
Zweifel olefination yields 124 as the single (E)-isomer (Scheme 27). After second hydroboration, hy-
drolysis and subsequent protodeborylation bombykol is generated (see Figure 4).1 
In the same year, Brown and co-workers also showed that the Zweifel olefination can be applied to the 
synthesis of alkynes not bearing an olefin, a procedure that was readily utilized in total syntheses.126,130 
In addition, Evans and Matteson presented the potential of boronic esters to participate in this type of 
olefination, thus greatly enhancing the viability of the approach.131 Exploiting those findings, Aggarwal 
and co-workers highlighted that the Zweifel olefination is not only stereospecific, but also enantiospe-
cific. 
Performing the olefination on enantiomerically enriched benzylic tertiary boronic esters like 127 fur-
nished the desired coupling products (129) in 100% enantiospecifity (Scheme 28A), which also held 
true for alkylic tertiary boronic esters as substrates.132 Hereby, a very reactive and unstable vinyl lithium 
species 126 was generated via transmetalation from tetravinyltin 125 to access bisorganoborinate 128. 
Moreover, it was demonstrated by the same group that more stable organomagnesium instead of usually 
employed organolithium compounds could be used in Zweifel olefinations.133 In case of alkenylmagne-
sium compounds (131) however, over-addition of the organometallic was observed onto the pinacol 
boronic ester 130, resulting in the formation of tetraorganoboronate 133 and full conversion was there-
fore only achieved using 4.0 equivalents of the organometallic species. This problem was circumvented 
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by the addition of DMSO, which precipitated the desired salt 132 from solution and thereby rendered it 
unreactive for further additions. The olefinated compound 134 was isolated in excellent yields of up to 
96% (Scheme 28B).134 
 
Scheme 28: Recent developments in Zweifel olefinations by Aggarwal and co-workers. 
As olefins represent valuable and important structural motifs in nature, it is not surprising that Zweifel 
olefinations have been applied in natural product syntheses. Even though it remains in steady competi-
tion with the pervasive Suzuki-Miyaura cross-coupling,3,12c,16,135 many reports – starting with Negishi’s 
bombykol synthesis – have implemented the Zweifel olefination as a transition-metal free alternative 
into their protocol. While most reports convert the alkenyl moiety toward the final steps of their total 
synthesis via hydrogenations, epoxidations or cyclizations, some of them preserve it.136 These efforts 
are summarized in Figure 4.129,137 
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Figure 4: Examples of Zweifel olefinations in natural product syntheses with preserved alkenyl moiety. 
4 Electrochemistry 
4.1 Overview 
The manipulation of an organic molecule under reductive or oxidative conditions is one of the most 
fundamental principles in organic chemistry.138 While these processes are traditionally facilitated by 
molecular oxidizing or reducing agents like transition-metal catalysts (Suzuki-Miyaura coupling, sec-
tion 3.3) or organic molecules like iodine (Zweifel Olefination, section 3.4), electrochemistry can be 
considered the simplest, most eco-friendly and atom-economic operation to remove or add electrons 
from or to an organic molecule, as stochiometric amounts of reagent waste are avoided.139 The direct 
control over current and potential and consequential tuneability from very mild to forcing oxidizing and 
reducing conditions at reusable anodes and cathodes are innate advantages of electrochemical setups. 
Moreover, the inherently safe, sustainable and “green” reaction conditions in addition to economic as-
pects and easy scalability are key factors that make electrochemical transformations desirable.140 
Even though well-established in industrial applications, electrochemistry was considered a niche tech-
nology in the organic community throughout the majority of the last century, largely due to complex 
reaction systems and numerous optimization parameters.141 It is currently experiencing a renaissance, 
since more user-friendly and simple setups have paved the way for regular organic chemists to imple-
ment electrochemical processes into their protocols.138,142 Ground-breaking work by the groups of 
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Yoshida143, Waldvogel140, Baran144 and many more has not only demonstrated to mimic conventional 
organic synthesis but has displayed novel reactivity patterns by rethinking essential mechanistic path-
ways and transposing those from two- to one-electron processes, usually enabling more step-economic 
syntheses.145 In recent years, electrochemistry has emerged in the fields of natural product synthesis, 
organocatalysis and flow electrochemistry.139b,140c,146 As excessive energy consumption and environ-
mental considerations are major topics of current political and social discourse, the use of “green” elec-
trochemistry from renewable energy sources will most certainly become increasingly important in 21st 
century organic synthesis.139a 
Dating back to the invention of the “Volta pile”, the first battery in 1800,147 the basic principle behind 
electroorganic synthesis lies in the constant movement of electrons through a circuit.138b For this reason, 
sufficient conductivity in solution between anode and cathode has to be ensured, which is usually guar-
anteed by addition of a supporting electrolyte to a solvent with a high dielectricity constant and electro-
chemical stability. As electroorganic synthesis essentially resembles redox chemistry, both anodic oxi-
dation and cathodic reduction have to occur simultaneously. The most prominent electrodes are made 
from non-destructive carbon-based materials or noble metals. Modern electrochemical transformations 
favor a simple undivided cell-setup, meaning that both electrodes reside in the same chamber, and run 
the reaction under constant current (galvanostatic) conditions, while more sophisticated and complex 
divided-cell setups and constant potential (potentiostatic) reaction conditions are used less frequently, 
as they require a third reference electrode and additional porous materials that separate the anodic and 
cathodic compartments. Constant current conditions are additionally operatively convenient, as they 
allow for the precise addition of electrons to the system.138b,140,142 
𝑟𝑒𝑎𝑐𝑡𝑖𝑜𝑛 𝑡𝑖𝑚𝑒 (𝑠)  = 𝑛 ∙
𝐹
𝐼
 (𝑤𝑖𝑡ℎ 𝐹 = 𝑁𝐴 ∙ 𝑒 ≈ 96485 
𝐴𝑠
𝑚𝑜𝑙
)                   (equation 1) 
Faraday’s constant (F, equation 1) resembles the equivalent to one mole of electrons and can therefore 
be used to calculate the time needed for the electrochemical setup to add the desired number of 
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electrons, knowing the current and amount of substrate used. For instance, if 1.0 mmol of substrate (n) 
were to be oxidized under a constant current (I) of 10 mA, then 1.0 equivalents of electrons would be 
added after 9648.5 seconds or approximately 2 hours and 41 minutes. The excess number of electrons 
added versus the number of theoretically needed electrons is called Faradaic or current efficiency (Feff) 
and is a general metric for electrochemical experiments and their cost and energy efficiency (equa-
tion 2).142 
𝐹
𝑒𝑓𝑓= 
𝐹𝑒𝑥𝑝 
𝐹𝑡ℎ𝑒𝑜
                                                    (equation 2) 
4.2 Oxidative C-C Couplings 
As a very early example of a synthetically useful electrochemical oxidation Kolbe demonstrated the 
decarboxylative homocoupling of carboxylic acids in 1847 (Figure 5).148 Inspired by the first pioneering 
electrochemical transformations conducted by Faraday in the 1830s,149 the carboxylic acid 135 under-
goes anodic oxidation to yield the intermediate aliphatic or benzylic radical 136, which then recombines 
to the desired homocoupled hydrocarbon 137. In this undivided cell process, the counter reaction at the 
cathode is the reduction of hydrogen ions to hydrogen, which is facilitated by the small overpotential 
for this process at a platinum electrode.150 
 
Figure 5: Schematic representation of the Kolbe electrolysis in a two-electrode, undivided cell setup. 
One of the biggest challenges with electroorganic synthesis lies in overoxidation or reduction of the 
final desired product.139a,140 For instance, if the intermediate radical 136 is not long-lived enough to 
recombine to the desired product 137 and is instead further oxidized to the undesired carbenium-ion, 
unwanted side reactions such as esterification with 135 or quench with the present solvent are likely. 
For this reason, substrates, solvents, electrolytes, additives, electrodes and current densities as well as 
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the potential have to be chosen carefully in order to dial in the perfect conditions that minimize side 
product formation, which can result in laborious optimizations.142 In general, the molecule with the 
highest electron-density will get oxidized first, while the molecule with the highest electron-deficiency 
will be reduced first. The oxidizing or reducing power of the electrochemical system is defined by its 
potential, meaning that a high voltage results in a strong redox environment and vice versa.141b,142 
 
Scheme 29: An example of C-C cross-coupling enabled by Yoshida’s cation pool method. 
Adhering to this fundamental groundwork, the last two decades of electrochemical organic synthesis 
have produced tremendous developments, especially in the field of oxidative C-C cross-cou-
plings.138b,140 For instance, Yoshida and co-workers established the “cation pool method” in 1999, in 
which via anodic oxidation cations are cumulated in a divided cell setup and then reacted with respective 
nucleophiles under non-electrochemical conditions to yield the desired coupled products.151 By sepa-
rating the oxidation and coupling events, unwanted overoxidation of the substrates and homocoupling 
side-reactions are elegantly suppressed. More recently, the same authors were able to expand the scope 
of their reaction to radical arene cations, as treatment of naphthalene 138 at cryogenic temperatures 
yielded cation 139, which was then further reacted with heteroaromatics such as 140 to yield the cross-
coupled product 141 in high yields (Scheme 29).152 However, using this “radical cation pool method” 
the temperature has to be kept very low and BARF anions have to be used to tame the reactivity of the 
synthesized intermediates. An elaborate divided cell-setup must be employed to generate a selective 
coupling process, making this method less attractive for large-scale synthesis.139a,b 
In a different approach toward electrochemical aryl-aryl cross-couplings, Waldvogel and co-workers 
highlighted the advantages of boron-doped diamond (BDD) electrodes over different anodes and hex-
afluoroisopropanol (HFIP) over other solvents for the cross-coupling of phenols and arenes. The unique 
electrochemical stability, solvation and stabilization capability of radicals by HFIP allow for the selec-
tive oxidation of phenol 142 over electron-rich arene 143 in an undivided cell via hydrogen-bonding 
 
151 a) J. Yoshida, S. Suga, S. Suzuki, N. Kinomura, A. Yamamoto, K. Fujiwara, J. Am. Chem. Soc. 1999, 121, 
9546–9549; b) J. Yoshida, S. Suga, Chem. Eur. J. 2002, 8, 2650–2658; c) S. Suga, T. Nishida, D. Yamada, A. 
Nagaki, J. Yoshida, J. Am. Chem. Soc. 2004, 126, 14338–14339; d) S. Suga, S. Suzuki, A. Yamamoto, J. Yoshida, 
J. Am. Chem. Soc. 2000, 122, 10244–10245; e) T. Nokami, T. Watanabe, N. Musya, T. Morofuji, K. Tahara, Y. 
Tobe, J. Yoshida, Chem. Commun. 2011, 47, 5575–5577; f) R. Hayashi, A. Shimizu, J. Yoshida, J. Am. Chem. 
Soc. 2016, 138, 8400–8403; g) T. Maruyama, Y. Mizuno, I. Shimizu, S. Suga, J. Yoshida, J. Am. Chem. Soc. 
2007, 129, 1902–1903. 
152 a) T. Morofuji, A. Shimizu, J. Yoshida, Angew. Chem. Int. Ed. 2012, 51, 7259–7262; b) T. Arai, H. Tateno, K. 
Nakabayashi, T. Kashiwagi, M. Atobe, Chem. Commun. 2015, 51, 4891–4894. 
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interactions, even though both compounds exhibit similar electron-densities and oxidation poten-
tials.140a,c The formed radical 144 is then selectively attacked in ortho-position by arene 143 instead of 
phenol 142 preventing homo-coupling, as the former is only weakly solvated by HFIP resulting in a 
highly nucleophilic species. Importantly, the ortho-selectivity was only observed at BDD anodes and 
was related to their high electrochemical stability and overpotential for oxygen evolution in aqueous 
media.139b The resulting cross-coupled biaryl 145 (Scheme 30) is only one product of a diverse library 
of compounds accessible via this method,153 allowing for the synthesis of biphenols154, protected bian-
iline derivatives155, bi(hetero)aryls156 and also terphenyls157 via double anodic C-C couplings. The 
Waldvogel group has therefore impressively demonstrated that the discrimination for oxidation between 
two species with similar oxidation potentials via solvation can be achieved with HFIP and BDD elec-
trodes, resulting in a versatile and general procedure, which can be conveniently run at ambient tem-
perature in an undivided cell.139a 
 
Scheme 30: Selective electrochemical cross-coupling of phenols and arenes by Waldvogel. 
4.3 Tetracoordinated Boron Salts 
In addition to their work on HFIP assisted C-C cross-couplings, the group of Waldvogel also devised a 
boron templated method for the regioselective coupling of phenols in MeCN without the necessity of 
HFIP as a solvent. Hereby, various symmetrical tetraphenoxy borate salts were synthesized (146) and 
subsequently oxidized at a platinum electrode in an undivided cell under constant current to yield inter-
mediate 147. This oxidation was found to proceed solely through an intramolecular pathway, yielding 
the homocoupled biphenol 148 after acidic workup with citric acid (Scheme 31). Interestingly, no 
 
153 a) A. Kirste, G. Schnakenburg, F. Stecker, A. Fischer, S. R. Waldvogel, Angew. Chem. Int. Ed. 2010, 49, 971–
975; b) A. Kirste, B. Elsler, G. Schnakenburg, S. R. Waldvogel, J. Am. Chem. Soc. 2012, 134, 3571–3576. 
154 a) B. Elsler, D. Schollmeyer, K. M. Dyballa, R. Franke, S. R. Waldvogel, Angew. Chem. Int. Ed. 2014, 53, 
5210–5213; b) A. Wiebe, D. Schollmeyer, K. M. Dyballa, R. Franke, S. R. Waldvogel, Angew. Chem. Int. Ed. 
2016, 55, 11801–11805. 
155 L. Schulz, M. Enders, B. Elsler, D. Schollmeyer, K. M. Dyballa, R. Franke, S. R. Waldvogel, Angew. Chem. 
Int. Ed. 2017, 56, 4877–4881. 
156 A. Wiebe, S. Lips, D. Schollmeyer, R. Franke, S. R. Waldvogel, Angew. Chem. Int. Ed. 2017, 56, 14727–
14731. 
157 a) S. Lips, A. Wiebe, B. Elsler, D. Schollmeyer, K. M. Dyballa, R. Franke, S. R. Waldvogel, Angew. Chem. 
Int. Ed. 2016, 55, 10872–10876; b) A. Wiebe, B. Riehl, S. Lips, R. Franke, S. R. Waldvogel, Sci. Adv. 2017, 3, 
eaao3920. 
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additional electrolyte was needed as the borate salt itself served as one and the procedure was easily 
scaled up to a multikilogram scale.158 
 
Scheme 31: Intramolecular oxidation of tetraphenoxy borate anions to biphenols. 
Additionally, fundamental work by Schlegel and Schäfer showed that otherwise inactive triorganobo-
ranes are activated for oxidation after addition of a nucleophile to form the tetraorganoborate. Im-
portantly, the donating character of the nucleophile influences the oxidation potential so that weakly 
nucleophilic THF- and F-coordinated tri-n-butylborane complexes 149 and 150 exhibit high oxidation 
potentials, whereas strong and electron-rich nucleophiles like cyanide and hydroxide anions yield com-
plexes 151 and 152, which undergo more facile anodic oxidation (Figure 6). Subsequently, the authors 
showcased that tetraorganoborates of type 152 could be oxidized to yield the corresponding aliphatic 
hydrocarbons. However, no cross-coupling products could be detected in useful yields, as deboronative 
alkyl radical formations were observed, thereby disassembling the selectivity-enabling boron-template 
and yielding almost statistical distributions of homo- and heterocoupling products.159 
 
Figure 6: Influence of the substituents on the oxidation potential of the tetraorganoborate. 
In the emerging field of photoredox catalysis, which is closely related to electrochemistry as typically 
one-electron processes are studied,120b,160 such deboronative alkyl radical formations of tetracoordinated 
 
158 a) I. M. Malkowsky, C. E. Rommel, R. Fröhlich, U. Griesbach, H. Pütter, S. R. Waldvogel, Chem. Eur. J. 
2006, 12, 7482–7488; b) I. M. Malkowsky, R. Fröhlich, U. Griesbach, H. Pütter, S. R. Waldvogel, Eur. J. Inorg. 
Chem. 2006, 1690–1697. 
159 a) G. Schlegel, H. J. Schäfer, Chem. Ber. 1984, 117, 1400–1423; b) J. H. Morris, H. J. Gysling, D. Reed, Chem. 
Rev. 1985, 85, 51–76. 
160 a) J. M. R. Narayanam, C. R. J. Stephenson, Chem. Soc. Rev. 2011, 40, 102–113; b) C. K. Prier, D. A. Rankic, 
D. W. C. MacMillan, Chem. Rev. 2013, 113, 5322–5363. 
A. INTRODUCTION      35 
organoboron compounds are frequently used to trigger follow-up transformations.79c,161 Moreover, 
Stahl’s group recently highlighted that redox inactive benzylic boronic esters can be activated by addi-
tion of sodium hydroxide and further used in electrochemical processes. In a ferrocene-mediated162 
anodic oxidation of the tetraorganoboronate 153 under potentiostatic conditions in a divided cell setup 
the resulting benzylic radical 154 was trapped almost quantitively employing TEMPO 155 to yield 156 
(Scheme 32).163 
 
Scheme 32: In situ quench of electrochemically generated benzyl radicals by Stahl and co-workers. 
The electrochemical properties of related tetraarylborates are already well-studied.164 Initial data on the 
electrochemical synthesis of biaryls from tetraphenylborate salts was provided by Geske and co-work-
ers. In their pioneering studies the tetraphenylborate ion 77 was found to be oxidized at a platinum 
anode to form biphenyl.165 Similar to the later work by Hirao and others (chapter 3.2), in which molec-
ular oxidants promoted the oxidation of tetraarylborate salts,87,88,89 an intramolecular two-electron pro-
cess was proposed and control experiments using fully deuterated tetraphenylborate were conducted to 
exclude intermolecular pathways.166 However, the possibility of a one-electron process was neglected 
at that time,167 even though seminal work by Doty et al. on photochemical oxidation of the tetraphenyl-
borate anion with in situ generated singlet oxygen suggested the possibility of a one-electron 
 
161 a) Y. Yasu, T. Koike, M. Akita, Adv. Synth. Catal. 2012, 354, 3414–3420; b) J. C. Tellis, D. N. Primer, G. A. 
Molander, Science 2014, 345, 433–436; c) H. Huang, G. Zhang, L. Gong, S. Zhang, Y. Chen, J. Am. Chem. Soc. 
2014, 136, 2280–2283; d) H. Huang, K. Jia, Y. Chen, Angew. Chem. Int. Ed. 2015, 54, 1881–1884; e) D. N. 
Primer, I. Karakaya, J. C. Tellis, G. A. Molander, J. Am. Chem. Soc. 2015, 137, 2195–2198; f) F. Lima, M. A. 
Kabeshov, D. N. Tran, C. Battilocchio, J. Sedelmeier, G. Sedelmeier, B. Schenkel, S. V: Ley, Angew. Chem. Int. 
Ed. 2016, 55, 14085–14089; g) H. Huo, K. Harms, E. Meggers, J. Am. Chem. Soc. 2016, 138, 6936–6939; h) D. 
N. Primer, G. A. Molander, J. Am. Chem. Soc. 2017, 139, 9847–9850; i) F. Lima, U. K. Sharma, L. Grunenberg, 
D. Saha, S. Johannsen, J. Sedelmeier, E. V. Van der Eycken, S. V. Ley, Angew. Chem. Int. Ed. 2017, 56, 15136–
15140; j) S. B. Lang, R. J. Wiles, C. B. Kelly, G. A. Molander, Angew. Chem. Int. Ed. 2017, 56, 15073–15077; 
k) W. Liu, P. Liu, L. Lv, C. Li, Angew. Chem. Int. Ed. 2018, 57, 13499–13503; l) H. Yan, Z.-W. Hou, H.-C. Xu, 
Angew. Chem. Int. Ed. 2019, 131, 4640–4643. 
162 a) J.-M. Savéant, Chem. Rev. 2008, 108, 2348–2378; b) R. Francke, R. D. Little, Chem. Soc. Rev. 2014, 43, 
2492–2521. 
163 A. J. J. Lennox, J. E. Nutting, S. S. Stahl, Chem. Sci. 2018, 9, 356–361. 
164 a) F. Barrière; W. E. Geiger, J. Am. Chem. Soc. 2006, 128, 3980–3989; b) W. E. Geiger; F. Barrière, Acc. 
Chem. Res. 2010, 43, 1030–1039. 
165 D. H. Geske, J. Phys. Chem. 1959, 63, 1062–1070.  
166 D. H. Geske, J. Phys. Chem. 1962, 66, 1743–1744. 
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pathway.168 Almost a decade later, Janzen and co-workers supported this idea with spin-trapping exper-
iments and proved the presence of radical species in solution.169 Most recently, Waldvogel and co-
workers reassured Geske’s fundamental work and demonstrated the electrochemical instability of 
tetraarylborates toward oxidation on two BARF substrates (Scheme 33). While BARF anion 87 was 
smoothly oxidized to the homocoupled biaryl 158 in 73% yield at a graphite anode, the expected biaryl 
159 from oxidation of BARF anion 157 was only observed in traces. Even after extensive optimizations, 
biaryl 159 was only obtained in 20% yield at a molybdenium anode, presumably due to its very high 
oxidation potential (see Figure 6). Although radical trapping and crossover experiments were per-
formed, the exact mechanistic pathway remained unsolved, as both cationic and radical pathway were 
imaginable.170 
 
Scheme 33: Oxidation of symmetrical tetraarylborates toward homocoupled biaryls. 
  
 
168 a) J. C. Doty, P. J. Grisdale, T. R. Evans, J. L. R. Williams, J. Organomet. Chem. 1971, 32, C35–C37; b) A. 
Pelter, R. T. Pardasani, P. Pardasani, Tetrahedron 2000, 56, 7339–7369. 
169 a) E. E. Bancroft, H. N. Blount, E. G. Janzen, J. Am. Chem. Soc. 1979, 101, 3692–3694; b) P. K. Pal, S. 
Chowdhury, M. G. B. Drew, D. Datta, New. J. Chem. 2002, 26, 367–371. 
170 S. B. Beil, S. Möhle, P. Enders, S. R. Waldvogel, Chem. Comm. 2018, 54, 6128–6131. 
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5 Objectives 
This work should present complementary approaches to fundamental and well-established methods re-
lying on organoboron chemistry, such as Suzuki-Miyaura cross-couplings. The reliance on potentially 
toxic, hazardous and expensive transition-metal catalysts is the major drawback of these powerful and 
incredibly versatile methods. Therefore, this work will heavily focus on the extension of more environ-
mentally benign strategies, involving underestimated transition-metal free olefinations and electro-
chemical alternatives, circumventing the use of transition-metal catalysis. 
For this reason, the preparation and stability of tetracoordinated organoboron salts should be investi-
gated first. Based on previous results, highly strained cyclic carbenoid and therefore reactive organo-
metallic intermediates 160 shall be trapped with borontrialkoxides to yield the corresponding organo-
boronate salts 161. These salts will then be stored under different conditions for varying amounts of 
time to determine their stability, which will be measured by comparing the residual conversion in sub-
sequent Suzuki-Miyaura cross-couplings toward 162 (Scheme 34). 
 
Scheme 34: Synthesis and stability assessment of organoboronates 161. 
In a second step, the usefulness of such salts should be examined in Zweifel olefinations. Since modern 
Zweifel olefinations mostly employ pinacol boronic esters, their applicability is limited as especially 
more sophisticated substrates tend to be expensive or unavailable. Therefore, it is highly desirable to 
develop a general methodology that allows for the rapid formation of diverse bisorganoborinates 165 
via metalation, metal-exchange and transmetalation strategies onto inexpensive borontrialkoxides for 
their implementation in Zweifel olefinations (Scheme 35). 
 
Scheme 35: Access to bisorganoborinates 165 via organometallic methods and follow-up Zweifel olefination. 
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Furthermore, there is significant interest in the development of novel organometallics that might fill 
gaps and combine functional group tolerance and reactivity. For instance, most examples of Zweifel 
olefination rely on the use of highly reactive organolithium species for smooth addition onto the boron 
pinacol ester. While functional group tolerance is therefore limited, additions of milder arylmagnesium 
compounds to boron pinacol esters tend to be problematic and the use of alkenylmagnesium species 
usually results in overaddition. Based on previous results, organolanthanide reagents show promising 
behavior with balanced functional group tolerance and reactivity due to intermediate electronegativities 
compared to magnesium and lithium. For this reason, a halogen-metal exchange reagent from the most-
abundant and cheap lanthanide metal cerium should be developed and its reactivity and tolerance tested 
in Zweifel olefination chemistry and related nucleophilic additions (Scheme 36). 
 
Scheme 36: Halogen-cerium exchange and subsequent Zweifel olefination. 
The last aim of this work is to expand the applicability of tetrahedrally coordinated boron salts to C-C 
bond formations other than olefination reactions. As biaryl frameworks pose as essential moieties in 
pharmaceutical and agricultural industries, they will serve as eligible products. Based on fundamental 
previous work, it is envisioned to first synthesize mixed or unsymmetrical tetraarylborates 175 from 
commercially available potassium trifluoroborates 173 via simple transmetalation chemistry. Those 
salts shall then be anodically oxidized employing “green” electrochemistry, resulting in intramolecu-
larly cross-coupled (hetero)biaryls 177. Envisioning a radical pathway, this electrocoupling concept 
should then be expanded to olefinations, which in theory should lead to a transition-metal free method 
for the functionalization of alkenes 178 (Scheme 37). 
 
Scheme 37: Envisioned electrocoupling and electro-olefination of potassium tetraorganoborate salts. 
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1 One-Pot Preparation of Stable Organoboronate Reagents for the Func-
tionalization of Unsaturated Four- and Five-Membered Carbo- and Het-
erocycles 
1.1 Relevance 
Saturated four- and five-membered carbo- and heterocycles are ubiquitous in nature and important mo-
tifs for the pharmaceutical industry, most prominently in the area of -lactams.171 In addition, their 
unique range of reactivity caused by the inherent ring-strain makes them valuable intermediates, which 
was recently highlighted by the groups of Baran and Carreira, who demonstrated applications of pro-
pellanes172, azetidines173 and oxetanes174 in synthesis. 
However, unsaturated analogues are scarcely represented in natural products and synthesis, mainly due 
to their even higher reactivity, resulting instability and lack of synthetic protocols. Even though some 
representative examples are found in nature, the addition of an internal C-C double bond to an already 
strained cyclic system makes those compounds privileged intermediates for further transfor-
mations.82d,175 While organometallic chemistry involving such structures is challenging and has to be 
usually performed at cryogenic temperatures, this chapter presents a method that allows for the for-
mation of room temperature stable organoboronates, which can be used as building blocks for further 
applications. 
1.2 Preamble 
The following work was reprinted with permission from A. N. Baumann, M. Eisold, A. Music and D. 
Didier, Synthesis 2018, 50, 3149–3160. The manuscript is presented as a modified version compared to 
the original publication online in order to prevent copyright infringement with the Georg Thieme Ver-
lag, Stuttgart – New York. The project was conducted in equal contribution with A. N. Baumann and 
M. Eisold. 
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2 Single-Pot Access to Bisorganoborinates: Applications in Zweifel Olefina-
tion 
2.1 Relevance 
The vast majority of Zweifel olefinations performed in recent publications utilizes alkyl, alkenyl or aryl 
pinacol boronic esters as substrates.126 Especially sp2-configured substrates are directly available via a 
variety of pathways, including transition-metal catalyzed borylations of aryl halides176 and ethers177, 
transition-metal free alternatives thereof178 and transition-metal catalyzed C-H borylations179 with 
bis(pinacolato)diboron or pinacolborane. Nevertheless, the arguably still most utilized and rapid access 
toward pinacol boronic esters is represented by the addition of a borontrialkoxide to an organolithium 
species.75,180 However, such a process is not step-economic, as after generation of the tetracoordinated 
organoborate those species are usually hydrolyzed and then protected with pinacol to furnish the desired 
pinacol boronic ester.180 In the next step, the ester is engaged with another organometallic compound to 
form the tetracoordinated bisorganoborinate, which is only then applicable in Zweifel olefinations. To 
facilitate the synthesis of bisorganoborinates and improve step-economy in follow-up Zweifel transfor-
mations, an inexpensive protocol is herein reported, in which the addition of two organometallic rea-
gents onto borontrialkodixes directly furnishes bisorganoborinates in an in situ single-pot process. 
2.2 Preamble 
The following work was reprinted with permission from Arif Music, A. N. Baumann, P. Spieß, N. 
Hilgert, M. Köllen and D. Didier, Org. Lett. 2019, 21, 2189–2193. Copyright© 2019 American Chemi-
cal Society. The project was conducted in equal contribution with A. N. Baumann. 
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180 W. C. Chow, O. Y. Yuen, P. Y. Choy, C. M. So, C. P. Lau, W. T. Wong, F. Y. Kwong, RSC Advances 2013, 
3, 12518–12539. 
B. RESULTS AND DISCUSSION      51 
 
52      B. RESULTS AND DISCUSSION 
 
B. RESULTS AND DISCUSSION      53 
 
54      B. RESULTS AND DISCUSSION 
 
B. RESULTS AND DISCUSSION      55 
 
56      B. RESULTS AND DISCUSSION 
3 Catalyst‐Free Enantiospecific Olefination with in situ Generated Or-
ganocerium Species 
3.1 Relevance 
While lanthanides are often called rare-earth metals, they are not so rare after all.181 In fact, the most 
naturally occurring – cerium – with its abundancy of approximately 66 ppm in the earth’s crust is more 
abundant than other frequently encountered metals in organometallic chemistry such as cobalt, tin and 
zinc.69b In addition, cerium is relatively non-toxic and can therefore be considered an environmentally 
sound alternative to other transition-metals.182 Since the lanthanides main difference to other metals is 
the existence of electrons in f-orbitals, their reactivity and chemical properties are uniquely different. 
For example, organocerium reagents were found to represent non-basic but highly nucleophilic and 
oxophilic reagents, which makes them highly selective for 1,2-additions to carbonyl or imine sub-
strates.67,69,183 Those additions in complex substrates with traditional organolithium or organomagne-
sium reagents typically cause multiple side reactions such as reduction, self-condensation and enoliza-
tion.69a However, in this case superior organocerium species can be easily synthesized by transmeta-
lation from the respective organometallics (see chapter A, 2.3). Moreover, organocerium compounds 
display significant scope and have therefore been utilized in several total syntheses, making them val-
uable alternatives to conventional organometallics.184 In order to broaden the access toward those spe-
cies, this chapter presents the generation of organocerium reagents by novel halogen-cerium exchange 
chemistry and their use in Zweifel olefinations. 
3.2 Preamble 
The following work was reprinted with permission from A. Music, C. Hoarau, N. Hilgert, F. Zischka 
and D. Didier, Angew. Chem. Int. Ed.  2019, 58, 1188–1192. Copyright© 2019 Wiley-VCH Verlag 
GmbH & Co. KGaA, Weinheim. 
 
181 R. Anwander, M. Dolg, F. T. Edelmann, Chem. Soc. Rev. 2017, 46, 6697–6709. 
182 T. Imamoto, Lanthanides in Organic Synthesis 1994, Academic Press, New York. 
183 a) T. Imamoto, Y: Sugiura, N. Takiyama, Tetrahedron Lett. 1984, 25, 4233–4236; b) T. Imamoto, T. Kusu-
moto, Y. Tawarayama, Y. Sugiura, T. Mita, Y. Hatanaka, M. Yokoyama, J. Org. Chem. 1984, 49, 3904–3912; c) 
T. Imamoto, Pure & Appl. Chem. 1990, 62, 747–752; d) M. Badioli, R. Ballini, M. Bartolacci, G. Bosica, E. 
Torregiani, E. Marcantoni, J. Org. Chem. 2002, 67, 8938–8942; e) S. E. Denmark, J. P. Edwards, T. Weber, D. 
W. Piotrowski, Tetrahedron Asymmetry 2010, 21, 1278–1302; f) J. E. Kim, A. V. Zabula, P. J. Carroll, E. J. 
Schelter, Organometallics 2016, 35, 2086–2091; g) K.-J. Xiao, A.-E. Wang, P.-Q. Huang, Angew. Chem. Int. Ed. 
2012, 51, 8314–8317; h) N. E. Behnke, J. H. Siitonen, S. A. Chamness, L. Kürti, Org. Lett. 2020, accepted man-
uscript, doi.org/10.1021/acs.orglett.0c01229. 
184 a) C. M. J. Fox, R. M. Hiner, U. Warrier, J. D. White, Tetrahedron Lett. 1988, 29, 2923–2926; b) F. E. Ziegler, 
C. A. Metcalf III, A. Nangia, G. Schulte, J. Am. Chem. Soc. 1993, 115, 2581–2589; c) S. F. Martin, W. C. Lee, 
G. J. Pacofsky, R. P. Gist, T. A. Mulhern, J. Am. Chem. Soc. 1994, 116, 4674–4688; d) J. Boukouvalas, Y. X. 
Cheng, J. Robichaud, J. Org. Chem. 1998, 63, 228–229; e) D. Crich, S. Natarajan, J. Chem. Soc., Chem. Commun. 
1995, 85–86; f) M. Kurosu, L. R. Marcin, T. J. Grinsteiner, Y. Kishi, J. Am. Chem. Soc. 1998, 120, 6627–6628; 
g) M. Kurosu, Y. Kishi, Tetrahedron Lett. 1998, 39, 4793–4796; h) A. Fürstner, H. Weintritt, J. Am. Chem. Soc. 
1998, 120, 2817–2825; i) C. L. Martin, L. E. Overman, J. M. Rohde, J. Am. Chem. Soc. 2008, 130, 7568–7569. 
B. RESULTS AND DISCUSSION      57 
 
58      B. RESULTS AND DISCUSSION 
 
B. RESULTS AND DISCUSSION      59 
 
60      B. RESULTS AND DISCUSSION 
 
B. RESULTS AND DISCUSSION      61 
 
 
62      B. RESULTS AND DISCUSSION 
4 Electrochemical Synthesis of Biaryls via Oxidative Intramolecular Cou-
pling of Tetra(hetero)arylborates 
4.1 Relevance 
Out of the top 50 small molecule pharmaceuticals sorted by retail sales, six molecules hold bi(het-
ero)aryl moieties within their molecular structure, highlighting their key role in drug discovery pro-
cesses (Figure 7).185 Additionally, aryl moieties play an outstanding role in material sciences and nan-
otechnology, as they represent great building blocks for the formation of complex, non-symmetric struc-
tures.135a,186 
 
Figure 7: Top-selling drugs (small molecules) with bi(hetero)aryl moieties in 2018 by retail sales. Data was cap-
tured from the Njardarson group.187 
Based on their importance, a plethora of methods already exists to create such structures, but none of 
them can cope with the generality and diversity of transition-metal catalyzed cross-coupling chemis-
try.188 This chapter presents an electrochemical and transition-metal free alternative that replaces the 
need for transition-metals with tetracoordinated organoborates, which serve as mediators for C-C bond 
formations. 
4.2 Preamble 
The following work was reprinted with permission from A. Music, A. N. Baumann, P. Spieß, A. Plante-
fol, T. C. Jagau and D. Didier, J. Am. Chem. Soc. 2020, 142, 4341–4348. Copyright© 2020 American 
Chemical Society. 
 
185 Njardarson Web site. https://njardarson.lab.arizona.edu/content/top-pharmaceuticals-poster (accessed 1st May 
2020) 
186 a) S. P. Stanforth, Tetrahedron 1997, 54, 263–303; b) R. Franke, D. Selent, A. Börner, Chem. Rev. 2012, 112, 
5675–5732; c) K. Okamoto, J. Zhang, J. B. Housekeeper, S. R. Marder, C. K. Luscombe, Macromolecules 2013, 
46, 8059–8078. 
187 N. A. McGrath, M. Brichacek, J. T. Njardarson, J. Chem. Educ. 2010, 87, 1348–1349. 
188 a) J. A. Ashenhurst, Chem. Soc. Rev. 2010, 39, 540–548; b) A. H. Cherney, N. T. Kadunce, S. E. Reisman, 
Chem. Rev. 2015, 115, 9587–9652. 
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5 Electro-Olefination – a Catalyst Free, Stereoconvergent Strategy for the 
Functionalization of Alkenes 
5.1 Relevance 
Convergent protocols are highly respected synthetic tools, as they allow for the transformation of race-
mic compounds into stereo- or even enantio-enhanced and more valuable products.189 Exceptional syn-
thetic and mechanistic contributions by the Fu group and others have shown the power of nickel catal-
ysis in combination with chiral ligands to perform stereo- and enantioconvergent cross-coupling chem-
istry. While alkyl-aryl190, alkyl-alkyl191, aryl-alkynyl192 couplings are well-described, convergent pro-
tocols involving and preserving alkenyl-moieties are still rare.193  
Even though radical intermediates with Ni(I), Ni(II) and Ni(III) species are believed to play key roles 
in all of those transformations194 and the group of Molander has demonstrated the applicability of ste-
reoconvergent strategies in SET photoredox/nickel dual catalysis,161b,195 there are very few reports of 
electrochemical olefination chemistry and none on stereoconvergent and transition-metal free variants 
thereof.196 To fill this gap, the following chapter presents a stereoconvergent and transition-metal free 
electrochemical formation of arylated alkenes via tetracoordinated organoborates. 
5.2 Preamble 
The following work was reprinted with permission from A. N. Baumann, A. Music, J. Dechent, N. 
Müller, T. C. Jagau and D. Didier, Chem. Eur. J. 2020, 26, 8382–8387. Copyright© 2020 Wiley-VCH 
Verlag GmbH & Co. KGaA, Weinheim. The project was conducted in equal contribution with A. N. 
Baumann. 
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6 Conclusions 
6.1 Summary 
This work has presented several methods based on organometallic principles, which enable the for-
mation of fundamental C-C bonds without the need of transition-metals. A major part of this thesis has 
been dedicated to the synthesis and generalized access toward tetrahedrally coordinated organoboro-
nates, bisorganoborinates and tetraorganoborates, all bearing the boron atom rather than a transition-
metal as their reaction center. It has been demonstrated that molecular oxidants such as iodine in com-
bination with a base in Zweifel olefinations or electrons themselves as the most frugal oxidants via 
anodic electrochemical oxidation in combination with the mentioned organoboron reagents offer ap-
pealing alternatives to transition-metal catalysis.  
The starting point for this work was set at the synthesis of variously substituted and highly strained 
cyclobutenyl- and cyclopentenylboronates via halogen-metal exchange on the corresponding iodides 
with n-BuLi under cryogenic temperatures and following addition of borontriisopropoxide. The result-
ing reagents showed remarkable stability in solution at –20 °C or neat at room temperature under inert 
atmosphere, which was measured with conversion data in follow-up Suzuki-Miyaura cross-couplings. 
Importantly, this concept has been successfully applied to even more reactive azetinylboronates gener-
ated via metalation with TMEDA complexed s-BuLi, forming stable boronate building blocks 161 that 
exhibit excellent functional group tolerance and yields in cross-coupling reactions toward 162. Im-
portantly, this sequence could also be conveniently run as a one-pot protocol (Scheme 38). 
 
Scheme 38: Versatile preparation of organoboronates and their application in Suzuki-Miyaura cross-coupling 
chemistry. 
Having established the stability of such systems, a one-pot sequence for the assembly of structurally 
related bisorganoborinates has been designed. After generation of the required aryl- and alkenyl organ-
omagnesium and organolithium species via metalation and halogen-metal exchanges, the first addition 
of an organometallic to the boronalkoxide proved to selectively form the intermediate organoboronate 
(181 or 182), while the second addition of another organometallic proceeded selectively via transmeta-
lation resulting in ligand-exchanges at the boron-center and yielding bisorganoborinate 185. While all 
four possible options to assemble two different organometallics onto boronalkoxides toward bisorgano-
borinates were viable, the most convenient and rapid method was found to be the direct insertion of 
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magnesium into a carbon-halogen bond in the presence of tributylborate, which facilitated the insertion 
by immediate formation of the desired organoboronate of type 181 or 182. The use of 1,4-dioxane as 
cosolvent has been crucial to prevent overaddition, as the organoboronate instantly precipitated out of 
solution, thereby preventing further transmetalation. After consecutive formation of the bisorgano-
borinate of type 185, these salts have shown to be excellent precursors for Zweifel olefinations and 
olefinated arenes of type 186 were isolated in good yields in an overall five-step in situ sequence 
(Scheme 39). Notably, the addition of additional base has not been necessary employing this procedure, 
as one equivalent of basic metal methoxide salt is released during the transmetalation step, making this 
process an atom-economic and inexpensive alternative to usually employed boron pinacol esters. 
 
Scheme 39: One-pot sequence toward stable bisorganoborinates and subsequent Zweifel olefination. 
Moreover, the role of the employed organometallics within the formation of bisorganoborinates has 
been studied in more detail. Organolithium species were the only reliable organometallics to add onto 
alkenyl- and arylboron pinacol esters, as especially alkenyl- and arylmagnesium species were prone to 
either overaddition or leading to complex product mixtures. In order to fill this gap between organo-
magnesium and more reactive organolithium species, the novel halogen-metal exchange reagent “n-
Bu3Ce” was developed by transmetalation from dry CeCl3 and n-BuLi. A fast triple halogen-cerium 
exchange was observed at –50 °C within 20 min with (hetero)aryl bromides and iodides 187 as well as 
alkenylbromides of type 168, whilst tolerating a broad range of functional groups. These species have 
then been added onto aryl, alkenyl and alkyl boron pinacol esters, selectively forming the bisorgano-
borinates and ultimately enabling the enantiospecific synthesis of olefins from sterically enhanced bo-
ron pinacol esters (188). Lastly, additions onto easily enolizable and sterically hindered ketones have 
been described, which selectively favor the formation of products via 1,2-additions (189, Scheme 40). 
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Scheme 40: Development of the novel “n-Bu3Ce” exchange reagent, exchanges with various aryl- and alkenyl 
halides and further transformations in Zweifel olefinations and 1,2-additions to ketones. 
In the last part of this work, the electrochemical properties of unsymmetrical potassium tetra(hetero)ar-
ylborate of type 175 and alkenyltri(hetero)arylborate of type 176 salts have been extensively studied. 
Hereby, those unprecedented tetraorganoborate salts were first synthesized from commercially availa-
ble potassium aryl- and alkenyltrifluoroborates (173 and 174) in triple-ligand exchanges onto boron via 
transmetalations with arylmagnesium or arylzinc reagents. A great diversity of salts has been found to 
be prone to oxidation, in which the most electron-rich aromatic system is oxidized first. Likely follow-
ing a one-electron radical process, which was supported by theoretical calculations, an intramolecular 
rearrangement of one of the remaining less electron-rich aromatics is then taking place, which after 
elimination has yielded (hetero)biaryls of type 177 or olefinated arenes of type 178 in a chemoselective 
fashion. In case of the electro-olefination the reaction was found to proceed in a stereoconvergent man-
ner, exclusively forming the thermodynamically favored (E)-olefins (Scheme 41). Importantly, even 
the most sophisticated tetraorganoborate salts have showcased excellent stability at ambient atmosphere 
and temperature, therefore allowing for the reaction to be conducted in protic and “green” solvents such 
as ethanol and without the necessity of an inert atmosphere. Finally, in conventional cross-couplings 
problematic polyhalogenated substrates have been tolerated in the electrocoupling protocol, presenting 
otherwise inaccessible chemical space. 
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Scheme 41: Electrocoupling and electro-olefination of diverse tetraorganoborates for the synthesis of (het-
ero)biaryls and olefinated arenes. 
6.2 Outlook 
In order to generalize the presented electrochemical methods, the extension of the electrocoupling to-
ward other C-C bond formations should be investigated. As alkyl borates tend to undergo homolytic C-
B bond cleavage upon oxidation and are therefore not suitable for selective intramolecular couplings, 
the focus should be set onto alkynylation chemistry. In order to obtain selectivity in these reactions, the 
tetraorganoborate should consist of one aryl and three alkynyl moieties, as a single-electron oxidation 
should be preferred in the sp2-hybridized aromatic rather than the sp-hybridized alkyne. Following the 
previous procedures, a triple transmetalation of alkynylmetal species onto potassium aryl trifluorobo-
rates 173 should lead to unprecedented aryltrialkynylborates 190, which could then be studied in elec-
trocoupling reactions for the formation of alkynylated arenes 191 (Scheme 42). 
 
Scheme 42: Potential extension of the electrocoupling toward alkynylations. 
In addition, the tendencies of tetraorganoborates to perform transformations in photochemical oxida-
tions could be analyzed, since those transformations are strongly related to single-electron transfers in 
electrochemical reactions and can be considered as another environmentally benign strategy to forge C-
C bonds. Especially the area of organophotoredox catalysis has produced a great variety of catalysts 
with a broad range of oxidation potentials, which could enable the coupling of tetrahedrally coordinated 
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borates. As organophotoredox catalysis is usually performed under very mild conditions, more sensitive 
functional groups compared to electrochemical oxidations might be tolerated. Importantly, selectivity 
for the desired heterocoupling might be achieved, since every organocatalyst shows a defined oxidizing 
and reducing potential, which could be tailored to a specific borate substrate (Scheme 43). 
 
Scheme 43: Envisioned photochemical oxidation of potassium tetraorganoborate salts. 
Even though oxidative intramolecular couplings of tetraorganoborates constitute a novel addition to the 
C-C bond formation toolbox, their applicability is limited by one obvious drawback: Two of the three 
organometallic aromatics required in the borate salt formation are wasted in the coupling process. For 
this reason, the development of non-transferrable “dummy” ligands on the boron-template (192) would 
be highly desirable. Besides fixing the problem of atom-economy, those novel species should greatly 
enlarge the scope of the electrocoupling and eliminate homocoupling side reactions completely, since 
no discrimination for oxidation between the two coupling partners would be necessary (Scheme 44).  
 
Scheme 44: Extension and improvement of the electrocoupling approach and potential photochemical oxidations 
employing dummy ligands. 
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1 General Considerations 
All reactions involving organometallic compounds were carried out using standard Schlenk-techniques 
in flame-dried glassware equipped with rubber septum and magnetic stirring bars under nitrogen atmos-
phere. Syringes for transferring anhydrous solvents or reagents were purged with nitrogen prior to use. 
Reaction endpoints were determined by GC, TLC or 11B NMR monitoring of the reactions. Yields are 
referred to isolated compounds with a purity >95% as determined by 1H-NMR (25 °C) or capillary GC. 
Countercations are usually omitted for more clarity. The experimental part contains general experi-
mental procedures, condensed data and selected spectral data for each topic discussed. The numbering 
is in accordance with the published data found in section B of this work. Starting material synthesis is 
abbreviated with SM and numbered continuously. Compounds synthesized by equally contributing co-
authors are marked (*). The full supporting information for each publication can be downloaded free of 
charge on the corresponding website of the publishing company. 
1.1 Solvents 
For the preparation of anhydrous solvents, the crude solvents were first purified by distillation and then 
dried according to standard methods by distillation from drying agents as stated below and were stored 
under nitrogen. Non-anhydrous solvents were obtained from commercial sources and used without fur-
ther purification. Solvents for column chromatography were distilled prior to use. 
THF was continuously refluxed and freshly distilled from sodium benzophenone ketyl under nitrogen 
and stored over molecular sieves.  
DCM was predried over CaCl2, continuously refluxed and freshly distilled from CaH2 under nitrogen. 
Et2O was predried over CaCl2 and passed through activated Al2O3 (using a solvent purification system 
SPS-400-2 from Innovative Technologies Inc.). 
Toluene was predried just like DCM over CaCl2 and distilled from CaH2. 
MeCN was purchased in HPLC gradient grade (≥99.9%) from Fisher Scientific. 
1.2 Reagents 
Commercially available starting materials were used without further purification unless otherwise 
stated. 
iPrMgCl•LiCl was prepared by careful addition of i-PrCl (78.5 g, 91.3 mL, 1.00 mol, 1.00 equiv) to a 
suspension of Mg turnings (26.7 g, 1.10 mol, 1.10 equiv) and LiCl (46.63 g, 1.10 mol, 1.10 equiv) in 
dry THF (900 mL). The reaction mixture was stirred for 12 h after which the floating particles were 
filtered. The solution was cannulated into a flame-dried and nitrogen flushed Schlenk flask and the 
concentration of the active species was determined by titration against I2 in THF.197 
 
197 A. Krasovskiy, P. Knochel, Synthesis 2006, 5, 890–891. 
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n-BuLi, s-BuLi and MeLi were purchased as solutions in cyclohexane/hexanes mixtures from Rock-
wood Lithium GmbH or Albemarle . The concentration was determined by titration against N-ben-
zylbenzamide in THF at 0 °C or by titration of isopropyl alcohol using the indicator 1,10-phenanthroline 
in THF at – 78 °C.198 Organozinc and Grignard reagents were freshly prepared and titrated against 
iodine at room temperature.197 
1.3 Chromatography 
Flash-column chromatography (FCC) was performed using silica gel 60 (SiO2, 0.040–0.063 mm, 230–
400 mesh ASTM) from Merck. Thin layer chromatography (TLC) was performed using aluminum 
plates covered with SiO2 (Merck 60, F–254). Spots were visualized by UV light irradiation (254 nm) 
and/or by staining of the TLC plate with one of the solutions below, followed by careful warming with 
a heat gun. 
KMnO4 solution: KMnO4 (1.50 g), K2CO3 (10.0 g) and NaOH (0.15 g) in water (150 mL). 
p-Anisaldehyde solution: conc. H2SO4 (10 mL), EtOH (200 mL), AcOH (3 mL), p-anisaldehyde 
(4 mL). 
1.4 Analytical data 
NMR spectra were recorded on Varian Mercury 200 or Bruker AC 300, Avance III HD 400 and 
AMX 600 instruments. Chemical shifts are reported as δ-values in parts per million (ppm) relative to 
the residual solvent peak: CDCl3 (δH: 7.26; δC: 77.16), DMSO- d6 (δH: 2.50; δC: 39.52), C6D6 (δH: 7.16; 
δC: 128.06), CD3CN (δH: 1.94; δC: 1.39 and 118.69) and (CD3)2CO (δH: 2.05; δC: 29.84 and 206.26). For 
the observation of the signal multiplicities, the following abbreviations and combinations thereof were 
used: s (singlet), d (doublet), t (triplet), q (quartet), quint (quintet), sext (sextet), sept (septet), m (mul-
tiplet) and br (broad). If not otherwise noted, the coupling constants given are either H-H or H-F cou-
pling constants for proton signals, C-F coupling constants for carbon signals and fluorine signals and 
B-F coupling constants for boron signals. 
Melting points are uncorrected and were measured on a Büchi B.540 apparatus.  
Infrared spectra were recorded from 4000–650 cm−1 on a Perkin Elmer Spectrum BX-59343 instru-
ment. For detection a Smiths Detection DuraSample IR II Diamond ATR sensor was used. The main 
absorption peaks are reported in cm−1. Samples were measured neat and abbreviations for intensity were 
as follows: vs (very strong; maximum intensity), s (strong; above 75% of max. intensity), m (medium; 
from 50% to 75% of max. intensity), w (weak; below 50% of max. intensity) and br (broad). 
Gas chromatography (GC) was performed with instruments of the type Hewlett-Packard 
5890/6850/6890 Series II, using a column of the type HP 5 (Hewlett-Packard, 5% phenylme-
thylpolysiloxane; length: 10 m, diameter: 0.25 mm, film thickness 0.25 μm). The detection was accom-
plished using a flame ionization detector.  
 
198 A. F. Burchat, J. M. Chong, N. Nielsen, J. Organomet. Chem. 1997, 542, 281–283. 
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For the combination of gas chromatography with mass spectroscopic (LRMS) detection, a GC–MS 
of the type Hewlett-Packard 6890/MSD 5793 networking was used (column: HP 5–MS, Hewlett–Pack-
ard; 5% phenylmethylpolysiloxane; length: 15 m, diameter: 0.25 mm, film thickness: 0.25 μm).  
High resolution mass spectra (HRMS) were recorded on a Finnigan MAT 95Q, Finnigan MAT 90 or 
JEOL JMS-700 instrument for electron impact ionization (EI). Electron spray ionization (ESI) high 
resolution mass spectra were measured on a Thermo Finnigan LTQ FT Ultra High-Performance Mass 
Spectrometer with a resolution of 100.000 at m/z 400. The spray-capillary voltage of the IonMax ESI-
unit is set to 4 kV while the heating-capillary temperature is set to 250 °C.  
Enantiomeric excess (ee) of chiral products was determined via chiral HPLC analysis on a Shimadzu 
Prominence 20A HPLC system running LabSolutions V5.42SP5. For developing a chiral resolution 
method, different chiral normal phase columns (Daicel Chemical Industries Chiralcel OD-H, OB-H) 
were tested with n-heptane and i-PrOH as mobile phase (isocratic) using a racemic mixture of the com-
pound.  
The diastereomeric ratio (dr) was determined either by NMR, GC or HPLC analysis.  
Specific rotation []D20 values of chiral products were measured in DCM at 20 °C using a wavelength 
of λ = 589 nm and a P8000-P8100-T polarimeter from A. Kruss Optronic, running software V3.0 with 
5 cm path length. The sample concentration was 0.01 g/mL and the values are reported in 
°⋅mL⋅dm−1⋅g−1.  
Low temperature raman measurements were performed on a Brucker MultiRAM FT-Raman spec-
trometer with a Nd:YAG laser excitation (λ = 1064 nm).  
Electrochemical oxidations on scales smaller than 1.0 mmol were performed on the IKA Electra-
Syn 2.0. All used electrodes were purchased from IKA, except the RVC (reticulated vitreous carbon) 
electrodes which were obtained from Goodfellow (Carbon – Vitreous – 3000C Foam, Thickness: 
6.35 mm, Bulk density: 0.05 g/cm3, Porosity: 96.5%, Pores/cm: 24). Electrochemical Oxidations on a 
scale greater than 1.0 mmol were performed on an Atlas 0931 Potentiostat – Galvanostat using a two-
electrode undivided cell setup.  
Cyclic voltammetry measurements were performed in MeCN containing 0.1 M NBu4ClO4 with the 
TAB salt (1a−g) (c ≈ 3.4 × 10−4 M) and ferrocene (c = 3.8 × 10−4 M) as an internal standard. The 
E1/2(fc+/fc in MeCN) = +0.382 V was used to calibrate EpOx (in MeCN) vs SCE.199 The experiments 
were performed on a CH Instruments 630E electrochemical analyzer using a 2 mm diameter platinum 
working electrode, a platinum wire counter electrode and an Ag wire pseudo-reference electrode apply-
ing a scan rate of 0.1 V/s. 
  
 
199 J. R. Aranzaes, M.-C. Daniel, D. Astruc, Can. J. Chem. 2006, 84, 288−299. 
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1.5 Single Crystal X-Ray Diffraction Studies200 
Single crystals suitable for X-ray diffraction were obtained by slow solvent evaporation. The crystals 
were introduced into perfluorinated oil and a suitable single crystal was carefully mounted on the top 
of a thin glass wire. Data collection was performed on a Bruker D8 Venture TXS diffractometer using 
Mo-K radiation (λ = 0.71073 Å). The structures were solved by direct methods (SHELXT)201 and refined 
by full-matrix least squares techniques against Fo2 (SHELXL-2014/7)202. 
2 One-Pot Preparation of Stable Organoboronate Reagents for the Func-
tionalization of Unsaturated Four- and Five-Membered Carbo- and Het-
erocycles203 
2.1 General Procedures  
The general procedures and analytical data for this chapter can be found in section B, chapter 1.1 of this 
work. They are printed as a direct part of the published manuscript. Therefore, only one exemplary 
spectral characterization (Figure 8) and crystallographic data (Table 1–Table 3) are shown below.  
  
 
200 X-Ray measurements, data collection and processing were performed by Dr. Peter Mayer, Department of 
Chemistry, LMU Munich. 
201 Sheldrick, G. M. (2015). Acta Cryst. A71, 3−8. 
202 Sheldrick, G. M. (2015). Acta Cryst. C71, 3−8. 
203 The full supporting information can be found under the following link: https://doi.org/10.1055/s-0036-
1592004. This project was conducted in equal contribution with M. Eisold and A. N. Baumann.  
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2.2 Representative NMR Spectra 
 
Figure 8: 1H NMR (400 MHz, CDCl3) and 13C NMR (101 MHz, CDCl3) of 3-Fluoro-6-methoxy-4-(2-methyl-
cyclopent-1-en-1-yl)quinoline (4f). 
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2.3 Single X-Ray Diffraction 
Supporting Information available: Crystallographic data has been deposited with the Cambridge 
Crystallographic Data Centre: CCDC-1825251 for 3a, CCDC-1826225 for 4g and CCDC-1825250 for 
7a. Copies of the data can be obtained free of charge: https://www.ccdc.cam.ac.uk/structures/. 
Table 1: Crystallographic data for compound 3a. 
 
Compound 3a 
net formula C11H11NO2 absorption correction Multi-Scan 
CCDC 1825251 transmission factor range 0.90–1.00 
Mr/g mol−1 189.21 refls. measured 10601 
crystal size/mm 0.080 × 0.050 × 0.020 Rint 0.0669 
T/K 103.(2) mean σ(I)/I 0.0468 
radiation MoKα θ range 3.146–25.349 
diffractometer 'Bruker D8 Venture TXS' observed refls. 1236 
crystal system orthorhombic x, y (weighting scheme) 0.0447, 1.6457 
space group 'P b c a' hydrogen refinement constr 
a/Å 8.2178(10) refls in refinement 1710 
b/Å 13.1821(16) parameters 128 
c/Å 17.446(2) restraints 0 
α/° 90 R(Fobs) 0.0551 
β/° 90 Rw(F2) 0.1340 
γ/° 90 S 1.056 
V/Å3 1889.9(4) shift/errormax 0.001 
Z 8 max electron density/e Å−3 0.254 
calc. density/g cm−3 1.330 min electron density/e Å−3 −0.220 
μ/mm−1 0.092   
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Table 2: Crystallographic data for compound 4g. 
 
Compound 4g 
net formula C11H12O2 absorption correction Multi-Scan 
Mr/g mol−1 176.21 transmission factor range 0.89–1.00 
crystal size/mm 0.100 × 0.090 × 0.020 refls. measured 6569 
T/K 100.(2) Rint 0.0280 
radiation MoKα mean σ(I)/I 0.0279 
diffractometer 'Bruker D8 Venture TXS' θ range 3.548–26.371 
crystal system monoclinic observed refls. 1640 
space group 'P 1 21/c 1' x, y (weighting scheme) 0.0506, 0.7671 
a/Å 7.6659(4) hydrogen refinement constr 
b/Å 8.1023(3) refls in refinement 1867 
c/Å 14.9034(7) parameters 119 
α/° 90 restraints 0 
β/° 98.931(2) R(Fobs) 0.0498 
γ/° 90 Rw(F2) 0.1297 
V/Å3 914.45(7) S 1.047 
Z 4 shift/errormax 0.001 
calc. density/g cm−3 1.280 max electron density/e Å−3 0.473 
μ/mm−1 0.087 min electron density/e Å−3 −0.227 
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Table 3: Crystallographic data for compound 7a. 
 
Compound 7a 
net formula C11H10N2O2 absorption correction Multi-Scan 
Mr/g mol−1 202.21 transmission factor range 0.97–1.00 
crystal size/mm 0.080 × 0.060 × 0.020 refls. measured 17906 
T/K 100.(2) Rint 0.0370 
radiation MoKα mean σ(I)/I 0.0192 
diffractometer 'Bruker D8 Venture TXS' θ range 3.393–26.372 
crystal system orthorhombic observed refls. 1696 
space group 'P b c a' x, y (weighting scheme) 0.0406, 1.0718 
a/Å 7.0425(2) hydrogen refinement constr 
b/Å 14.7911(4) refls in refinement 1942 
c/Å 18.2537(6) parameters 137 
α/° 90 restraints 0 
β/° 90 R(Fobs) 0.0363 
γ/° 90 Rw(F2) 0.0930 
V/Å3 1901.42(10) S 1.073 
Z 8 shift/errormax 0.001 
calc. density/g cm−3 1.413 max electron density/e Å−3 0.208 
μ/mm−1 0.100 min electron density/e Å−3 −0.254 
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3 Single-Pot Access to Bisorganoborinates: Applications in Zweifel Olefina-
tion204 
3.1 11B NMR Analysis 
 
Figure 9: 11B NMR Analysis of the transmetalation of B(On-Bu)3 with Grignard reagents. 
11B NMR studies were performed under inert conditions at room temperature in non-deuterated solvents 
and CDCl3 (5:2 v/v), see Figure 9 and Figure 10. In all cases, 4-bromo-1,2-dimethoxybenzene was used 
as the arylbromide for insertions with magnesium (general procedure C) or exchange reactions with 
n-BuLi (general procedure F). As a test substrate for alkenyl magnesium ligand exchanges prop-1-en-
2-ylmagnesium bromide (SM1) was used, whereas (1-ethoxyvinyl)lithium (SM5) was used as a test 
substrate for alkenyl lithium ligand exchanges.  
A) Reference NMR of B(On-Bu)3. 
B) Magnesium insertion of the aryl bromide in the presence of equimolar amounts of B(On-Bu)3 in pure 
THF shows incomplete consumption of the B(On-Bu)3. Two closely related peaks were detected, which 
were attributed to the monoorganoboronate and bisorganoborinate (2.02 and 1.91 ppm). 
C) In the presence of 1,4-dioxane (1:9 v/v), full conversion of the B(On-Bu)3 into the monoorganoboro-
nate is observed. 
D) 1.0 equiv of alkenyl magnesium reagent (SM1) result in no significant change of the measured boron 
species. The spectrum is almost identical to spectrum C). 
 E) 3.0 equiv of alkenyl magnesium reagent (SM1) result in full conversion of the monoorganoboro-
nate. Four new signals are detected (–8.12, –8.21, –8.26, –8.63 ppm), which were all attributed to boron 
species with up to three consecutive ligand exchanges. 
  
 
204 The full supporting information can be found under the following link: https://doi.org/10.1021/acs.or-
glett.9b00493. This project was conducted in equal contribution with A. N. Baumann. 
A)  
B)                in THF 
C)                in 9:1 THF: 1.4-Dioxane 
D)                      1.0 equiv  
E)                     3.0 equiv  
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Figure 10: 11B NMR Analysis of the transmetalation of B(On-Bu)3 with organolithium reagents. 
F) Reference NMR of B(On-Bu)3. 
G) Lithium exchange of the aryl bromide followed by addition of equimolar amounts of B(On-Bu)3 in 
pure THF. Complete consumption of the B(On-Bu)3 was observed. Again, two closely related peaks 
were detected, which were attributed to the monoorganoboronate and bisorganoborinate (4.38 and 
2.39 ppm, 9:1 ratio by integration). Unfortunately, addition of 1,4-dioxane did not improve the selec-
tivity toward the formation of the monoorganoboronate. 
H) 1.0 equiv of alkenyl lithium reagent (SM5) result in nearly full consumption of the monoorgano-
boronate and the desired bisorganoborinate is detected (2.23 ppm). 
I) 2.0 equiv of alkenyl lithium reagent (SM5) result in full consumption of the monoorganoboronate 
and the desired bisorganoborinate is detected (2.23 ppm). 
3.2 Synthesis of Organometallic Reagents 
Prop-1-en-2-ylmagnesium bromide (SM1), vinylmagnesium bromide (SM2), (1-phenylvinyl)magne-
sium bromide (SM3) and (3,4-dimethoxyphenyl)magnesium bromide (SM8) were prepared according 
to literature.205 (3,4-Dihydro-2H-pyran-6-yl)lithium (SM4), (1-ethoxyvinyl)lithium (SM5) and (cyclo-
hexylidenemethyl)lithium (SM6) were prepared according to literature.32 (1-Phenylvinyl)lithium 
(SM7) was prepared via the same protocol. 
  
 
205 F. M. Piller, P. Appukkuttan, A. Gavryushin, M. Helm, P. Knochel, Angew. Chem. 2008, 120, 6907–6911. 
F)  
G)                in THF 
H)                                1.0 equiv 
I)                      2.0 equiv  
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3.3 General Procedures 
3.3.1 General Procedure A: Synthesis of Alkenylmagnesium Reagents 
 
A Schlenk flask was charged with LiCl (1.17 g, 27.5 mmol, 1.1 equiv) and magnesium turnings 
(972 mg, 40 mmol, 1.6 equiv). LiCl and magnesium were dried in vacuo using a heat gun (600 °C, 
2 ×  5 min). After addition of THF (5.0 mL) and 1,2-dibromoethane (2 drops), the mixture was heated 
to boil with a heat gun to activate the magnesium. The bromoalkene (25 mmol, 1.0 equiv) was dissolved 
in THF (20.0 mL) and added to the activated magnesium suspension dropwise. After completion of the 
addition, the mixture was stirred for one hour at room temperature to yield a THF-solution of the 
alkenylmagnesium reagents SM1–3. 
3.3.2 General Procedure B: Mg-Insertion / Transmetalation / Ligand Exchange with Alkenyllith-
ium Reagents / Zweifel Olefination Sequence 
 
A reaction flask was charged with LiCl (47 mg, 1.1 mmol, 1.1 equiv) and magnesium turnings (39 mg, 
1.6 mmol, 1.6 equiv). LiCl and magnesium were dried in vacuo using a heat gun (600 °C, 2 × 5 min). 
After addition of THF (0.8 mL) / Dioxane (0.2 mL) and 1,2-dibromoethane (1 drop), the mixture was 
heated to boil with a heat gun to activate the magnesium, before tributylborate (270 µL, 1.0 mmol, 
1.0 equiv) was added at once. The (hetero)aryl bromide (1.0 mmol, 1.0 equiv) was dissolved in THF 
(1.0 mL) and added dropwise to the activated magnesium suspension at room temperature (a water bath 
was used to keep the solution at ~23 °C). The mixture was then stirred for one hour at ~23 °C to yield 
a THF-solution of the magnesium organoboronate. The solution was cooled to –78 °C, before the solu-
tion of alkenyllithium reagent SM4/SM5 (1.0–2.0 mmol, 1.0–2.0 equiv) was added dropwise. After 
half an hour, the reaction was warmed to 0 °C and stirred for 1 h. Then, after cooling back to –78 °C, 
iodine (761 mg, 3.0 mmol, 3.0 equiv) dissolved in THF (2.0 mL), was added dropwise to the solution. 
After 20 min a suspension of sodium methoxide (270 mg, 5.0 mmol, 5.0 equiv) in methanol (2.0 mL) 
was added at once. The reaction was allowed to reach room temperature, after which it was completed. 
The reaction was then quenched by the addition of sat. aq. Na2S2O3 and extracted with diethyl ether 
(3 × 20 mL). The combined organic phases were dried over MgSO4, filtered and concentrated under 
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reduced pressure. The crude product was purified by column chromatography on silica gel to yield 
compounds 8a–f. 
3.3.3 General Procedure C: Mg-Insertion / Transmetalation / Ligand Exchange with Alkenyl-
magnesium Reagents / Zweifel Olefination Sequence 
 
A reaction flask was charged with LiCl (47 mg, 1.1 mmol, 1.1 equiv) and magnesium turnings (39 mg, 
1.6 mmol, 1.6 equiv). LiCl and magnesium were dried in vacuo using a heat gun (600 °C, 2 × 5 min). 
After addition of THF (0.8 mL) / Dioxane (0.2 mL) and 1,2-dibromoethane (1 drop), the mixture was 
heated to boil with a heat gun to activate the magnesium, before tributylborate (270 µL, 1.0 mmol, 
1.0 equiv) was added at once. The (hetero)aryl bromide (1.0 mmol, 1.0 equiv) was dissolved in THF 
(1.0 mL) and added to the activated magnesium suspension at room temperature dropwise (to keep the 
solution at ~23 °C a water bath was used). The mixture was then stirred for one hour at ~23 °C to yield 
a THF-solution of the magnesium organoboronate. A solution of alkenylmagnesium reagent SM1–3 
(3.0 mmol, 3.0 equiv) was then added dropwise at 0 °C and stirred for another 1 h at 0 °C. Then, after 
the mixture was cooled back to –78 °C, iodine (1.142 g, 4.5 mmol, 4.5 equiv) dissolved in THF 
(2.0 mL), was added dropwise to the solution. After 20 min a suspension of sodium methoxide (348 mg, 
6.0 mmol, 6.0 equiv) in methanol (2.0 mL) was added at once. The reaction was allowed to reach room 
temperature, after which it was completed. The reaction was then quenched by the addition of sat. aq. 
Na2S2O3 and extracted with diethyl ether (3 × 20 mL). The combined organic phases were dried over 
MgSO4, filtered and concentrated under reduced pressure. The crude product was purified by column 
chromatography on silica gel to yield 9a–v. 
3.3.4 General Procedure D: Br/Li Exchange / Transmetalation / Ligand Exchange with Alkenyl-
magnesium Reagents / Zweifel Olefination Sequence 
 
Under inert atmosphere, (hetero)aryl bromide (1.0 mmol, 1.0 equiv) was dissolved in a reaction flask 
in THF (1.0 mL) and the solution was cooled down to –78 °C before adding a solution of n-BuLi in 
hexanes (1.0 mmol, 2.45 M, 1.0 equiv) dropwise. The mixture was stirred for 30 min before 
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tributylborate (270 µL, 1.0 mmol, 1.0 equiv) was added dropwise at –78 °C. The mixture was stirred 
for 30 min at –78 °C before warming to 0 °C and stirred for another 1 h. A solution of alkenylmagne-
sium reagent SM1/SM2 (3.0 mmol, 3.0 equiv) was then added dropwise at 0 °C and stirred for another 
1 h at 0 °C. Then, after cooling back to –78 °C, iodine (1.142 g, 4.5 mmol, 4.5 equiv) dissolved in THF 
(2.0 mL), was added dropwise to the solution. After 20 min a suspension of sodium methoxide (348 mg, 
6.0 mmol, 6.0 equiv) in methanol (2.0 mL) was added at once. The reaction was allowed to reach room 
temperature, after which it was completed. The reaction was then quenched by the addition of sat. aq. 
Na2S2O3 and extracted with diethyl ether (3 × 20 mL). The combined organic phases were dried over 
MgSO4, filtered and concentrated under reduced pressure. The crude product was purified by column 
chromatography on silica gel to yield 10a–c. 
3.3.5 General Procedure E: Double Br/Li exchange / Transmetalation / Ligand Exchange with 
Alkenylmagnesium Reagents / Zweifel Olefination Sequence 
 
Under inert atmosphere, (hetero)aryl bromide (2.0 mmol, 1.0 equiv) was dissolved in a reaction flask 
in THF (2.0 mL) and the solution was cooled down to –78 °C before adding a solution of n-BuLi in 
hexanes (2.0 mmol, 2.45 M, 1.0 equiv) dropwise. The mixture was stirred for 30 min before tributyl-
borate (540 µL, 2.0 mmol, 1.0 equiv) was added dropwise at –78 °C. The mixture was stirred for 30 min 
at –78 °C before warming to 0 °C and stirred for another 1 h. A solution of alkenylmagnesium reagent 
SM1/SM2 (6.0 mmol, 3.0 equiv) was then added dropwise at 0 °C and stirred for another 1 h at 0 °C. 
Then, after cooling back to –78 °C, iodine (2.284 g, 9.0 mmol, 9.0 equiv) dissolved in THF (2.0 mL), 
was added dropwise to the solution. After 20 min a suspension of sodium methoxide (648 mg, 
12.0 mmol, 12 equiv) in methanol (2.0 mL) was added at once. The reaction was allowed to reach room 
temperature, after which it was completed. The reaction was then quenched by the addition of sat. aq. 
Na2S2O3 and extracted with diethyl ether (3 × 20 mL). The combined organic phases were dried over 
MgSO4, filtered and concentrated under reduced pressure. The crude product was purified by column 
chromatography on silica gel to yield 10d–f. 
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3.3.6 General procedure F: Br/Li-Exchange / Transmetalation / Ligand Exchange with Alkenyl-
lithium Reagents / Zweifel Olefination Sequence 
 
Under inert atmosphere, (hetero)aryl bromide (2.0 mmol, 1.0 equiv) was dissolved in a reaction flask 
in THF (2.0 mL) and the solution was cooled down to –78 °C before adding a solution of n-BuLi in 
hexanes (2.0 mmol, 2.45 M, 1.0 equiv) dropwise. The mixture was stirred for 30 min before tributyl-
borate (540 µL, 2.0 mmol, 1.0 equiv) was added dropwise at –78 °C. The mixture was stirred for 30 min 
at –78 °C before warming to 0 °C and stirred for another 1 h. The solution was cooled to –78 °C, before 
the solution of alkenyllithium reagent SM6/SM7 (1.5 mmol, 1.5 equiv) was added dropwise. After half 
an hour, the reaction was warmed to 0 °C and stirred for 1 h. Then, after cooling back to –78 °C, iodine 
(761 mg, 3.0 mmol, 3.0 equiv) dissolved in THF (2.0 mL), was added dropwise to the solution. After 
20 min a suspension of sodium methoxide (270 mg, 5.0 mmol, 5.0 equiv) in methanol (2.0 mL) was 
added at once. The reaction was allowed to reach room temperature, after which it was completed. The 
reaction was then quenched by the addition of sat. aq. Na2S2O3 and extracted with diethyl ether (3 × 
20 mL). The combined organic phases were dried over MgSO4, filtered and concentrated under reduced 
pressure. The crude product was purified by column chromatography on silica gel to yield 11a–b. 
3.3.7 General Procedure G: Mg-Insertion / Transmetalation / Ligand Exchange with (Het-
ero)Aryl-Lithium or -Magnesium Reagents / Zweifel Olefination Sequence 
 
A reaction flask was charged with LiCl (47 mg, 1.1 mmol, 1.1 equiv) and magnesium turnings (39 mg, 
1.6 mmol, 1.6 equiv). LiCl and magnesium were dried in vacuo using a heat gun (600 °C, 2 × 5 min). 
After addition of THF (0.8 mL) / Dioxane (0.2 mL) and 1,2-dibromoethane (1 drop), the mixture was 
heated to boil with a heat gun to activate the magnesium, before tributylborate (270 µL, 1.0 mmol, 
1.0 equiv) was added at once. Alkenylbromide (1.0 mmol, 1.0 equiv) was dissolved in THF (1.0 mL) 
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and added to the activated magnesium suspension at 0 °C. The mixture was then stirred for 1 h at 0 °C 
to yield a THF-solution of the magnesium organoboronate. 
 
a) Use of (hetero)aryl lithium reagent 
In the meantime, a solution of (hetero)aryl lithium was prepared by using the corresponding bromide 
(1.5 mmol, 1.5 equiv) in THF (2.0 mL) followed by the dropwise addition of a solution of n-BuLi in 
hexanes (1.5 mmol, 1.5 equiv) at –78 °C. This solution was stirred for 30 min. The prior formed or-
ganoboronate was then slowly added to the (hetero)aryl lithium species at –78 °C. The combined mix-
ture was stirred for 30 min at –78 °C before warming to 0 °C and being stirred for another 1 h.  
 
b) Use of (hetero)aryl magnesium reagent 
A prior synthesized and titrated (hetero)aryl magnesium reagent was prepared by charging a Schlenk 
flask with LiCl (448 mg, 11 mmol, 1.1 equiv) and magnesium turnings (389 mg, 16 mmol, 1.6 equiv). 
LiCl and magnesium were dried in vacuo using a heat gun (600 °C, 2 × 5 min). After addition of THF 
(5.0 mL) and 1,2-dibromoethane (2 drops), the mixture was heated to boil with a heat gun to activate 
the magnesium. The corresponding (hetero)aryl bromide (10 mmol, 1.0 equiv) was dissolved in THF 
(5.0 mL) and added to the activated magnesium suspension dropwise. After completion of the addition, 
the mixture was stirred for one hour at room temperature to yield a THF-solution of the organomagne-
sium reagent. Then, after cooling back to –78 °C, iodine (761 mg, 3.0 mmol, 3.0 equiv) dissolved in 
THF (2.0 mL), was added dropwise to the solution. After 20 min a suspension of sodium methoxide 
(270 mg, 5.0 mmol, 5.0 equiv) in methanol (2.0 mL) was added at once. The reaction was allowed to 
reach room temperature. After reaching room temperature the reaction is completed. The reaction was 
then quenched by the addition of sat. aq. Na2S2O3 and extracted with diethyl ether (3 × 20 mL). The 
combined organic phases were dried over MgSO4, filtered and concentrated under reduced pressure. 
The crude product was purified by column chromatography on silica gel to yield 12a–d. 
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3.3.8 Optimizations for General Procedure G (b): 
GC-ratios were determined by comparing to n-undecane as internal standard (SD). As shown in Table 
4, no significant increase in product formation of 9h was observed with increasing amount of aryl mag-
nesium reagent SM8. 
Table 4: Influence of added equivalents of Grignard SM8 on conversion rates. 
 
Entry SM8 (equiv) GC-ratio 9h : SD (%) 
1 1.0 37 : 63 
2 2.0 36 : 64 
3 3.0 39 : 61 
 
3.4 Experimental Data 
6-Chloro-3-(3,4-dihydro-2H-pyran-6-yl)-2-methylpyridine (8a) 
Using 3-bromo-6-chloro-2-methylpyridine and (3,4-dihydro-2H-pyran-6-yl)lithium 
(SM4) according to general procedure B, provided 8a (0.54 mmol, 114 mg, 54%) as 
orange oil. Rf = 0.40 (hexane/EtOAc 95:5 and 1 % NEt3, UV, PAA, KMnO4). 1H 
NMR (400 MHz, CDCl3) δ 7.53 – 7.51 (d, J = 8.1 Hz, 1H), 7.12 – 7.10 (d, J = 8.0 Hz, 1H), 4.89 – 4.87 
(t, J = 3.9 Hz, 1H), 4.15 – 4.13 (t, J = 5.1 Hz, 2H), 2.55 (s, 3H), 2.21 – 2.17 (td, J = 6.4, 3.9 Hz, 2H), 
1.96 – 1.90 (m, 2H) ppm.13C NMR (101 MHz, CDCl3) δ 157.8, 150.9, 149.3, 139.0, 131.3, 120.9, 96.9, 
66.3, 23.2, 22.5, 22.1 ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 209.1 (100), 194.1 (19), 180.1 (45), 
166.1 (24), 154.0 (95). HRMS (EI-Orbitrap): m/z calcd for C11H12ClNO+: 209.0607; found: 209.0596. 
IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 2939 (s), 2935 (m), 2872 (m), 1714 (w), 1690 (s). Fast decom-
position in chloroform was observed.  
1,2-Dichloro-4-(1-ethoxyvinyl)benzene (8b) 
Using 4-bromo-1,2-dichlorobenzene and (1-ethoxyvinyl)lithium (SM5) according to 
general procedure B, provided 8b (0.58 mmol, 125 mg, 58%) as colorless liquid. Rf 
= 0.50 (hexane and 1 % NEt3, UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 
7.71 (d, J = 2.0 Hz, 1H), 7.45 (dd, J = 8.4, 2.0 Hz, 1H), 7.38 (d, J = 8.4 Hz, 1H), 4.64 (d, J = 3.0 Hz, 
1H), 4.24 (d, J = 3.0 Hz, 1H), 3.91 (q, J = 7.0 Hz, 2H), 1.42 (t, J = 7.0 Hz, 3H) ppm. 13C NMR (101 
MHz, Benzene-d6) δ 157.9, 137.1, 132.8, 132.6, 130.3, 127.6, 124.9, 83.5, 63.5, 14.3 ppm. LRMS 
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(DEP/EI-Orbitrap): m/z [%]: 216.0 (8), 188.0 (23), 175.0 (64), 173.0 (100), 146.0 (19), 109.0 (6). 
HRMS (EI-Orbitrap): m/z calcd for C10H10Cl2O+: 216.0109; found: 216.0104. IR (Diamond-ATR, neat) 
𝜈𝑚𝑎𝑥 (cm
-1): 2977 (w), 2932 (w), 2886 (w), 1724 (w), 1693 (m), 1584 (w), 1557 (w), 1469 (s), 1378 
(m), 1268 (s), 1240 (s), 1122 (s), 1050 (s). 
2-Chloro-4-(1-ethoxyvinyl)-1-fluorobenzene (8c)* 
Using 4-bromo-2-chloro-1-fluorobenzene and (1-ethoxyvinyl)lithium (SM5) accord-
ing to general procedure B, provided 8c (0.58 mmol, 116 mg, 58%) as colorless oil. 
Rf = 0.41 (hexane, UV, PAA, KMnO4). 1H NMR (400 MHz, C6D6) δ 7.72 (dd, J = 
7.2, 2.2 Hz, 1H), 7.19 (m, 1H), 6.61 (t, J = 8.7 Hz, 1H), 4.38 (d, J = 2.9 Hz, 1H), 3.95 (d, J = 2.9 Hz, 
1H), 3.43 (q, J = 7.0 Hz, 2H), 1.03 (t, J = 7.0 Hz, 3H) ppm.13C NMR (101 MHz, C6D6) δ 158.5 (d, J = 
249.8 Hz), 158.1 (d J = 0.8 Hz), 134.3 (d, J = 3.9 Hz), 125.5, 125.4, 121.2 (d, J = 18.0 Hz), 116.3 (d, J 
= 21.2 Hz), 82.9 (d, J = 1.4 Hz), 63.5, 14.3 ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 200.0 (7), 174.0 
(14), 172.0 (19), 159.0 (33), 158.0 (7), 157.0 (100), 156 (11), 130.0 (11), 129.0 (35). HRMS (EI-Or-
bitrap): m/z calcd for C10H10ClFO+: 200.0404; found: 200.0396. IR (Diamond-ATR, neat) ?̃?max (cm-1): 
2976 (w), 2279 (w), 1692 (w), 1593 (w).  
6-Phenyl-3,4-dihydro-2H-pyran (8d)* 
Using bromobenzene and (3,4-dihydro-2H-pyran-6-yl)lithium (SM4) according to gen-
eral procedure B, provided 8d (0.41 mmol, 66 mg, 41%) as colorless oil. Rf = 0.65 (hex-
ane/EtOAc 95:5, UV, KMnO4). 1H NMR (400 MHz, C6D6) δ 7.72 – 7.64 (m, 2H), 7.21 
– 7.12 (m, 2H), 7.10 – 7.00 (m, 1H), 5.22 (t, J = 4.0 Hz, 1H), 3.83 (t, J = 6.2, 4.7 Hz, 2H), 1.86 (td, J = 
6.4, 4.0 Hz, 2H), 1.51 – 1.39 (m, 2H) ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 160.1 (65), 131.1 (15), 
115.1 (10), 105.1 (100), 77.1 (45), 51.1 (15). Analytical data in accordance to literature.206 
5-(3,4-Dihydro-2H-pyran-6-yl)-2,4-dimethoxypyrimidine (8e) 
Using 5-bromo-2,4-dimethoxypyrimidine and (3,4-dihydro-2H-pyran-6-yl)lithium 
(SM4) according to general procedure B, provided 8e (0.45 mmol, 101 mg, 45%) 
as yellowish oil. Repeated in 10 mmol gram scale provided 8e (4.20 mmol, 
933 mg, 42%) as yellowish oil. Rf = 0.30 (hexane/EtOAc 95:5 and 1 % NEt3, UV, PAA, KMnO4). 1H 
NMR (400 MHz, CDCl3) δ 8.42 (s, 1H), 5.50 – 5.48 (t, J = 4.0 Hz, 1H), 4.15 – 4.13 (t, J = 5.2 Hz, 2H), 
4.02 (s, 3H), 3.99 (s, 3H), 2.23 – 2.19 (td, J = 6.4, 4.1 Hz, 2H), 1.93 – 1.87 (dt, J = 11.7, 6.3 Hz, 2H) 
ppm. 13C NMR (101 MHz, CDCl3) δ 167.8, 164.0, 156.5, 145.7, 111.7, 102.5, 66.6, 54.9, 54.3, 22.4, 
20.9 ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 222.2 (98), 207.1 (14), 193.0 (19), 167.1 (100). HRMS 
(EI-Orbitrap): m/z calcd for C11H14N2O3+: 222.1004; found: 222.0997. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 
 
206 U. Lehmann, S. Awasthi, T. Minehan, Org. Lett, 2003, 5, 2405–2408. 
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(cm-1): 2928 (m), 2870 (w), 1733 (vw), 1717 (w), 1691 (w). Fast decomposition in chloroform was 
observed. 
4-(3,4-Dihydro-2H-pyran-6-yl)-3,5-dimethylisoxazole (8f) 
Using 4-bromo-3,5-dimethylisoxazole and (3,4-dihydro-2H-pyran-6-yl)lithium (SM4) 
according to general procedure B, provided 8f (0.41 mmol, 74 mg, 41%) as orange oil. 
Rf = 0.40 (hexane/EtOAc 95:5 and 1 % NEt3, UV, PAA, KMnO4). 1H NMR (400 MHz, 
CDCl3) δ 4.80 – 4.78 (t, J = 3.9 Hz, 1H), 4.11 – 4.09 (t, J = 5.1 Hz, 2H), 2.41 (s, 3H), 2.26 (s, 3H), 2.19 
– 2.15 (td, J = 6.4, 3.9 Hz, 2H), 1.92 – 1.87 (m, 2H) ppm.13C NMR (101 MHz, CDCl3) δ 166.3, 158.7, 
144.9, 113.1, 101.1, 66.4, 22.4, 20.7, 12.3, 11.5 ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 179.1 (100), 
149.8 (21), 135.9 (90), 123.9 (38), 108.9 (22). HRMS (EI-Orbitrap): m/z calcd for C10H13NO2+: 
179.0946; found: 179.0938. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 2929 (w), 2848 (w), 1672 (m), 1653 
(w), 1646 (w). Fast decomposition in chloroform was observed. 
1,3-Dimethoxy-2-vinylbenzene (9a)* 
Using 2-bromo-1,3-dimethoxybenzene and vinylmagnesium bromide (SM2) according to 
general procedure C, provided 9a (0.70 mmol, 115 mg, 70%) as yellow oil. Rf = 0.67 (hex-
ane/EtOAc 98:2, UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 7.04 (t, J = 8.3 Hz, 
1H), 6.88 (dd, J = 18.0, 12.1 Hz, 1H), 6.44 (d, J = 8.4 Hz, 2H), 5.98 (dd, J = 18.0, 2.8 Hz, 1H), 5.35 
(dd, J = 12.2, 2.8 Hz, 1H), 3.72 (s, 6H) ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 164.1 (75), 149.1 
(100), 121.1 (30), 105.1 (10), 91.1 (95), 78.1 (25), 63.1 (12), 51.1 (10). Analytical data in accordance 
to literature.207 
2,2-Difluoro-5-vinylbenzo[d][1,3]dioxole (9b)* 
Using 5-bromo-2,2-difluorobenzo[d][1,3]dioxole and vinylmagnesium bromide 
(SM2) according to general procedure C, provided 9b (0.64 mmol, 118 mg, 64% 
yield determined by 19F NMR vs internal standard hexafluorobenzene) as colorless oil. Rf = 0.68 (pen-
tane, UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 7.16 (d, J = 1.6 Hz, 1H), 7.07 (dd, J = 8.2, 
1.7 Hz, 1H), 7.00 (d, J = 8.3 Hz, 1H), 6.66 (dd, J = 17.5, 10.8 Hz, 1H), 5.66 (d, J = 17.5 Hz, 1H), 5.25 
(d, J = 10.8 Hz, 1H) ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 184.1 (95), 118.1 (10), 89.1 (100), 63.1 
(30), 51.1 (10). Analytical data in accordance to literature.208 
4-(4-Vinylbenzyl)morpholine (9c) 
Using 4-(4-bromobenzyl)morpholine and vinylmagnesium bromide (SM2) accord-
ing to general procedure C, provided 9c (0.502 mmol, 102 mg, 50%) as colorless 
oil. Rf = 0.26 (hexane/EtOAc 7:3, UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) 
 
207 B. Bieszczad, M. Barbasiewicz, Chem. Eur. J. 2015, 21, 10322–10325. 
208 G. Wang, R. Shang, Y. Fu, Org. Lett. 2018, 20, 888–891. 
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δ 7.30 (d, J = 8.1 Hz, 2H), 7.22 (d, J = 8.0 Hz, 2H), 6.64 (dd, J = 17.6, 10.9 Hz, 1H), 5.67 (d, J = 17.6 
Hz, 1H), 5.16 (d, J = 10.8 Hz, 1H), 3.64 (t, J = 4.6 Hz, 4H), 3.41 (s, 2H), 2.48 – 2.30 (m, 4H) ppm. 13C 
NMR (101 MHz, CDCl3) δ 137.5, 136.6, 129.5, 128.3, 126.2, 113.7, 67.1, 63.2, 53.7 ppm. LRMS 
(DEP/EI-Orbitrap): m/z [%]: 203.2 (40), 172.2 (25), 130.1 (10), 117.1 (100), 100.1 (5), 86.1 (25), 56.1 
(8). HRMS (EI-Orbitrap): m/z calcd for C13H17NO+: 203.1310; found: 203.1306. IR (Diamond-ATR, 
neat) 𝜈𝑚𝑎𝑥 (cm
-1): 2958 (vw), 2853 (w), 2805 (w), 2360 (vw), 1511 (vw), 1454 (w), 1395 (vw), 1349 
(w), 1288 (w), 1116 (vs), 1007 (m), 913 (m), 866 (s), 741 (vw), 668 (vw). 
1-Fluoro-4-vinylnaphthalene (9d)* 
Using 1-bromo-4-fluoronaphthalene and vinylmagnesium bromide (SM2) according to 
general procedure C, provided 9d (0.63 mmol, 109 mg, 63%) as colorless oil. Rf = 0.79 
(pentane, UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 8.17 – 8.08 (m, 2H), 7.63 – 
7.52 (m, 3H), 7.41 (dd, J = 17.3, 10.9 Hz, 1H), 7.14 (dd, J = 10.4, 8.0 Hz, 1H), 5.76 (dd, J = 17.2, 
1.5 Hz, 1H), 5.47 (dd, J = 10.9, 1.4 Hz, 1H) ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 171.1 (100), 
151.1 (5), 85.1 (10), 75.1 (4). Analytical data in accordance to literature.209 
1-Methyl-5-vinyl-1H-indole (9e) 
Using 5-bromo-1-methyl-1H-indole and vinylmagnesium bromide (SM2) according to 
general procedure C provided 9e (0.52 mmol, 82 mg, 52%) as colorless oil. Rf = 0.32 
(hexane, UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3): δ 7.65 (s, 1H), 7.39 (dd, J = 
8.5, 1.5 Hz, 1H), 7.28 (d, J = 8.5 Hz, 1H), 7.04 (d, J = 3.1 Hz, 1H), 6.86 (dd, J = 17.6, 10.9 Hz, 1H), 
6.49 – 6.48 (m, 1H), 5.72 (dd, J = 17.6, 1.0 Hz, 1H), 5.15 (dd, J = 10.9, 0.9 Hz, 1H), 3.79 (s, 3H) ppm. 
LRMS (DEP/EI-Orbitrap): m/z [%]: 158.1 (11), 157.1 (100), 156.1 (33), 154 (12), 130.1 (8), 115.1 
(13). Analytical data in accordance to literature.210 
6-Chloro-2-methyl-3-vinylpyridine (9f) 
Using 3-bromo-6-chloro-2-methylpyridine and vinylmagnesium bromide (SM2) ac-
cording to general procedure C, provided 9f (0.45 mmol, 69 mg, 45%) as colorless oil. 
Rf = 0.25 (hexane/EtOAc 95:5, UV, KMnO4). 1H NMR (400 MHz, CDCl3) δ 7.68 (d, J 
= 8.1 Hz, 1H), 7.15 (d, J = 8.2 Hz, 1H), 6.83 (dd, J = 17.4, 11.0 Hz, 1H), 5.66 (dd, J = 17.5, 0.9 Hz, 
1H), 5.42 (dd, J = 11.0, 0.8 Hz, 1H), 2.55 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 156.5, 149.2, 
135.7, 132.3, 131.0, 122.0, 117.9, 22.4 ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 153.1 (100), 116.1 
(50), 91.1 (25), 77.1 (25), 63.1 (20), 51.1 (25). HRMS (EI-Orbitrap): m/z calcd for C8H8ClN+: 153.0345; 
found: 153.0340. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 2924 (vw), 1692 (vw), 1625 (w), 1575 (m), 
1441 (vs), 1252 (w), 1146 (s), 986 (m), 893 (vs), 829 (s), 738 (w) 664 (vw). 
 
209 C. Yang, J. Han, Y. Zhang, H. Yu, S. Hu, X. Wang, Chem. Eur. J. 2018, 24, 10324–10328. 
210 J. J. Molloy, C. P. Seath, M. J. West, C. McLaughlin, N. J. Fazakerley, A. R. Kennedy, D. J. Nelson, A. J. B. 
Watson, J. Am. Chem. Soc. 2018, 140, 126–130. 
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1-Methoxy-4-(prop-1-en-2-yl)benzene (9g) 
Using 1-bromo-4-methoxybenzene and prop-1-en-2-ylmagnesium bromide (SM1) 
according to general procedure C provided 9g (0.89 mmol, 187 mg, 89%) as color-
less solid. Rf = 0.20 (pentane/Et2O 9:1, UV, PAA, KMnO4). 1H NMR (400 MHz, 
CDCl3) δ 7.43 – 7.41 (d, J = 8.8 Hz, 2H), 6.88 – 6.86 (d, J = 8.8 Hz, 2H), 5.29 (s, 1H), 4.99 (s, 1H), 
3.82 (s, 3H), 2.13 (s, 3H) ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 148.1 (100), 133.1 (82), 115.0 (11), 
105.1 (24). Analytical data in accordance to literature.211 
1,2-Dimethoxy-4-(prop-1-en-2-yl)benzene (9h)* 
Using 4-bromo-1,2-dimethoxybenzene and prop-1-en-2-ylmagnesium bromide 
(SM1) according to general procedure C provided 9h (0.72 mmol, 128 mg, 72%) as 
colorless oil. General procedure C without base (NaOMe) provided 9h in 61%. 
General procedure G (a) provided 9h in 45%. General procedure G (b) using (3,4-dimethoxy-
phenyl)magnesium bromide (SM8) provided 9h in 40% Rf = 0.79 (hexane/EtOAc 96:4, UV, PAA, 
KMnO4). 1H NMR (400 MHz, CDCl3) δ 7.04 – 7.00 (m, 2H), 6.83 (d, J = 8.8 Hz, 1H), 5.30 (s, 1H), 
5.02 (s, 1H), 3.91 (s, 3H), 3.89 (s, 3H), 2.14 (s, 3H) ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 178.2 
(100), 163.1 (35), 135.1 (14), 115.1 (11), 107.1 (18), 91.1 (36), 77.1 (16). Analytical data in accordance 
to literature.212  
N,N-Dimethyl-4-(prop-1-en-2-yl)aniline (9i)  
Using 4-bromo-N,N-dimethylaniline and prop-1-en-2-ylmagnesium bromide 
(SM2) according to general procedure C provided 9i (0.63 mmol, 101 mg, 63%) as 
colorless oil. General procedure G (a) provided 9i in 31%. Rf = 0.11 (hexane/EtOAc 
99:1, UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 7.41 (d, J = 9.0 Hz, 2H), 6.71 (d, J = 9.0 Hz, 
2H), 5.28 (s, 1H), 4.93 (s, 1H), 2.97 (s, 6H), 2.14 (s, 3H) ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 
161.1 (100), 146.1 (42), 129.9 (10), 114.9 (13), 102.9 (9), 77.1 (11). Analytical data in accordance to 
literature.213 
2-(3-(Prop-1-en-2-yl)phenyl)-1,3-dioxolane (9j) 
Using 2-(3-bromophenyl)-1,3-dioxolane and prop-1-en-2-ylmagnesium bromide 
(SM1) according to general procedure C, provided 9j (0.49 mmol, 93 mg, 49%) as 
colorless oil. Rf = 0.20 (hexane, UV, PAA KMnO4). 1H NMR (400 MHz, CDCl3) 
δ 7.57 (s, 1H), 7.47 (dt, J = 7.4, 1.7 Hz, 1H), 7.41 – 7.32 (m, 2H), 5.83 (s, 1H), 5.39 (s, 1H), 5.10 (t, J 
= 1.5 Hz, 1H), 4.18 – 4.01 (m, 4H), 2.16 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 143.1, 141.6, 
137.9, 128.4, 126.5, 125.6, 123.7, 113.0, 103.9, 65.5, 22.0 ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 
 
211 W. J. Kerr, A. J. Morrison, M. Pazicky, T. Weber, Org. Lett 2012, 14, 2250–2253. 
212 A. Flores-Gaspar, R. Martin, Adv. Synth. Catal. 2011, 353, 1223–1228. 
213 E. Peyroux, F. Berthiol, H. Doucet, M. Santelli, Eur. J. Org. Chem. 2004, 1075–1082. 
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189.2 (100), 175.1 (25), 162.1 (25), 145.1 (65), 134.1 (20), 118.1 (75), 103.1 (15), 91.1 (35), 77.1 (15), 
73.1 (60), 63.1 (10), 51.1 (10). HRMS (EI-Orbitrap): m/z calcd for C12H14O2+: 190.0994; found: 
190.0998. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): n.d. 
1-Phenyl-4-(prop-1-en-2-yl)naphthalene (9k)* 
Using 1-bromo-4-phenylnapthalene and prop-1-en-2-ylmagnesium bromide (SM1) 
according to general procedure C provided 9k (0.59 mmol, 133 mg, 59%) as colorless 
oil. Rf = 0.75 (hexane, UV, PAA KMnO4). 1H NMR (400 MHz, CDCl3) δ 8.25 (dd, J 
= 8.5, 1.3 Hz, 1H), 8.08 – 8.01 (m, 1H), 7.63 – 7.55 (m, 6H), 7.54 – 7.45 (m, 3H), 5.56 (s, 1H), 5.24 (s, 
1H), 2.37 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 144.9, 142.0, 141.0, 139.5, 132.0, 131.2, 130.2, 
128.4, 127.3, 126.6, 126.5, 126.2, 125.9, 125.8, 124.2, 116.4, 25.5 ppm. LRMS (DEP/EI-Orbitrap): m/z 
[%]: 244.2 (70), 229.2 (100), 215.1 (5), 202.1 (15), 165.1 (15), 152.1 (8), 113.1 (8), 101.1 (5), 91.1 (6). 
HRMS (EI-Orbitrap): m/z calcd for C19H16+: 244.1252; found: 244.1250. IR (Diamond-ATR, neat) 
𝜈𝑚𝑎𝑥 (cm
-1): 1492 (vw), 1443 (w), 1370 (vw), 1157 (vw), 1031 (w), 902 (m), 842 (m), 767 (vs), 701 
(vs). 
1-Bromo-3-methoxy-5-(prop-1-en-2-yl)benzene (9l) 
Using 1,3-dibromo-5-(prop-1-en-2-yl)benzene and prop-1-en-2-ylmagnesium bro-
mide (SM1) according to general procedure D provided 9l (0.34 mmol, 154 mg, 34%) 
as colorless oil. Rf = 0.59 (hexane/EtOAc 98:2, UV, PAA, KMnO4). 1H NMR (400 
MHz, CDCl3) δ 7.17 (t, J = 1.6 Hz, 1H), 6.94 (t, J = 2.0 Hz, 1H), 6.89 (t, J = 1.9 Hz, 1H), 5.34 (s, 1H), 
5.09 (s, 1H), 3.79 (s, 3H), 2.09 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 160.3, 144.4, 142.1, 122.8, 
121.4, 115.7, 114.0, 111.0, 55.6, 21.9 ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 229.0 (11), 228.0 (98), 
227.0 (11), 226 (100), 188.0 (15), 186.0 (15). HRMS (EI-Orbitrap): m/z calcd for C10H11BrO+: 
225.9993; found: 225.9995. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 2938 (br/w), 1599 (m), 1557 (vs), 
1560 (s). 
6-Chloro-2-methyl-3-(prop-1-en-2-yl)pyridine (9m) 
Using 3-bromo-6-chloro-2-methylpyridine and prop-1-en-2-ylmagnesium bromide 
(SM1) according to general procedure C provided 9m (0.71 mmol, 119 mg, 71%) as 
yellow oil. Rf = 0.50 (hexane/EtOAc 9:1 UV, PAA, KMnO4). 1H NMR (400 MHz, 
CDCl3) δ 7.37 – 7.35 (d, J = 8.0 Hz, 1H), 7.12 – 7.10 (d, J = 8.0 Hz, 1H), 5.27 (s, 1H), 4.91 (s, 1H), 
2.51 (s, 3H), 2.03 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 156.2, 148.7, 142.8, 138.5, 137.6, 121.3, 
116.9, 24.0, 22.8 ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 167.0 (100), 151.9 (35), 132.0 (18), 117.0 
(68). HRMS (EI-Orbitrap): m/z calcd for C9H10ClN+: 167.0502; found: 167.0493. IR (Diamond-ATR, 
neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3508 (m), 3484 (m), 3468 (m), 3444 (m), 3416 (m), 3411 (m), 3397 (m), 3275 (w), 
1703 (vs), 1675 (m), 1668 (m), 1662 (m). 
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2,4-Dimethoxy-5-(prop-1-en-2-yl)pyrimidine (9n) 
Using 5-bromo-2,4-dimethoxypyrimidine and prop-1-en-2-ylmagnesium bromide 
(SM1) according to general procedure C provided 9n (0.74 mmol, 134 mg, 74%) as 
yellowish oil. General procedure G (a) provided 9n in 44%. Rf = 0.40 (hexane/ 
EtOAc 9:1, UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 8.13 (s, 1H), 5.22 (s, 1H), 5.16 (s, 1H), 
4.01 (s, 3H), 3.99 (s, 3H), 2.07 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 168.4, 164.5, 156.5, 138.1, 
117.6, 116.5, 54.9, 54.1, 22.7 ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 180.1 (100), 165.1 (57), 150.1 
(39), 135.1 (36). HRMS (EI-Orbitrap): m/z calcd for C9H11N2O2+: 179.0821; found: 179.0814. IR (Di-
amond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3082 (vw), 2956 (w), 1700 (vw), 1684 (vw), 1662 (vw), 1652 (vw), 
1587 (s), 1552 (s).  
5-(Prop-1-en-2-yl)benzofuran (9o) 
Using 5-bromobenzofuran and prop-1-en-2-ylmagnesium bromide (SM1) according 
to general procedure C provided 9o (0.66 mmol, 104 mg, 66%) as colorless oil. Rf = 
0.80 (hexane, UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 7.68 (s, 1H), 7.62 
– 7.61 (d, J = 2.2 Hz, 1H), 7.45 – 7.45 (m, 2H), 6.77 – 6.76 (d, J = 2.1 Hz, 1H), 5.36 (s, 1H), 5.08 (s, 
1H), 2.22 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 154.5, 145.4, 143.5, 136.5, 127.4, 122.3, 118.1, 
111.9, 110.9, 106.8, 22.4 ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 158.1 (100), 143.1 (38), 129.1 (24), 
115.1 (50). HRMS (EI-Orbitrap): m/z calcd for C11H10O+: 158.0732; found: 158.0725. IR (Diamond-
ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3083 (vw), 2971 (w), 2858 (vw), 1772 (vw), 1705 (vw), 1652 (vw), 1628 (w), 
1610 (w). 
3-(Prop-1-en-2-yl)benzo[b]thiophene (9p) 
Using 3-bromobenzo[b]thiophene and prop-1-en-2-ylmagnesium bromide (SM1) ac-
cording to general procedure C provided 9p (0.62 mmol, 108 mg, 62%) as yellow oil. Rf 
= 0.70 (hexane, UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 8.01 – 7.99 (d, J = 
7.5 Hz, 1H), 7.88 – 7.86 (d, J = 7.5 Hz, 1H), 7.40 – 7.33 (m, 2H), 7.30 (s, 1H), 5.36 (s, 1H), 5.33 (s, 
1H), 2.22 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 140.8, 139.1, 139.0, 137.7, 124.4, 124.3, 123.6, 
123.0, 122.7, 114.9, 24.1 ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 174.1 (100), 159.1 (26), 148.0 (14), 
141.1 (60), 134.0 (25). HRMS (EI-Orbitrap): m/z calcd for C11H10S+: 174.0503; found: 174.0496. IR 
(Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3065 (vw), 2969 (w), 2914 (vw), 2851 (vw), 1941 (vw), 1937 (vw), 
1910 (vw), 1791 (vw), 1733 (vw), 1700 (vw), 1695 (vw), 1669 (w). 
1,3,5-Trimethyl-4-(prop-1-en-2-yl)-1H-pyrazole (9q) 
Using 4-bromo-1,3,5-trimethyl-1H-pyrazole and prop-1-en-2-ylmagnesium bromide 
(SM1) according to general procedure C provided 9q (0.48 mmol, 72 mg, 48%) as 
yellowish oil. General procedure G (a) provided 9q in 55%. Rf = 0.20 (pentane/Et2O 
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7:3, UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 5.13 (s, 1H), 4.76 (s, 1H), 3.71 (s, 3H), 2.21 
(s, 3H), 2.20 (s, 3H), 1.99 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 144.6, 137.8, 135.8, 120.4, 
114.9, 35.9, 23.9, 12.9, 10.4 ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 150.1 (83), 135.0 (100), 93.9 
(14). HRMS (EI-Orbitrap): m/z calcd for C9H14N2+: 150.1157; found: 150.1150. IR (Diamond-ATR, 
neat) 𝜈𝑚𝑎𝑥 (cm
-1): 2923 (m), 2858 (w), 1634 (m), 1553 (m). 
6-Chloro-2-methyl-3-(1-phenylvinyl)pyridine (9r) 
Using 3-bromo-6-chloro-2-methylpyridine and (1-phenylvinyl)magnesium bromide 
(SM3) according to general procedure C provided 9r (0.70 mmol, 161 mg, 70%) as 
yellow oil. Rf = 0.20 (hexane/EtOAc 98:2, UV, PAA, KMnO4). 1H NMR (400 MHz, 
CDCl3) δ 7.48 – 7.46 (d, J = 8.0 Hz, 1H), 7.33 – 7.30 (m, 3H), 7.24 – 7.20 (m, 3H), 5.84 (s, 1H), 5.23 
(s, 1H), 2.28 (s, 3H) ppm.13C NMR (101 MHz, CDCl3) δ 157.8, 149.5, 146.6, 140.4, 139.4, 135.6, 
128.8, 128.4, 128.3, 127.3, 126.5, 24.9 ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 229.0 (24), 214.0 
(100), 178.0 (35), 165.0 (13). HRMS (EI-Orbitrap): m/z calcd for C14H12ClN+: 229.0658; found: 
229.0654. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3081 (vw), 3056 (vw), 2977 (vw), 2925 (vw), 1809 
(vw), 1700 (vw), 1684 (w), 1669 (vw). 
2,4-Dimethoxy-5-(1-phenylvinyl)pyrimidine (9s) 
Using 5-bromo-2,4-dimethoxypyrimidine and (1-phenylvinyl)magnesium bromide 
(SM3) according to general procedure C provided 9s (0.48 mmol, 116 mg, 48%) as 
yellow solid. General procedure G (a) provided 9s in 41%. Rf = 0.20 (hexane/EtOAc 
95:5, UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 8.14 (s, 1H), 7.32 – 7.27 (m, 5H), 5.69 (s, 
1H), 5.39 (s, 1H), 4.03 (s, 3H), 3.85 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 168.7, 164.9, 158.3, 
141.9, 139.9, 128.3, 127.9, 126.5, 116.9, 116.3, 54.9, 54.0 ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 
242.1 (100), 227.0 (93), 212.1 (18), 170.0 (13). HRMS (EI-Orbitrap): m/z calcd for C14H14N2O2+: 
242.1055; found: 242.1053. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3370 (w), 2989 (w), 2956 (w), 2933 
(w), 1591 (vs), 1574 (m), 1554 (vs). Mp (°C): 53–56.  
1,2-Dichloro-4-(1-phenylvinyl)benzene (9t)* 
Using 4-bromo-1,2-dichlorobenzene and (1-phenylvinyl)magnesium bromide (SM3) 
according to general procedure C provided 9t (0.76 mmol, 189 mg, 76%) as colorless 
oil. Rf = 0.50 (hexane, UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 7.44 (d, J 
= 2.1 Hz, 1H), 7.40 (d, J = 8.3 Hz, 1H), 7.38 – 7.33 (m, 3H), 7.33 – 7.28 (m, 2H), 7.17 (dd, J = 8.3, 
2.1 Hz, 1H), 5.50 (d, J = 0.9 Hz, 1H), 5.47 (d, J = 0.9 Hz, 1H) ppm. LRMS (DEP/EI-Orbitrap): m/z 
[%]: 248.1 (71), 213.1 (49), 178.1 (100), 152.1 (12), 88.1 (24). Analytical data in accordance to litera-
ture.214 
 
214 P. K. Tiwari, B. SivaRaman, I. S. Aidhen, Eur. J. Org. Chem., 2017, 3594–3605. 
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1-(1-Phenylvinyl)-4-(trifluoromethyl)benzene (9u) 
Using 1-bromo-4-(trifluoromethyl)benzene and (1-phenylvinyl)magnesium bromide 
(SM3) according to general procedure C provided 9u (0.53 mmol, 132 mg, 53%) as 
colorless oil. Rf = 0.74 (hexane, UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 
7.60 (d, J = 8.2 Hz, 2H), 7.46 (d, J = 8.1 Hz, 2H), 7.39 – 7.30 (m, 5H), 5.57 (s, 1H), 5.53 (s, 1H) ppm. 
LRMS (DEP/EI-Orbitrap): m/z [%]: 248.1 (99), 233.0 (32), 178.1 (100), 151.1 (16), 89.0 (19), 77.0 
(20), 51.0 (17). Analytical data in accordance to literature.215 
2,4-Dimethoxy-5-(1-(4-methoxyphenyl)vinyl)pyrimidine (9v) 
Using 5-bromo-2,4-dimethoxypyrimidine and (1-(4-methoxyphenyl)vi-
nyl)magnesium bromide according to general procedure C provided 9v 
(0.67 mmol, 183 mg, 67%) as colorless solid. Rf = 0.30 (hexane/EtOAc 
8:2, UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 8.14 (s, 1H), 7.21 – 7.19 (d, J = 8.8 Hz, 2H), 
6.85 – 6.82 (d, J = 8.8 Hz, 2H), 5.61 (s, 1H), 5.27 (s, 1H), 4.02 (s, 3H), 3.86 (s, 3H), 3.81 (s, 3H) 
ppm.13C NMR (101 MHz, CDCl3) δ 168.9, 165.0, 159.5, 158.3, 141.4, 132.6, 127.8, 116.7, 115.4, 
113.8, 55.4, 55.0, 54.2 ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 272.1 (69), 257.1 (100), 200.1 (10), 
173.1 (11). HRMS (EI-Orbitrap): m/z calcd for C15H16N2O3+: 272.1161; found: 272.1156. IR (Dia-
mond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3091 (vw) 3033 (vw), 3006 (w), 2995 (w), 2958 (w), 2933 (w), 2837 
(w), 1604 (m), 1591 (s). Mp (°C): 52–55. 
9-Vinylphenanthrene (10a)* 
Using 9-bromophenanthrene and vinylmagnesium bromide (SM2) according to general 
procedure D provided 10a (0.55 mmol, 112 mg, 55%) as colorless oil. Rf = 0.56 (hexane, 
UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 8.75 (dd, J = 7.8, 1.7 Hz, 1H), 8.68 
(d, J = 8.0 Hz, 1H), 8.19 (dd, J = 7.7, 1.7 Hz, 1H), 7.92 (dd, J = 7.5, 1.7 Hz, 1H), 7.88 
(s, 1H), 7.73 – 7.58 (m, 4H), 7.50 (dd, J = 17.1, 10.8 Hz, 1H), 5.90 (dd, J = 17.2, 1.7 Hz, 1H), 5.56 (dd, 
J = 10.8, 1.7 Hz, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 135.2, 134.8, 131.9, 130.6, 130.4, 130.4, 
128.8, 126.9, 126.8, 126.7, 126.6, 126.6, 124.7, 123.2, 122.6, 117.7 ppm. LRMS (DEP/EI-Orbitrap): 
m/z [%]: 203.1 (100), 176.1 (10), 150.1 (5), 101.1 (40), 88.0 (15), 75.0 (5), 63.1 (3). Analytical data in 
accordance to literature.216 
  
 
215 D. S. Choi, J. H. Kim, U. S. Shin, R. R. Deshmukh, C. E. Song, Chem. Commun. 2007, 3482–3484. 
216 K. T. Neumann, S. Klimczyk, M. N. Burhardt, B. Bang-Andersen, T. Skrydstrup, A. T. Linhardt, ACS Catal. 
2016, 6, 4710–4714. 
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1-Phenyl-4-vinylnaphthalene (10b) 
Using 1-bromo-4-phenylnaphthalene and vinylmagnesium bromide (SM2) according to 
general procedure D provided 10b (0.70 mmol, 161 mg, 70%) as colorless oil. Rf = 0.31 
(hexane, UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 8.22 (d, J = 8.5 Hz, 1H), 
7.96 (dd, J = 8.5, 1.6 Hz, 1H), 7.74 – 7.65 (m, 1H), 7.58 – 7.42 (m, 9H), 5.86 (dd, J = 17.3, 1.6 Hz, 1H), 
5.54 (dd, J = 10.9, 1.6 Hz, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 140.9, 140.4, 135.3, 134.6, 131.8, 
131.5, 130.2, 128.4, 127.4, 126.9, 126.8, 126.1, 126.0, 124.2, 123.4, 117.3 ppm. LRMS (DEP/EI-Or-
bitrap): m/z [%]: 230.2 (100), 215.2 (15), 202.1 (20), 153.1 (20), 113.1 (10), 101.1 (10). HRMS (EI-
Orbitrap): m/z calcd for C18H14+: 230.1096; found: 230.1092. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 
1492 (vw), 1443 (vw), 1377 (w), 984 (w), 912 (m), 843 (m), 766 (vs), 700 (s). 
3-Bromo-9-phenyl-6-(prop-1-en-2-yl)-9H-carbazole (10c) 
Using 3,6-dibromo-9-phenyl-9H-carbazole and prop-1-en-2-ylmagnesium bro-
mide (SM1) according to general procedure D provided 10c (1.20 mmol, 433 mg, 
80%) as colorless oil. Rf = 0.60 (hexane/EtOAc 98:2, UV, PAA, KMnO4). 1H 
NMR (400 MHz, CDCl3) δ 8.17 (d, J = 1.8 Hz, 1H), 8.06 (d, J = 1.5 Hz, 1H), 
7.53 – 7.46 (m, 3H), 7.43 – 7.33 (m, 4H), 7.22 (d, J = 8.6 Hz, 1H), 7.15 (d, J = 8.9 Hz, 1H), 5.34 (s, 
1H), 5.04 – 5.00 (m, 1H), 2.19 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 143.5, 140.8, 140.0, 137.3, 
134.0, 130.1, 128.7, 127.9, 127.0, 125.4, 124.7, 123.2, 122.3, 117.5, 112.9, 111.5, 109.8, 22.5 ppm. One 
carbon signal could not be detected. LRMS (DEP/EI-Orbitrap): m/z [%]: 361.1 (100), 348.0 (25), 267.1 
(35), 241.1 (12), 133.6 (10). HRMS (EI-Orbitrap): m/z calcd for C21H16BrN+: 361.0466; found: 
361.0459. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3068 (w), 2966 (w), 2359 (m), 2341 (m), 2334 (m), 
1624 (m), 1597 (m), 1500 (vs). 
9-Phenyl-3,6-divinyl-9H-carbazole (10d) 
Using 3,6-dibromo-9-phenyl-9H-carbazole and vinylmagnesium bromide 
(SM2) according to general procedure E provided 10d (0.63 mmol, 186 mg, 
63%) as yellowish oil. Rf = 0.50 (hexane, UV, PAA, KMnO4). 1H NMR 
(400 MHz, CDCl3) δ 8.21 (s, 2H), 7.65 – 7.47 (m, 7H), 7.37 (d, J = 8.5 Hz, 2H), 6.96 (dd, J = 17.6, 
10.9 Hz, 2H), 5.85 (d, J = 17.5 Hz, 2H), 5.28 (d, J = 10.9 Hz, 2H) ppm.13C NMR (101 MHz, CDCl3) δ 
141.1, 137.5, 137.4, 130.2, 130.0, 127.6, 127.0, 124.5, 123.7, 118.4, 111.7, 110.0 ppm. LRMS 
(DEP/EI-Orbitrap): m/z [%]: 295.3 (100), 279.1 (5), 267.1 (10), 254.2 (2). HRMS (EI-Orbitrap): m/z 
calcd for C22H17N+: 295.1361; found: 295.1353. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3040 (vw), 
2959 (w), 2926 (w), 2869 (w), 2246 (vw), 1684 (w), 1626 (w), 1596 (m), 1569 (w), 1501 (s). 
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2,8-Di(prop-1-en-2-yl)dibenzo[b,d]thiophene (10e) 
Using 2,8-dibromodibenzo[b,d]thiophene and prop-1-en-2-ylmagnesium 
bromide (SM1) according to general procedure E provided 10e (0.61 mmol, 
161 mg, 61%) as colorless oil. Rf = 0.50 (hexane, UV, PAA, KMnO4). 1H 
NMR (400 MHz, CDCl3) δ 8.24 (d, J = 1.7 Hz, 2H), 7.79 (d, J = 8.4 Hz, 2H), 7.62 (dd, J = 8.4, 1.8 Hz, 
2H), 5.54 (dd, J = 1.5, 0.8 Hz, 2H), 5.24 – 5.20 (m, 2H), 2.33 (s, 6H) ppm. 13C NMR (101 MHz, CDCl3) 
δ 143.3, 139.0, 138.0, 135.7, 124.7, 122.6, 118.4, 112.7, 22.3 ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 
264.1 (100), 249.2 (30), 234.1 (10), 221.1 (15), 208.1 (35). HRMS (EI-Orbitrap): m/z calcd for 
C18H16S+: 264.0973; found: 264.0969.  
4,4'-Oxybis(prop-1-en-2-ylbenzene) (10f) 
Using 4,4'-oxybis(bromobenzene) and prop-1-en-2-ylmagnesium bro-
mide (SM1) prop-1-en-2-ylmagnesium bromide E provided 10f 
(0.63 mmol, 158 mg, 63%) as colorless solid. Rf = 0.15 (hexane, UV, 
PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 7.44 (d, J = 8.7 Hz, 4H), 6.97 (d, J = 8.7 Hz, 4H), 5.33 
(s, 2H), 5.05 (s, 2H), 2.14 (s, 6H) ppm. 13C NMR (101 MHz, CDCl3) δ 156.7, 142.5, 136.4, 127.0, 
118.6, 111.9, 22.1 ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 251.1 (20), 250.1 (100), 235.1 (28), 165.1 
(9), 115.1 (13). HRMS (EI-Orbitrap): m/z calcd for C18H18O+: 250.1358 found: 250.1353. IR (Dia-
mond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 2971 (w), 2251 (w), 1624 (w), 1596 (w). Mp (°C): 99–101. 
(4-(Cyclohexylidenemethyl)phenyl)(methyl)sulfane (11a)* 
Using (4-bromophenyl)(methyl)sulfane and (cyclohexylidenemethyl)lithium 
(SM6) according to general procedure F provided 11a (0.47 mmol, 103 mg, 
47%) as colorless oil. Rf = 0.30 (hexane, UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 7.23 – 
7.18 (m, 2H), 7.15 – 7.10 (m, 2H), 6.17 (s, 1H), 2.48 (s, 3H), 2.39 – 2.33 (m, 2H), 2.27 – 2.21 (m, 2H), 
1.67 – 1.51 (m, 6H) ppm. 13C NMR (101 MHz, CDCl3) δ 143.7, 135.6, 135.5, 129.5, 126.7, 121.5, 37.8, 
29.6, 28.7, 28.0, 26.8, 16.3 ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 218.1 (100), 203.1 (2), 189.1 (5), 
171.1 (5). HRMS (EI-Orbitrap): m/z calcd for C14H18S+: 218.1129; found: 218.1119. IR (Diamond-
ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): n.d. 
Trimethyl(3-(1-phenylvinyl)phenyl)silane (11b) 
Using (3-bromophenyl)trimethylsilane and (1-phenylvinyl)lithium (SM7) accord-
ing to general procedure F provided 11b (0.26 mmol, 65 mg, 51%) as colorless oil. 
(1-phenylvinyl)lithium was prepared by treating (1-bromovinyl)benzene (1.5 equiv) 
with a solution of n-BuLi in hexanes (1.5 equiv) in Et2O at –78 °C for 30 min. Rf = 0.40 (hexane, UV, 
PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 7.53 – 7.51 (m, 1H), 7.48 (dt, J = 7.0, 1.4 Hz, 1H), 7.38 
– 7.28 (m, 7H), 5.49 (d, J = 1.2 Hz, 1H), 5.46 (d, J = 1.2 Hz, 1H), 0.26 (s, 9H) ppm. 13C NMR (101 MHz, 
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CDCl3) δ 150.4, 141.6, 140.8, 140.5, 133.2, 132.9, 129.1, 128.3, 128.3, 127.8, 127.6, 114.4, -1.0 ppm. 
LRMS (DEP/EI-Orbitrap): m/z [%]: 252.1 (30), 237.1 (100), 178.1 (12), 75.1 (8). HRMS (EI-Or-
bitrap): m/z calcd for C17H20Si+: 252.1334; found: 252.1328. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥(cm 
- 1): 
3081 (vw), 3053 (vw), 3023 (vw), 2955 (w), 2896 (vw), 1610 (vw). 
3,3',6,6'-Tetrahydro-2H,2'H-4,4'-bipyran (11c)* 
Under inert atmosphere, 4-bromo-3,6-dihydro-2H-pyran (2.0 mmol, 1.0 equiv) was dis-
solved in a reaction flask in THF (5.0 mL) and the solution was cooled down to - 78 °C 
before adding a solution of t-BuLi in pentane (4.0 mmol, 2.0 equiv) dropwise. The mix-
ture was stirred for 30 min before tributylborate (270 µL, 1.0 mmol, 0.5 equiv) was added dropwise at 
–78 °C. The mixture was stirred for 30 min at –78 °C before warming to 0 °C and was then stirred for 
another 1 h. Then, after cooling back to –78 °C, iodine (1.52 g, 6.0 mmol, 3.0 equiv) dissolved in THF 
(2.0 mL), was added dropwise to the solution. After 20 min a suspension of sodium methoxide (405 mg, 
7.5 mmol, 3.75 equiv) in methanol (2.0 mL) was added at once. The reaction was allowed to reach room 
temperature, after which it was completed, providing 11c (0.88 mmol, 146 mg, 88%) after purification 
as greenish oil. Rf = 0.30 (hexane/Et2O 8:2, UV, PAA, KMnO4). 1H NMR (400 MHz, C6D6) δ 5.31 (s, 
2H), 4.09 (d, J = 2.1 Hz, 4H), 3.65 (t, J = 5.6 Hz, 4H), 2.03 – 1.91 (m, 4H) ppm. 13C NMR (101 MHz, 
C6D6) δ 133.5, 121.0, 65.8, 64.4, 25.5 ppm LRMS (DEP/EI-Orbitrap): m/z [%]: 166.1 (40), 137.1 (10), 
121.1 (15). HRMS (EI-Orbitrap): m/z calcd for C10H14O2+: 166.0994; found: 166.0988. IR (Diamond-
ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 2927 (w), 2848 (w), 1724 (w), 1671 (vw), 1627 (w). 
1,2-Dimethoxy-4-(1-phenylvinyl)benzene (12a) 
Using (1-bromovinyl)benzene and (3,4-dimethoxyphenyl)lithium according to 
general procedure G (a) provided 12a (0.50 mmol, 120 mg, 50%) as colorless 
oil. Rf = 0.40 (hexane/EtOAc 9:1, UV, PAA, KMnO4). 1H NMR (400 MHz, 
CDCl3) δ 7.39 – 7.30 (m, 5H), 6.92 – 6.87 (m, 2H), 6.83 (d, J = 8.0 Hz, 1H), 5.40 (dd, J = 10.1, 1.3 Hz, 
2H), 3.90 (s, 3H), 3.84 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 149.8, 148.9, 148.6, 141.7, 134.4, 
128.4, 128.3, 127.9, 121.0, 113.3, 111.5, 110.8, 56.0, 56.0 ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 
240.1 (100), 225.1 (10), 209.1 (5), 193.1 (10), 181.1 (10). HRMS (EI-Orbitrap): m/z calcd for 
C16H16O2+: 240.1150; found: 240.1140. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3055 (vw), 2999 (w), 
2934 (w), 2835 (w), 1601 (w). 
2-(1-(3,4-Dimethoxyphenyl)vinyl)benzo[b]thiophene (12b) 
Using 2-(1-bromovinyl)benzo[b]thiophene and (3,4-dimethoxyphenyl)lith-
ium according to general procedure G (a) provided 12b (0.52 mmol, 154 mg, 
52%) as colorless oil. Rf = 0.30 (hexane/EtOAc 9:1, UV, PAA, KMnO4). 1H 
NMR (400 MHz, CDCl3) δ 7.82 – 7.76 (m, 1H), 7.68 – 7.64 (m, 1H), 7.36 – 7.28 (m, 2H), 7.13 (s, 1H), 
7.06 (dd, J = 8.2, 2.1 Hz, 1H), 7.00 (d, J = 2.0 Hz, 1H), 6.90 (d, J = 8.3 Hz, 1H), 5.65 (s, 1H), 5.36 (s, 
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1H), 3.93 (s, 3H), 3.88 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 149.2, 148.7, 145.1, 143.6, 140.2, 
139.6, 133.4, 124.8, 124.5, 123.8, 123.6, 122.3, 121.1, 115.3, 111.8, 110.9, 56.1 ppm. One carbon signal 
could not be detected. LRMS (DEP/EI-Orbitrap): m/z [%]: 296.1 (100), 281.1 (10), 265.1 (10), 249.0 
(10), 237.1 (5). HRMS (EI-Orbitrap): m/z calcd for C18H16O2S+: 296.0871; found: 296.0864. IR (Dia-
mond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3056 (vw), 3000 (w), 2933 (w), 2834 (w), 1667 (w), 1602 (w), 1578 
(w), 1512 cm-1 (vs). 
4-(Prop-1-en-2-yl)benzonitrile (12c) 
Using 2-bromoprop-1-ene and (4-cyanophenyl)lithium according to general proce-
dure G (a) provided 12c (0.35 mmol, 50 mg, 35%) as yellowish oil. Rf = 0.50 (hex-
ane/EtOAc 9:1, UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 7.60 (d, J = 8.5, 
2H), 7.53 (d, J = 8.5, 2H), 5.46 (s, 1H), 5.25−5.24 (m, 1H), 2.15 (s, 3H) ppm. LRMS (DEP/EI-Or-
bitrap): m/z [%]: 143.1 (100), 127.9 (50), 116.0 (60). Analytical data in accordance to literature.217 
4-(Prop-1-en-2-yl)benzoic acid (12d)* 
Using 2-bromoprop-1-ene and lithium (4-carboxylatophenyl)lithium according to 
general procedure G (a) provided 12d (0.53 mmol, 86 mg, 53%) as colorless solid. 
Rf = 0.30 (CH2Cl2/MeOH 99:1, UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) 
δ 8.08 (d, J = 8.0 Hz, 2H), 7.56 (d, J = 8.4 Hz, 2H), 5.50 (s, 1H), 5.24 – 5.21 (m, 1H), 2.19 (s, 3H) ppm. 
The carboxylic acid proton was not observed. LRMS (DEP/EI-Orbitrap): m/z [%]: 162.1 (5), 144.0 (5), 
133.1 (5), 120.1 (50), 105.0 (100). Analytical data in accordance to literature.218 
1-Phenylcyclohept-1-ene (13)* 
For the following preparation a modified procedure by Keay et al. was used.219 In a dry 
Schlenk flask N'-cycloheptylidene-4-methylbenzenesulfonohydrazide (1.0 mmol, 
1.0 equiv) was added under nitrogen stream. Then, hexane (2 mL) was added resulting in 
a suspension. After cooling down to –78 °C, TMEDA (1 mL) was added and the mixture 
was further stirred for 10 min. Then, a solution of n-BuLi in hexanes (3.0 mmol, 3.0 equiv) was added 
at –78 °C resulting in a red colored solution. After 10 min of stirring, the reaction mixture was allowed 
to reach 0 °C for 15 min (N2 evolution was observed) before cooling down to –78 °C again. B(On-Bu)3 
was added and after 5 min of stirring the solution was allowed to warm to 0 °C. The solvent was re-
moved in vacuo with the Schlenk line. At 0 °C phenylmagnesium bromide (3.0 mmol, 3.0 equiv) was 
added. The resulting mixture was allowed to reach room temperature after 10 min and was stirred for 1 
h. After cooling down to –78 °C, iodine (4.0 mmol, 4.0 equiv, dissolved in 4 mL THF) was added and 
 
217 G. Pratsch, L. E. Overman, J. Org. Chem. 2015, 80, 11388–11397. 
218 a) B. Yang, Z. Lu, ACS Catal., 2017, 7, 8362–8365; b) R. L. Letsinger, S. B. Hamilton, J. Am. Chem. Soc. 
1959, 81, 3009–3012. 
219 M. S. Passafaro, B. A. Keay, Tetrahedron Lett. 1996, 37, 429–432. 
112      C. EXPERIMENTAL PART 
the reaction mixture stirred for 20 min, followed by portion wise addition of sodium methoxide 
(8.0 mmol, 8.0 equiv, dissolved in 5 mL MeOH). The resulting mixture was allowed to reach 0 °C after 
10 min and was stirred for further 30 min. The reaction was then quenched by the addition of sat. aq. 
Na2S2O3 and extracted with diethyl ether (3 × 20 mL). The combined organic phases were dried over 
MgSO4, filtered and concentrated under reduced pressure. The crude product was purified by column 
chromatography on silica gel yielding 13 as a colorless liquid (0.29 mmol, 50 mg, 29 %). Rf = 0.89 
(hexane, UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 7.29 – 7.18 (m, 4H), 7.16 – 7.07 (m, 1H), 
6.02 (t, J = 6.8 Hz, 1H), 2.59 – 2.45 (m, 2H), 2.29 – 2.15 (m, 2H), 1.76 (quint, J = 5.9 Hz, 2H), 1.61 – 
1.52 (m, 2H), 1.52 – 1.40 (m, 2H) ppm. 13C NMR (101 MHz, CDCl3) δ 145.1, 145.0, 130.6, 128.2, 
126.4, 125.8, 33.0, 32.9, 29.0, 27.1, 26.9 ppm. LRMS (DEP/EI-Orbitrap): m/z [%]: 172.1 (50), 155.1 
(9), 144.1 (74), 143.1 (34), 141.1 (15), 130.1 (23), 129.1 (100). HRMS (EI-Orbitrap): m/z calcd for 
C13H16+: 172.1252; found: 172.1246. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3056 (w), 3024 (w), 2916 
(m), 2846 (w), 1639 (w). 
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3.5 Representative NMR Spectra 
 
 
Figure 11: 1H NMR (400 MHz, CDCl3) and 13C NMR (101 MHz, CDCl3) of 3-Bromo-9-phenyl-6-(prop-1-en-
2-yl)-9H-carbazole (10c).  
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4 Catalyst‐Free Enantiospecific Olefination with in situ Generated Or-
ganocerium Species220 
4.1 Synthesis of the Exchange Reagent 
4.1.1 Preparation of CeCl3•2LiCl (0.33 M in THF) 
Adapted from a previously reported procedure,49 commercially available CeCl3•7H2O (50.0 mmol, 
18.63 g) was mixed with LiCl (100 mmol, 4.24 g) and water (20 mL) in a 500 mL Schlenk flask and 
the mixture was stirred vigorously for 4 h at room temperature under high vacuum. Stirring under vac-
uum was continued for 4 h at 40 °C, 4 h at 60 °C, 4 h at 80 °C, 4 h at 100 °C, 4 h at 120 °C, 4 h at 140 
°C and lastly 4 h at 160 °C. The resulting solid was allowed to reach room temperature and 150 mL of 
dry THF were added. To the resulting slurry, molecular sieves (25.0 g, 4 Å) were added and the mixture 
was stirred vigorously for 24 h at room temperature. In a last step, the molecular sieves were filtered 
off via Schlenk-filtration under a nitrogen atmosphere, resulting in a clear and slightly orange solution 
of CeCl3•2LiCl (0.33 M), which was stable for several months under nitrogen storage at room temper-
ature. 
4.1.2 Preparation of n-Bu3Ce•5LiCl 
A Schlenk flask was charged with CeCl3•2LiCl (0.33 M, 0.33 mL, 0.11 mmol, 0.33 equiv) solution and 
cooled to –30 °C. A solution of n-BuLi in hexanes (2.32 M, 0.14 mL, 0.33 mmol, 1.00 equiv) was then 
added and the resulting yellow solution was stirred for 15 min at –30 °C before being used. 
4.2 General Procedures 
4.2.1 General Procedure H: Zweifel Olefination of (Hetero)Aromatic Halides with Vinyl 4,4,5,5-
Tetramethyl-1,3,2-Dioxaborolanes using n-Bu3Ce•5LiCl (6a–u, 8a–f) 
 
To a freshly prepared yellow solution of n-Bu3Ce•5LiCl (0.11 mmol, 0.37 equiv) at –50 °C was added 
the (hetero)aryl iodide or bromide (0.30 mmol, 1.00 equiv, dissolved in 1.0 mL of THF) and stirred for 
15 min. After complete exchange, which was followed by GC and GC-MS, the desired vinyl 4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (0.26 mmol, 0.85 equiv, dissolved in 1.0 mL of THF) was added and 
the resulting solution was stirred for 20 min at –50 °C. The solution was allowed to gradually warm to 
 
220 The full supporting information can be found under the following link: https://doi.org/10.1002/anie.201810327 
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room temperature and further stirred for 20 min. After cooling down to 0 °C, sodium methoxide 
(1.50 mmol, 5.00 equiv, dissolved in 2 mL of MeOH) was first added, followed by dropwise addition 
of iodine (0.45 mmol, 1.50 equiv, dissolved in 1 mL of THF). The mixture was allowed to reach room 
temperature after 10 min and further stirred for 20 min. The reaction was then quenched by the addition 
of sat. aq. Na2S2O3 and extracted with diethyl ether (3 × 15 mL). The combined organic phases were 
dried over MgSO4, filtered and concentrated in vacuo. The crude product was purified by column chro-
matography on silica gel to yield the desired products 6a–u and 8a–f. 
4.2.2 General procedure I: Zweifel Olefination of Vinyl Bromides with (Hetero)Aromatic (10a–l) 
and Aliphatic (11a–h) 4,4,5,5-Tetramethyl-1,3,2-Dioxaborolanes using n-Bu3Ce•5LiCl 
 
To a freshly prepared yellow solution of n-Bu3Ce•5LiCl (0.11 mmol, 0.37 equiv) at –50 °C was added 
the desired vinyl bromide (0.30 mmol, 1.00 equiv, dissolved in 1.0 mL of THF/Et2O 1:1) and stirred 
for 20 min. After complete exchange, which was followed by GC and GC-MS, the desired (hetero)ar-
omatic or aliphatic 4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.26 mmol, 0.85 equiv, dissolved in 1.0 
mL of THF) was added and the resulting solution was stirred for 20 min at –50 °C. The solution was 
allowed to gradually warm to room temperature and stirred for further 20 min. After cooling back to –
50 °C, sodium methoxide (1.50 mmol, 5.00 equiv, dissolved in 2 mL of MeOH) was first added, fol-
lowed by dropwise addition of iodine (0.45 mmol, 1.50 equiv, dissolved in 1 mL of THF). The mixture 
was allowed to reach room temperature after 10 min and further stirred for 20 min. The reaction was 
quenched by addition of sat. aq. Na2S2O3 and extracted with diethyl ether (3 × 15 mL). The combined 
organic phases were dried over MgSO4, filtered and concentrated in vacuo. The crude product was 
purified by column chromatography on silica gel to yield the desired products 10a–i and 11a–h. 
4.2.3 General Procedure J: Synthesis of Tertiary Alcohols 12a–f using n-Bu3Ce•5LiCl 
 
To a freshly prepared yellow solution of n-Bu3Ce•5LiCl (0.15 mmol, 0.37 equiv) at –50 °C was added 
the (hetero)aryl bromide (0.40 mmol, 1.00 equiv, dissolved in 1.0 mL of THF) and stirred for 15 min. 
After complete exchange, which was followed by GC and GC-MS, the desired aliphatic or aromatic 
ketone (0.34 mmol, 0.85 equiv, dissolved in 1.0 mL of THF) was added and the resulting solution was 
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stirred for 5 min at –50 °C and then warmed to room temperature. The reaction was then quenched by 
the addition of sat. aq. NH4Cl and extracted with EtOAc (3 × 15 mL). The combined organic phases 
were dried over MgSO4, filtered and concentrated in vacuo. The crude product was purified by column 
chromatography on silica gel to yield the desired products 12a–f. 
4.3 Optimizations 
Table 5: Optimizations on Br/Ce exchanges. 
 
RLi x (equiv) RxCeCl3-x conv. (%) 
n-BuLi 1 (1.1) n-BuCeCl2 97 
n-BuLi 2 (2.2) n-Bu2CeCl 95 
n-BuLi 3 (3.3) n-Bu3Ce 93  
MeLi 1 (1.1) MeCeCl2 90 
MeLi 2 (2.2) Me2CeCl 38 
MeLi 3 (3.3) Me3Ce 30 
s-BuLi 1 (1.1) s-BuCeCl2 n.d. 
s-BuLi 2 (2.2) s-Bu2CeCl 78 
s-BuLi 3 (3.3) s-Bu3Ce 55 
 
Conversion rates of the 1-bromo-4-chlorobenzene were assessed by hydrolysis and GC analysis with 
n-undecane as an internal standard, see Table 5. 
4.4 Experimental Data 
4.4.1 Synthesis of 4,4,5,5-Tetramethyl-1,3,2-Dioxaborolanes 
(E)-4,4,5,5-Tetramethyl-2-(1-phenylprop-1-en-1-yl)-1,3,2-dioxaborolane (SM9) 
Following a procedure published by Tanaka et al.,221 SM9 was synthesized as a colorless 
oil (E/Z = 99:1, 0.25 mmol, 61 mg, 25%). Rf = 0.40 (hexane/EtOAc 99:1, UV, KMnO4, 
PAA). 1H NMR (400 MHz, CDCl3) δ 7.32 (t, J = 7.6 Hz, 2H), 7.23 – 7.12 (m, 3H), 6.72 (q, J = 7.0 Hz, 
1H), 1.77 (d, J = 7.0 Hz, 3H), 1.27 (s, 12H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 244.1 (29), 229.2 
(10), 187.1 (81), 171.1 (11), 143.1 (100), 129.0 (11), 116.0 (59), 105.0 (69), 91.0 (22), 71.1 (14), 55.0 
(15). Analytical data in accordance to literature.221 
(E)-4,4,5,5-Tetramethyl-2-(pent-1-en-1-yl)-1,3,2-dioxaborolane (SM10) 
Following a procedure published by Tanaka et al.,221 SM10 was synthesized as a 
colorless solid (E/Z = 88:12, 0.54 mmol, 106 mg, 54%). Rf = 0.30 (hexane/EtOAc 99:1, UV, KMnO4, 
PAA). 1H NMR (400 MHz, CDCl3) δ 6.63 (dt, J = 18.0, 6.4 Hz, 1H), 5.43 (dt, J = 18.0, 1.6 Hz, 1H), 
 
221 S. Tanaka, Y. Sairo, T. Yamamoto, T. Hattori, Org. Lett. 2018, 20, 1828–1831. 
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2.18 – 2.09 (m, 2H), 1.44 (h, J = 7.4 Hz, 2H), 1.26 (s, 12H), 0.91 (t, J = 7.4 Hz, 3H) ppm. LRMS 
(DEP/EI-Orbitrap): m/z (%): 196.2 (10), 181.1 (52), 153.1 (59), 139.1 (13), 110.1 (82), 97.1 (100), 85.1 
(42), 69.1 (44), 55.1 (49). Analytical data in accordance to literature.221 
(R)-2-(1-(4-Methoxyphenyl)ethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (SM11) 
Following a procedure published by Noh et al.,222 SM11 was synthesized as a 
colorless oil (98% ee, 1.56 mmol, 408 mg, 52%). Rf = 0.75 (hexane/EtOAc 95:5, 
UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.20 – 7.02 (m, 2H), 6.87 – 
6.76 (m, 2H), 3.78 (s, 3H), 2.37 (q, J = 7.5 Hz, 1H), 1.30 (d, J = 7.5 Hz, 3H), 1.21 (s, 6H), 1.19 (s, 
6H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 262.1 (40), 247.2 (100), 161.0 (20), 147.0 (42), 135.1 
(50), 121.1 (16), 91.0 (18). Analytical data in accordance to literature.222 
(S)-2-(1-(4-Methoxyphenyl)ethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (SM12) 
Following a procedure published by Noh et al.,222 SM12 was synthesized as a 
colorless oil (99% ee, 0.66 mmol, 173 mg, 66%). Rf = 0.75 (hexane/EtOAc 95:5, 
UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.20 – 7.02 (m, 2H), 6.87 – 
6.76 (m, 2H), 3.78 (s, 3H), 2.37 (q, J = 7.5 Hz, 1H), 1.30 (d, J = 7.5 Hz, 3H), 1.21 (s, 6H), 1.19 (s, 
6H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 262.1 (40), 247.2 (100), 161.0 (20), 147.0 (42), 135.1 
(50), 121.1 (16), 91.0 (18). Analytical data in accordance to literature.222 
(R)-2-(2,3-Dihydro-1H-inden-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (SM13) 
Following a procedure published by Noh et al.,222 SM13 was synthesized as a colorless 
oil (97% ee, 2.50 mmol, 610 mg, 50%). Rf = 0.36 (hexane/EtOAc 99:1, UV, KMnO4, 
PAA). 1H NMR (400 MHz, CDCl3) δ 7.30 – 7.26 (m, 1H), 7.23 – 7.19 (m, 1H), 7.14 
– 7.05 (m, 2H), 2.97 – 2.87 (m, 2H), 2.73 (t, J = 8.7 Hz, 1H), 2.28 – 2.17 (m, 1H), 2.14 – 2.03 (m, 1H), 
1.26 (s, 6H), 1.25 (s, 6H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 244.2 (30), 229.1 (10), 143.1 (33), 
116.1 (100), 85.1 (75). Analytical data in accordance to literature.222 
(S)-2-(2,3-Dihydro-1H-inden-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (SM14) 
Following a procedure published by Noh et al.,222 SM14 was synthesized as a colorless 
oil (97% ee, 2.72 mmol, 665 mg, 54%). Rf = 0.36 (hexane/EtOAc 99:1, UV, KMnO4, 
PAA). 1H NMR (400 MHz, CDCl3) δ 7.30 – 7.26 (m, 1H), 7.23 – 7.19 (m, 1H), 7.14 
– 7.05 (m, 2H), 2.97 – 2.87 (m, 2H), 2.73 (t, J = 8.7 Hz, 1H), 2.28 – 2.17 (m, 1H), 2.14 – 2.03 (m, 1H), 
1.26 (s, 6H), 1.25 (s, 6H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 244.2 (30), 229.1 (10), 143.1 (33), 
116.1 (100), 85.1 (75). Analytical data in accordance to literature.222 
  
 
222 D. Noh, S. K. Yoon, J. Won, J. Y. Lee, J. Yun, Chem. Asian J. 2011, 6, 1967–1969. 
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 (S)-2-(1,2-Diphenylethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (SM15) 
Following a procedure published by Noh et al.,222 SM15 was synthesized as a colorless oil 
(98% ee, 2.03 mmol, 620 mg, 70%). Rf = 0.40 (hexane/EtOAc 99:1, UV, KMnO4, PAA). 
1H NMR (400 MHz, CDCl3) δ 7.29 – 7.12 (m, 10H), 3.17 (dd, J = 13.5, 9.8 Hz, 1H), 2.98 
(dd, J = 13.4, 6.9 Hz, 1H), 2.70 (dd, J = 9.8, 6.8 Hz, 1H), 1.12 (s, 6H), 1.11 (s, 6H) ppm. LRMS 
(DEP/EI-Orbitrap): m/z (%): 308.2 (13), 217.1 (100), 180.0 (15), 131.0 (20), 117.0 (48), 104.0 (20), 
91.0 (75). Analytical data in accordance to literature.222 
(R)-2-(1,2-Diphenylethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (SM16) 
Following a procedure published by Noh et al.,222 SM16 was synthesized as a colorless oil 
(98% ee, 1.60 mmol, 500 mg, 54%). Rf = 0.40 (hexane/EtOAc 99:1, UV, KMnO4, PAA). 
1H NMR (400 MHz, CDCl3) δ 7.29 – 7.12 (m, 10H), 3.17 (dd, J = 13.5, 9.8 Hz, 1H), 2.98 
(dd, J = 13.4, 6.9 Hz, 1H), 2.70 (dd, J = 9.8, 6.8 Hz, 1H), 1.12 (s, 6H), 1.11 (s, 6H) ppm. LRMS 
(DEP/EI-Orbitrap): m/z (%): 308.2 (13), 217.1 (100), 180.0 (15), 131.0 (20), 117.0 (48), 104.0 (20), 
91.0 (75). Analytical data in accordance to literature.222 
2-((4R,5R)-5-(4-Chlorophenyl)octan-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (SM17) 
Following a procedure published by Logan et al.,223 SM17 was synthesized as a 
colorless solid (dr > 99:1, 0.54 mmol, 190 mg, 27%). Rf = 0.33 (hexane/EtOAc 
99:1, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.20 (d, J = 8.4 Hz, 2H), 
7.11 (d, J = 8.4 Hz, 2H), 2.54 (td, J = 10.4, 3.5 Hz, 1H), 1.88 – 1.74 (m, 1H), 1.60 – 1.50 (m, 1H), 1.44 
– 1.20 (m, 7H), 0.98 (s, 6H), 0.96 (s, 6H), 0.91 (t, J = 7.2 Hz, 3H), 0.80 (t, J = 7.3 Hz, 3H) ppm. LRMS 
(DEP/EI-Orbitrap): m/z (%): 307.1 (10), 251.0 (12), 221.9 (13), 167.0 (30), 125.0 (100), 101.0 (20), 
85.1 (30). Analytical data in accordance to literature.223 
2-((1S,2R)-2-(4-Chlorophenyl)cyclopentyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (SM18) 
Following a procedure published by Logan et al.,223 SM18 was synthesized as a 
colorless oil (dr > 99:1, 0.19 mmol, 57 mg, 38%). Rf = 0.19 (hexane/EtOAc 99:1, UV, 
KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.23 – 7.13 (m, 4H), 3.33 – 3.31 (m, 
1H), 2.07 (dtd, J = 11.8, 7.9, 3.5 Hz, 1H), 1.96 – 1.72 (m, 5H), 1.70 – 1.59 (m, 1H), 
0.98 (s, 6H), 0.94 (s, 6H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 306.1 (13), 205.0 (12), 178.0 (66), 
151.0 (30), 138.0 (35), 115.0 (40), 101.1 (28), 84.1 (100). Analytical data in accordance to literature.223 
  
 
223 K. M. Logan, S. R. Sardini, S. D. White, M. K. Brown, J. Am. Chem. Soc. 2018, 140, 159–162. 
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4,4,5,5-Tetramethyl-2-((1R,2S,3R,5R)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-yl)-1,3,2-
dioxaborolane (SM19) 
Following a procedure published by Odachowski et al.,224 SM19 was synthesized as a 
colorless oil (dr > 99:1, 2.27 mmol, 600 mg, 69%). Rf = 0.40 (hexane/EtOAc 98:2, UV, 
KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 2.29 (dtd, J = 9.4, 6.2, 2.0 Hz, 1H), 2.17 – 
2.09 (m, 1H), 2.08 – 1.99 (m, 1H), 1.91 – 1.79 (m, 2H), 1.75 (ddd, J = 6.7, 5.0, 2.0 Hz, 1H), 1.25 (s, 
6H), 1.24 (s, 6H), 1.16 (s, 3H), 1.03 (s, 3H), 1.02 (s, 3H), 0.90 – 0.84 (m, 1H), 0.81 (d, J = 9.4 Hz, 1H) 
ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 264.1 (8), 249.2 (10), 208.2 (40), 136.1 (59), 121.1 (32), 
101.1 (51), 83.1 (100), 69.1 (40). Analytical data in accordance to literature.224 
4.4.2 Synthesis of Vinyl Bromides 
1-(1-Bromovinyl)-4-methoxybenzene (SM20) 
Following a procedure published by Rosiak et al.,225 SM20 was synthesized as a 
light-yellow oil (12.7 mmol, 2.7 g, 85%). Rf = 0.50 (hexane/EtOAc 99:1, UV, 
KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.56 – 7.49 (m, 2H), 6.91 – 6.81 (m, 
2H), 6.01 (d, J = 2.0 Hz, 1H), 5.67 (d, J = 2.0 Hz, 1H), 3.83 (s, 3H) ppm. LRMS (DEP/EI-Orbitrap): 
m/z (%): 213.9 (12), 133.0 (100), 118.0 (20), 103.0 (11), 89.0 (27), 77.0 (14), 63.0 (22). Analytical data 
in accordance to literature.225 
5-(1-Bromovinyl)-1,2,3-trimethoxybenzene (SM21) 
Following a procedure published by Rosiak et al.,225 SM21 was synthesized as an 
orange oil (3.78 mmol, 1.03 g, 85%). Rf = 0.35 (hexane/EtOAc 90:10, UV, KMnO4, 
PAA). 1H NMR (400 MHz, CDCl3) δ 6.81 (s, 2H), 6.05 (d, J = 2.0 Hz, 1H), 5.74 
(d, J = 2.0 Hz, 1H), 3.89 (s, 6H), 3.86 (s, 3H) ppm. LRMS (DEP/EI-Orbitrap): 
m/z (%): 272.0 (25), 193.1 (100), 163.1 (19), 150.1 (15), 133,0 (13), 119.0 (11), 92.0 (12). Analytical 
data in accordance to literature.226 
4.4.3 Remaining Experimental Data 
4-4(Chlorophenyl)-3,6-dihydro-2H-pyran (6a) 
Using 1-bromo-4-chlorobenzene and 2-(3,6-dihydro-2H-pyran-4-yl)-4,4,5,5-tetra-
methyl-1,3,2-dioxaborolane procedure A (0.45 mmol scale), provided 6a (0.32 
mmol, 63 mg, 86%) as a colorless oil. Rf = 0.22 (hexane/EtOAc 94:6, UV, KMnO4, 
PAA). 1H NMR (400 MHz, CDCl3) δ 7.37 – 7.27 (m, 4H), 6.13 – 6.09 (m, 1H), 4.33 – 4.30 (m, 2H), 
 
224 M. Odachowski, A. Bonet, S. Essafi, P. Conti-Ramsden, J. N. Harvey, D. Leonori, V. K. Aggarwal, J. Am. 
Chem. Soc. 2016, 138, 9521–9532. 
225 A. Rosiak, W. Frey, J. Christoffers, Eur. J. Org. Chem. 2006, 4044–4054. 
226 A. Hamze, J.-D. Brion, M. Alami, Org. Lett. 2012, 14, 2782–2785. 
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3.93 (t, J = 5.5 Hz, 2H), 2.49 (tt, J = 5.6, 2.7 Hz, 2H) ppm. 13C NMR (101 MHz, CDCl3) δ 138.8, 133.2, 
133.1, 128.7, 126.1, 123.1, 65.9, 64.5, 27.2 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 194.0 (15), 176.0 
(14), 159.1 (100), 141.1 (15), 131.0 (28), 129.1 (48), 115.1 (35). HRMS (EI-Orbitrap): m/z calcd for 
C11H11ClO+: 194.0498; found: 194.0491. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
- 1): 3302 (vw), 3038 (vw), 
2962 (w), 2924 (w), 2852 (w), 2829 (w), 2754 (vw), 1687 (vw), 1649 (vw), 1592 (w), 1491 (s), 1462 
(w), 1426 (w), 1404 (m), 1385 (m), 1362 (m), 1284 (w), 1257 (w), 1229 (m), 1132 (vs), 1093 (vs), 1045 
(m), 1012 (s), 975 (m), 853 (m), 807 (s), 731 (s). 
Ethyl 4´-chloro-2,3,4,5-tetrahydro-[1,1´-biphenyl]-4-carboxylate (6b) 
Using 1-bromo-4-chlorobenzene and ethyl 4-(4,4,5,5-tetramethyl-1,3,2-di-
oxaborolan-2-yl)cyclohex-3-ene-1-carboxylate according to general proce-
dure H, provided 6b (0.13 mmol, 34 mg, 50%) as a colorless oil. Fast de-
composition of product 6b to the carboxylic acid was observed by NMR 
spectroscopy. Rf = 0.35 (hexane/EtOAc 95:5, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.33 
– 7.23 (m, 4H), 6.14 – 6.04 (m, 1H), 4.17 (q, J = 7.1 Hz, 2H), 2.69 – 2.52 (m, 1H), 2.51 – 2.41 (m, 3H), 
2.23 – 2.13 (m, 1H), 1.91 – 1.76 (m, 1H), 1.28 (t, J = 7.1 Hz, 3H) ppm. 13C NMR (101 MHz, CDCl3) 
δ 175.8, 140.3, 135.4, 132.7, 128.5, 126.4, 123.3, 60.6, 39.1, 28.3, 26.8, 25.7, 14.4 ppm. LRMS 
(DEP/EI-Orbitrap): m/z (%): 192.1 (32), 190.1 (100), 155.1 (45), 153.1 (28), 129.1 (15), 125.0 (34). 
HRMS (EI-Orbitrap): m/z calcd for C15H17ClO2+: 264.0917, found 264.0907. IR (Diamond-ATR, neat) 
𝜈𝑚𝑎𝑥 (cm
-1): 2979 (w), 2958 (w), 2930 (w), 2840 (w), 1729 (vs), 1493 (m), 1436 (w), 1402 (w), 1378 
(w), 1311 (w), 1255 (w), 1221 (m), 1175 (m), 1094 (m), 1032 (m), 1011 (w), 806 (m). 
4-(3,6-Dihydro-2H-pyran-4-yl)-N,N-diisopropylbenzamide (6c) 
 Using 4-iodo-N,N-diisopropylbenzamide and 2-(3,6-dihydro-2H-pyran-4-yl)-
4,4,5,5-tetramethyl-1,3,2-dioxaborolane according to general procedure H, pro-
vided 6c (0.14 mmol, 39 mg, 52%) as a colorless oil. Rf = 0.15 (hexane/EtOAc 
80:20, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.42 – 7.37 (m, 2H), 
7.31 – 7.26 (m, 2H), 6.18 – 6.13 (m, 1H), 4.34 – 4.32 (m, 2H), 3.93 (t, J = 5.4 Hz, 2H), 3.89 – 3.39 (m, 
2H), 2.58 – 2.45 (m, 2H), 1.71 – 0.98 (m, 12H) ppm. 13C NMR (101 MHz, CDCl3) δ 170.9, 140.6, 
137.9, 133.7, 126.0, 124.8, 123.3, 66.0, 64.5, 51.2, 46.4, 27.2, 20.9 ppm. LRMS (DEP/EI-Orbitrap): 
m/z (%) = 287.1 (5), 244.1 (30), 187.1 (43), 97.1 (16), 71.1 (40), 57.1 (94), 43.0 (100). HRMS (DEP/EI-
Orbitrap): m/z calcd for C18H25NO2+: 287.1885; found: 287.1870. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 
(cm-1): 2966 (m), 2931 (m), 2878 (w), 2862 (w), 1722 (w), 1691 (w), 1625 (s), 1608 (s), 1512 (w), 1447 
(s), 1440 (s), 1402 (m), 1370 (s), 1339 (vs), 1292 (m), 1261 (m), 1212 (m), 1185 (m), 1160 (m), 1135 
(s), 1097 (m), 1077 (m), 1036 (m), 1017 (m), 989 (m), 975 (m), 939 (m), 917 (m), 877 (m), 849 (m), 
827 (m), 762 (m), 730 (m). 
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tert-Butyl 4-(4-methoxyphenyl)-3,6-dihydropyridine-1(2H)-carboxylate (6d) 
Using 1-bromo-4-methoxybenzene and tert-butyl 4-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)-3,6-dihydropyridine-1(2H)-carboxylate according to 
general procedure H (0.50 mmol scale), provided 6d (0.26 mmol, 75 mg, 61%) 
as a light-yellow oil. Rf = 0.16 (hexane/EtOAc 95:5, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) 
δ 7.34 – 7.27 (m, 2H), 6.90 – 6.83 (m, 2H), 5.94 (s, 1H), 4.05 (d, J = 1.6 Hz, 2H), 3.81 (s, 3H), 3.62 (t, 
J = 5.6 Hz, 2H), 2.49 (s, 2H), 1.49 (s, 9H) ppm. 13C NMR (101 MHz, CDCl3) δ 159.0, 155.0, 133.4, 
130.7, 126.1, 119.1, 113.8, 79.7, 55.4, 44.0, 39.9, 28.6, 27.6 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 
232.1 (100), 202.1 (15), 188.1 (34), 160.0 (16), 145.0 (16), 115.0 (13), 57.0 (63), 41.0 (28). HRMS 
(EI-Orbitrap): m/z calcd for C17H23NO3+: 289.1678; found: 289.1690. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 
(cm-1): 3037 (vw), 3002 (vw), 2975 (w), 2932 (w), 2836 (w), 1693 (vs), 1608 (m), 1578 (vw), 1513 (s), 
1478 (w), 1454 (m), 1421 (s), 1365 (m), 1339 (w), 1290 (m), 1278 (m), 1237 (vs), 1170 (s), 1114 (m), 
1061 (w), 1036 (m), 988 (w), 988 (w), 971 (w), 938 (vw), 864 (w), 840 (w), 809 (w), 769 (w), 730 (vw). 
(3-(3,6-Dihydro-2H-pyran-4-yl)phenyl)trimethylsilane (6e) 
Using (3-bromophenyl)trimethylsilane and 2-(3,6-dihydro-2H-pyran-4-yl)-
4,4,5,5-tetramethyl-1,3,2-dioxaborolane according to general procedure H 
(0.40 mmol scale), provided 6e (0.23 mmol, 53 mg, 67%) as a colorless oil. Rf 
= 0.31 (hexane/EtOAc 95:5, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.54 (s, 1H), 7.46 – 
7.41 (m, 1H), 7.40 – 7.31 (m, 2H), 6.12 (tt, J = 3.0, 1.6 Hz, 1H), 4.34 (q, J = 2.8 Hz, 2H), 3.95 (t, J = 
5.5 Hz, 2H), 2.62 – 2.46 (m, 2H), 0.29 (s, 9H) ppm. 13C NMR (101 MHz, CDCl3) δ 140.7, 139.7, 134.7, 
132.5, 129.7, 128.0, 125.5, 122.6, 66.1, 64.7, 27.5, -1.0 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 231.1 
(88), 217.1 (66), 187.1 (100), 155.1 (18), 143.1 (21), 142.1 (53), 128.1 (58), 115.1 (40), 75.0 (57). 
HRMS (EI-Orbitrap): m/z calcd for C14H20OSi+: 232.1283; found: 232.1278. IR (Diamond-ATR, neat) 
𝜈𝑚𝑎𝑥 (cm
-1): 3055 (vw), 3024 (vw), 2953 (w), 2923 (w), 2895 (w), 2848 (w), 2810 (w), 1726 (vw), 
1684 (vw), 1462 (vw), 1446 (vw), 1403 (w), 1384 (w), 1354 (w), 1313 (vw), 1261 (w), 1247 (m), 1229 
(w), 1133 (m), 1120 (m), 1080 (w), 1046 (w), 1013 (w), 982 (w), 963 (w), 943 (w), 910 (w), 856 (s), 
837 (vs), 794 (w), 778 (w), 753 (m), 736 (w), 692 (w). 
4-(2-Fluorophenyl)-3,6-dihydro-2H-pyran (6f) 
Using 1-bromo-2-fluorobenzene and 2-(3,6-dihydro-2H-thiopyran-4-yl)-4,4,5,5-tetra-
methyl-1,3,2-dioxaborolane according to general procedure H (0.50 mmol scale), pro-
vided 6f (0.30 mmol, 58 mg, 70%) as a light-yellow oil. Rf = 0.20 (hexane/EtOAc 99:1, 
UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.28 – 7.17 (m, 2H), 7.13 – 6.98 (m, 2H), 6.01 (tt, 
J = 4.1, 1.8 Hz, 1H), 3.33 (dt, J = 4.4, 2.3 Hz, 2H), 2.86 (t, J = 5.7 Hz, 2H), 2.71 – 2.60 (m, 2H) ppm. 
13C NMR (101 MHz, CDCl3) δ 159.9 (d, J = 247.0 Hz), 135.2 (d, J = 1.0 Hz), 131.4 (d, J = 14.1 Hz), 
129.7 (d, J = 4.4 Hz), 128.7 (d, J = 8.3 Hz), 124.5 (d, J = 2.0 Hz), 124.2 (d, J = 3.5 Hz), 115.9 (d, J = 
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22.7 Hz), 29.6 (d, J = 3.5 Hz), 26.0, 25.3 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 194.1 (90), 191.0 
(27), 165.0 (100), 159.1 (22), 147.1 (22), 133.0 (42), 109.0 (12). HRMS (EI-Orbitrap): m/z calcd for 
C11H11FS+: 194.0565; found: 194.0559. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3058 (w), 3034 (w), 
2956 (w), 2920 (m), 2893 (w), 2827 (w), 1654 (w), 1613 (w), 1577 (w), 1488 (s), 1449 (m), 1421 (w), 
1348 (w), 1285 (w), 1264 (w), 1235 (m), 1205 (m), 1196 (m), 1144 (w), 1104 (m), 1035 (m), 1009 (m), 
955 (m), 941 (m), 884 (m), 813 (m), 799 (m), 754 (vs). 
2-(3,6-Dihydro-2H-pyran-4-yl)benzonitrile (6g) 
Using 2-bromobenzonitrile and 2-(3,6-dihydro-2H-pyran-4-yl)-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane according to general procedure H (0.50 mmol scale), provided 6g 
(0.31 mmol, 57 mg, 72%) as a light-orange oil. Rf = 0.26 (hexane/EtOAc 85:15, UV, 
KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.70 – 7.64 (m, 1H), 7.55 (td, J = 7.7, 1.4 Hz, 1H), 7.39 
– 7.30 (m, 2H), 6.08 (tt, J = 2.9, 1.6 Hz, 1H), 4.35 – 4.33 (m, 2H), 3.95 (t, J = 5.4 Hz, 2H), 2.57 – 2.48 
(m, 2H) ppm. 13C NMR (101 MHz, CDCl3) δ 145.8, 133.8, 133.2, 132.8, 128.4, 128.1, 127.5, 118.8, 
110.4, 65.5, 64.3, 28.8 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 184.1 (35), 156.1 (100), 140.1 (16), 
129.1 (34), 115.1 (18). HRMS (EI-Orbitrap): m/z calcd for C12H11NO+: 185.0841; found: 185.0833. IR 
(Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3060 (w), 2964 (m), 2920 (w), 2865 (w), 2833 (w), 2748 (w), 
2704 (w), 2223 (m), 1982 (w), 1950 (w), 1836 (w), 1718 (w), 1645 (w), 1593 (w), 1566 (w), 1484 (m), 
1456 (w), 1437 (m), 1382 (m), 1361 (m), 1306 (w), 1286 (w), 1283 (w), 1267 (m), 1252 (w), 1227 (m), 
1198 (m), 1182 (w), 1164 (w), 1131 (vs), 1106 (m), 1071 (m), 1046 (m), 1036 (m), 1012 (m), 979 (m), 
958 (m), 950 (m), 939 (m), 847 (m), 836 (m), 760 (vs), 733 (s). 
5-(3,6-Dihydro-2H-pyran-4-yl)-2,2-difluorobenzo[d][1,3]dioxole (6h) 
Using 5-bromo-2,2-difluorobenzo[d][1,3]dioxole and 2-(3,6-dihydro-2H-py-
ran-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane according to general proce-
dure H (0.40 mmol scale), provided 6h (0.22 mmol, 52 mg, 64%) as a colorless 
oil. Rf = 0.42 (hexane/EtOAc 90:10, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.13 – 7.05 
(m, 2H), 7.04 – 6.97 (m, 1H), 6.06 (tt, J = 3.0, 1.6 Hz, 1H), 4.32 – 4.30 (m, 2H), 3.93 (t, J = 5.4 Hz, 
2H), 2.55 – 2.39 (m, 2H) ppm. 13C NMR (101 MHz, CDCl3) δ 144.1, 142.9, 137.0, 132.0 (t, J = 
255.5 Hz), 131.6, 123.1, 120.0, 109.2, 106.2, 65.8, 64.3, 27.4 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 
240.1 (100), 222.1 (53), 211.0 (32), 197.0 (33), 171.0 (34), 158.0 (44), 131.1 (30), 117.1 (23), 115.1 
(85), 89.0 (29). HRMS (EI-Orbitrap): m/z calcd for C12H10F2O3+: 240.0598; found: 240.0593. IR (Di-
amond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 2966 (w), 2924 (w), 2860 (vw), 2360 (w), 1733 (w), 1501 (m), 1447 
(w), 1387 (w), 1371 (w), 1257 (s), 1238 (vs), 1181 (m), 1158 (m), 1131 (m), 1033 (w), 968 (w), 908 
(w), 808(w). 
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4-(4-Chloro-3-(trifluoromethyl)phenyl)-3,6-dihydro-2H-pyran (6i) 
Using 4-bromo-1-chloro-2-(trifluoromethyl)benzene and 2-(3,6-dihydro-2H-py-
ran-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane according to general procedure 
H (0.40 mmol scale), provided 6i (0.21 mmol, 55 mg, 62%) as a colorless oil. Rf 
= 0.35 (hexane/EtOAc 90:10, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.68 (s, 1H), 7.51 – 
7.40 (m, 2H), 6.20 (tt, J = 3.1, 1.6 Hz, 1H), 4.35 – 4.32 (m, 2H), 3.94 (t, J = 5.4 Hz, 2H), 2.53 – 2.46 
(m, 2H) ppm. 13C NMR (101 MHz, CDCl3) δ 139.2, 132.4, 131.6, 130.9 (q, J = 1.8 Hz), 128.9, 128.5 
(q, J = 31.1 Hz), 124.8, 123.9 (q, J = 5.3 Hz), 123.0 (q, J = 273.3 Hz), 65.9, 64.3, 27.1 ppm. LRMS 
(DEP/EI-Orbitrap): m/z (%): 262.0 (15), 244.0 (25), 227.1 (100), 199.0 (32), 193.0 (29), 183.0 (26), 
177.1 (49), 169.0 (22), 151.0 (19), 128.1 (40). HRMS (EI-Orbitrap): m/z calcd for C12H10ClF3O+: 
262.0372; found: 262.0369. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 2976 (vw), 2934 (vw), 2892 (vw), 
1726 (w), 1696 (w), 1649 (vw), 1604 (w), 1575 (vw), 1482 (m), 1408 (w), 1388 (w), 1358 (w), 
1320 (s), 1261 (m), 1255 (m), 1242 (m), 1177 (s), 1131 (vs), 1115 (s), 1051 (w), 1034 (m), 1011 (w), 
957 (w), 944 (m), 905 (w), 853 (w), 832 (w), 815 (w), 733 (w), 724 (vw), 664 (m). 
5-(3,6-Dihydro-2H-pyran-4-yl)benzofuran (6j) 
Using 5-bromobenzofuran and 2-(3,6-dihydro-2H-pyran-4-yl)-4,4,5,5-tetrame-
thyl-1,3,2-dioxaborolane according to general procedure H (0.40 mmol scale), pro-
vided 6j (0.25 mmol, 50 mg, 73%) as a colorless solid. Rf = 0.22 (hexane/EtOAc 
95:5, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.62 (d, J = 2.2 Hz, 1H), 7.60 (d, J = 1.9 Hz, 
1H), 7.47 (d, J = 8.6 Hz, 1H), 7.37 (dd, J = 8.6, 1.9 Hz, 1H), 6.76 (dd, J = 2.3, 0.9 Hz, 1H), 6.10 (tt, J 
= 3.0, 1.6 Hz, 1H), 4.36 – 4.34 (m, 2H), 3.97 (t, J = 5.5 Hz, 2H), 2.62 – 2.54 (m, 2H) ppm. 13C NMR 
(101 MHz, CDCl3) δ 154.5, 145.6, 135.8, 134.5, 127.7, 122.0, 121.7, 117.4, 111.3, 106.9, 66.0, 64.7, 
27.9 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 200.1 (61), 182.1 (68), 170.1 (61), 157.1 (26), 153.1 
(40), 141.1 (100), 128.1 (39), 115.1 (50). HRMS (EI-Orbitrap): m/z calcd for C13H12O2+: 200.0837; 
found: 200.0832. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3146 (vw), 3114 (vw), 2964 (w), 2923 (w), 
2850 (w), 2830 (w), 2812 (w), 2750 (vw), 1721 (vw), 1605 (vw), 1536 (w), 1467 (m), 1440 (w), 1427 
(w), 1385 (w), 1370 (w), 1332 (w), 1276 (w), 1267 (m), 1238 (w), 1219 (m), 1130 (vs), 1111 (m), 
1073 (w), 1043 (w), 1030 (m), 1011 (w), 982 (w), 965 (w), 945 (w), 878 (w), 870 (m), 850 (w), 
804 (m), 764 (s), 736 (m). Mp (°C) = 80–84. 
5-(3,6-Dihydro-2H-pyran-4-yl)-1-methyl-1H-indole (6k) 
Using 5-bromo-1-methyl-1H-indole and 2-(3,6-dihydro-2H-pyran-4-yl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane according to general procedure H (0.40 mmol 
scale), provided 6k (0.24 mmol, 51 mg, 70%) as a colorless solid. Rf = 0.27 (hex-
ane/EtOAc 90:10, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.65 (s, 1H), 
7.35 (dd, J = 8.6, 1.7 Hz, 1H), 7.29 (d, J = 8.6 Hz, 1H), 7.05 (d, J = 3.1 Hz, 1H), 6.49 (d, J = 3.1 Hz, 
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1H), 6.18 – 6.00 (m, 1H), 4.38 – 4.36 (m, 2H), 3.99 (t, J = 5.5 Hz, 2H), 3.79 (s, 3H), 2.71 – 2.53 (m, 
2H) ppm. 13C NMR (101 MHz, CDCl3) δ 136.3, 135.0, 132.1, 129.4 (d, J = 5.0 Hz), 128.6, 120.6, 
119.1, 117.1, 109.2, 101.4, 66.2, 64.8, 33.0, 28.0 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 213.1 (85), 
195.1 (65), 182.1 (94), 167.1 (100), 157.1 (28), 144.1 (23), 131.1 (16), 115.1 (21). HRMS (EI-Or-
bitrap): m/z calcd for C14H15NO+: 213.1154; found: 213.1145. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 
2981 (m), 2936 (m), 2837 (w), 1731 (vs), 1494 (m), 1434 (m), 1377 (m), 1315 (m), 1257 (m), 1222 (m), 
1177 (s), 1094 (m), 1035 (m), 1012 (m), 916 (m), 807 (m), 733 (s). Mp (°C) = 146–150. 
4- (Benzo[b]thiophen-3-yl)-3,6-dihydro-2H-pyran (6l) 
Using 3-bromobenzo[b]thiophene and 2-(3,6-dihydro-2H-pyran-4-yl)-4,4,5,5-tetra-
methyl-1,3,2-dioxaborolane according to general procedure H (0.50 mmol scale), 
provided 6l (0.33 mmol, 72 mg, 78%) as a light-yellow oil. Rf = 0.25 (hexane/EtOAc 
95:5, UV, KMnO4, PAA). 1H NMR (400 MHz CDCl3) δ 8.00 – 7.94 (m, 1H), 7.91 – 7.84 (m, 1H), 7.44 
– 7.31 (m, 3H), 6.12 (tt, J = 3.0, 1.6 Hz, 1H), 4.40 – 4.38 (m, 2H), 4.00 (t, J = 5.4 Hz, 2H), 2.66 – 2.51 
(m, 2H) ppm. 13C NMR (101 MHz, CDCl3) δ 140.8, 137.9, 137.5, 130.4, 125.0, 124.5, 124.3, 123.2, 
123.1, 122.1, 65.7, 64.6, 29.5 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 216.1 (100), 187.0 (40), 173.0 
(43), 160.0 (14), 147.0 (22), 134.0 (32), 115.1 (23). HRMS (EI-Orbitrap): m/z calcd for C13H12OS+: 
216.0609; found: 216.0603. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
- 1): 3096 (w), 3065 (w), 2963 (w), 
2925 (w), 2851 (w), 2825 (w), 2751 (w), 1721 (m), 1670 (w), 1555 (w), 1496 (w), 1458 (m), 1426 (m), 
1384 (m), 1332 (m), 1270 (w), 1261 (w), 1236 (w), 1165 (m), 1128 (s), 1072 (m), 1033 (m), 972 (m), 
942 (m), 903 (m), 828 (m), 760 (vs), 733 (vs). 
3-(3,6-Dihydro-2H-thiopyran-4-yl)benzofuran (6m)  
Using 3-bromobenzofuran and 2-(3,6-dihydro-2H-thiopyran-4-yl)-4,4,5,5-tetrame-
thyl-1,3,2-dioxaborolane according to general procedure H, provided 6m 
(0.08 mmol, 16 mg, 29%) as a light-yellow oil. Rf = 0.43 (hexane/EtOAc 98:2, UV, 
KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.79 (dd, J = 7.8, 1.5 Hz, 1H), 7.61 (s, 1H), 7.51 (d, J = 
8.7 Hz, 1H), 7.38 – 7.25 (m, 2H), 6.47 (tt, J = 4.2, 1.8 Hz, 1H), 3.41 (dt, J = 4.4, 2.3 Hz, 2H), 2.94 (t, J 
= 5.8 Hz, 2H), 2.79 – 2.60 (m, 2H) ppm. 13C NMR (101 MHz, CDCl3) δ 155.8, 141.1, 130.1, 125.9, 
124.6, 123.3, 122.9, 121.8, 121.2, 111.9, 28.8, 26.1, 25.3 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 
216.1 (60), 187.0 (100), 169.1 (22), 115.1 (23), 76.0 (10). HRMS (EI-Orbitrap): m/z calcd for 
C13H12OS+: 216.0609; found: 216.0607. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 2956 (w), 2918 (w), 
2853 (w), 2360 (w), 1740 (w), 1550 (w), 1474 (w), 1451 (s), 1421 (w), 1380 (w), 1331 (w), 1288 (m), 
1261 (w), 1207 (m), 1115 (m), 1100 (m), 1016 (w), 930 (w), 878 (w), 856 (m), 791 (w), 746 (vs). 
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4-(3,6-Dihydro-2H-pyran-4-yl)-3,5-dimethylisoxazole (6n) 
Using 4-bromo-3,5-dimethylisoxazole and 2-(3,6-dihydro-2H-pyran-4-yl)-4,4,5,5-tet-
ramethyl-1,3,2-dioxaborolane according to general procedure H (0.40 mmol scale), 
provided 6n (0.22 mmol, 40 mg, 66%) as a colorless oil. Rf = 0.22 (hexane/EtOAc 
80:20, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 5.67 (tt, J = 3.0, 1.7 Hz, 1H), 4.28 – 4.26 
(m, 2H), 3.88 (t, J = 5.4 Hz, 2H), 2.35 (s, 3H), 2.32 – 2.25 (m, 2H), 2.22 (s, 3H) ppm. 13C NMR 
(101 MHz, CDCl3) δ 164.8, 158.5, 126.9, 125.6, 116.7, 65.6, 64.3, 29.0, 11.9, 11.2 ppm. LRMS 
(DEP/EI-Orbitrap): m/z (%): 179.1 (100), 151.1 (32), 136.1 (81), 123.0 (31), 110.0 (70), 95.0 (67), 
82.0 (33), 67.1 (25). HRMS (EI-Orbitrap): m/z calcd for C10H13NO2+: 179.0946; found: 179.0938. IR 
(Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 2970 (w), 2926 (m), 2853 (w), 2824 (w), 1723 (vw), 1662 (w), 
1621 (w), 1446 (m), 1421 (s), 1384 (m), 1277 (w), 1239 (m), 1221 (s), 1205 (w), 1132 (vs), 1039 (m), 
1010 (w), 976 (m), 933 (w), 894 (w), 846 (m), 823 (w). 
4-(3,6-Dihydro-2H-thiopyran-4-yl)-3,5-dimethylisoxazole (6o) 
Using 4-bromo-3,5-dimethylisoxazole and 2-(3,6-dihydro-2H-thiopyran-4-yl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane according to general procedure H, provided 6o 
(0.22 mmol, 43 mg, 87%) as a colorless oil. Rf = 0.27 (hexane/EtOAc 90:10, UV, 
KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 5.79 (tt, J = 4.1, 1.9 Hz, 1H), 3.29 (dt, J = 4.5, 2.4 Hz, 
2H), 2.83 (t, J = 5.7 Hz, 2H), 2.45 – 2.38 (m, 2H), 2.33 (s, 3H), 2.21 (s, 3H) ppm. 13C NMR (101 MHz, 
CDCl3) δ 164.8, 158.6, 128.8, 125.7, 118.4, 29.9, 25.9, 25.2, 11.7, 11.0 ppm. LRMS (DEP/EI-Orbitrap): 
m/z (%): 195.1 (82), 154.0 (83), 153.0 (100), 134.1 (20), 126.0 (25), 111.0 (45), 97.0 (12), 77.0 (16). 
HRMS (EI-Orbitrap): m/z calcd for C10H13NOS+: 195.0718; found: 195.0710. IR (Diamond-ATR, neat) 
𝜈𝑚𝑎𝑥 (cm
-1): 2960 (w), 2931 (w), 2887 (w), 282 6(w), 1662 (w), 1621 (m), 1493 (w), 1442 (m), 1420 
(vs), 1381 (w), 1306 (w), 1282 (m), 1258 (w), 1220 (m), 1200 (w), 1170 (w), 1144 (w), 1062 (w), 1039 
(w), 1004 (w), 977 (w), 944 (m), 888 (m), 804 (w). 
6-Chloro-3-(3,6-dihydro-2H-pyran-4-yl)-2-methylpyridine (6p)  
Using 3-bromo-6-chloro-2-methylpyridine and 2-(3,6-dihydro-2H-pyran-4-yl)-
4,4,5,5-tetramethyl-1,3,2-dioxaborolane according to general procedure H 
(0.40 mmol scale), provided 6p (0.25 mmol, 53 mg, 74%) as an orange solid. Rf = 
0.19 (hexane/EtOAc 90:10, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.34 (d, J = 8.0 Hz, 
1H), 7.12 (d, J = 8.0 Hz, 1H), 5.68 (tt, J = 2.8, 1.6 Hz, 1H), 4.29 – 4.27 (m, 2H), 3.91 (t, J = 5.4 Hz, 
2H), 2.50 (s, 3H), 2.37 – 2.25 (m, 2H) ppm. 13C NMR (101 MHz, CDCl3) δ 156.6, 148.8, 138.7, 136.1, 
133.7, 126.7, 121.4, 65.5, 64.3, 29.6, 22.8 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 209.1 (14), 194.0 
(20), 180.1 (19), 174.1 (57), 166.0 (100), 152.0 (42), 131.1 (48), 115.1 (21), 89.0 (15). HRMS (EI-
Orbitrap): m/z calcd for C11H12ClNO+: 209.0607; found: 209.0600. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 
(cm- 1): 2968 (w), 2927 (w), 2892 (w), 2851 (w), 2823 (w), 1575 (m), 1552 (m), 1444 (s), 1430 (s), 
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1383 (m), 1361 (w), 1274 (w), 1268 (w), 1228 (m), 1192 (m), 1131 (vs), 1037 (m), 976 (m), 910 (w), 
875 (s), 844 (m), 819 (m), 730 (m). Mp (°C) = 99–103. 
5-(3,6-Dihydro-2H-pyran-4-yl)-2-methoxypyridine (6q) 
Using 5-bromo-2-methoxypyridine and 2-(3,6-dihydro-2H-pyran-4-yl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane according to general procedure H (0.40 mmol 
scale), provided 6q (0.28 mmol, 53 mg, 82%) as a colorless oil. Rf = 0.29 (hex-
ane/EtOAc 80:20, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 8.17 (d, J = 2.6 Hz, 1H), 7.60 
(dd, J = 8.7, 2.6 Hz, 1H), 6.71 (d, J = 8.6 Hz, 1H), 6.03 (tt, J = 3.0, 1.6 Hz, 1H), 4.31 – 4.29 (m, 2H), 
3.92 (t, J = 5.5 Hz, 2H), 3.92 (s, 3H), 2.54 – 2.37 (m, 2H) ppm. 13C NMR (101 MHz, CDCl3) δ 163.6, 
143.1, 135.3, 131.3, 129.2, 122.0, 110.6, 65.9, 64.4, 53.6, 27.1 ppm. LRMS (DEP/EI-Orbitrap): m/z 
(%): 191.1 (57), 162.1 (99), 148.1 (100), 134.1 (30), 123.1 (21), 103.1 (10), 77.0 (11). HRMS (EI-
Orbitrap): m/z calcd for C11H13NO2+: 191.0946; found: 191.0940. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 
(cm-1): 3020 (vw), 2946 (w), 2927 (w), 2848 (w), 2818 (w), 2753 (vw), 1719 (vw), 1649 (vw), 1600 (s), 
1563 (m), 1495 (vs), 1462 (m), 1445 (w), 1381 (s), 1352 (m), 1285 (vs), 1245 (s), 1229 (w), 1177 (w), 
1130 (s), 1076 (w), 1045 (w), 1028 (s), 1020 (m), 1016 (m), 975 (w), 940 (w), 852 (m), 813 (m), 
775 (w). 
tert-Butyl 6-methyl-3´-6´-dihydro-[2,4´-bipyridine]-1´(2´H)-carboxylate (6r) 
Using 2-bromo-6-methylpyridine and tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)-3,6-dihydropyridine-1(2H)-carboxylate according to gen-
eral procedure H, provided 6r (0.38 mmol, 60 mg, 85%) as a light-yellow oil. 
Rf = 0.22 (hexane/EtOAc 80:20, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.52 (t, J = 7.7 Hz, 
1H), 7.12 (d, J = 7.8 Hz, 1H), 7.00 (d, J = 7.6 Hz, 1H), 6.61 (tt, J = 3.5, 1.6 Hz, 1H), 4.13 – 4.11 (m, 
2H), 3.68 – 3.58 (m, 2H), 2.66 – 2.57 (m, 2H), 2.53 (s, 3H), 1.48 (s, 9H) ppm. 13C NMR (101 MHz, 
CDCl3) δ 157.8, 156.6, 155.0, 136.8, 135.5, 124.2, 121.7, 116.2, 79.7, 43.9, 40.5, 28.6, 26.2, 24.8 ppm. 
Signal splitting was observed, which was presumably caused by rotational barriers. LRMS (DEP/EI-
Orbitrap): m/z (%): 218.1 (100), 201.1 (15), 173.1 (38), 158.1 (16), 144.1 (37), 131.1 (31), 57.1 (76), 
41.0 (23). HRMS (EI-Orbitrap): m/z calcd for C16H22N2O2+: 274.1681; found: 274.1676. IR (Diamond-
ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3001 (vw), 2974 (w), 2925 (w), 2849 (vw), 2361 (vw), 1689 (vs), 1653 (w), 
1584 (m), 1574 (m), 1478 (w), 1454 (s), 1415 (s), 1391 (m), 1364 (s), 1336 (m), 1294 (m), 1272 (m), 
1236 (s), 1160 (vs), 1112 (s), 1075 (w), 1066 (w), 1039 (w), 983 (m), 976 (w), 949 (m), 865 (m), 825 
(w), 789 (s), 766 (m). 
2-(3,6-Dihydro-2H-pyran-4-yl)thiazole (6s) 
Using 2-bromothiazole and 2-(3,6-dihydro-2H-pyran-4-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane according to general procedure H (0.40 mmol scale), provided 6s 
(0.18 mmol, 30 mg, 52%) as a light-yellow oil. Rf = 0.20 (hexane/EtOAc 80:20, UV, 
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KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.75 (d, J = 3.3 Hz, 1H), 7.22 (d, J = 3.3 Hz, 1H), 6.60 
(tt, J = 3.1, 1.6 Hz, 1H), 4.34 – 4.32 (m, 2H), 3.92 (t, J = 5.5 Hz, 2H), 2.73 – 2.65 (m, 2H) ppm. 13C 
NMR (101 MHz, CDCl3) δ 168.9, 143.1, 130.1, 127.5, 117.9, 65.4, 64.2, 26.8 ppm. LRMS (DEP/EI-
Orbitrap): m/z (%): 167.0 (72), 152.0 (31), 138.0 (100), 123.0 (70), 110.0 (34), 58.0 (14). HRMS (EI-
Orbitrap): m/z calcd for C8H9NOS+: 167.0405; found: 167.0398. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
- 1): 
3120 (w), 3081 (w), 2970 (w), 2927 (w), 2856 (w), 2816 (w), 1720 (w), 1647 (vw), 1485 (m), 1462 
(w), 1440 (w), 1422 (w), 1383 (w), 1358 (w), 1316 (w), 1278 (w), 1242 (w), 1220 (w), 1147 (m), 1122 
(vs), 1073 (w), 1056 (w), 1034 (w), 972 (w), 911 (w), 872 (w), 843 (m), 724 (w). 
4-(3,6-Dihydro-2H-pyran-4-yl)-3-fluoro-6-methoxyquinoline (6t) 
Using 3-fluoro-4-iodo-6-methoxyquinoline and 2-(3,6-dihydro-2H-pyran-4-yl)-
4,4,5,5-tetramethyl-1,3,2-dioxaborolane according to general procedure H (0.50 mmol 
scale), provided 6t (0.25 mmol, 64 mg, 58%) as a light-yellow oil. Rf = 0.21 (hex-
ane/EtOAc 80:20, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 8.62 (d, J = 1.2 
Hz, 1H), 7.99 (d, J = 9.2 Hz, 1H), 7.32 (dd, J = 9.2, 2.8 Hz, 1H), 7.20 (d, J = 2.8 Hz, 1H), 5.91 (td, J = 
2.7, 1.4 Hz, 1H), 4.43 – 4.41 (m, 2H), 4.03 (t, J = 5.4 Hz, 2H), 3.91 (s, 3H), 2.51 – 2.40 (m, 2H) ppm. 
13C NMR (101 MHz, CDCl3) δ 158.8, 153.3 (d, J = 253.0 Hz), 141.9 (d, J = 2.4 Hz), 138.6 (d, J = 
28.9 Hz), 131.5, 130.7 (d, J = 13.5 Hz), 129.1, 128.7 (d, J = 3.0 Hz), 127.4, 120.7 (d, J = 2.8 Hz), 103.2 
(d, J = 5.5 Hz), 65.5, 64.4, 55.7, 29.0 (d, J = 1.8 Hz) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 259.1 
(89), 228.1 (16), 214.1 (100), 198.1 (29), 185.1 (41), 172.1 (41), 159.0 (12). HRMS (EI-Orbitrap): m/z 
calcd for C15H14FNO2+: 259.1009; found: 259.1004. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
- 1): 2962 (w), 
2930 (w), 2848 (w), 2832 (w), 1621 (s), 1505 (s), 1468 (m), 1426 (m), 1383 (w), 1353 (m), 1310 (m), 
1268 (m), 1223 (vs), 1206 (m), 1153 (m), 1130 (s), 1028 (m), 974 (w), 947 (w), 907 (w), 831 (m), 791 
(m). 
tert-Butyl 4-(2,4-dimethoxypyrimidin-5-yl)-3,6-dihydropyridine-1(2H)-carboxylate  (6u)  
Using 5-bromo-2,4-dimethoxypyrimidine and tert-butyl 4-(4,4,5,5-tetrame-
thyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydropyridine-1(2H)-carboxylate ac-
cording to general procedure H, provided 6u (0.22 mmol, 72 mg, 88%) as a 
colorless oil. This experiment was redone on a gram scale (5.0 mmol), resulting in almost the same 
yield of product 6u (3.66 mmol, 1.18 g, 86%). Rf = 0.17 (hexane/EtOAc 80:20, UV, KMnO4, PAA). 1H 
NMR (400 MHz, CDCl3) δ 8.06 (s, 1H), 5.86 (s, 1H), 4.06 – 4.01 (m, 2H), 3.98 (s, 3H), 3.98 (s, 3H), 
3.58 (t, J = 5.7 Hz, 2H), 2.41 (s, 2H), 1.48 (s, 9H) ppm. 13C NMR (101 MHz, CDCl3) δ 168.3, 164.4, 
156.1, 155.0, 130.3, 124.2, 116.9, 79.8, 54.9, 54.1, 43.8, 40.4, 28.6, 28.2 ppm. Signal splitting was 
observed, which was presumably caused by rotational barriers. LRMS (DEP/EI-Orbitrap): m/z (%): 
264.1 (100), 220.1 (37), 192.1 (15), 57.1 (99), 43.0 (58). HRMS (EI-Orbitrap): m/z calcd for 
C12H14N3O4+ [M-t-Bu]+: 264.0984; found: 264.1025. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3000 (w), 
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2980 (w), 2929 (w), 2859 (w), 1695 (s), 1592 (s), 1556 (s), 1468 (s), 1396 (vs), 1363 (s), 1338 (m), 
1291 (m), 1232 (s), 1169 (s), 1113 (m), 1080 (m), 1056 (w), 1015 (m), 986 (w), 968 (w), 862 (w), 827 
(w), 797 (w), 771 (w). 
(Z)-2-Methyl-6-(1-phenylprop-1-en-1-yl)pyridine (8a) 
Using 2-bromo-6-methylpyridine and (E)-4,4,5,5-tetramethyl-2-(1-phenylprop-1-
en-1-yl)-1,3,2-dioxaborolane (SM9) according to general procedure H, provided 8a 
(0.14 mmol, 29 mg, 54%) as a colorless oil. Rf = 0.16 (hexane/EtOAc 95:5, UV, 
KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.63 (t, J = 7.7 Hz, 1H), 7.37 – 7.21 (m, 5H), 7.13 (d, J 
= 7.7 Hz, 1H), 7.04 (d, J = 7.7 Hz, 1H), 6.34 (q, J = 7.1 Hz, 1H), 2.65 (s, 3H), 1.85 (d, J = 7.1 Hz, 
3H) ppm. 13C NMR (101 MHz, CDCl3) δ 158.5, 158.3, 142.1, 141.8, 136.4, 128.2, 127.2, 126.9, 126.6, 
122.2, 121.3, 24.9, 15.7 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 209.1 (30), 208.1 (100), 194.1 (12), 
193.1 (18), 107.1 (11). HRMS (EI-Orbitrap): m/z calcd for C15H15N+: 209.1204; found: 209.1199. IR 
(Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3079 (w), 3057 (w), 3021 (w), 2975 (w), 2919 (w), 2854 (w), 
1882 (vw), 1631 (vw), 1583 (m), 1571 (s), 1494 (m), 1456 (m), 1443 (s), 1373 (w), 1354 (w), 1247 (w), 
1192 (w), 1153 (w), 1091 (w), 1075 (w), 1032 (w), 990 (w), 965 (w), 908 (s), 843 (w), 796 (s), 758 
(vs), 729 (vs), 696 (vs). 
(Z)-2-Methoxy-5-(pent-1-en-1-yl)pyridine (8b) 
Using 5-bromo-2-methoxypyridine and (E)-4,4,5,5-tetramethyl-2-(pent-1-en-1-
yl)-1,3,2-dioxaborolane (SM10) according to general procedure H, provided 8b 
(E/Z = 12:88, 0.18 mmol, 32 mg, 70%) as a colorless oil. Rf = 0.10 (hexane/EtOAc 98:2, UV, KMnO4, 
PAA). 1H NMR (400 MHz, CDCl3) δ 8.09 (d, J = 2.4 Hz, 1H), 7.49 (dd, J = 8.5, 2.4 Hz, 1H), 6.76 – 
6.63 (m, 1H), 6.28 (dt, J = 11.6, 1.8 Hz, 1H), 5.67 (dt, J = 11.6, 7.3 Hz, 1H), 3.93 (s, 3H), 2.26 (qd, J = 
7.4, 1.8 Hz, 2H), 1.52 – 1.43 (m, 2H), 0.93 (t, J = 7.4 Hz, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 
162.7, 146.8, 139.1, 133.4, 126.9, 125.1, 110.4, 53.6, 30.8, 23.2, 14.0 ppm. LRMS (DEP/EI-Orbitrap): 
m/z (%): 177.1 (31), 148.1 (100), 133.1 (40), 120.1 (16), 105.1 (14), 91.1 (10). HRMS (EI-Orbitrap): 
m/z calcd for C11H15NO+: 177.1154; found: 177.1149. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
- 1): 3009 (w), 
2960 (m), 2929 (w), 2875 (w), 1601 (m), 1562 (w), 1492 (vs), 1463 (w), 1408 (w), 1368 (m), 1306 (m), 
1288 (m), 1260 (m), 1126 (w), 1027 (m), 927 (w), 830 (w). 
(Z)-1-Methyl-5-(pent-1-en-1-yl)-1H-indole (8c) 
Using 5-bromo-1-methyl-1H-indole and (E)-4,4,5,5-tetramethyl-2-(pent-1-en-1-
yl)-1,3,2-dioxaborolane (SM10) according to general procedure H, provided 8c 
(E/Z = 12:88, 0.21 mmol, 43 mg, 84%) as a colorless oil. Rf = 0.17 (hexane/EtOAc 
100:0, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.58 (s, 1H), 7.30 (dt, J = 8.4, 0.8 Hz, 1H), 
7.21 (dd, J = 8.5, 1.6 Hz, 1H), 7.06 (d, J = 3.1 Hz, 1H), 6.58 (dt, J = 11.7, 1.9 Hz, 1H), 6.50 (dd, J = 
3.1, 0.8 Hz, 1H), 5.63 (dt, J = 11.6, 7.1 Hz, 1H), 3.80 (s, 3H), 2.42 (qd, J = 7.3, 1.9 Hz, 2H), 1.58 – 1.47 
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(m, 2H), 0.98 (t, J = 7.4 Hz, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 135.7, 131.0, 129.9, 129.4, 129.3, 
128.5, 123.2, 121.0, 108.9, 101.2, 33.0, 30.9, 23.5, 14.1 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 
199.1 (41), 170.1 (100), 168.1 (25), 155.1 (28), 128.1 (10). HRMS (EI-Orbitrap): m/z calcd for 
C14H17N+: 199.1361; found: 199.1357. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3000 (m), 2960 (vs), 
2927 (s), 2872 (m), 1616 (m), 1513 (s), 1491 (s), 1422 (m), 1377 (m), 1335 (m), 1245 (s), 1154 (m), 
1096 (m), 1078 (m), 886 (m), 804 (s), 708 (s). 
(Z)-tert-Butyl((4-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)but-3-en-1-yl)oxy)dimethylsilane (8d) 
Using 5-bromo-2,2-difluorobenzo[d][1,3]dioxole and (E)-tert-butyldime-
thyl((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-1-yl)oxy)silane 
according to general procedure H, provided 8d (0.23 mmol, 78 mg, 89%) as a 
colorless oil. Rf = 0.44 (hexane/EtOAc 98:2, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.09 
(s, 1H), 7.00 (s, 2H), 6.45 (dt, J = 11.7, 1.8 Hz, 1H), 5.71 (dt, J = 11.6, 7.4 Hz, 1H), 3.73 (t, J = 6.4 Hz, 
2H), 2.54 – 2.47 (m, 2H), 0.90 (s, 9H), 0.06 (s, 6H) ppm. 13C NMR (101 MHz, CDCl3) δ 143.7, 142.3, 
133.7 (t, J = 50.0 Hz), 131.6, 129.9, 129.2, 124.1, 109.8, 109.0, 62.6, 32.0, 25.9, 18.4, -5.3 ppm. LRMS 
(DEP/EI-Orbitrap): m/z (%): 285.1 (100), 173.1 (14), 146.1 (10), 115.1 (30), 89.0 (14), 73.0 (20). 
HRMS (ESI pos): calcd for C16H21F2O3Si+ [M-Me]+:327.1228; found: 327.1216. IR (Diamond-ATR, 
neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3017 (vw), 2954 (w), 2929 (w), 2896 (w), 2885 (w), 2857 (w), 1616 (vw), 1497 (m), 
1472 (w), 1446 (w), 1388 (w), 1361 (w), 1237 (vs), 1154 (s), 1100 (s), 1034 (m), 1006 (w), 937 (m), 
900 (w), 870 (w), 835 (s), 775 (s), 744 (w), 704 (w). 
(Z)-4-(4-((tert-Butyldimethylsilyl)oxy)but-1-en-1-yl)-3,5-dimethylisoxazole (8e) 
Using 4-bromo-3,5-dimethylisoxazole and (E)-tert-butyldimethyl((4-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-1-yl)oxy)silane according to gen-
eral procedure H, provided 8e (0.18 mmol, 51 mg, 71%) as a colorless oil. Rf = 
0.16 (hexane/EtOAc 98:2, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 5.98 (d, J = 11.2 Hz, 
1H), 5.89 – 5.80 (m, 1H), 3.63 (t, J = 6.5 Hz, 2H), 2.27 (s, 3H), 2.21 – 2.13 (m, 2H), 2.15 (s, 3H), 0.87 
(s, 9H), 0.03 (s, 6H) ppm. 13C NMR (101 MHz, CDCl3) δ 164.8, 159.5, 133.8, 117.6, 112.4, 62.5, 32.9, 
26.1, 18.5, 12.0, 10.6, -5.2 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 224.1 (78), 208.1 (31), 183.1 (24), 
153.1 (23), 136.1 (16), 109.1 (18), 89.0 (27), 75.0 (100). HRMS (EI-Orbitrap): m/z calcd for 
C11H18NO2Si+ [M-t-Bu]+: 224.1107; found: 224.1106. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3010 
(vw), 2954 (w), 2928 (w), 2857 (w), 1472 (w), 1447 (w), 1422 (w), 1393 (w), 1361 (w), 1256 (w), 1182 
(w), 1105 (m), 906 (s), 837 (m), 776 (w), 729 (vs). 
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(Z)-4-(4-((tert-Butyldimethylsilyl)oxy)but-1-en-1-yl)-3-fluoro-6-methoxyquinoline (8f) 
Using 3-fluoro-4-iodo-6-methoxyquinoline and (E)-tert-butyldimethyl((4-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-1-yl)oxy)silane accord-
ing to general procedure H, provided 8f (0.18 mmol, 66 mg, 72%) as a colorless 
oil. Rf = 0.38 (hexane/EtOAc 90:10, UV, KMnO4, PAA). 1H NMR (400 MHz, 
CDCl3) δ 8.63 (d, J = 1.2 Hz, 1H), 7.99 (d, J = 9.2 Hz, 1H), 7.31 (dd, J = 9.2, 2.8 Hz, 1H), 7.09 (d, J = 
2.8 Hz, 1H), 6.52 (dq, J = 11.5, 1.5 Hz, 1H), 6.32 – 6.23 (m, 1H), 3.92 (s, 3H), 3.66 (t, J = 6.5 Hz, 2H), 
2.25 – 2.18 (m, 2H), 0.84 (s, 9H), -0.01 (s, 6H) ppm. 13C NMR (101 MHz, CDCl3) δ 158.7, 153.3 (d, J 
= 253.4 Hz), 141.5 (d, J = 2.3 Hz), 138.6 (d, J = 25.4 Hz), 136.2, 131.4, 129.1 (d, J = 3.1 Hz), 126.0 (d, 
J = 13.8 Hz), 121.0, 119.1, 102.9, 62.2, 55.7 (d, J = 11.6 Hz), 33.6, 26.0 (d, J = 5.3 Hz), 18.4, -5.2 ppm. 
LRMS (DEP/EI-Orbitrap): m/z (%): 304.1 (69), 289.1 (18), 273.1 (13), 261.1 (21), 210.1 (100), 195.1 
(25), 184.1 (18), 167.1 (44), 152.1 (14), 73.0 (45). HRMS (EI-Orbitrap): m/z calcd for C20H28FNO2Si+: 
361.1873; found: 361.1865. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3007 (vw), 2953 (m), 2928 (m), 
2907 (w), 2903 (w), 2897 (w), 2890 (w), 2885 (w), 2881 (w), 2876 (w), 2873 (w), 2857 (m), 1621 (m), 
1505 (s), 1467 (m), 1427 (m), 1357 (m), 1303 (w), 1264 (m), 1258 (m), 1227 (vs), 1197 (m), 1175 (w), 
1142 (m), 1096 (s), 1071 (w), 1031 (m), 1005 (w), 939 (w), 926 (w), 907 (m), 831 (vs), 811 (m), 
800 (m), 776 (s), 730 (s). 
1-Chloro-4-vinylbenzene (10a) 
Using vinyl bromide (1 M in THF) and 2-(4-chlorophenyl)-4,4,5,5-tetramethyl-1,3,2-di-
oxaborolane according to general procedure I (1.50 mmol scale), provided 10a 
(0.88 mmol, 122 mg, 69%) as a light-yellow oil. General procedure I was slightly changed 
for product 10a to maximize the conversion of the vinyl bromide. Therefore, the freshly prepared 
n-Bu3Ce•5LiCl solution was concentrated in vacuo to about 0.50 M at –30 °C prior to the addition of 
the vinyl bromide. Rf = 0.70 (hexane/EtOAc 100:0, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) 
δ 7.32 – 7.22 (m, 4H), 6.62 (dd, J = 17.6, 10.9 Hz, 1H), 5.68 (d, J = 17.5 Hz, 1H), 5.22 (d, J = 10.9 Hz, 
1H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 138.1 (100), 103.1 (76), 77.1 (31). Analytical data in 
accordance to literature.227 
1-Methyl-4-(prop-1-en-2-yl)benzene (10b) 
Using 2-bromoprop-1-ene and 4,4,5,5-tetramethyl-2-(p-tolyl)-1,3,2-dioxaborolane 
according to general procedure I (0.40 mmol scale), provided 10b (0.22 mmol, 
29 mg, 64%) as a colorless oil. Rf = 0.73 (hexane/EtOAc 100:0, UV, KMnO4, 
PAA).1H NMR (400 MHz, CDCl3) δ 7.39 (d, J = 8.2 Hz, 2H), 7.16 (d, J = 8.0 Hz, 2H), 5.36 (s, 1H), 
 
227 S. Rej, S. Pramanik, H. Tsurugi, K. Mashima, Chem. Comm. 2017, 53, 13157–13160. 
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5.06 – 5.04 (m, 1H), 2.36 (s, 3H), 2.16 (s, 3H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 132.1 (95), 
117.1 (100), 91.1 (55), 65.1 (24). Analytical data in accordance to literature.228 
1-Chloro-4-(prop-1-en-2-yl)benzene (10b’) 
Using 2-bromoprop-1-ene and 2-(4-chlorophenyl)-4,4,5,5-tetramethyl-1,3,2-diox-
aborolane according to general procedure I (0.40 mmol scale), provided 10b’ 
(0.23 mmol, 35 mg, 68%) as a colorless oil. Rf = 0.73 (hexane/EtOAc 100:0, UV, 
KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.42 – 7.37 (m, 2H), 7.32 – 7.27 (m, 2H), 5.35 (s, 1H), 
5.12 – 5.09 (m, 1H), 2.13 (s, 3H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 152.1 (100), 137.1 (41), 
117.1 (80), 102.1 (30), 75.1 (20). Analytical data in accordance to literature.228 
Trimethyl(1-(p-tolyl)vinyl)silane (10c) 
Using (1-bromovinyl)trimethylsilane and 4,4,5,5-tetramethyl-2-(p-tolyl)-1,3,2-di-
oxaborolane according to general procedure I, provided 10c (0.11 mmol, 21 mg, 
44%) as a colorless oil. Rf = 0.60 (hexane/EtOAc 100:0, UV, KMnO4, PAA). 1H 
NMR (400 MHz, CDCl3) δ 7.16 – 7.07 (m, 4H), 5.83 (d, J = 3.0 Hz, 1H), 5.59 (d, J = 3.0 Hz, 1H), 2.36 
(s, 3H), 0.19 (s, 9H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 190.1 (70), 175.0 (100), 158.8 (35), 
149.0 (81), 115.1 (73), 90.9 (32), 73.0 (100). Analytical data in accordance to literature.229 
Methyl 4-(1-phenylvinyl)benzoate (10d) 
Using (1-bromovinyl)benzene and methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxabo-
rolan-2-yl)benzoate according to general procedure I, provided 10d (0.15 mmol, 
36 mg, 60%) as a colorless solid. Rf = 0.20 (hexane/EtOAc 98:2, UV, KMnO4, 
PAA). 1H NMR (400 MHz, CDCl3) δ 8.04 – 7.97 (m, 2H), 7.44 – 7.39 (m, 2H), 7.37 – 7.28 (m, 5H), 
5.57 – 5.52 (m, 2H), 3.93 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 167.1, 149.4, 146.2, 140.9, 
129.7, 129.5, 128.5, 128.4, 128.3, 128.1, 116.0, 52.3 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 238.1 
(71), 207.1 (58), 178.1 (100), 152.1 (17), 89.0 (14), 76.0 (10). HRMS (EI-Orbitrap): m/z calcd for 
C16H14O2+: 238.0994; found: 238.0989. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3085 (vw), 3062 (vw), 
3024 (vw), 2998 (vw), 2949 (w), 1720 (vs), 1608 (w), 1493 (w), 1435 (m), 1404 (w), 1312 (w), 
1280 (vs), 1181 (w), 1150 (w), 1107 (m), 1017 (w), 968 (vw), 905 (w), 864 (w), 781 (w), 776 (m), 
719 (w), 701 (m). Mp (°C) = 76–80. 
2-(1-Phenylvinyl)phenyl acetate (10e) 
Using (1-bromovinyl)benzene and 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phe-
nyl acetate according to general procedure I, provided 10e (0.11 mmol, 27 mg, 44%) as 
a colorless oil. Rf = 0.16 (hexane/EtOAc 98:2, UV, KMnO4, PAA). 1H NMR (400 MHz, 
 
228 A. Cabre, G. Sciortino, G. Ujaque, X. Verdaguer, A. Lledos, A. Riera, Org. Lett. 2018, 20, 5747–5751. 
229 H. A. Laub, H. Mayr, Chem. Eur. J. 2014, 20, 1103–1110. 
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CDCl3) δ 7.42 – 7.35 (m, 2H), 7.33 – 7.24 (m, 6H), 7.09 (d, J = 8.0 Hz, 1H), 5.67 (d, J = 1.2 Hz, 1H), 
5.36 (d, J = 1.2 Hz, 1H), 1.78 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 169.1, 148.2, 146.4, 140.9, 
134.7, 131.4, 129.0, 128.4, 127.9, 127.0, 126.2, 123.1, 116.9, 20.4 ppm. LRMS (DEP/EI-Orbitrap): m/z 
(%): 238.1 (1), 223.1 (6), 195.1 (100), 181.1 (39), 165.1 (24), 152.1 (11). HRMS (EI-Orbitrap): m/z 
calcd for C16H14O2+: 238.0994; found: 238.0988. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3085 (vw), 
3056 (vw), 3029 (vw), 2930 (vw), 1814 (vw), 1766 (s), 1749 (w), 1614 (vw), 1602 (w), 1575 (vw), 
1494 (w), 1483 (w), 1447 (w), 1367 (m), 1327 (vw), 1191 (vs), 1150 (w), 1101 (w), 1081 (w), 
1065 (w), 1027 (w), 1009 (w), 945 (vw), 913 (m), 840 (vw), 810 (w), 781 (w), 764 (m), 705 (w). 
2-(1-Phenylvinyl)benzonitrile (10f) 
Using (1-bromovinyl)benzene and 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ben-
zonitrile according to general procedure I, provided 10f (0.18 mmol, 36 mg, 69%) as a 
colorless oil. Rf = 0.19 (hexane/EtOAc 98:2, UV, KMnO4, PAA). 1H NMR (400 MHz, 
CDCl3) δ 7.71 (dd, J = 7.8, 1.4 Hz, 1H), 7.57 (td, J = 7.7, 1.4 Hz, 1H), 7.43 (td, J = 7.6, 1.2 Hz, 1H), 
7.39 – 7.35 (m, 1H), 7.35 – 7.30 (m, 3H), 7.29 – 7.23 (m, 2H), 5.88 (s, 1H), 5.49 (s, 1H) ppm. 13C NMR 
(101 MHz, CDCl3) δ 146.6, 145.9, 139.9, 133.5, 132.6, 130.5, 128.6, 128.4, 128.1, 127.5, 118.3, 118.2, 
112.5 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 205.1 (100), 190.1 (24), 178.1 (10), 102.0 (10), 88.0 
(11). HRMS (EI-Orbitrap): m/z calcd for C15H11N+: 205.0891; found: 205.0879. IR (Diamond-ATR, 
neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3086 (w), 3067 (w), 3027 (w), 2225 (m), 1611 (w), 1595 (w), 1575 (w), 1565 (w), 
1495 (m), 1484 (m), 1442 (m), 1326 (w), 1310 (w), 1264 (w), 1158 (w), 1028 (w), 912 (m), 770 (vs), 
699 (s). 
4-(1-Phenylvinyl)-3,6-dihydro-2H-pyran (10g) 
Using (1-bromovinyl)benzene and 2-(3,6-dihydro-2H-pyran-4-yl)-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane according to general procedure I, provided 10g (0.18 mmol, 33 mg, 
70%) as a colorless oil. Rf = 0.32 (hexane/EtOAc 98:2, UV, KMnO4, PAA). 1H NMR 
(400 MHz, CDCl3) δ 7.38 – 7.27 (m, 5H), 5.61 – 5.56 (m, 1H), 5.25 (s, 1H), 5.07 (s, 1H), 4.22 – 4.20 
(m, 2H), 3.89 (t, J = 5.5 Hz, 2H), 2.43 – 2.33 (m, 2H) ppm. 13C NMR (101 MHz, CDCl3) δ 149.9, 
141.2, 134.7, 128.9, 128.1, 127.4, 126.7, 112.4, 65.9, 64.5, 26.5 ppm. LRMS (DEP/EI-Orbitrap): 
m/z (%): 186.1 (24), 171.1 (11), 156.1 (28), 141.1 (75), 128.1 (100), 115.1 (60), 103.1 (25), 91.1 (20), 
83.0 (60). HRMS (EI-Orbitrap): m/z calcd for C13H14O+: 186.1045; found: 186.1037. IR (Diamond-
ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 2977 (s), 2936 (m), 2886 (m), 1712 (m), 1698 (m), 1606 (m), 1589 (m), 
1514 (m), 1474 (vs), 1454 (vs), 1443 (vs), 1381 (s), 1372 (s), 1328 (vs), 1273 (s), 1217 (s), 1144 (vs), 
1009 (s), 981 (s), 951 (s), 927 (m), 851 (s), 755 (s), 672 (s). 
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tert-Butyl 4-(1-phenylvinyl)-3,6-dihydropyridine-1(2H)-carboxylate (10h) 
Using (1-bromovinyl)benzene and tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaboro-
lan-2-yl)-3,6-dihydropyridine-1(2H)-carboxylate according to general procedure I, 
provided 10h (0.18 mmol, 52 mg, 72%) as a colorless oil. Rf = 0.10 (hexane/EtOAc 
99:1, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.33 – 7.27 (m, 2H), 7.25 – 7.20 (m, 2H), 
5.51 (s, 1H), 5.21 (s, 1H), 5.05 (s, 1H), 3.96 – 3.91 (m, 2H), 3.56 (t, J = 5.7 Hz, 2H), 2.37 – 2-31 (m, 
2H), 1.45 (s, 9H) ppm. 13C NMR (101 MHz, CDCl3) δ 155.0, 150.1, 141.2, 135.7, 128.8, 128.1, 127.4, 
124.9, 112.6, 79.8, 43.7, 40.5, 28.6, 26.5 ppm. Signal splitting was observed, which was presumably 
caused by rotational barriers. LRMS (DEP/EI-Orbitrap): m/z (%): 229.1 (51), 212.1 (11), 185.1 (13), 
168.5 (10), 155.0 (14), 141.0 (13), 126.1 (29), 115.0 (10), 82.0 (42). HRMS (EI-Orbitrap): m/z calcd 
for C18H23NO2+: 285.1729; found: 285.1723. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 2973 (w), 
2931 (w), 2859 (vw), 1695 (vs), 1601 (w), 1476 (w), 1419 (m), 1392 (m), 1365 (m), 1337 (w), 
1281 (w), 1240 (m), 1169 (s), 1113 (m), 1068 (w), 982 (w), 956 (w), 893 (w), 866 (w), 833 (w), 
773 (w), 702 (m). 
4-(1-Phenylvinyl)-3,6-dihydro-2H-thiopyran (10i) 
Using (1-bromovinyl)benzene and 2-(3,6-dihydro-2H-thiopyran-4-yl)-4,4,5,5-tetrame-
thyl-1,3,2-dioxaborolane according to general procedure I, provided 10i (0.17 mmol, 35 
mg, 68%) as a colorless oil. Rf = 0.20 (hexane/EtOAc 99:1, UV, KMnO4, PAA). 1H 
NMR (400 MHz, CDCl3) δ 7.38 – 7.24 (m, 5H), 5.84 (tt, J = 4.1, 1.7 Hz, 1H), 5.26 (s, 1H), 5.10 (s, 
1H), 3.26 (dt, J = 4.4, 2.2 Hz, 2H), 2.83 (t, J = 5.8 Hz, 2H), 2.56 – 2.48 (m, 2H) ppm. 13C NMR (101 
MHz, CDCl3) δ 151.8, 141.2, 138.5, 128.6, 128.2, 127.4, 124.9, 112.3, 27.6, 26.3, 25.4 ppm. LRMS 
(DEP/EI-Orbitrap): m/z (%): 202.0 (38), 187.0 (36), 173.1 (30), 155.0 (100), 141.0 (70), 128.1 (59), 
115.0 (48), 99.0 (55), 77.0 (70). HRMS (EI-Orbitrap): m/z calcd for C13H14S+: 202.0816; found: 
202.0824. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3087 (w), 3055 (w), 3024 (w), 2953 (w), 2923 (w), 
1675 (w), 1599 (w), 1492 (m), 1444 (m), 1422 (w), 1287 (w), 1259 (w), 1065 (w), 1027 (m), 905 (w), 
884 (w), 778 (m), 762 (m), 700 (vs). 
2-Chloro-5-(1-phenylvinyl)pyridine (10j) 
Using (1-bromovinyl)benzene and 2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaboro-
lan-2-yl)pyridine according to general procedure I, provided 10j (0.20 mmol, 44 mg, 
80%) as a colorless oil. Rf = 0.33 (hexane/EtOAc 97:3, UV, KMnO4, PAA). 1H NMR 
(400 MHz, CDCl3) δ 8.40 (d, J = 2.4 Hz, 1H), 7.57 (dd, J = 8.3, 2.5 Hz, 1H), 7.40 – 7.32 (m, 3H), 7.32 
– 7.27 (m, 3H), 5.58 (s, 1H), 5.50 (s, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 150.8, 149.2, 145.9, 
140.0, 138.5, 136.2, 128.7, 128.5, 128.1, 123.8, 116.4 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 214.0 
(100), 200.0 (50), 180.1 (94), 178.1 (75), 151.1 (34), 90.0 (10), 76.0 (12). HRMS (EI-Orbitrap): m/z 
calcd for C13H10ClN+: 215.0502; found: 215.0496. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3087 (w), 
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3061 (w), 3027 (w), 1613 (w), 1581 (m), 1552 (w), 1494 (m), 1459 (vs), 1444 (m), 1358 (m), 1320 (w), 
1308 (w), 1287 (w), 1157 (m), 1139 (w), 1104 (s), 1018 (m), 906 (m), 837 (m), 778 (s), 758 (m), 
748 (w), 705 (m). 
3-Methyl-2-(1-phenylvinyl)thiophene (10k) 
Using (1-bromovinyl)benzene and 4,4,5,5-tetramethyl-2-(3-methylthiophen-2-yl)-1,3,2-
dioxaborolane according to general procedure I, provided 10k (0,19 mmol, 38 mg, 75%) 
as a colorless oil. Rf = 0.49 (hexane/EtOAc 100:0, UV, KMnO4, PAA). 1H NMR 
(400 MHz, CDCl3) δ 7.40 – 7.29 (m, 5H), 7.18 (d, J = 5.1 Hz, 1H), 6.88 (d, J = 5.1 Hz, 1H), 5.65 (d, J 
= 1.3 Hz, 1H), 5.41 (d, J = 1.3 Hz, 1H), 1.99 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 142.7, 141.1, 
137.5, 135.2, 130.7, 128.4, 128.0, 127.4, 123.5, 117.2, 15.2 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 
200.0 (18), 185.0 (100), 152.1 (15), 141.1 (8), 115.1 (6). HRMS (EI-Orbitrap): m/z calcd for C13H12S+: 
200.0660; found: 200.0652. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3095 (vw), 3078 (w), 3055 (w), 
3020 (w), 2942 (w), 2921 (w), 2859 (vw), 1758 (vw), 1606 (w), 1573 (w), 1491 (m), 1445 (m), 
1381 (w), 1366 (w), 1316 (w), 1302 (w), 1227 (w), 1181 (vw), 1156 (vw), 1134 (vw), 1073 (w), 
1048 (w), 1027 (w), 1006 (w), 934 (w), 899 (m), 839 (w), 796 (w), 775 (s), 699 (vs). 
1-Benzyl-4-(1-phenylvinyl)-1H-pyrazole (10l) 
Using (1-bromovinyl)benzene and 1-benzyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxabo-
rolan-2-yl)-1H-pyrazole according to general procedure I, provided 10l 
(0.19 mmol, 49 mg, 74%) as a light-yellow oil. Rf = 0.28 (hexane/EtOAc 90:10, 
UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.58 (s, 1H), 7.41 – 7.35 (m, 2H), 7.34 – 7.24 (m, 
7H), 7.23 – 7.15 (m, 2H), 5.37 (d, J = 1.3 Hz, 1H), 5.24 (s, 2H), 5.15 (d, J = 1.3 Hz, 1H) ppm. 13C NMR 
(101 MHz, CDCl3) δ 141.6, 140.9, 138.6, 136.5, 129.0, 128.4, 128.3, 128.2, 128.0, 127.8, 127.7, 123.6, 
111.5, 56.2 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 260.1 (86), 259.1 (50), 181.1 (6), 169.1 (20), 
115.1 (13), 91.1 (100), 65.0 (11). HRMS (EI-Orbitrap): m/z calcd for C18H16N2+: 260.1313; found: 
260.1310. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3087 (w), 3061 (w), 3029 (w), 2931 (vw), 1608 (w), 
1572 (w), 1550 (w), 1493 (m), 1455 (m), 1442 (m), 1430 (w), 1389 (w), 1357 (w), 1282 (w), 1253 (m), 
1159 (w), 1137 (w), 1073 (w), 1028 (w), 997 (m), 888 (m), 859 (w), 810 (w), 776 (s), 720 (s), 696 (vs). 
(R)-1-Methoxy-4-(3-phenylbut-3-en-2-yl)benzene (11a) 
Using (1-bromovinyl)benzene and (R)-2-(1-(4-methoxyphenyl)ethyl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (SM11) according to general procedure I 
(0.40 mmol scale), provided 11a (0.32 mmol, 75 mg, 93%) as a light-yellow oil. 
Rf = 0.16 (hexane/EtOAc 99:1, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.37 – 7.17 (m, 
7H), 6.88 – 6.81 (m, 2H), 5.43 (s, 1H), 5.19 – 5.17 (m, 1H), 4.03 (q, J = 7.1 Hz, 1H), 3.80 (s, 3H), 1.49 
(d, J = 7.1 Hz, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 157.9, 153.0, 142.4, 137.2, 128.7, 128.2, 127.2, 
126.8, 113.8, 112.9, 55.3, 43.4, 21.9 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 238.1 (27), 223.1 (44), 
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207.1 (10), 165.1 (8), 135.1 (100), 115.1 (11), 105.1 (15), 91.1 (9). HRMS (EI-Orbitrap): m/z calcd for 
C17H18O+: 238.1358; found: 238.1351. []D22: -72.08 ( = 0.99, CH2Cl2). Chiral HPLC: 98% ee 
(er 98.9:1.1), OB-H column, i-PrOH:heptane = 0.5:99.5, 1.0 mL/min, 30 °C. IR (Diamond-ATR, neat) 
𝜈𝑚𝑎𝑥 (cm
-1): 3090 (vw), 3056 (vw), 3029 (w), 3002 (vw), 2964 (w), 2930 (w), 2903 (w), 2877 (vw), 
2834 (w), 1623 (w), 1609 (w), 1583 (w), 1573 (w), 1510 (vs), 1493 (w), 1461 (w), 1442 (w), 1368 (w), 
1301 (w), 1245 (s), 1177 (m), 1109 (w), 1070 (w), 1036 (m), 1000 (vw), 902 (w), 830 (m), 811 (w), 
779 (m), 755 (w), 700 (m). 
(S)-1-Methoxy-4-(3-phenylbut-3-en-2-yl)benzene (ent-11a) 
Using (1-bromovinyl)benzene and (S)-2-(1-(4-methoxyphenyl)ethyl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (SM12) according to general procedure I 
(0.40 mmol scale), provided ent-11a (0.33 mmol, 78 mg, 96%) as a light-yellow 
oil. Rf = 0.16 (hexane/EtOAc 99:1, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.37 – 7.17 (m, 
7H), 6.88 – 6.81 (m, 2H), 5.43 (s, 1H), 5.19 – 5.17 (m, 1H), 4.03 (q, J = 7.1 Hz, 1H), 3.80 (s, 3H), 1.49 
(d, J = 7.1 Hz, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 157.9, 153.0, 142.4, 137.2, 128.7, 128.2, 127.2, 
126.8, 113.8, 112.9, 55.3, 43.4, 21.9 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 238.1 (27), 223.1 (44), 
207.1 (10), 165.1 (8), 135.1 (100), 115.1 (11), 105.1 (15), 91.1 (9). HRMS (EI-Orbitrap): m/z calcd for 
C17H18O+: 238.1358; found: 238.1351. []D22: +73.74 ( = 0.87, CH2Cl2). Chiral HPLC: 99% ee (er 
99.5:0.5), OB-H column, i-PrOH:heptane = 0.5:99.5, 1.0 mL/min, 30 °C. IR (Diamond-ATR, neat) 
𝜈𝑚𝑎𝑥 (cm
-1): 3090 (vw), 3056 (vw), 3029 (w), 3002 (vw), 2964 (w), 2930 (w), 2903 (w), 2877 (vw), 
2834 (w), 1623 (w), 1609 (w), 1583 (w), 1573 (w), 1510 (vs), 1493 (w), 1461 (w), 1442 (w), 1368 (w), 
1301 (w), 1245 (s), 1177 (m), 1109 (w), 1070 (w), 1036 (m), 1000 (vw), 902 (w), 830 (m), 811 (w), 
779 (m), 755 (w), 700 (m). 
(S)-1-(1-(4-Methoxyphenyl)vinyl)-2,3-dihydro-1H-indene (11b) 
Using 1-(1-bromovinyl)-4-methoxybenzene (SM20) and (R)-2-(2,3-dihy-
dro-1H-inden-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (SM13) ac-
cording to general procedure I (0.40 mmol scale), provided 11b (0.33 mmol, 
83 mg, 98%) as a colorless oil. Rf = 0.15 (hexane/EtOAc 100:0, UV, KMnO4, PAA). 1H NMR 
(400 MHz, CDCl3) δ 7.36 – 7.31 (m, 2H), 7.29 – 7.24 (m, 1H), 7.22 – 7.14 (m, 3H), 6.89 – 6.81 (m, 
2H), 5.29 (d, J = 1.3 Hz, 1H), 4.85 – 4.82 (m, 1H), 4.31 (t, J = 7.5 Hz, 1H), 3.82 (s, 3H), 3.02 – 2.82 
(m, 2H), 2.47 – 2.31 (m, 1H), 2.04 – 1.90 (m, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 159.1, 150.7, 
145.8, 144.6, 134.3, 127.9, 126.7, 126.3, 125.2, 124.6, 113.7, 112.1, 55.4, 50.7, 33.1, 31.5 ppm. Signal 
splitting was observed, which was presumably caused by rotational barriers. LRMS (DEP/EI-Orbitrap): 
m/z (%): 250.1 (16), 235.1 (26), 225.0 (100), 209.0 (45), 191.0 (19), 151.0 (11), 133.1 (94), 115.1 (56), 
91.1 (12). HRMS (EI-Orbitrap): m/z calcd for C18H18O+: 250.1358; found: 250.1351. []D20: +89.18 
( = 0.92, CH2Cl2). Chiral HPLC: 98% ee (er 98.7:1.3), OD-H column, EtOAc:heptane = 0.5:99.5, 
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1.0 mL/min, 30 °C. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3068 (w), 3033 (w), 3005 (w), 2955 (w), 
2931 (w), 2838 (w), 1606 (m), 1510 (vs), 1476 (w), 1458 (m), 1441 (w), 1295 (m), 1245 (s), 1179 (m), 
1034 (m), 896 (w), 835 (m), 750 (m). 
(R)-1-(1-(4-Methoxyphenyl)vinyl)-2,3-dihydro-1H-indene (ent-11b) 
Using 1-(1-bromovinyl)-4-methoxybenzene (SM20) and (S)-2-(2,3-dihy-
dro-1H-inden-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (SM14) ac-
cording to general procedure I (0.40 mmol scale), provided ent-11b 
(0.32 mmol, 81 mg, 95%) as a colorless oil. Rf = 0.15 (hexane/EtOAc 100:0, UV, KMnO4, PAA). 1H 
NMR (400 MHz, CDCl3) δ 7.36 – 7.31 (m, 2H), 7.29 – 7.24 (m, 1H), 7.22 – 7.14 (m, 3H), 6.89 – 6.81 
(m, 2H), 5.29 (d, J = 1.3 Hz, 1H), 4.85 – 4.82 (m, 1H), 4.31 (t, J = 7.5 Hz, 1H), 3.82 (s, 3H), 3.02 – 
2.82 (m, 2H), 2.47 – 2.31 (m, 1H), 2.04 – 1.90 (m, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 159.1, 
150.7, 145.8, 144.6, 134.3, 127.9, 126.7, 126.3, 125.2, 124.6, 113.7, 112.1, 55.4, 50.7, 33.1, 31.5 ppm. 
Signal splitting was observed, which was presumably caused by rotational barriers. LRMS (DEP/EI-
Orbitrap): m/z (%): 250.1 (16), 235.1 (26), 225.0 (100), 209.0 (45), 191.0 (19), 151.0 (11), 133.1 (94), 
115.1 (56), 91.1 (12). HRMS (EI-Orbitrap): m/z calcd for C18H18O+: 250.1358; found: 250.1351. []D20: 
-88.34 ( = 1.18, CH2Cl2). Chiral HPLC: 96% ee (er 98.0:2.0), OD-H column, EtOAc:heptane = 
0.5:99.5, 1.0 mL/min, 30 °C. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3068 (w), 3033 (w), 3005 (w), 
2955 (w), 2931 (w), 2838 (w), 1606 (m), 1510 (vs), 1476 (w), 1458 (m), 1441 (w), 1295 (m), 1245 (s), 
1179 (m), 1034 (m), 896 (w), 835 (m), 750 (m). 
(S)-But-3-ene-1,2,3-triyltribenzene (11c) 
Using (1-bromovinyl)benzene and (S)-2-(1,2-diphenylethyl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (SM15) according to general procedure I, provided 11c (0.19 mmol, 
53 mg, 73%) as a colorless oil. Rf = 0.20 (hexane/EtOAc 100:0, UV, KMnO4, PAA). 1H 
NMR (400 MHz, CDCl3) δ 7.35 – 7.15 (m, 13H), 7.12 – 7.03 (m, 2H), 5.53 (s, 1H), 5.38 (s, 1H), 4.23 
– 4.14 (m, 1H), 3.35 (dd, J = 13.7, 6.4 Hz, 1H), 3.14 (dd, J = 13.7, 8.9 Hz, 1H) ppm. 13C NMR 
(101 MHz, CDCl3) δ 151.2, 142.6, 142.5, 140.5, 129.2, 128.4, 128.3, 128.2, 128.2, 127.3, 126.9, 126.4, 
126.0, 113.9, 52.2, 41.9 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 284.2 (14), 206.1 (11), 193.1 (100), 
189.1 (8), 178.1 (52), 165.1 (13), 115.1 (71), 91.1 (16). HRMS (EI-Orbitrap): m/z calcd for C22H20+: 
284.1565; found: 284.1558. []D20: +208.07 ( = 1.19, CH2Cl2). Chiral HPLC: 99% ee (er 99.7:0.3), 
OD-H column, EtOAc:heptane = 0:100, 1.0 mL/min, 30 °C. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 
3083 (w), 3059 (w), 3025 (w), 3003 (w), 2921 (w), 2855 (w), 1944 (vw), 1879 (vw), 1805 (w), 
1625 (w), 1599 (w), 1573 (w), 1493 (m), 1452 (m), 1443 (w), 1296 (w), 1262 (w), 1179 (w), 1155 (w), 
1071 (w), 1029 (w), 965 (w), 901 (m), 777 (m), 745 (m), 696 (vs). 
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(R)-But-3-ene-1,2,3-triyltribenzene (ent-11c) 
Using (1-bromovinyl)benzene and (R)-2-(1,2-diphenylethyl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (SM16) according to general procedure I, provided ent-11c (0.13 mmol, 
37 mg, 51%) as a colorless oil. Rf = 0.20 (hexane/EtOAc 100:0, UV, KMnO4, PAA). 1H 
NMR (400 MHz, CDCl3) δ 7.35 – 7.15 (m, 13H), 7.12 – 7.03 (m, 2H), 5.53 (s, 1H), 5.38 (s, 1H), 4.23 
– 4.14 (m, 1H), 3.35 (dd, J = 13.7, 6.4 Hz, 1H), 3.14 (dd, J = 13.7, 8.9 Hz, 1H) ppm. 13C NMR 
(101 MHz, CDCl3) δ 151.2, 142.6, 142.5, 140.5, 129.2, 128.4, 128.3, 128.2, 128.2, 127.3, 126.9, 126.4, 
126.0, 113.9, 52.2, 41.9 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 284.2 (14), 206.1 (11), 193.1 (100), 
189.1 (8), 178.1 (52), 165.1 (13), 115.1 (71), 91.1 (16). HRMS (EI-Orbitrap): m/z calcd for C22H20+: 
284.1565; found: 284.1558. []D20: -180.73 ( = 0.97, CH2Cl2). Chiral HPLC: 97% ee (er 98.5:1.5), 
OD-H column, EtOAc:heptane = 0:100, 1.0 mL/min, 30 °C. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 
3083 (w), 3059 (w), 3025 (w), 3003 (w), 2921 (w), 2855 (w), 1944 (vw), 1879 (vw), 1805 (w), 
1625 (w), 1599 (w), 1573 (w), 1493 (m), 1452 (m), 1443 (w), 1296 (w), 1262 (w), 1179 (w), 1155 (w), 
1071 (w), 1029 (w), 965 (w), 901 (m), 777 (m), 745 (m), 696 (vs). 
(S)-(3-(4-Methoxyphenyl)but-3-ene-1,2-diyl)dibenzene (11d) 
Using 1-(1-bromovinyl)-4-methoxybenzene (SM20) and (S)-2-(1,2-diphe-
nylethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (SM15) according to general 
procedure I (0.40 mmol scale), provided 11d (0.24 mmol, 75 mg, 70%) as a col-
orless oil. Rf = 0.15 (hexane/EtOAc 99:1, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.23 – 
7.09 (m, 10H), 7.03 – 6.97 (m, 2H), 6.78 – 6.72 (m, 2H), 5.41 (s, 1H), 5.24 (s, 1H), 4.11 – 4.04 (m, 1H), 
3.75 (s, 3H), 3.27 (dd, J = 13.7, 6.3 Hz, 1H), 3.06 (dd, J = 13.7, 8.9 Hz, 1H) ppm. 13C NMR (101 MHz, 
CDCl3) δ 158.9, 150.4, 142.8, 140.6, 134.9, 129.2, 128.4, 128.3, 128.1, 127.9, 126.4, 126.0, 113.6, 
112.6, 55.3, 52.2, 41.9 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 314.2 (21), 281.1 (16), 223.1 (100), 
207.0 (84), 191.1 (27), 178.1 (79), 165.1 (66), 152.1 (21), 115.1 (93), 91.1 (52). HRMS (EI-Orbitrap): 
m/z calcd for C23H22O+: 314.1671; found: 314.1665. []D20: +145.62 ( = 1.78, CH2Cl2). Chiral HPLC: 
92% ee (er 96.0:4.0), OD-H column, EtOAc:heptane = 1.0:99.0, 1.0 mL/min, 30 °C. IR (Diamond-
ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3078 (w), 3065 (w), 3026 (w), 3001 (w), 2944 (w), 2833 (w), 1670 (w), 
1606 (m), 1511 (vs), 1495 (m), 1453 (m), 1292 (m), 1248 (s), 1178 (m), 1069 (w), 1032 (m), 900 (w), 
835 (m), 759 (m), 700 (s). 
(R)-(3-(4-Methoxyphenyl)but-3-ene-1,2-diyl)dibenzene (ent-11d) 
Using 1-(1-bromovinyl)-4-methoxybenzene (SM20) and (R)-2-(1,2-diphe-
nylethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (SM16) according to general 
procedure I, provided ent-11d (0.19 mmol, 59 mg, 73%) as a colorless oil. Rf = 
0.17 (hexane/EtOAc 99:1, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.23 – 7.09 (m, 10H), 
7.03 – 6.97 (m, 2H), 6.78 – 6.72 (m, 2H), 5.41 (s, 1H), 5.24 (s, 1H), 4.11 – 4.04 (m, 1H), 3.75 (s, 3H), 
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3.27 (dd, J = 13.7, 6.3 Hz, 1H), 3.06 (dd, J = 13.7, 8.9 Hz, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 
158.9, 150.4, 142.8, 140.6, 134.9, 129.2, 128.4, 128.3, 128.1, 127.9, 126.4, 126.0, 113.6, 112.6, 55.3, 
52.2, 41.9 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 314.2 (21), 281.1 (16), 223.1 (100), 207.0 (84), 
191.1 (27), 178.1 (79), 165.1 (66), 152.1 (21), 115.1 (93), 91.1 (52). HRMS (EI-Orbitrap): m/z calcd 
for C23H22O+: 314.1671; found: 314.1665. []D20: -135.74 ( = 1.22, CH2Cl2). Chiral HPLC: 89% ee 
(er 94.5:5.5), OD-H column, EtOAc:heptane = 1.0:99.0, 1.0 mL/min, 30 °C. IR (Diamond-ATR, neat) 
𝜈𝑚𝑎𝑥 (cm
-1): 3078 (w), 3065 (w), 3026 (w), 3001 (w), 2944 (w), 2833 (w), 1670 (w), 1606 (m), 
1511 (vs), 1495 (m), 1453 (m), 1292 (m), 1248 (s), 1178 (m), 1069 (w), 1032 (m), 900 (w), 835 (m), 
759 (m), 700 (s). 
(S)-(3-(3,4,5-Trimethoxyphenyl)but-3-ene-1,2-diyl)dibenzene (11e) 
Using 5-(1-bromovinyl)-1,2,3-trimethoxybenzene (SM21) and (S)-2-(1,2-diphe-
nylethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (SM15) according to general 
procedure I (0.40 mmol scale), provided 11e (0.27 mmol, 102 mg, 80%) as a col-
orless oil. Rf = 0.19 (hexane/EtOAc 95:5, UV, KMnO4, PAA). 1H NMR (400 
MHz, CDCl3) δ 7.25 – 7.11 (m, 8H), 7.04 – 6.98 (m, 2H), 6.36 (s, 2H), 5.43 (s, 1H), 5.30 (s, 1H), 4.02 
(t, J = 7.6 Hz, 1H), 3.79 (s, 3H), 3.71 (s, 6H), 3.25 (dd, J = 13.6, 6.8 Hz, 1H), 3.09 (dd, J = 13.6, 8.4 
Hz, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 152.8, 151.1, 143.0, 140.4, 138.3, 137.4, 129.3, 128.4, 
128.3, 128.2, 126.6, 126.1, 113.8, 104.2, 61.0, 56.1, 52.7, 41.8 ppm. LRMS (DEP/EI-Orbitrap): 
m/z (%): 374.2 (38), 283.1 (39), 252.1 (40), 237.1 (25), 225.0 (21), 207.0 (39), 193.1 (17), 178.1 (47), 
165.1 (60), 152.1 (28), 115.1 (100), 91.1 (56). HRMS (EI-Orbitrap): m/z calcd for C25H26O3+: 374.1882; 
found: 374.1876. []D20: +118.70 ( = 0.77, CH2Cl2). Chiral HPLC: 95% ee (er 97.5:2.5), OD-H col-
umn, EtOAc:heptane = 10:90, 1.0 mL/min, 30 °C. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3083 (w), 
3061 (w), 3029 (w), 2998 (w), 2934 (w), 2834 (w), 1579 (m), 1504 (m), 1496 (m), 1461 (m), 1453 (m), 
1410 (m), 1334 (m), 1240 (m), 1180 (w), 1173 (w), 1127 (vs), 1007 (w), 905 (m), 840 (w), 731 (m), 
701 (m). 
(R)-(3-(3,4,5-Trimethoxyphenyl)but-3-ene-1,2-diyl)dibenzene (ent-11e) 
Using 5-(1-bromovinyl)-1,2,3-trimethoxybenzene (SM21) and (R)-2-(1,2-diphe-
nylethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (SM16) according to general 
procedure I (0.40 mmol scale), provided ent-11e (0.29 mmol, 108 mg, 85%) as a 
colorless oil. Rf = 0.19 (hexane/EtOAc 95:5, UV, KMnO4, PAA). 1H NMR (400 
MHz, CDCl3) δ 7.25 – 7.11 (m, 8H), 7.04 – 6.98 (m, 2H), 6.36 (s, 2H), 5.43 (s, 1H), 5.30 (s, 1H), 4.02 
(t, J = 7.6 Hz, 1H), 3.79 (s, 3H), 3.71 (s, 6H), 3.25 (dd, J = 13.6, 6.8 Hz, 1H), 3.09 (dd, J = 13.6, 8.4 
Hz, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 152.8, 151.1, 143.0, 140.4, 138.3, 137.4, 129.3, 128.4, 
128.3, 128.2, 126.6, 126.1, 113.8, 104.2, 61.0, 56.1, 52.7, 41.8 ppm. LRMS (DEP/EI-Orbitrap): m/z 
(%): 374.2 (38), 283.1 (39), 252.1 (40), 237.1 (25), 225.0 (21), 207.0 (39), 193.1 (17), 178.1 (47), 165.1 
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(60), 152.1 (28), 115.1 (100), 91.1 (56). HRMS (EI-Orbitrap): m/z calcd for C25H26O3+: 374.1882; 
found: 374.1876. []D20: -118.21 ( = 1.45, CH2Cl2). Chiral HPLC: 99% ee (er 99.5:0.5), OD-H col-
umn, EtOAc:heptane = 10:90, 1.0 mL/min, 30 °C. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3083 (w), 
3061 (w), 3029 (w), 2998 (w), 2934 (w), 2834 (w), 1579 (m), 1504 (m), 1496 (m), 1461 (m), 1453 (m), 
1410 (m), 1334 (m), 1240 (m), 1180 (w), 1173 (w), 1127 (vs), 1007 (w), 905 (m), 840 (w), 731 (m), 
701 (m). 
1-Chloro-4-((4S,5S)-5-(1-(4-methoxyphenyl)vinyl)octan-4-yl)benzene (11f) 
Using 1-(1-bromovinyl)-4-methoxybenzene (SM20) and 2-((4R,5R)-5-
(4-chlorophenyl)octan-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(SM17) according to general procedure I, provided 11f (dr > 99:1, 
0.20 mmol, 70 mg, 77%) as a colorless oil. Rf = 0.16 (hexane/EtOAc 100:0, UV, KMnO4, PAA). 1H 
NMR (400 MHz, CDCl3) δ 7.16 – 7.11 (m, 2H), 7.10 – 7.04 (m, 2H), 6.94 (d, J = 8.4 Hz, 2H), 6.84 – 
6.75 (m, 2H), 5.14 (d, J = 1.0 Hz, 1H), 4.79 (s, 1H), 3.81 (s, 3H), 2.78 – 2.68 (m, 1H), 2.66 – 2.56 (m, 
1H), 1.75 – 1.58 (m, 2H), 1.58 – 1.40 (m, 3H), 1.31 – 1.15 (m, 1H), 1.13 – 1.01 (m, 1H), 1.01 – 0.93 
(m, 1H), 0.89 (t, J = 7.2 Hz, 3H), 0.77 (t, J = 7.3 Hz, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 158.8, 
150.3, 142.8, 136.8, 131.3, 130.2, 127.8, 127.8, 113.5, 113.1, 55.4, 50.4, 49.1, 33.7, 33.4, 20.9, 20.8, 
14.6, 14.2 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 225.0 (16), 207.0 (18), 166.1 (11), 151.0 (14), 
131.1 (20), 125.0 (100), 115.1 (30), 91.1 (12). HRMS (EI-Orbitrap): m/z calcd for C23H29ClO+: 
356.1907; found: 356.1902. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3088 (vw), 3039 (vw), 2954 (m), 
2931 (w), 2870 (w), 2835 (vw), 1607 (m), 1573 (w), 1509 (s), 1490 (m), 1464 (m), 1456 (w), 1441 (w), 
1409 (w), 1377 (w), 1292 (w), 1244 (s), 1177 (m), 1113 (w), 1093 (m), 1035 (m), 1014 (m), 905 (s), 
832 (s), 802 (m), 729 (vs). 
1-Chloro-4-((1R,2S)-2-(1-phenylvinyl)cyclopentyl)benzene) (11g) 
Using (1-bromovinyl)benzene and 2-((1S,2R)-2-(4-chlorophenyl)cyclopentyl)-
4,4,5,5-tetramethyl-1,3,2-dioxaborolane (SM18) according to general procedure I, 
provided 11g (dr > 99:1, 0.13 mmol, 38 mg, 52%) as a colorless oil. Rf = 0.50 (hex-
ane/EtOAc 97:3, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.26 – 7.18 (m, 
3H), 7.13 – 7.07 (m, 2H), 7.05 – 6.98 (m, 2H), 6.70 – 6.62 (m, 2H), 5.04 (s, 1H), 4.79 (s, 1H), 3.49 – 
3.40 (m, 1H), 3.29 (td, J = 8.0, 4.4 Hz, 1H), 2.33 – 2.17 (m, 1H), 2.08 – 1.75 (m, 5H) ppm. 13C NMR 
(101 MHz, CDCl3) δ 149.1, 142.9, 142.8, 131.2, 130.0, 128.1, 127.4, 127.1, 126.5, 113.2, 49.2, 46.9, 
33.2, 29.8, 24.1 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 282.1 (7), 207.0 (21), 157.1 (13), 143.1 (20), 
129.1 (100), 115.1 (38), 103.1 (16), 91.1 (20). HRMS (EI-Orbitrap): m/z calcd for C19H19Cl+: 282.1175; 
found: 282.1167. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3091 (vw), 3058 (w), 3027 (w), 2954 (m), 
2871 (w), 2365 (w), 2338 (w), 1626 (w), 1596 (w), 1573 (w), 1492 (vs), 1443 (w), 1410 (w), 1305 (w), 
1184 (vw), 1091 (m), 1014 (m), 905 (m), 817 (m), 776 (s), 731 (m), 701 (s). 
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(1R,2R,3R,5R)-2,6,6-Trimethyl-3-(1-phenylvinyl)bicyclo[3.1.1]heptane (11h) 
Using (1-bromovinyl)benzene and 4,4,5,5-tetramethyl-2-((1R,2S,3R,5R)-2,6,6-trime-
thylbicyclo[3.1.1]heptan-3-yl)-1,3,2-dioxaborolane (SM19) according to general proce-
dure I (0.40 mmol scale), provided 11h (dr > 99:1, 0.21 mmol, 51 mg, 63%) as a colorless 
oil. Rf = 0.70 (hexane/EtOAc 100:0, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 
7.39 – 7.23 (m, 5H), 5.16 (d, J = 4.0 Hz, 2H), 2.99 (dt, J = 9.8, 8.0 Hz, 1H), 2.38 – 2.17 (m, 3H), 1.96 
– 1.90 (m, 1H), 1.86 (td, J = 5.8, 1.9 Hz, 1H), 1.70 (ddd, J = 13.6, 7.7, 2.4 Hz, 1H), 1.23 (s, 3H), 1.11 
(s, 3H), 1.03 (d, J = 7.1 Hz, 3H), 0.85 (d, J = 9.5 Hz, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 156.4, 
144.2, 128.2, 127.3, 127.1, 111.3, 48.3, 42.7, 42.0, 41.8, 39.1, 36.0, 34.5, 28.5, 23.2, 21.8 ppm. LRMS 
(DEP/EI-Orbitrap): m/z (%): 240.2 (8), 197.1 (15), 185.1 (32), 169.1 (20), 155.1 (21), 143.1 (45), 129.1 
(50), 115.1 (31), 93.1 (80), 83.1 (100), 69.1 (28), 55.1 (61). HRMS (EI-Orbitrap): m/z calcd for C18H24+: 
240.1878; found: 240.1872. []D20: -18.98 ( = 1.48, CH2Cl2). IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 
3078 (w), 3054 (w), 3018 (w), 2984 (m), 2950 (m), 2918 (m), 2900 (s), 2869 (m), 1625 (w), 1599 (w), 
1573 (w), 1491 (w), 1470 (w), 1452 (m), 1442 (w), 1384 (w), 1372 (w), 1266 (w), 1217 (vw), 
1147 (w), 1072 (w), 1027 (w), 1009 (vw), 891 (m), 780 (w), 770 (m), 701 (vs). 
(-)-1,7,7-Trimethyl-2-(thiazol-2-yl)bicyclo[2.2.1]heptan-2-ol (12a) 
Using 2-bromothiazole and (+)-camphor according to general procedure J (0.40 mmol 
scale), provided 12a (dr > 99:1, 0.34 mmol, 82 mg, 86%) as a yellow solid. Rf = 0.56 
(hexane/EtOAc 80:20, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.72 (d, J = 
3.3 Hz, 1H), 7.24 (d, J = 3.3 Hz, 1H), 3.09 (s, 1H), 2.37 – 2.33 (m, 2H), 1.91 – 1.87 (m, 
1H), 1.79 – 1.67 (m, 1H), 1.37 – 1.24 (m, 2H), 1.19 (s, 3H), 1.02 (s, 3H, OH), 0.91 (s, 3H), 0.88 – 0.79 
(m, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 177.8, 142.1, 118.8, 83.5, 54.4, 50.1, 47.1, 45.4, 31.0, 
26.8, 21.4, 21.2, 9.9 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 237.2 (20), 209.2 (10), 176.1 (9), 128.1 
(100), 112.0 (21), 95.1 (80), 86.0 (40). HRMS (EI-Orbitrap): m/z calcd for C13H19NOS+: 237.1187; 
found: 237.1183. []D22: -57.28 ( = 1.10, CH2Cl2). IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3421 (br/m), 
2987 (m), 2952 (vs), 2934 (s), 2882 (m), 2874 (m), 1492 (m), 1479 (m), 1454 (s), 1422 (m), 1389 (s), 
1370 (m), 1274 (w), 1253 (w), 1220 (m), 1197 (w), 1157 (m), 1131 (m), 1114 (m), 1095 (m), 1069 (vs), 
1057 (s), 1007 (m), 970 (m), 951 (m), 943 (m), 910 (m), 866 (m), 801 (m), 723 (vs). Mp (°C) = 58–61. 
2-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)bicyclo[2.2.2]octan-2-ol (12b) 
Using 5-bromo-2,2-difluorobenzo[d][1,3]dioxole and bicyclo[2.2.2]octan-2-one 
according to general procedure J (0.40 mmol scale), provided 12b (0.22 mmol, 
63 mg, 66%) as a colorless oil. Rf = 0.38 (hexane/EtOAc 90:10, UV, KMnO4, 
PAA). 1H NMR (400 MHz, C6D6) δ 6.96 (d, J = 1.8 Hz, 1H), 6.75 (dd, J = 8.5, 1.8 Hz, 1H), 6.44 (d, J 
= 8.4 Hz, 1H), 2.24 – 2.14 (m, 1H, OH), 1.87 (dt, J = 14.3, 2.6 Hz, 1H), 1.70 – 1.56 (m, 2H), 1.49 – 
1.34 (m, 3H), 1.32 – 1.22 (m, 2H), 1.22 – 1.09 (m, 2H), 1.08 – 0.97 (m, 2H) ppm. 13C NMR (101 MHz, 
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C6D6) δ 145.4, 144.1, 142.6, 132.6 (t, J = 254.0 Hz), 121.4, 108.4, 108.4, 74.5, 42.5, 36.5, 26.2, 25.2, 
24.3, 22.3, 21.3 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 282.1 (13), 264.1 (33), 236.1 (96), 200.1 
(100), 185.1 (56), 171.0 (31), 141.1 (32), 115.1 (32). HRMS (EI-Orbitrap): m/z calcd for C15H16F2O3+: 
282.1068; found: 282.1063. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3413 (br/w), 2941 (w), 2917 (w), 
2867 (w), 1620 (vw), 1494 (m), 1476 (w), 1456 (w), 1436 (w), 1238 (vs), 1153 (s), 1085 (w), 1032 (m), 
1012 (w), 982 (w), 939 (w), 935 (w), 906 (w), 869 (w), 859 (w), 812 (w). 
1-(4-Methoxyphenyl)-1-phenylethan-1-ol (12c) 
Using 1-bromo-4-methoxybenzene and acetophenone according to general pro-
cedure J (0.40 mmol scale), provided 12c (0.28 mmol, 63 mg, 81%) as a color-
less oil. Rf = 0.17 (hexane/EtOAc 95:5, UV, KMnO4, PAA). 1H NMR 
(400 MHz, CDCl3) δ 7.40 – 7.34 (m, 2H), 7.31 – 7.25 (m, 4H), 7.23 – 7.17 (m, 1H), 6.84 – 6.77 (m, 
2H), 3.75 (s, 3H), 2.16 (s, 1H, OH), 1.90 (s, 3H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 210.1 (100), 
195.0 (70), 165.1 (71), 152.0 (47), 115.0 (13), 89.0 (13). Analytical data in accordance to literature.49  
(-)-2-(6-Methoxypyridin-3-yl)-4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-ol (12d) 
Using 5-bromo-2-methoxypyridine and (-)-verbenone according to general procedure J 
(0.40 mmol scale), provided 12d (dr > 99:1, 0.29 mmol, 74 mg, 84%) as a colorless 
solid. Rf = 0.36 (hexane/EtOAc 80:20, UV, KMnO4, PAA). 1H NMR (400 MHz, C6D6) 
δ 8.43 (d, J = 2.4 Hz, 1H), 7.58 (dd, J = 8.6, 2.5 Hz, 1H), 6.70 (d, J = 8.6 Hz, 1H), 5.25 
– 5.19 (m, 1H), 3.88 (s, 3H), 2.21 (td, J = 6.0, 2.1 Hz, 1H), 2.01 (ddd, J = 9.5, 6.1, 
5.3 Hz, 1H), 1.77 – 1.73 (m, 1H), 1.60 (s, 1H), 1.58 (d, J = 1.6 Hz, 3H), 1.25 (d, J = 9.5 Hz, 1H), 1.21 
(s, 3H), 1.15 (s, 3H) ppm. 13C NMR (101 MHz, C6D6) δ 163.8, 147.1, 145.8, 137.7, 136.2, 120.9, 110.5, 
77.5, 53.9, 53.3, 47.5, 43.4, 34.0, 27.3, 23.5, 22.8 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 241.2 (81), 
226.2 (78), 198.1 (100), 184.1 (25), 154.1 (20), 128.1 (25), 115.1 (31), 91.1 (11). HRMS (EI-Orbitrap): 
m/z calcd for C16H21NO2+: 259.1572; found: 259.1565. []D22: -66.01 ( = 1.01, CH2Cl2). IR (Diamond-
ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3373 (br/w), 2973 (m), 2921 (m), 2867 (w), 1603 (m), 1571 (m), 1491 (vs), 
1462 (w), 1442 (m), 1433 (w), 1376 (m), 1333 (w), 1287 (s), 1250 (m), 1230 (w), 1167 (w), 1129 (w), 
1121 (w), 1052 (m), 1030 (m), 1022 (m), 1008 (m), 957 (m), 831 (m). Mp (°C) = 97–100. 
(+)-2-(3-Chloro-4-fluorophenyl)-4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-ol (12e) 
Using 4-bromo-2-chloro-1-fluorobenzene and (-)-verbenone according to general proce-
dure J (0.40 mmol scale), provided 12e (dr > 99:1, 0.27 mmol, 75 mg, 79%) as a light-
yellow oil. Rf = 0.54 (hexane/EtOAc 80:20, UV, KMnO4, PAA). 1H NMR (400 MHz, 
CDCl3) δ 7.50 (dd, J = 7.2, 2.2 Hz, 1H), 7.32 (ddd, J = 8.5, 4.6, 2.2 Hz, 1H), 7.07 (t, J = 
8.7 Hz, 1H), 5.43 (s, 1H), 2.32 – 2.21 (m, 2H), 2.14 (s, 1H, OH), 2.06 (t, J = 5.4 Hz, 1H), 
1.86 (d, J = 1.5 Hz, 3H), 1.40 (s, 3H), 1.26 (d, J = 9.2 Hz, 1H), 1.21 (s, 3H) ppm. 13C NMR (101 MHz, 
CDCl3) δ 157.2 (d, J = 248.1 Hz), 148.6, 144.3, 129.3, 126.7 (d, J = 7.1 Hz), 120.0, 116.0, 115.8, 78.8, 
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54.0, 47.4, 43.9, 34.0, 27.2, 23.4, 23.1 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 280.1 (9), 262.1 (60), 
247.1 (52), 219.1 (100), 197.1 (54), 183.1 (93), 170.1 (30), 157.0 (68), 133.1 (25), 91.1 (29). HRMS 
(EI-Orbitrap): m/z calcd for C16H18ClFO+: 280.1030; found: 280.1025. []D22: +4.50 ( = 1.19, CH2Cl2). 
IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3413 (br/w), 2975 (m), 2925 (m), 2869 (w), 1654 (w), 1599 (w), 
1590 (w), 1496 (vs), 1443 (w), 1391 (m), 1366 (w), 1333 (w), 1261 (m), 1246 (s), 1166 (w), 1131 (w), 
1059 (m), 1048 (m), 1008 (m), 994 (m), 966 (w), 908 (m), 896 (w), 888 (w), 819 (m). 
3-(2,4-Dimethoxypyrimidin-5-yl)-2,2,4,4-tetramethylpentan-3-ol (12f) 
Using 5-bromo-2,4-dimethoxypyrimidine and hexamethylacetone according to gen-
eral procedure J (0.40 mmol scale), provided 12f (0.24 mmol, 67 mg, 70%) as a col-
orless solid. Rf = 0.21 (hexane/EtOAc 90:10, UV, KMnO4, PAA). 1H NMR 
(400 MHz, CDCl3) δ 8.71 (s, 1H), 4.00 (s, 3H), 3.95 (s, 3H), 1.89 (s, 1H, OH), 1.08 (s, 
18H) ppm. 13C NMR (101 MHz, CDCl3) δ 167.8, 164.1, 160.8, 119.0, 84.3, 54.8, 52.8, 42.4, 29.3 ppm. 
LRMS (DEP/EI-Orbitrap): m/z (%): 225.2 (80), 207.2 (10), 167.1 (10), 141.1 (100), 109.1 (8), 57.1 
(25). HRMS (EI-Orbitrap): m/z calcd for C11H17N2O3+ [M-t-Bu]+: 225.1239; found: 225.1237. IR (Di-
amond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3386 (br/m), 2961 (m), 2920 (m), 2874 (m), 2359 (m), 2341 (m), 1579 
(s), 1558 (s), 1473 (s), 1462 (s), 1395 (vs), 1319 (m), 1279 (m), 1241 (m), 1195 (m), 1139 (m), 1074 
(m), 1060 (m), 1017 (s), 924 (m). Mp (°C) = 143–147. 
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4.5 Raman Spectroscopy230 
4.5.1 Measurements 
Raman spectroscopy was performed at –50 °C in a sealed glass vessel under argon atmosphere. The 
sample was concentrated under high vacuum prior to measuring to give maximum intensities (Figure 
12). 
 
Figure 12: Comparative Raman spectra of different metallic salts and organometallic species. 
The Raman spectra of the reaction mixture show a significant Raman line at 420 cm-1, indicating a 
carbon stretching mode. This observation and the absence of CeCl3 and n-BuLi vibrations point to the 
existence of a cerium carbon species. In addition, comparable Raman frequencies of other alkylic metal 
complexes can be found in the literature.231 No further significant Raman lines or shifts compared to 
the n-BuLi were observed in the Raman spectrum of “n-Bu3Ce”.  
  
 
230 Raman measurements and theoretical calculations were performed by Dr. Florian Zischka, Department of 
Chemistry, LMU Munich. 
231 K. Nakamoto, Infrared and Raman Spectra of Inorganic and Coordination Compounds, Part B: Applications 
in Coordination, Organometallic, and Bioinorganic Chemistry, 6th Ed., Wiley & Sons, Hoboken, USA, 2009, 275–
331. 
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4.7.2 Calculations 
In order to gain insights on the vibrational frequencies of the Ce-C stretching modes, the gas phase 
structure of RxCeCl3-x (x=3) was calculated with the Program Gaussian 09 Revision B. 01 as an exam-
ple. The equilibrium geometry and the vibrational frequencies were calculated at the B3LYP/aug-cc-
pvdz level of theory for H and C atoms.232 For the calculation of cerium the Effective Core Potential 
MWB28 was employed. The vibrational analysis exhibits no negative frequencies, indicating a true 
minimum on the energy hypersurface. Calculated vibrational frequencies were scaled with an empirical 
factor of 0.97 according to the NIST CCCB Data Base (https://cccbdb.nist.gov/vibscalejust.asp). 
The theoretical calculations predict the νs (Ce-C) at 452 cm-1 and two degenerated antisymmetric Ce-C 
stretching modes at 446 cm-1. The calculated frequencies are in reasonable agreement with the observed 
Raman line at 420 cm-1. The two discussed Ce-C modes, showing only a small difference in frequency, 
may be a good explanation of the broad Raman line observed in the experiment. The calculated equi-
librium geometry is depicted in Table 6. 
Calculated vibrational frequencies (B3LYP/aug-cc-pvdz/MWB28) of RxCeCl3-x (x=3) in cm-1 (IR Ab-
sorption/Raman Intensity): 
3096 (32/111), 3096 (43/126), 3096 (48/133), 3088 (98/23), 3088 (107/12), 3087 (24/61), 3082 
(20/118), 3080 (27/122), 3079 (12/131), 3059 (4/93), 3059 (2/61), 3059 (2/61), 3033 (33/47), 3032 
(37/39), 3030 (45/30), 3021 (4/505), 3021 (11/155), 3021 (9/63), 3019 (66/222), 3019 (4/24), 3019 
(8/40), 3000 (24/134), 2998 (22/112), 2997 (20/93), 2574 (147/70), 2566 (231/19), 2563 (244/10), 1480 
(6/0), 1480 (4/0), 1479 (4/0), 1474 (3/2), 1474 (6/5), 1474 (8/7), 1465 (1/2), 1464 (1/4), 1464 (0/12), 
1463 (3/16), 1462 (3/8), 1459 (3/6), 1431 (3/4), 1428 (1/1), 1428 (1/1), 1390 (11/0), 1390 (2/0), 1390 
(0/0), 1376 (7/10), 1375 (7/8), 1374 (1/14), 1334 (7/4), 1332 (9/4), 1331 (4/4), 1299 (8/1), 1298 (9/3), 
1298 (9/3), 1272 (1/0), 1271 (1/0), 1270 (1/0), 1189 (4/5), 1189 (4/4), 1188 (3/5), 1108 (0/39), 1107 
(3/6), 1107 (2/7), 1064 (8/3), 1064 (7/4), 1064 (4/15), 1021 (3/8), 1021 (3/6), 1020 (3/7), 990 (2/1), 990 
(2/1), 989 (3/0), 920 (46/98), 919 (7/27), 918 (6/25), 847 (42/18), 842 (1/9), 842 (1/11), 832 (10/18), 
827 (3/17), 826 (4/18), 725 (0/0), 724 (0/0), 724 (0/1), 466 (4/3), 461 (60/1), 461 (60/1), 427 (27/2), 
424 (29/2), 416 (20/20), 372 (12/1), 370 (11/1), 319 (0/0), 266 (23/1), 265 (24/1), 257 (1/8), 235 (0/0), 
234 (0/0), 234 (0/0), 201 (5/1), 199 (5/2), 197 (5/1), 106 (2/0), 98 (1/1), 98 (1/1), 70 (0/2), 69 (0/2), 67 
(0/1), 59 (1/2), 58 (1/2), 26 (0/0), 20 (0/0), 13 (0/1), 12 (0/1). 
 
232 a) A. D. Becke, J. Chem. Phys. 1993, 98, 5648–5652; b) E. R. Davidson, Chem. Phys. Lett. 1996, 260, 514–
518; c) T. H. Dunning, J. Chem. Phys. 1989, 90, 1007–1023; d) R. A. Kendall, T. H. Dunning, R. J. Harrison, J. 
Chem. Phys. 1992, 96, 6796–6806; e) K. A. Peterson, D. E. Woon, T. H. Dunning, J. Chem. Phys. 1994, 100, 
7410–7415; f) D. E. Woon, T. H. Dunning, J. Chem. Phys. 1993, 98, 1358–1371. 
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Scaled calculated vibrational frequencies (B3LYP/aug-cc-pvdz/MWB28) of “RxCeCl3-x (x=3)” in cm-1. 
Calculated frequencies were scaled with an empirical factor of 0.97 according to the NIST CCCB Data 
Base (https://cccbdb.nist.gov/vibscalejust.asp). 
3004, 3004, 3004, 2996, 2996, 2995, 2990, 2989, 2988, 2969, 2968, 2968, 2943, 2941, 2940, 2932, 
2931, 2931, 2930, 2929, 2929, 2912, 2909, 2908, 2495, 2488, 2486, 1436, 1436, 1435, 1431, 1430, 
1430, 1422, 1421, 1420, 1419, 1419, 1416, 1389, 1386, 1385, 1349, 1349, 1348, 1334, 1333, 1332, 
1292, 1292, 1291, 1260, 1259, 1257, 1233, 1233, 1232, 1154, 1153, 1153, 1075, 1074, 1074, 1033, 
1032, 1031, 992, 990, 990, 961, 960, 959, 893, 892, 891, 823, 818, 817, 807, 803, 802, 704, 703, 702, 
452, 448, 447, 418, 412, 404, 364, 360, 315, 260, 257, 250, 233, 230, 228, 197, 192, 192, 104, 97, 97, 
71, 69, 68, 60, 55, 27, 22, 13, 11. 
Table 6: Cartesian coordinates of the equilibrium geometry of RxCeCl3-x (x=3) calculated at B3LPY/aug-cc-
pvdz/MWB28 and depicted structure of the calculated molecule. 
 
Atom Number Label X Y Z Element 
1 C1 0.0503 24.194 -13.276 C 
2 H2 10.360 27.309 -17.149 H 
3 H3 -0.7303 29.255 -19.123 H 
4 Ce4 -0.0035 -0.0124 -0.9505 Ce 
5 C5 -0.0729 27.011 0.1667 C 
6 H6 -10.892 30.428 0.4185 H 
7 H7 0.0281 17.489 0.7895 H 
8 C8 0.9544 36.671 0.7797 C 
9 H9 0.8317 46.452 0.2908 H 
10 H10 19.661 33.193 0.5174 H 
11 C11 0.8355 38.221 22.984 C 
12 H12 15.854 45.247 26.879 H 
13 H13 -0.1572 42.019 25.827 H 
14 H14 0.9839 28.599 28.121 H 
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15 C15 20.909 -12.603 -13.184 C 
16 H16 29.132 -0.836 -19.112 H 
17 H17 18.800 -22.771 -16.938 H 
18 C18 24.039 -12.752 0.1745 C 
19 H19 31.949 -0.5479 0.4166 H 
20 H20 15.246 -0.8982 0.7989 H 
21 C21 27.575 -26.351 0.7995 C 
22 H22 36.749 -30.013 0.3149 H 
23 H23 19.671 -33.581 0.5429 H 
24 C24 29.489 -25.922 23.183 C 
25 H25 32.063 -35.836 27.164 H 
26 H26 37.571 -19.001 25.979 H 
27 H27 20.324 -22.576 28.280 H 
28 C28 -21.528 -11.679 -13.069 C 
29 H29 -22.203 -21.044 -18.781 H 
30 H30 -29.086 -0.4649 -16.996 H 
31 C31 -23.325 -13.934 0.1911 C 
32 H32 -20.848 -24.328 0.4599 H 
33 H33 -15.823 -0.79 0.805 H 
34 C34 -36.970 -10.259 0.7985 C 
35 H35 -44.603 -16.594 0.3223 H 
36 H36 -39.407 0.0107 0.5167 H 
37 C37 -37.632 -11.795 23.206 C 
38 H38 -47.560 -0.9088 27.061 H 
39 H39 -35.582 -22.164 26.258 H 
40 H40 -30.256 -0.5329 28.201 H 
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4.6 Representative NMR Spectra 
 
 
Figure 13: 1H NMR (400 MHz, CDCl3) and 13C NMR (101 MHz, CDCl3) of (Z)-2-Methyl-6-(1-phe-
nylprop-1-en-1-yl)pyridine (8a). 
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Figure 14: NOESY, observed NOEs (top) and zoom on relevant NOESY area (bottom) of (Z)-2-Methyl-6-(1-
phenylprop-1-en-1-yl)pyridine (8a). 
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4.7 Chiral HPLC Analysis 
 
 
 
  
Figure 15: HPLC chromatogram, peak table and footprint for (R) and (S)-1-Methoxy-4-(3-phenylbut-3-en-2-
yl)benzene (11a and ent-11a). 
 
Figure 16: HPLC chromatogram, peak table and footprint for racemic 1-Methoxy-4-(3-phenylbut-3-en-2-yl)ben-
zene (11a and ent-11a). 
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Figure 17: HPLC chromatogram, peak table and footprint for (R) and (S)-1-(1-(4-Methoxyphenyl)vinyl)-2,3-
dihydro-1H-indene (ent-11b and 11b). 
 
Figure 18: HPLC chromatogram, peak table and footprint for racemic 1-(1-(4-Methoxyphenyl)vinyl)-2,3-dihy-
dro-1H-indene (ent-11b and 11b). 
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Figure 19: HPLC chromatogram, peak table and footprint for (S) and (R)-But-3-ene-1,2,3-triyltribenzene (11c 
and ent-11c). 
 
Figure 20: HPLC chromatogram, peak table and footprint for racemic But-3-ene-1,2,3-triyltribenzene (11c and 
ent-11c). 
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Figure 21: HPLC chromatogram, peak table and footprint for (S) and (R)-(3-(4-Methoxyphenyl)but-3-ene-1,2-
diyl)dibenzene (11d and ent-11d). 
 
Figure 22: HPLC chromatogram, peak table and footprint for racemic (3-(4-Methoxyphenyl)but-3-ene-1,2-
diyl)dibenzene (11d and ent-11d). 
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Figure 23: HPLC chromatogram, peak table and footprint for (S) and (R)-(3-(3,4,5-Trimethoxyphenyl)but-3-
ene-1,2-diyl)dibenzene (11e and ent-11e). 
 
Figure 24: HPLC chromatogram, peak table and footprint for racemic (3-(3,4,5-Trimethoxyphenyl)but-3-ene-
1,2-diyl)dibenzene (11e and ent-11e). 
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5 Electrochemical Synthesis of Biaryls via Oxidative Intramolecular Cou-
pling of Tetra(hetero)arylborates233 
5.1 General Procedures  
5.1.1 General Procedure K: Synthesis of Aryl Grignard Reagents 
 
A Schlenk flask was charged with magnesium turnings (972 mg, 40 mmol, 1.6 equiv) and dried in 
vacuo using a heat gun (600 °C, 2 × 5 min). After addition of THF (2.0 mL) and 1,2-dibromoethane 
(2 drops), the mixture was heated to boil with a heat gun to activate the magnesium. The corresponding 
aryl bromide (25 mmol, 1.0 equiv) was dissolved in THF (23.0 mL for approximately 1 M solution or 
48.0 mL for 0.5 M solution) and added to the activated magnesium suspension dropwise. After comple-
tion of the addition, the mixture was stirred for one hour at room temperature to yield a THF-solution 
of the arylmagnesium reagents. 
5.1.2 General Procedure L: Synthesis of Arylzinc Reagents 
 
According to a previously reported procedure,234 a Schlenk flask was charged with LiCl (212 mg, 
5.0 mmol, 1.0 equiv) and dried in vacuo using a heat gun (500 °C, 2 × 5 min). Zinc powder (490 mg, 
7.5 mmol, 1.5 equiv) was added and the flask was dried again in vacuo (350 °C, 2 × 5 min). After 
addition of THF (5.0 mL), 1,2-dibromoethane (2 drops) and TMSCl (5 drops), the mixture was heated 
to boil with a heat gun to activate the zinc. The corresponding aryl iodide (5.0 mmol, 1.0 equiv) was 
added neat to the activated zinc suspension at room temperature and the reaction was stirred at 50 °C 
until complete consumption of the aryl iodide was observed by GC analysis.  
  
 
233 The full supporting information can be found under the following link: https://doi.org/10.1021/jacs.9b12300 
234 A. Krasovskiy, V. Malakhov, A. Gavryushin, P. Knochel, Angew. Chem. 2006, 118, 6186–6190. 
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5.1.3 General Procedure M: Preparation of Aryl Boronic Acids starting from Aryl Bromides 
 
Adapted from a previously reported procedure,235 commercially available aryl bromides (5.0 mmol, 
1.0 equiv) were dissolved in 20 mL of THF and cooled to –78 °C. A solution of n-BuLi in hexanes 
(5.5 mmol, 2.43 M, 1.1 equiv) was added dropwise and the reaction stirred for 30 min. B(Oi-Pr)3 was 
then added dropwise (10 mmol, 2.0 equiv) and the reaction stirred for further 30 min. The reaction was 
then allowed to reach 0 °C and was stirred at that temperature for one hour. The reaction was then 
quenched with 1 M HCl (40 mL) and extracted with EtOAc (3 × 50 mL). The combined organic phases 
were dried over MgSO4, filtered and concentrated under reduced pressure. The crude product was used 
without further purification in general procedure N.  
5.1.4 General Procedure N: Preparation of Potassium Trifluoroborate Salts starting from Aryl 
Boronic Esters and Acids 
 
Adapted from a previously reported procedure,235 5.0 mmol (1.0 equiv) of commercially available Aryl 
pinacol boronic esters, boronic acids or crude intermediates from general procedure M were dissolved 
in 15 mL of a 4:1 (v/v) mixture of MeOH and H2O. The mixture was cooled to 0 °C and KHF2 
(4.0 equiv) was added neat. The mixture was vigorously stirred at room temperature overnight and then 
concentrated under reduced pressure. The remaining solids were extracted with boiling acetone (2 × 
50 mL) and twice with acetone at room temperature (2 × 50 mL). The acetone was removed under 
reduced pressure and the remaining solid was dissolved in a minimum amount of boiling acetone, before 
being treated with diethyl ether, resulting in the precipitation of a colorless solid. The solids were fil-
tered, washed with diethyl ether and dried in vacuo to yield potassium aryltrifluoroborate salts 
SM22−27 and SM30–35. (Note: A recrystallization in hexanes/acetone mixtures was performed in 
cases, where the desired potassium trifluoroborate salt was not pure by 1H NMR.) 
  
 
235 S. Darses, G. Michaud, J.-P. Genet, Eur. J. Org. Chem. 1999, 1875–1883. 
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5.1.5 General Procedure O: Preparation of Tetra(hetero)arylborate Salts (TABs) 
 
A 25 mL Schlenk flask was charged with the corresponding potassium trifluoroborate salt (3.0 mmol, 
1.0 equiv) and 6 mL of THF were added. The mixture was cooled to 0 °C and the desired aryl Grignard 
reagent (9.45 mmol, 3.15 equiv) was added dropwise over 30 min via syringe pump. The reaction was 
allowed to warm to room temperature and was stirred one hour. The reaction was then quenched with 
5 mL of sat. aq. K2CO3 solution and extracted with EtOAc (3 × 40 mL). The combined organic phases 
were filtered and concentrated under reduced pressure. The crude solid product was washed with cold 
diethyl or diisopropyl ether, filtered and dried in vacuo to afford TABs 1a−f. (Note: The final TABs are 
very soluble in most organic solvents. Therefore, complete removal of residual EtOAc in vacuo is es-
sential for their solidification. Only small amounts of ether are necessary in the washing step, since 
TABs are also slightly soluble in ethers.) 
5.1.6 General Procedure P: Electrochemical Oxidation of TABs into Biaryls 
 
A 10 mL IKA glass vial was charged with 0.40 mmol (1.0 equiv) TAB salt 1a−f and dissolved in 8 mL 
of HPLC-grade MeCN. The reaction was started using the IKA ElectraSyn 2.0 with RVC as working 
and counter electrode under galvanostatic conditions (5 mA, 3.0 F, 700 rpm stirring). The crude mixture 
was then treated with water and extracted with diethyl ether (3 × 15 mL). The combined organic phases 
were dried over MgSO4, filtered and concentrated under reduced pressure. The crude product was pu-
rified by column chromatography on silica gel to yield the desired products 2a and 10a−e. 
a) Adaptation for potentiostatic oxidation of compound 1a 
A 10 mL IKA glass vial was charged with 0.40 mmol (1.0 equiv) TAB salt 1a, 2.0 mmol (5.0 equiv) of 
LiClO4 and dissolved in 8 mL of HPLC-grade MeCN. The reaction was started using the IKA Electra-
Syn 2.0 with RVC as working and counter electrode under potentiostatic conditions (1.6 V, 3.0 F, 700 
rpm stirring, 60 seconds alternating mode). The crude was then treated with water and extracted with 
diethyl ether (3 × 15 mL). The combined organic phases were dried over MgSO4, filtered and concen-
trated under reduced pressure. The crude product was purified by column chromatography on silica gel 
to yield the desired product 2a. 
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5.1.7 General Procedure Q (Two-pot Procedure): Synthesis of Biaryls starting from Potassium 
Aryltrifluoroborate Salts 
 
A 25 mL Schlenk flask was charged with the corresponding potassium trifluoroborate salt (0.40 mmol, 
1.0 equiv) and 2 mL of THF were added. The mixture was cooled to 0 °C and a solution of the desired 
aryl Grignard reagent (1.26 mmol, 3.15 equiv) was added dropwise over 30 min via syringe pump. The 
reaction was allowed to warm to room temperature and was stirred one hour. The reaction was then 
quenched with 5 mL of sat. aq. K2CO3 solution and extracted with EtOAc (3 × 40 mL). The combined 
organic phases were filtered and concentrated under reduced pressure. The crude product was then dis-
solved in 8 mL of HPLC-grade MeCN and transferred into a 10 mL IKA glass vial. Following general 
procedure P, products 2a–q, 3a–g, 3i–o, 4c–j and 8a–b were isolated. 
b) Adaptation for the Use of Arylzinc Reagents 
After addition of the arylzinc species (instead of the aryl Grignard reagent as described above) via 
syringe pump, the reaction was heated to 50 °C for 16 hours to ensure full conversion of the potassium 
trifluoroborate salt into the desired TAB salt. general procedure Q was then followed to give products 
2r, 3h, 4a–b, 6a–c. 
5.2 Formation of TAB Salt 1a by 11B NMR 
 
Figure 25: 11B NMR analysis of the TAB salt formation to yield 1a. 
As depicted in Figure 25, a smooth transformation of the starting trifluoro(4-methoxyphenyl)borate into 
the desired TAB salt 1a was observed in the crude 11B NMR, which was measured as a 1:1 THF:CD3CN 
(v/v) mixture following general procedure O. 
Following General Procedure O  
at 0 °C after 1.5 h 
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5.3 Optimizations 
5.3.1 Conditions for the Electrochemical Coupling 
Table 7: Screening of different electrode materials and solvents. 
 
Anode || Cathode Solvent T (°C) conv. (%) 2a:2aa 
Graphite || Graphite MeCN 25 80:7 
GCE || GCE236 MeCN 25 81:4 
RVC || RVC MeCN 25 82:5 (79% isolated) 
RVC || Platinum MeCN 25 80:6 
RVC || RVC EtOH 25 81:4 
RVC || RVC THF 25 50:14 
RVC || RVC MeCN 70 82:17 
 
Conversion rates into 4-fluoro-4'-methoxy-1,1'-biphenyl (2a) were assessed by hydrolysis and GC anal-
ysis with n-undecane as an internal standard. As seen in Table 7, the oxidation process can be performed 
with different carbon or platinum electrode setups, resulting in good conversion and selectivity ratios. 
In addition, the oxidation process can also be performed in environmentally friendly solvents such as 
ethanol with only marginal conversion loss.  
5.3.2 Attempted Oxidations with Dummy Ligands 
Table 8: Screening of different salt materials. 
 
Borate Salt conv. (%) 2a:2aa 
 
0:0 
 
0:0 
 
82:5 
 
236 Glassy carbon electrodes. 
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As seen in Table 8, the oxidation process only leads to the desired product formation when TAB salts 
are used. Other substituents on the tetracoordinated boron atom such as pinacol or fluoride do not result 
in any product formation by GC analysis. 
5.3.3 Attempted Oxidations with Dummy Ligands 
Table 9: Screening of different additives during the electrochemical oxidation. 
 
Conditions Additive conv. (%) 2a:2aa 
Open to air 0.1 M LiClO4 63:3 
Open to air - 82:5 
O2 balloon - 75:4 
Open to air 1,4-Naphthochinon (2 equiv) 82:6 
Open to air TBHP (2 equiv) 55:2 
Open to air CCl3Br (2 equiv) 40:10 
N2 balloon (inert) - 80:5 
Open to air H2O (2 mol%) 81:4 
Open to air H2O (5 mol%) 81:4 
Open to air BHT (2 equiv) 79:4 
Open to air TEMPO (2.0 equiv) 80:4 
Open to air t-BuOH (5.0 equiv) 82:5 
 
As seen in Table 9, electrolyte slows the reaction down significantly. In addition, externally added 
oxidants do not improve conversion rates and small amounts of water have no impact on the conversion 
rates. Lastly, no radical species could be trapped by using TEMPO or BHT as trapping agents. 
5.3.4 Oxidative Couplings with Chemical Oxidants 
Table 10: Screening of different chemical oxidants. 
 
Chemical oxidant conv. (%) 2a:2aa 
Ceric ammonium nitrate (CAN) 34:14 
Phenyliodine(II) diacetate (PIDA) 35:9 
Ferrocenium tetrafluoroborate 68:7 
Iodine 0:0 
NBS 0:0 
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As seen in Table 10, the oxidation process can also be performed using several equivalents of chemical 
oxidants instead of the presented electrochemical oxidation. Best results are achieved using ferrocenium 
tetrafluoroborate, where a decent selectivity for the formation of biaryl 2a was observed. Two-electron 
oxidants such as Iodine or NBS do not result in any biaryl coupling products. 
5.4 NMR Experiments 
 
Figure 26: 1H NMR analysis of the electrochemical oxidation in CD3CN. 
As seen in Figure 26, the TAB salt 1a is consumed after approximately 2.5 F. In addition, the crude 
NMR shows only marginal side product formation. The residual water within the CD3CN is consumed 
within the oxidative process, which indicates that it is essential for the formation of the aryl borinic 
acid, which is the main side product of the transformation. Interestingly, the borinic acid seems to be 
consumed during the electrochemical process, probably due to oxidation into the corresponding boronic 
acid. However, it can still be isolated after 3.0 F as a colorless solid in 33% yield and gives further 
indication for the plausibility of the proposed mechanism of this electrochemical process. Figure 27 
shows the 1H and 11B NMR of the isolated borinic acid. 
Bis(4-fluorophenyl)(hydroxy)borane (2ab) 
Rf = 0.51 (DCM/MeOH 100:0, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) 
δ 7.78 (dd, J = 8.2, 6.3 Hz, 4H), 7.14 (dd, J = 8.8, 8.8 Hz, 4H), 5.85 (s, 1H) ppm. 
11B NMR (128 MHz, CDCl3) δ 39.61 ppm. Analytical data in accordance to lit-
erature.237 
  
 
237 X. Chen, H. Ke, Y. Chen, C. Guan, G. Zou, J. Org. Chem. 2012, 77, 7572–7578. 
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Figure 27: 1H NMR (400 MHz, CDCl3) and 11B NMR (128 MHz, CDCl3) of acid 2ab. 
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5.5 Experimental Data 
5.5.1 Synthesis of Potassium Aryl Trifluoroborate Salts 
Potassium trifluoro(3,4,5-trimethoxyphenyl)borate (SM22) 
Using 5-bromo-1,2,3-trimethoxybenzene according to general procedure M 
(10.0 mmol scale), provided SM22 (6.57 mmol, 1.81 g, 66%) as a colorless solid. 
1H NMR (400 MHz, CD3CN) δ 6.69 (s, 2H), 3.78 (s, 6H), 3.66 (s, 3H) ppm. HRMS 
(ESI-Quadrupole): m/z calcd for C9H11BF3O3- [M-K]-: 235.0759; found: 235.0757. Analytical data in 
accordance to literature.238 
Potassium trifluoro(4-(trimethylsilyl)phenyl)borate (SM23) 
Using (4-(trimethylsilyl)phenyl)boronic acid according to general procedure N 
(4.33 mmol scale), provided SM23 (4.26 mmol, 1.09 g, 98%) as a colorless solid. 
1H NMR (400 MHz, CD3CN) δ 7.42 (d, J = 7.3 Hz, 2H), 7.35 (d, J = 6.3 Hz, 2H), 0.22 (s, 9H) ppm. 
HRMS (ESI-Quadrupole): m/z calcd for C9H13BF3Si- [M-K]-: 217.0837; found: 217.0835. Analytical 
data in accordance to literature.239 
Potassium trifluoro(6-methoxynaphthalen-2-yl)borate (SM24) 
Using 2-bromo-6-methoxynaphthalene according to general procedure M 
(5.0 mmol scale), provided SM24 (3.97 mmol, 1.05 g, 79%) as a colorless 
solid. 1H NMR (400 MHz, CD3CN) δ 7.82 (s, 1H), 7.69 (d, J = 8.9 Hz, 1H), 7.60 – 7.55 (m, 2H), 7.16 
(d, J = 2.6 Hz, 1H), 7.02 (dd, J = 8.9, 2.6 Hz, 1H), 3.87 (s, 3H) ppm. HRMS (ESI-Quadrupole): m/z 
calcd for C11H9BF3O- [M-K]-: 225.0704; found: 225.0702. Analytical data in accordance to literature.240 
Potassium benzofuran-5-yltrifluoroborate (SM25) 
Using 5-bromobenzofuran according to general procedure M (4.7 mmol scale), pro-
vided SM25 (1.58 mmol, 354 mg, 34%) as a colorless solid. 1H NMR (400 MHz, 
CD3CN) δ 7.67 (s, 1H), 7.61 (d, J = 2.2 Hz, 1H), 7.41 (d, J = 7.1 Hz, 1H), 7.32 (d, J = 8.0 Hz, 1H), 6.75 
(dd, J = 2.2, 1.0 Hz, 1H) ppm. HRMS (ESI-Quadrupole): m/z calcd for C8H5BF3O- [M-K]-: 185.0391; 
found: 185.0389. Analytical data in accordance to literature.241 
  
 
238 E. F. Santos-Filho, J. C. Sousa, N. M. M. Bezerra, P. H. Menezes, Tetrahedron Lett. 2011, 52, 5288–5291. 
239 N. M. Ellis, G. A. Molander, J. Org. Chem. 2006, 71, 7491–7493. 
240 J. Lindh, J. Sävmarker, P. Nilsson, P. J. R. Sjöberg, M. Larhed, Chem. Eur. J. 2009, 15, 4630–4636. 
241 L. N. Cavalcanti, C. García-García, G. A. Molander, J. Org. Chem. 2013, 78, 6427–6439. 
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Potassium trifluoro(quinolin-5-yl)borate (SM26) 
Using 5-bromoquinoline according to general procedure M (5.0 mmol scale), provided 
SM26 (1.32 mmol, 310 mg, 26%) as a light-yellow solid. 1H NMR (400 MHz, CD3CN) 
δ 8.92 (d, J = 8.5 Hz, 1H), 8.77 (dd, J = 4.4, 1.8 Hz, 1H), 7.82 (d, J = 8.3 Hz, 1H), 7.75 
(d, J = 6.7 Hz, 1H), 7.62 (t, J = 7.5 Hz, 1H), 7.42 (dd, J = 8.5, 4.3 Hz, 1H) ppm. HRMS (ESI-Quadru-
pole): m/z calcd for C9H6BF3N- [M-K]-: 196.0551; found: 196.0549. Analytical data in accordance to 
literature.239 
Potassium 3-deoxyestrone-3-trifluoroborate (SM27) 
Using 3-deoxyestrone-3-boronic acid pinacol ester240 according to general pro-
cedure N (2.9 mmol scale), provided SM27 (1.42 mmol, 510 mg, 49%) as a 
colorless solid. 1H NMR (400 MHz, CD3CN) δ 7.16 (d, J = 7.7 Hz, 1H), 7.13 
(s, 1H), 7.08 (d, J = 7.7 Hz, 1H), 2.91 – 2.79 (m, 2H), 2.48 – 2.36 (m, 2H), 2.29 
– 2.20 (m, 1H), 2.12 – 1.96 (m, 3H), 1.86 – 1.79 (m, 1H), 1.66 – 1.33 (m, 6H), 0.88 (s, 3H) ppm. HRMS 
(ESI-Quadrupole): m/z calcd for C18H21BF3O- [M-K]-: 321.1643; found: 321.1644. Analytical data in 
accordance to literature.242 
Potassium (Z)-styryltrifluoroborate (SM28) 
Following a procedure published by Molander et al. (5.0 mmol scale),243 provided SM28 
(2.67 mmol, 0.56 g, 53%) as a colorless solid. 1H NMR (400 MHz, (CD3)2CO) δ 7.68 – 
7.63 (m, 2H), 7.16 (t, J = 7.7 Hz, 2H), 7.07 – 7.00 (m, 1H), 6.61 – 6.47 (m, 1H), 5.70 (m, 1H) ppm. 
HRMS (ESI-Quadrupole): m/z calcd for C8H7BF3- [M-K]-: 171.0593; found: 171.0598. Analytical data 
in accordance to literature.243 
Potassium difluorodiphenylborate (SM29)  
Following a procedure published by Ito et al. (10.0 mmol scale),244 provided SM29 
(7.85 mmol, 1.90 g, 79%) as a colorless solid. 1H NMR (400 MHz, DMSO-d6) δ 7.33 
(d, J = 6.7 Hz, 4H), 7.02 (t, J = 7.3 Hz, 4H), 6.95 – 6.87 (m, 2H) ppm. HRMS (ESI-Quadrupole): m/z 
calcd for C12H10BF2- [M-K]-: 203.0849; found: 203.0847. Analytical data in accordance to literature.244 
  
 
242 D. van der Born, C. Sewing, J. (Koos) D. M. Herscheid, A. D. Windhorst, R. V. A. Orru, D. J. Vugts, Angew. 
Chem. Int. Ed. 2014, 53, 11046–11050. 
243 G. A. Molander, C. R. Bernardi, J. Org. Chem. 2002, 67, 8424–8429. 
244 T. Ito, T. Iwai, T. Mizuno, Y. Ishino, Synlett 2003, 10, 1435–1438. 
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5.5.2 Characterization of Potassium Aryl Trifluoroborate Salts 
Potassium trifluoro(4-methoxynaphthalen-1-yl)borate (SM30) 
Using 1-bromo-4-methoxynaphthalene according to general procedure M (5.0 mmol 
scale), provided SM30 (3.82 mmol, 1.10 g, 76%) as a colorless solid. 1H NMR (400 MHz, 
CD3CN) δ 8.43 – 8.33 (m, 1H), 8.16 – 8.10 (m, 1H), 7.55 (d, J = 7.6 Hz, 1H), 7.43 – 7.30 
(m, 2H), 6.79 (d, J = 7.6 Hz, 1H), 3.95 (s, 3H) ppm. 13C NMR (101 MHz, CD3CN) δ 
154.6, 138.6, 130.7, 129.7, 126.2, 125.3, 124.4, 121.9, 104.3, 55.7 ppm. The signal for the carbon atom 
adjacent to the boron center was not observed. 11B NMR (128 MHz, CD3CN) δ 3.88 (q, J = 56.2 Hz) 
ppm. 19F NMR (377 MHz, CD3CN) δ -137.40 – -138.18 (m) ppm. HRMS (ESI-Quadrupole): m/z calcd 
for C11H9BF3O- [M-K]-: 225.0704; found: 225.0702. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1580 (m), 
1509 (m), 1460 (w), 1448 (w), 1421 (m), 1366 (w), 1315 (m), 1243 (w), 1220 (m), 1194 (m), 1154 (s), 
1096 (m), 1072 (m), 1060 (s), 1028 (m), 1004 (m), 986 (s), 963 (m), 942 (m), 931 (m), 906 (s), 885 (s), 
872 (m), 844 (w), 824 (s), 791 (m), 766 (vs). Mp (°C) = 248–252. 
Potassium (1-benzyl-1H-pyrazol-4-yl)trifluoroborate (SM31) 
Using 1-benzyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole accord-
ing to general procedure N (3.5 mmol scale), provided SM31 (1.00 mmol, 264 mg, 
28%) as a colorless solid. 1H NMR (400 MHz, CD3CN) δ 7.35 – 7.29 (m, 2H), 7.28 
– 7.22 (m, 3H), 7.21 – 7.16 (m, 2H), 5.21 (s, 2H) ppm. 13C NMR (101 MHz, CD3CN) δ 143.4, 139.8, 
132.2, 129.3, 128.3, 128.2, 55.4 ppm. The signal for the carbon atom adjacent to the boron center was 
not observed. 11B NMR (128 MHz, CD3CN) δ 3.04 (q, J = 52.6 Hz) ppm. 19F NMR (377 MHz, CD3CN) 
δ -136.25 – -136.87 (m) ppm. HRMS (ESI-Quadrupole): m/z calcd for C10H9BF3N2- [M-K]-: 225.0816; 
found: 225.0815. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1541 (m), 1455 (w), 1434 (w), 1356 (w), 1336 
(w), 1204 (m), 1173 (m), 1161 (m), 1078 (w), 1064 (w), 1050 (m), 1027 (m), 1006 (m), 979 (m), 
971 (m), 919 (vs), 900 (s), 857 (s), 814 (m), 807 (m), 790 (w), 776 (w), 759 (w), 749 (w), 719 (vs). 
Mp (°C) = 222–227. 
Potassium (6-bromo-9-phenyl-9H-carbazol-3-yl)trifluoroborate (SM32) 
Using 3,6-dibromo-9-phenyl-9H-carbazole according to general procedure M 
(5.0 mmol scale), provided SM32 (4.55 mmol, 1.94 g, 90%) as a light-brown 
solid. 1H NMR (400 MHz, CD3CN) δ 8.33 (d, J = 2.0 Hz, 1H), 8.25 (s, 1H), 7.67 
– 7.56 (m, 5H), 7.52 – 7.46 (m, 1H), 7.43 (dd, J = 8.7, 2.0 Hz, 1H), 7.28 (d, J = 
8.7 Hz, 1H), 7.24 (d, J = 8.2 Hz, 1H) ppm. 13C NMR (101 MHz, CD3CN) δ 141.3, 140.0, 138.5, 131.9, 
130.8, 128.3, 128.3, 127.6, 126.9, 123.9, 123.6, 122.2, 112.4, 111.9, 109.1 ppm. The signal for the 
carbon atom adjacent to the boron center was not observed. 11B NMR (128 MHz, CD3CN) δ 3.76 (br, 
s) ppm. 19F NMR (377 MHz, CD3CN) δ -140.89 (br, s) ppm. HRMS (ESI-Quadrupole): m/z calcd for 
C18H11BBrF3N- [M-K]-: 388.0126; found: 388.0126. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1622 (w), 
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1597 (m), 1501 (s), 1478 (m), 1466 (m), 1436 (m), 1360 (w), 1279 (m), 1270 (s), 1230 (m), 1197 (s), 
1174 (m), 1160 (m), 1137 (w), 1119 (w), 1074 (w), 1056 (m), 970 (vs), 935 (vs), 893 (s), 812 (vs), 758 
(s). Mp (°C) = 296–300. 
Potassium dibenzo[b,d]thiophen-2-yltrifluoroborate (SM33) 
Using 2-bromodibenzo[b,d]thiophene according to general procedure M (5.0 mmol 
scale), provided SM33 (2.41 mmol, 700 mg, 48%) as a colorless solid. 1H NMR 
(400 MHz, CD3CN) δ 8.34 (s, 1H), 8.29 – 8.23 (m, 1H), 7.91 – 7.85 (m, 1H), 7.74 
(dt, J = 7.9, 0.7 Hz, 1H), 7.62 (d, J = 6.8 Hz, 1H), 7.48 – 7.40 (m, 2H) ppm. 13C NMR (101 MHz, 
CD3CN) δ 139.7, 137.4, 137.2, 135.1, 132.1, 126.9, 125.2, 125.1, 123.5, 122.4, 121.7 ppm. The signal 
for the carbon atom adjacent to the boron center was not observed. 11B NMR (128 MHz, CD3CN) δ 
3.55 (q, J = 56.4 Hz) ppm. 19F NMR (377 MHz, CD3CN) δ -141.42 –-142.10 (m) ppm. HRMS (ESI-
Quadrupole): m/z calcd for C12H7BF3S- [M-K]-: 251.0319; found: 251.0318. IR (Diamond-ATR, neat) 
𝜈𝑚𝑎𝑥 (cm
-1): 1601 (w), 1589 (w), 1466 (w), 1431 (w), 1400 (w), 1320 (w), 1271 (m), 1230 (m), 
1194 (m), 1151 (m), 1136 (w), 1078 (m), 1067 (m), 1020 (m), 958 (s), 936 (vs), 926 (vs), 900 (m), 
882 (s), 820 (s), 800 (s), 765 (vs), 736 (s). Mp (°C) = 268–272. 
Potassium trifluoro(2-methylquinolin-6-yl)borate (SM34) 
Using 6-bromo-2-methylquinoline according to general procedure M (5.0 mmol 
scale), provided SM34 (3.25 mmol, 810 mg, 65%) as a colorless solid. 1H NMR 
(400 MHz, CD3CN) δ 8.11 (d, J = 8.3 Hz, 1H), 7.89 (s, 1H), 7.84 (d, J = 7.0 Hz, 1H), 7.74 (d, J = 
7.3 Hz, 1H), 7.27 (d, J = 8.4 Hz, 1H), 2.65 (s, 3H) ppm. 13C NMR (101 MHz, CD3CN) δ 157.7, 147.4, 
137.5, 135.3, 130.4, 127.0, 126.1, 121.8, 24.9 ppm. The signal for the carbon atom adjacent to the boron 
center was not observed. 11B NMR (128 MHz, CD3CN) δ 3.30 (q, J = 53.7 Hz) ppm. 19F NMR 
(377 MHz, CD3CN) δ -141.95 – -142.48 (m) ppm. HRMS (ESI-Quadrupole): m/z calcd for C10H8BF3N- 
[M-K]-: 210.0707; found: 210.0706. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1646 (w), 1621 (w), 
1593 (w), 1567 (w), 1558 (w), 1532 (m), 1476 (m), 1464 (m), 1448 (m), 1439 (m), 1384 (m), 1336 (w), 
1226 (s), 1174 (s), 1150 (m), 1135 (m), 1123 (m), 1072 (w), 1035 (m), 1002 (s), 983 (s), 960 (s), 
942 (vs), 884 (vs), 842 (m), 830 (s), 819 (s), 798 (s). Mp (°C) >300. 
Potassium trifluoro(4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)phenyl)borate (SM35) 
Using 1-(4-bromophenyl)-5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazole accord-
ing to general procedure M (9.5 mmol scale), provided SM35 (7.35 mmol, 
3.01 g, 77%) as a colorless solid. 1H NMR (400 MHz, CD3CN) δ 7.49 – 7.43 
(m, 2H), 7.16 – 7.14 (m, 4H), 7.08 (d, J = 7.6 Hz, 2H), 6.85 (s, 1H), 2.32 (s, 
3H) ppm. 13C NMR (101 MHz, CD3CN) δ 145.9, 142.5 (q, J = 37.6 Hz), 140.0, 
138.0, 132.8, 130.0, 129.7, 127.4, 124.8, 122.8 (q, J = 267.6 Hz), 105.6, 21.1 ppm. The signal for the 
carbon atom adjacent to the boron center was not observed.11B NMR (128 MHz, CD3CN) δ 3.16 (br, 
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s) ppm. 19F NMR (377 MHz, CD3CN) δ -62.52, -142.26 – -142.89 (m) ppm. HRMS (ESI-Quadrupole): 
m/z calcd for C17H12BF6N2- [M-K]-: 369.1003; found: 369.1007. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 
1604 (w), 1506 (w), 1473 (m), 1449 (m), 1396 (w), 1376 (w), 1275 (w), 1233 (s), 1210 (s), 1160 (s), 
1128 (s), 1097 (m), 1067 (w), 978 (s), 954 (vs), 866 (w), 831 (s), 802 (s), 772 (w), 753 (m), 732 (m). 
Mp (°C) = 295–299. 
5.5.3 Characterization of TAB Salts 
Potassium tris(4-fluorophenyl)(4-methoxyphenyl)borate (1a) 
Using potassium 4-methoxyphenyltrifluoroborate and a solution of 4-fluor-
ophenylmagnesium bromide in THF according to general procedure O 
(3.0 mmol scale), provided 1a (2.49 mmol, 1.10 g, 83%) as a colorless solid. 
1H NMR (400 MHz, CD3CN) δ 7.21 – 7.13 (m, 6H), 7.11 – 7.04 (m, 2H), 6.79 – 6.71 (m, 6H), 6.66 – 
6.61 (m, 2H), 3.70 (s, 3H) ppm. 13C NMR (101 MHz, CD3CN) δ 161.9, 160.4 (d, J = 3.5 Hz), 159.9 (d, 
J = 3.3 Hz), 159.6, 159.4 (d, J = 3.3 Hz), 158.9 (d, J = 3.3 Hz), 156.7, 137.4 (ddd, J = 5.4, 3.3, 1.6 Hz), 
137.0 (dd, J = 3.4, 1.6 Hz), 112.8 (dd, J = 6.1, 3.0 Hz), 112.6 (dd, J = 6.1, 3.0 Hz), 112.4 (dd, J = 6.0, 
2.9 Hz), 55.2 ppm. The signals for the carbon atoms adjacent to the boron center were not observed. 
11B NMR (128 MHz, CD3CN) δ -7.66 ppm. 19F NMR (377 MHz, CD3CN) δ -124.85 (tt, J = 10.2, 
7.0 Hz) ppm. HRMS (ESI-Quadrupole): m/z calcd for C25H19BF3O- [M-K]-: 403.1487; found: 
403.1486. IR (Diamond-ATR, neat) 𝜈𝑎𝑥 (cm
-1): 1579 (m), 1486 (s), 1462 (w), 1272 (w), 1259 (w), 
1244 (w), 1218 (s), 1176 (w), 1159 (s), 1147 (w), 1086 (w), 1035 (w), 1015 (w), 841 (m), 816 (vs), 
787 (w), 775 (w). Mp (°C) >300. 
Potassium tris(4-fluorophenyl)(3-methoxyphenyl)borate (1b) 
Using potassium 3-methoxyphenyltrifluoroborate and a solution of 4-fluorophe-
nylmagnesium bromide in THF according to general procedure O (3.0 mmol 
scale), provided 1b (2.10 mmol, 929 mg, 70%) as a colorless solid. 1H NMR 
(400 MHz, CD3CN) δ 7.23 – 7.14 (m, 6H), 6.96 (t, J = 7.6 Hz, 1H), 6.81 – 6.71 
(m, 8H), 6.46 (ddd, J = 7.9, 2.9, 1.0 Hz, 1H), 3.62 (s, 3H) ppm. 13C NMR (101 MHz, CD3CN) δ 161.9, 
159.9 (d, J = 3.5 Hz), 159.6, 159.4 (d, J = 3.3 Hz), 158.9 (q, J = 3.4 Hz), 158.4 (d, J = 3.4 Hz), 137.4 
(ddd, J = 5.5, 3.5, 1.8 Hz), 129.3 – 129.0 (m), 127.3 (dd, J = 6.3, 3.1 Hz), 122.3 – 122.2 (m), 112.8 (dd, 
J = 6.2, 3.0 Hz), 112.6 (dd, J = 6.1, 3.0 Hz), 107.5, 54.9 ppm. The signals for the carbon atoms adjacent 
to the boron center were not observed. 11B NMR (128 MHz, CD3CN) δ -7.34 ppm. 19F NMR (377 MHz, 
CD3CN) δ -124.64 (tt, J = 10.2, 7.0 Hz) ppm. HRMS (ESI-Quadrupole): m/z calcd for C25H19BF3O- 
[M-K]-: 403.1487; found: 403.1485. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1703 (w), 1578 (s), 
1568 (m), 1487 (s), 1476 (m), 1468 (m), 1455 (m), 1447 (m), 1401 (m), 1377 (m), 1279 (m), 1245 (s), 
1216 (vs), 1188 (m), 1156 (vs), 1122 (m), 1087 (m), 1068 (w), 1038 (m), 1014 (m), 993 (w), 940 (w), 
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896 (w), 862 (w), 824 (s), 814 (vs), 798 (s), 778 (s), 770 (vs), 747 (m), 738 (m), 717 (m), 705 (s). 
Mp (°C) >300. 
Potassium tris(4-fluorophenyl)(2-methoxyphenyl)borate (1c) 
Using potassium 2-methoxyphenyltrifluoroborate and a solution of 4-fluorophe-
nylmagnesium bromide in THF according to general procedure O (3.0 mmol 
scale), provided 1c (1.61 mmol, 712 mg, 54%) as a colorless solid. 1H NMR 
(400 MHz, CD3CN) δ 7.14 – 7.06 (m, 6H), 7.00 – 6.94 (m, 2H), 6.76 – 6.67 (m, 8H), 3.16 (s, 3H) ppm. 
13C NMR (101 MHz, CD3CN) δ 164.5, 161.7, 160.0 (d, J = 3.3 Hz), 159.5 (d, J = 3.5 Hz), 159.4, 159.0 
(d, J = 3.3 Hz), 158.5 (d, J = 3.3 Hz), 137.5 – 137.2 (m), 137.0, 125.5, 120.2 (dd, J = 5.4, 2.5 Hz), 112.4 
(dd, J = 6.2, 2.9 Hz), 112.2 (dd, J = 6.1, 2.9 Hz), 111.7, 55.1 ppm. The signals for the carbon atoms 
adjacent to the boron center were not observed. 11B NMR (128 MHz, CD3CN) δ -8.04 ppm. 19F NMR 
(377 MHz, CD3CN) δ -125.38 (tt, J = 10.3, 7.0 Hz) ppm. HRMS (ESI-Quadrupole): m/z calcd for 
C25H19BF3O- [M-K]-: 403.1487; found: 403.1485. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1578 (m), 
1487 (m), 1465 (w), 1262 (w), 1222 (m), 1218 (m), 1161 (m), 1085 (w), 1026 (w), 1014 (w), 848 (w), 
835 (m), 817 (vs), 793 (w), 779 (m), 766 (w), 746 (w). Mp (°C) >300.  
Potassium tris(4-(trifluoromethyl)phenyl)(3-methoxyphenyl)borate (1d) 
Using potassium 3-methoxyphenyltrifluoroborate and a solution of 4-(trifluo-
romethyl)phenylmagnesium bromide in THF according to general procedure O 
(3.0 mmol scale), provided 1d (2.01 mmol, 1.19 g, 67%) as a light-orange solid. 
1H NMR (400 MHz, CD3CN) δ 7.48 – 7.40 (m, 6H), 7.35 (d, J = 7.9 Hz, 6H), 
7.01 (t, J = 7.7 Hz, 1H), 6.83 – 6.79 (m, 1H), 6.76 (ddq, J = 4.1, 3.0, 1.5 Hz, 1H), 6.51 (ddd, J = 8.0, 
2.8, 1.0 Hz, 1H), 3.64 (s, 3H) ppm. 13C NMR (101 MHz, CD3CN) δ 169.7, 169.3, 168.8, 168.3, 164.4, 
163.9, 163.4, 162.9, 159.2 (dd, J = 6.9, 3.3 Hz), 136.4, 129.0, 127.9 (q, J = 3.0 Hz), 126.5 (q, J = 269.7 
Hz), 124.85 (q, J = 31.1 Hz), 123.3 – 123.1 (m), 122.2, 108.1, 55.0 ppm. The signals for the carbon 
atoms adjacent to the boron center were not observed. 11B NMR (128 MHz, CD3CN) δ -6.59 ppm. 19F 
NMR (377 MHz, CD3CN) δ -62.02 ppm. HRMS (ESI-Quadrupole): m/z calcd for C28H19BF9O- [M-K]- : 
553.1391; found: 553.1396. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3307 (br, m), 1597 (m), 1319 (vs), 
1281 (m), 1224 (m), 1158 (s), 1121 (s), 1102 (s), 1060 (s), 1045 (m), 1016 (s), 961 (m), 844 (m), 823 
(s), 800 (m), 788 (s), 767 (m), 756 (s), 746 (m), 730 (s). Mp (°C) >300. 
Potassium tris(4-fluorophenyl)(4-phenoxyphenyl)borate (1e) 
Using potassium 4-phenoxyphenyltrifluoroborate and a solution of 4-fluor-
ophenylmagnesium bromide in THF according to general procedure O 
(3.0 mmol scale), provided 1e (1.20 mmol, 605 mg, 40%) as a colorless 
solid. 1H NMR (400 MHz, CD3CN) δ 7.35 – 7.28 (m, 2H), 7.25 – 7.16 (m, 8H), 7.05 – 6.99 (m, 1H), 
6.97 – 6.91 (m, 2H), 6.82 – 6.70 (m, 8H) ppm. 13C NMR (101 MHz, CD3CN) δ 162.1, 160.1 (d, J = 
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3.2 Hz), 159.8, 159.7, 159.6 (d, J = 3.2 Hz), 159.1 (d, J = 2.9 Hz), 158.6 (d, J = 3.5 Hz), 153.2, 137.6 – 
137.4 (m), 130.5, 122.89, 118.4, 118.0 (dd, J = 6.0, 3.0 Hz), 112.9 (dd, J = 6.1, 3.1 Hz), 112.7 (dd, J = 
6.1, 3.0 Hz) ppm. The signals for the carbon atoms adjacent to the boron center were not observed. 11B 
NMR (128 MHz, CD3CN) δ -7.55 ppm. 19F NMR (377 MHz, CD3CN) δ -124.62 (tt, J = 10.3, 
7.0 Hz) ppm. HRMS (ESI-Quadrupole): m/z calcd for C30H21BF3O- [M-K]-: 465.1643; found: 
465.1647. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1578 (m), 1483 (s), 1456 (w), 1388 (w), 1261 (w), 
1241 (m), 1232 (m), 1218 (s), 1158 (s), 1086 (w), 1014 (w), 942 (w), 903 (w), 869 (w), 839 (m), 816 
(vs), 794 (w), 781 (m), 750 (m), 708 (w), 693 (m). Mp (°C) >300. 
Potassium tris(4-fluorophenyl)(2,3,4 trimethoxyphenyl)borate (1f) 
Using potassium 2,3,4-trimethoxyphenyltrifluoroborate and a solution of 
4-fluorophenylmagnesium bromide in THF according to general proce-
dure O (3.0 mmol scale), provided 1f (1.49 mmol, 748 mg, 50%) as a col-
orless solid. 1H NMR (400 MHz, CD3CN) δ 7.21 (dddd, J = 8.7, 6.9, 5.1, 
2.6 Hz, 6H), 6.80 – 6.73 (m, 6H), 6.53 (dd, J = 5.8, 2.9 Hz, 2H), 3.65 (s, 3H), 3.58 (s, 6H) ppm. 13C 
NMR (101 MHz, CD3CN) δ 162.0, 160.0 (d, J = 3.1 Hz), 159.7, 159.5 (d, J = 3.0 Hz), 159.0 (d, J = 
3.6 Hz), 158.5 (d, J = 3.8 Hz), 152.1 (dd, J = 7.7, 3.8 Hz), 137.5 (ddd, J = 5.6, 3.5, 1.7 Hz), 134.9, 
113.8 – 113.6 (m), 112.9 (dd, J = 6.2, 3.0 Hz), 112.7 (dd, J = 6.1, 3.0 Hz), 60.6, 56.3 ppm. The signals 
for the carbon atoms adjacent to the boron center were not observed. 11B NMR (128 MHz, CD3CN) δ 
-7.16 ppm. 19F NMR (377 MHz, CD3CN) δ -124.67 (tt, J = 10.4, 7.0 Hz). HRMS (ESI-Quadrupole): 
m/z calcd for C27H23BF3O3- [M-K]-: 463.1698; found: 463.1700. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 
1578 (m), 1562 (w), 1487 (s), 1466 (w), 1443 (w), 1434 (w), 1393 (m), 1296 (w), 1290 (m), 1260 (w), 
1244 (w), 1236 (w), 1217 (m), 1206 (m), 1193 (m), 1158 (s), 1136 (w), 1104 (vs), 1088 (m), 1016 (m), 
996 (m), 973 (m), 845 (w), 814 (vs), 782 (w), 727 (m), 686 (m). Mp (°C) = 272–276 (decomposition). 
Potassium bis(4-methoxyphenyl)diphenylborate (1g) 
A 25 mL Schlenk flask was charged with Potassium difluorodiphenylborate 
(SM29) (3.0 mmol, 1.0 equiv, 726 mg) and 6.0 mL of THF were added. The 
mixture was cooled to 0 °C and a solution of (4-methoxyphenyl)magnesium 
bromide (6.3 mmol, 2.1 equiv, 6.8 mL, 0.93 M) in THF was added dropwise over 30 min via syringe 
pump. The reaction was allowed to warm to room temperature and was stirred one hour. The reaction 
was then quenched with 5 mL of sat. aq. K2CO3 solution and extracted with EtOAc (3 × 40 mL). The 
combined organic phases were filtered and concentrated under reduced pressure. The crude solid prod-
uct was washed with cold diethyl ether, filtered and dried in vacuo to afford TAB 1g as a colorless solid 
(2.46 mmol, 1.04 g, 83%).  1H NMR (400 MHz, CD3CN) δ 7.28 – 7.21 (m, 4H), 7.14 (tt, J = 5.2, 2.4 Hz, 
4H), 7.00 (t, J = 7.4 Hz, 4H), 6.84 (t, J = 7.2 Hz, 2H), 6.62 (d, J = 8.3 Hz, 4H), 3.70 (s, 6H) ppm. 13C 
NMR (101 MHz, CD3CN) δ 165.2 (dd, J = 98.4, 49.2 Hz), 156.4, 155.8 (dd, J = 100.3, 50.2 Hz), 137.2 
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(dd, J = 3.3, 1.7 Hz), 136.5 (q, J = 1.5 Hz), 126.4 (dd, J = 5.5, 2.6 Hz), 122.6, 112.2 (dd, J = 5.9, 2.9 Hz), 
55.2 ppm. The signals for the carbon atoms adjacent to the boron center were not observed. 11B NMR 
(128 MHz, CD3CN) δ -7.20 ppm. HRMS (ESI-Quadrupole): m/z calcd for C26H24BO2- [M-K]-: 
379.1875; found: 379.1874. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1590 (m), 1578 (w), 1493 (m), 
1461 (w), 1438 (w), 1427 (w), 1271 (m), 1251 (m), 1232 (m), 1184 (m), 1174 (s), 1152 (m), 1127 (w), 
1120 (w), 1098 (w), 1036 (m), 866 (w), 844 (w), 822 (w), 807 (vs), 785 (m), 762 (m), 732 (s), 724 (s), 
709 (vs). Mp (°C) >300. 
5.5.4 Characterization of Bi(hetero)aryls 
4-Fluoro-4'-methoxy-1,1'-biphenyl (2a) 
Using potassium trifluoro(4-methoxyphenyl)borate and a solution of (4-fluoro-
phenyl)magnesium bromide in THF according to general procedure Q 
(0.40 mmol scale), provided 2a (0.25 mmol, 50 mg, 62%) as a colorless solid. 
Using potassium tris(4-fluorophenyl)(4-methoxyphenyl)borate (1a) according to general procedure P 
(0.40 mmol scale), provided 2a (0.32 mmol, 64 mg, 79%) as a colorless solid. For the decagram-scale 
reaction see chapter 5.6. Rf = 0.21 (hexane/EtOAc 99:1, UV, KMnO4, PAA). 1H NMR (400 MHz, 
CDCl3) δ 7.53 – 7.44 (m, 4H), 7.15 – 7.07 (m, 2H), 7.01 – 6.94 (m, 2H), 3.85 (s, 3H) ppm. LRMS 
(DEP/EI-Orbitrap): m/z (%): 202.1 (100), 187.1 (69), 159.1 (71), 133.1 (46), 107.1 (10). Analytical data 
in accordance to literature.245 
4-Fluoro-4'-methyl-1,1'-biphenyl (2b) 
Using potassium trifluoro(p-tolyl)borate and a solution of (4-fluorophenyl)magne-
sium bromide in THF according to general procedure Q (0.40 mmol scale), pro-
vided 2b (0.21 mmol, 39 mg, 52%) as a colorless solid. Rf = 0.80 (hexane/EtOAc 
100:0, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.56 – 7.49 (m, 2H), 7.47 – 7.42 (m, 2H), 
7.25 (d, J = 8.1 Hz, 2H), 7.15 – 7.08 (m, 2H), 2.40 (s, 3H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 
186.0 (100), 165.0 (48), 133.0 (18), 91.1 (11). Analytical data in accordance to literature.246 
5-Phenylbenzo[d][1,3]dioxole (2c) 
Using potassium benzo[d][1,3]dioxol-5-yltrifluoroborate and a solution of phenyl-
magnesium bromide in THF according to general procedure Q (0.40 mmol scale), 
provided 2c (0.21 mmol, 42 mg, 53%) as a colorless solid. Rf = 0.22 (hexane/EtOAc 
100:0, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.56 – 7.52 (m, 2H), 7.46 – 7.40 (m, 2H), 
7.36 – 7.31 (m, 1H), 7.11 – 7.09 (m, 1H), 7.07 (d, J = 1.8 Hz, 1H), 6.91 (dd, J = 7.9, 0.6 Hz, 1H), 6.01 
 
245 W. Erb, M. Albini, J. Rouden, J. Blanchet, J. Org. Chem. 2014, 79, 10568–10580. 
246 T. Agrawal, S. P. Cook, Org. Lett. 2014, 16, 5080–5083. 
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(s, 2H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 198.0 (100), 139.0 (60), 115.0 (10), 98.7 (13). Ana-
lytical data in accordance to literature.247  
5-(4-Fluorophenyl)benzo[d][1,3]dioxole (2d) 
Using potassium benzo[d][1,3]dioxol-5-yltrifluoroborate and a solution of (4-
fluorophenyl)magnesium bromide in THF according to general procedure Q 
(0.50 mmol scale), provided 2d (0.28 mmol, 60 mg, 57%) as a colorless solid. Rf 
= 0.30 (hexane/EtOAc 98:2, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.49 – 7.43 (m, 2H), 
7.14 – 7.07 (m, 2H), 7.03 – 7.01 (m, 1H), 6.99 (d, J = 1.8 Hz, 1H), 6.88 (d, J = 7.9 Hz, 1H), 6.00 (s, 
2H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 216.0 (100), 157.0 (57), 138.0 (11), 133.0 (10), 107.8 
(14). Analytical data in accordance to literature.247 
2,4'-Dimethoxy-1,1'-biphenyl (2e) 
Using potassium trifluoro(4-methoxyphenyl)borate and a solution of (2-methoxy-
phenyl)magnesium bromide in THF according to general procedure Q (0.40 mmol 
scale), provided 2e (0.21 mmol, 45 mg, 53%) as a colorless solid. Rf = 0.42 (hex-
ane/EtOAc 98:2, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) 7.53 – 7.47 (m, 2H), 7.35 – 7.29 
(m, 2H), 7.07 – 7.02 (m, 1H), 7.01 – 6.96 (m, 3H), 3.87 (s, 3H), 3.83 (s, 3H) ppm. LRMS (DEP/EI-
Orbitrap): m/z (%): 214.1 (100), 199.1 (33), 184.0 (30), 168.0 (22), 139.0 (22), 128.0 (37), 115.0 (15). 
Analytical data in accordance to literature.248 
1-(4-Methoxyphenyl)naphthalene (2f) 
Using potassium trifluoro(4-methoxyphenyl)borate and a solution of naphthalen-
1-ylmagnesium bromide in THF according to general procedure Q (0.50 mmol 
scale), provided 2f (0.33 mmol, 77 mg, 66%) as a colorless solid. Rf = 0.44 (hex-
ane/EtOAc 98:2, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.98 (d, J = 8.3 Hz, 1H), 7.96 – 
7.92 (m, 1H), 7.88 (dt, J = 8.2, 1.1 Hz, 1H), 7.58 – 7.50 (m, 2H), 7.49 – 7.43 (m, 4H), 7.10 – 7.04 (m, 
2H), 3.92 (s, 3H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 234.1 (100), 219.1 (31), 203.1 (11), 189.1 
(48), 163.1 (10), 94.6 (11). Analytical data in accordance to literature.249 
4-Methyl-4'-(trifluoromethyl)-1,1'-biphenyl (2g) 
Using potassium trifluoro(p-tolyl)borate and a solution of (4-(trifluorome-
thyl)phenyl)magnesium bromide in THF according to general procedure Q 
(0.40 mmol scale), provided 2g (0.33 mmol, 77 mg, 82%) as a colorless solid. 
Rf = 0.79 (hexane/EtOAc 100:0, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.70 – 7.68 (m, 
 
247 F. Mäsing, H. Nüsse, J. Klingauf, A. Studer, Org. Lett. 2018, 20, 752–755. 
248 J. M. Quibell, G. Duan, G. J. P. Perry, I. Larrosa, Chem. Comm. 2019, 55, 6445–6448. 
249 Y.-Y. Chua, H. A. Duong, Chem. Comm. 2016, 52, 1466–1469. 
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4H), 7.54 – 7.49 (m, 2H), 7.32 – 7.28 (m, 2H), 2.43 (s, 3H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 
236.1 (100), 217.1 (10), 167.1 (42), 165.1 (40), 152.1 (11), 91.1 (10). Analytical data in accordance to 
literature.250 
Methyl(4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)sulfane (2h) 
Using potassium trifluoro(4-(methylthio)phenyl)borate and a solution of (4-
(trifluoromethyl)phenyl)magnesium bromide in THF according to general pro-
cedure Q (0.50 mmol scale), provided 2h (0.29 mmol, 78 mg, 58%) as a color-
less solid. Rf = 0.26 (hexane/EtOAc 99:1, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.71 – 
7.64 (m, 4H), 7.56 – 7.50 (m, 2H), 7.37 – 7.33 (m, 2H), 2.54 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) 
δ 144.1, 139.2, 136.4, 129.3 (q, J = 32.4 Hz), 127.7, 127.1, 126.9, 125.9 (q, J = 3.8 Hz), 124.4 (q, J = 
271.9 Hz), 15.7 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 268.1 (100), 233.0 (12), 222.0 (20), 201.1 
(10), 184.0 (27), 152.1 (17). HRMS (EI-Orbitrap): m/z calcd for C14H11F3S+: 268.0534; found: 
268.0528. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1734 (w), 1715 (m), 1684 (w), 1616 (w), 1595 (w), 
1490 (w), 1437 (w), 1418 (w), 1396 (w), 1362 (m), 1327 (s), 1279 (w), 1262 (w), 1221 (m), 1171 (m), 
1129 (s), 1114 (s), 1102 (s), 1074 (s), 1014 (w), 1001 (w), 973 (w), 958 (w), 852 (w), 813 (vs), 740 (w). 
Mp (°C) = 133–137. 
Trimethyl(4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)silane (2i) 
Using potassium trifluoro(4-(trimethylsilyl)phenyl)borate (SM23) and a solu-
tion of (4-(trifluoromethyl)phenyl)magnesium bromide in THF according to 
general procedure Q (0.50 mmol scale), provided 2i (0.31 mmol, 90 mg, 62%) 
as a colorless oil. Rf = 0.52 (hexane/EtOAc 100:0, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 
7.70 (s, 4H), 7.66 – 7.63 (m, 2H), 7.61 – 7.57 (m, 2H), 0.32 (s, 9H) ppm. 13C NMR (101 MHz, CDCl3) 
δ 144.8, 140.7, 140.2, 134.2, 129.5 (q, J = 32.5 Hz), 127.6, 126.7, 125.9 (q, J = 3.8 Hz), 123.1 (q, J = 
271.9 Hz), -1.0 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 294.1 (12), 279.1 (100), 263.1 (10), 203.1 
(18). HRMS (EI-Orbitrap): m/z calcd for C16H17F3Si+: 294.1052; found: 294.1047. IR (Diamond-ATR, 
neat) 𝜈𝑚𝑎𝑥 (cm
-1): n.d. 
4'-Phenoxy-3,5-bis(trifluoromethyl)-1,1'-biphenyl (2j) 
Using potassium trifluoro(4-phenoxyphenyl)borate and a solution of (3,5-
bis(trifluoromethyl)phenyl)magnesium bromide in THF according to general 
procedure Q (0.50 mmol scale), provided 2j (0.43 mmol, 166 mg, 87%) as a 
colorless oil. Rf = 0.30 (hexane/EtOAc 100:0, UV, KMnO4, PAA). 1H NMR 
(400 MHz, CDCl3) δ 7.99 (s, 2H), 7.84 (s, 1H), 7.61 – 7.55 (m, 2H), 7.43 – 7.37 (m, 2H), 7.20 – 7.15 
(m, 1H), 7.15 – 7.11 (m, 2H), 7.11 – 7.06 (m, 2H) ppm. 13C NMR (101 MHz, CDCl3) δ 158.5, 156.6, 
 
250 J. Tang, A. Biafora, L. J. Goossen, Angew. Chem. Int. Ed. 2015, 54, 13130–13133. 
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142.8, 133.1, 132.2 (q, J = 33.2 Hz), 130.1, 128.8, 127.2 – 126.9 (m), 124.1, 123.5 (q, J = 272.7 Hz), 
120.7 (qq, J = 3.8 Hz), 119.5, 119.3 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 382.1 (100), 354.1 (22), 
277.0 (18), 237.0 (11), 219.0 (18), 215.1 (18), 188.0 (21), 182.0 (11), 141.1 (11), 77.0 (41). HRMS 
(EI-Orbitrap): m/z calcd for C20H12F6O+: 382.0792; found: 382.0786. IR (Diamond-ATR, neat) 
𝜈𝑚𝑎𝑥 (cm
-1): 1610 (w), 1591 (m), 1513 (m), 1490 (m), 1466 (m), 1380 (s), 1276 (vs), 1261 (m), 1243 
(s), 1202 (m), 1173 (s), 1127 (vs), 1109 (m), 1070 (w), 1058 (m), 897 (m), 872 (m), 842 (m), 834 (m), 
788 (w), 752 (m), 714 (m), 705 (m), 693 (m), 682 (m). 
 (3',5'-Bis(trifluoromethyl)-[1,1'-biphenyl]-4-yl)(methyl)sulfane (2k) 
Using potassium trifluoro(4-(methylthio)phenyl)borate and a solution of (3,5-
bis(trifluoromethyl)phenyl)magnesium bromide in THF according to general 
procedure Q (0.50 mmol scale), provided 2k (0.33 mmol, 110 mg, 66%) as a 
colorless solid. (Note: Only 1 F was used in the electrochemical oxidation, as 
more electrons lead to oxidation of the desired product into the undesired sulfoxide.) Rf = 0.41 (hex-
ane/EtOAc 100:0, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.99 (d, J = 1.7 Hz, 2H), 7.84 
(s, 1H), 7.57 – 7.51 (m, 2H), 7.39 – 7.34 (m, 2H), 2.54 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 
142.8, 140.3, 134.7, 132.3 (q, J = 33.2 Hz), 127.6, 126.9, 126.9, 123.5 (q, J = 272.8 Hz), 120.9 (qq, J = 
3.8 Hz), 15.6 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 336.0 (100), 321.0 (31), 301.0 (20), 290.1 (11), 
252.0 (11). HRMS (EI-Orbitrap): m/z calcd for C15H10F6S+: 336.0407; found: 336.0402. IR (Diamond-
ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1717 (m), 1707 (w), 1700 (w), 1684 (w), 1654 (w), 1559 (w), 1541 (w), 1507 
(w), 1458 (w), 1382 (s), 1279 (vs), 1262 (w), 1221 (w), 1179 (m), 1132 (s), 1109 (w), 1054 (m), 897 
(w), 846 (w), 819 (w), 682 (m). Mp (°C) = 66–70. 
2-(3,5-Bis(trifluoromethyl)phenyl)-6-methoxynaphthalene (2l) 
Using potassium trifluoro(6-methoxynaphthalen-2-yl)borate (SM24) and 
a solution of (3,5-bis(trifluoromethyl)phenyl)magnesium bromide in THF 
according to general procedure Q (0.50 mmol scale), provided 2l 
(0.15 mmol, 55 mg, 30%) as a colorless oil. Rf = 0.43 (hexane/EtOAc 98:2, 
UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 8.12 (s, 2H), 8.01 (d, J = 1.9 Hz, 1H), 7.90 – 7.82 
(m, 3H), 7.70 (dd, J = 8.5, 1.9 Hz, 1H), 7.23 (dd, J = 8.9, 2.5 Hz, 1H), 7.19 (d, J = 2.5 Hz, 1H), 3.96 (s, 
3H) ppm. 13C NMR (101 MHz, CDCl3) δ 158.6, 143.5, 134.7, 133.3, 132.2 (q, J = 33.2 Hz), 130.0, 
129.1, 128.1, 127.3, 126.5, 125.3, 123.6 (q, J = 272.7 Hz), 120.7 (qq, J = 3.8 Hz), 120.0, 105.7, 
55.5 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 370.1 (75), 327.1 (100), 299.1 (14), 281.1 (18), 238.1 
(21), 225.0 (60), 207.0 (41), 189.1 (25), 151.0 (14), 73.0 (22). HRMS (EI-Orbitrap): m/z calcd for 
C19H12F6O+: 370.0792; found: 370.0784. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1716 (w), 1616 (w), 
1595 (w), 1559 (w), 1540 (w), 1490 (w), 1438 (w), 1418 (w), 1396 (w), 1362 (w), 1329 (m), 1279 (w), 
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1262 (w), 1220 (w), 1172 (m), 1133 (s), 1114 (vs), 1102 (s), 1075 (m), 1014 (w), 1001 (w), 973 (w), 
958 (w), 852 (w), 813 (vs), 740 (w), 674 (w). 
1-(3,5-Bis(trifluoromethyl)phenyl)-4-methoxynaphthalene (2m) 
Using potassium trifluoro(4-methoxynaphthalen-1-yl)borate (SM30) and a so-
lution of (3,5-bis(trifluoromethyl)phenyl)magnesium bromide in THF accord-
ing to general procedure Q (0.40 mmol scale), provided 2m (0.23 mmol, 
85 mg, 58%) as a colorless oil. Rf = 0.51 (hexane/EtOAc 100:0, UV, KMnO4, 
PAA). 1H NMR (400 MHz, CDCl3) δ 8.41 – 8.37 (m, 1H), 7.94 (s, 2H), 7.93 
(s, 1H), 7.71 – 7.66 (m, 1H), 7.58 – 7.49 (m, 2H), 7.35 (d, J = 7.9 Hz, 1H), 6.90 (d, J = 7.9 Hz, 1H), 
4.07 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 156.2, 143.2, 132.0, 131.8 (q, J = 33.2 Hz), 130.6 – 
130.3 (m), 129.4, 127.8, 127.6, 125.9, 125.8, 124.6, 122.8, 122.2 (q, J = 272.6 Hz), 120.9 (qq, J = 
3.8 Hz), 103.4, 55.8 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 370.1 (100), 355.1 (37), 327.1 (74), 
307.1 (17), 301.0 (11), 238.1 (18), 189.1 (17). HRMS (EI-Orbitrap): m/z calcd for C19H12F6O+: 
370.0792; found: 370.0782. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1718 (w), 1700 (w), 1684 (w), 1654 
(m), 1588 (w), 1559 (m), 1540 (m), 1522 (w), 1516 (w), 1508 (m), 1458 (m), 1424 (w), 1420 (w), 
1365 (m), 1278 (vs), 1246 (w), 1173 (m), 1131 (s), 1116 (m), 1106 (w), 1087 (w), 1005 (w), 899 (w), 
847 (w), 816 (w), 766 (w), 709 (w). 
3,5-Difluoro-4'-phenoxy-1,1'-biphenyl (2n) 
Using potassium trifluoro(4-phenoxyphenyl)borate and a solution of (3,5-difluor-
ophenyl)magnesium bromide in THF according to general procedure Q 
(0.50 mmol scale), provided 2n (0.25 mmol, 71 mg, 50%) as a colorless oil. Rf = 
0.33 (hexane/EtOAc 100:0, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 
7.54 – 7.49 (m, 2H), 7.42 – 7.35 (m, 2H), 7.20 – 7.14 (m, 1H), 7.12 – 7.05 (m, 6H), 6.78 (tt, J = 8.9, 
2.3 Hz, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 163.4 (dd, J = 247.8, 13.2 Hz), 158.0, 156.8, 144.0 
(t, J = 9.6 Hz), 133.8 (t, J = 2.6 Hz), 130.0, 128.5, 123.9, 119.4, 119.1, 109.7 (dd, J = 18.6, 7.2 Hz), 
102.3 (t, J = 25.5 Hz) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 282.1 (100), 254.1 (16), 233.1 (25), 
188.0 (31), 177.1 (39), 168.0 (11), 151.0 (59), 77.0 (49). HRMS (EI-Orbitrap): m/z calcd for 
C18H12F2O+: 282.0856; found: 282.0848. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): n.d. 
4-Methoxy-4'-(trifluoromethoxy)-1,1'-biphenyl (2o) 
Using potassium trifluoro(4-methoxyphenyl)borate and a solution of (4-(tri-
fluoromethoxy)phenyl)magnesium bromide in THF according to general pro-
cedure Q (0.40 mmol scale), provided 2o (0.28 mmol, 76 mg, 71%) as a col-
orless solid. Rf = 0.35 (hexane/EtOAc 98:2, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.56 – 
7.50 (m, 2H), 7.50 – 7.44 (m, 2H), 7.24 (d, J = 7.3 Hz, 2H), 7.01 – 6.91 (m, 2H), 3.83 (s, 3H) ppm. 
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LRMS (DEP/EI-Orbitrap): m/z (%): 268.0 (100), 253.0 (37), 225.0 (42), 199.0 (16), 139.0 (13), 128.0 
(21), 69.0 (18). Analytical data in accordance to literature.251 
2,3,4,5,6-Pentafluoro-4'-methoxy-1,1'-biphenyl (2p) 
Using potassium trifluoro(4-methoxyphenyl)borate and a solution of (perfluoro-
phenyl)magnesium bromide in THF according to general procedure Q 
(0.50 mmol scale), provided 2p (0.07 mmol, 19 mg, 14%) as a colorless solid. Rf 
= 0.37 (hexane/EtOAc 98:2, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 
7.39 – 7.33 (m, 2H), 7.04 – 6.99 (m, 2H), 3.87 (s, 3H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 274.0 
(100), 259.0 (11), 231.0 (83), 205.0 (27), 181.0 (12). Analytical data in accordance to literature.252 
4'-(Trifluoromethyl)-[1,1'-biphenyl]-3-ol (2q) 
Using potassium trifluoro(3-hydroxyphenyl)borate and a solution of (4-(trifluo-
romethyl)phenyl)magnesium bromide in THF according to general procedure Q 
(0.40 mmol scale), provided 2q (0.16 mmol, 38 mg, 40%) as a colorless solid. 
(Note: general procedure Q was modified, as 4.2 equiv (1.68 mmol) of Grignard reagent were used, 
since the alcohol had to be deprotonated first.) Rf = 0.30 (hexane/EtOAc 90:10, UV, KMnO4, PAA). 
1H NMR (400 MHz, CDCl3) δ 7.71 – 7.63 (m, 4H), 7.35 (t, J = 7.9 Hz, 1H), 7.18 (dt, J = 7.8, 1.3 Hz, 
1H), 7.08 (dd, J = 2.5, 1.7 Hz, 1H), 6.89 (ddd, J = 8.1, 2.6, 0.9 Hz, 1H), 5.12 (s, 1H, OH) ppm. LRMS 
(DEP/EI-Orbitrap): m/z (%): 238.0 (100), 219.0 (10), 209.0 (11), 141.0 (12), 115.0 (10). Analytical data 
in accordance to literature.253 
Ethyl 4-(benzo[d][1,3]dioxol-5-yl)benzoate (2r) 
Using potassium benzo[d][1,3]dioxol-5-yltrifluoroborate and a solution of (4-
(ethoxycarbonyl)phenyl)zinc iodide in THF according to general procedure Q 
(0.50 mmol scale), provided 2r (0.27 mmol, 73 mg, 54%) as a colorless solid. 
Rf = 0.35 (hexane/EtOAc 98:2, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 8.11 – 8.04 (m, 
2H), 7.60 – 7.54 (m, 2H), 7.13 – 7.07 (m, 2H), 6.92 – 6.88 (m, 1H), 6.01 (s, 2H), 4.39 (q, J = 7.1 Hz, 
2H), 1.41 (t, J = 7.1 Hz, 3H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 270.1 (100), 242.1 (42), 225.0 
(79), 167.0 (11), 139.1 (89), 112.1 (21). Analytical data in accordance to literature.254 
  
 
251 I. R. Baxendale, C. M. Griffiths-Jones, S. V. Ley, G. K. Tranmer, Chem. Eur. J. 2006, 12, 4407–4416. 
252 Y. Nakamura, N. Yosgikai, L. Illies, E. Nakamura, Org. Lett. 2012, 14, 3316–3319. 
253 J. Luo, S. Preciado, I. Larrosa, Chem. Comm. 2015, 51, 3127–3130. 
254 M. Ketels, M. A. Ganiek, N. Weidmann, P. Knochel, Angew. Chem. Int. Ed. 2017, 56, 12770–12773. 
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1-Benzyl-4-(3,5-difluorophenyl)-1H-pyrazole (3a) 
Using potassium (1-benzyl-1H-pyrazol-4-yl)trifluoroborate (SM31) and a solution 
of (3,5-difluorophenyl)magnesium bromide in THF according to general procedure 
Q (0.40 mmol scale), provided 3a (0.19 mmol, 52 mg, 48%) as a colorless solid. 
Rf = 0.25 (hexane/EtOAc 90:10, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) 
δ 7.71 (s, 1H), 7.53 (s, 1H), 7.34 – 7.24 (m, 3H), 7.22 – 7.17 (m, 2H), 6.90 – 6.83 (m, 2H), 6.56 (tt, J = 
9.0, 2.3 Hz, 1H), 5.26 (s, 2H) ppm. 13C NMR (101 MHz, CDCl3) δ 163.5 (dd, J = 247.4, 13.4 Hz), 
137.2, 136.0, 135.9 (t, J = 10.4 Hz), 129.1, 128.5, 128.0, 126.8, 121.9 (t, J = 2.9 Hz), 108.2 (dd, J = 
19.0, 6.9 Hz), 101.6 (t, J = 25.5 Hz), 56.5 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 270.1 (48), 269.1 
(100), 242.1 (10), 91.1 (97), 65.0 (10). HRMS (EI-Orbitrap): m/z calcd for C16H12F2N2+: 270.0969; 
found: 270.0970. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1709 (s), 1624 (s), 1591 (s), 1576 (m), 1570 
(m), 1560 (w), 1540 (w), 1521 (w), 1507 (w), 1498 (w), 1465 (m), 1457 (m), 1436 (m), 1431 (m), 1420 
(m), 1386 (m), 1361 (s), 1277 (w), 1221 (s), 1173 (m), 1116 (vs), 1091 (w), 1079 (w), 1030 (w), 1008 
(w), 996 (m), 984 (s), 849 (s), 829 (vs), 780 (w), 714 (s). Mp (°C) = 66–70.  
1-Benzyl-4-(3,5-bis(trifluoromethyl)phenyl)-1H-pyrazole (3b) 
Using potassium (1-benzyl-1H-pyrazol-4-yl)trifluoroborate (SM31) and a solu-
tion of (3,5-bis(trifluoromethyl)phenyl)magnesium bromide in THF according to 
general procedure Q (0.50 mmol scale), provided 3b (0.38 mmol, 139 mg, 75%) 
as a colorless solid. Rf = 0.14 (hexane/EtOAc 95:5, UV, KMnO4, PAA). 1H NMR 
(400 MHz, CDCl3) δ 7.87 (d, J = 18.5 Hz, 3H), 7.72 (d, J = 15.5 Hz, 2H), 7.43 – 7.33 (m, 3H), 7.32 – 
7.25 (m, 2H), 5.37 (s, 2H) ppm. 13C NMR (101 MHz, CDCl3) δ 137.2, 135.9, 134.9, 132.3 (q, J = 
33.2 Hz), 129.2, 128.6, 128.0, 127.0, 125.4, 123.4 (q, J = 272.7 Hz), 121.2, 119.9 (qq, J = 3.9 Hz), 
56.7 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 369.1 (100), 351.1 (11), 293.0 (10), 91.1 (56), 65.0 (13). 
HRMS (EI-Orbitrap): m/z calcd for C18H12F6N2+: 370.0905; found: 370.0883. IR (Diamond-ATR, neat) 
𝜈𝑚𝑎𝑥 (cm
-1): 1700 (w), 1684 (w), 1654 (w), 1559 (w), 1541 (w), 1507 (w), 1458 (w), 1383 (m), 1277 
(vs), 1264 (w), 1213 (w), 1176 (m), 1126 (s), 1110 (m), 1055 (w), 897 (w), 847 (w), 832 (w), 818 (m). 
Mp (°C) = 125–128. 
3-(4-(Trifluoromethyl)phenyl)benzo[b]thiophene (3c) 
Using potassium benzo[b]thiophen-3-yltrifluoroborate and a solution of (4-(tri-
fluoromethyl)phenyl)magnesium bromide in THF according to general procedure 
Q (0.40 mmol scale), provided 3c (0.21 mmol, 58 mg, 52%) as a colorless oil. Rf 
= 0.60 (hexane/EtOAc 100:0, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.98 – 7.92 (m, 1H), 
7.92 – 7.86 (m, 1H), 7.76 (d, J = 8.4 Hz, 2H), 7.71 (d, J = 8.4 Hz, 2H), 7.48 (s, 1H), 7.46 – 7.40 (m, 
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2H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 278.0 (100), 259.0 (10), 233.0 (17), 208.0 (15), 165.1 
(15). Analytical data in accordance to literature.255 
5-(4-(Trifluoromethyl)phenyl)benzofuran (3d) 
Using potassium benzofuran-5-yltrifluoroborate (SM25) and a solution of (4-
(trifluoromethyl)phenyl)magnesium bromide in THF according to general pro-
cedure Q (0.40 mmol scale), provided 3d (0.27 mmol, 70 mg, 67%) as a color-
less solid. Rf = 0.43 (hexane/EtOAc 100:0, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.81 (d, 
J = 1.7 Hz, 1H), 7.74 – 7.68 (m, 4H), 7.69 (d, J = 2.1 Hz, 1H), 7.60 (d, J = 8.6 Hz, 1H), 7.53 (dd, J = 
8.6, 1.9 Hz, 1H), 6.84 (dd, J = 2.2, 0.8 Hz, 1H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 262.0 (100), 
243.0 (10), 233.0 (12), 183.0 (10), 165.0 (26). Analytical data in accordance to literature.256 
5-(4-Fluoronaphthalen-1-yl)benzofuran (3e) 
Using potassium benzofuran-5-yltrifluoroborate (SM25) and a solution of (4-
fluoronaphthalen-1-yl)magnesium bromide in THF according to general procedure 
Q (0.40 mmol scale), provided 3e (0.15 mmol, 40 mg, 38%) as a colorless oil. Rf 
= 0.48 (hexane/EtOAc 100:0, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 8.24 (d, J = 8.5 Hz, 
1H), 7.96 – 7.91 (m, 1H), 7.76 (d, J = 2.2 Hz, 1H), 7.72 (d, J = 1.7 Hz, 1H), 7.66 (dt, J = 8.4, 0.8 Hz, 
1H), 7.61 (ddd, J = 8.3, 6.8, 1.2 Hz, 1H), 7.53 (ddd, J = 8.3, 6.8, 1.3 Hz, 1H), 7.45 – 7.40 (m, 2H), 7.27 
(dd, J = 20.7, 18.3 Hz, 1H), 6.89 (dd, J = 2.3, 1.0 Hz, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 158.3 
(d, J = 251.5 Hz), 154.5, 145.8, 136.6 (d, J = 4.5 Hz), 135.0, 133.4 (d, J = 4.6 Hz), 127.7, 127.0, 126.9, 
126.8, 126.3 (d, J = 2.7 Hz), 126.2 (d, J = 1.9 Hz), 123.9 (d, J = 16.3 Hz), 122.7, 120.9 (d, J = 5.6 Hz), 
111.2, 109.0 (d, J = 19.8 Hz), 106.8 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 262.1 (76), 233.1 (100), 
231.1 (21), 207.1 (11), 103.5 (10). HRMS (EI-Orbitrap): m/z calcd for C18H11FO+: 262.0794; found: 
262.0790. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1717 (w), 1700 (w), 1684 (w), 1654 (w), 1630 (w), 
1601 (m), 1590 (w), 1577 (w), 1559 (w), 1540 (w), 1534 (w), 1522 (w), 1509 (m), 1474 (w), 1458 (s), 
1437 (w), 1421 (w), 1392 (s), 1374 (w), 1329 (w), 1291 (m), 1262 (m), 1225 (s), 1184 (m), 1156 (w), 
1144 (w), 1131 (m), 1110 (m), 1082 (w), 1042 (m), 1031 (m), 1019 (w), 964 (w), 889 (w), 867 (m), 
833 (m), 814 (s), 785 (m), 764 (vs), 739 (vs). 
5-(3,5-Bis(trifluoromethyl)phenyl)benzo[c][1,2,5]oxadiazole (3f) 
Using potassium benzo[c][1,2,5]oxadiazol-5-yltrifluoroborate and a solution of 
(3,5-bis(trifluoromethyl)phenyl)magnesium bromide in THF according to gen-
eral procedure Q (0.40 mmol scale), provided 3f (0.23 mmol, 76 mg, 57%) as a 
colorless solid. Rf = 0.48 (hexane/EtOAc 98:2, UV, KMnO4, PAA). 1H NMR 
 
255 K. Funaki, T. Sato, S. Oi, Org. Lett. 2012, 14, 6186–6189. 
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(400 MHz, CDCl3) δ 8.09 (s, 2H), 8.08 – 8.06 (m, 1H), 8.03 (dd, J = 9.3, 0.9 Hz, 1H), 7.99 (s, 1H), 7.70 
(dd, J = 9.3, 1.5 Hz, 1H) ppm. 13C NMR (101 MHz, CDCl3) 149.5, 148.7, 141.5, 141.1, 132.9 (q, J = 
33.7 Hz), 131.8, 127.6, 123.2 (q, J = 272.9 Hz), 122.9 (qq, J = 3.7 Hz), 118.1, 114.9 ppm. LRMS 
(DEP/EI-Orbitrap): m/z (%): 332.0 (100), 312.0 (34), 302.0 (22), 282.0 (61), 265.0 (24), 237.0 (16), 
213.0 (30), 164.0 (13). HRMS (EI-Orbitrap): m/z calcd for C14H6F6N2O+: 332.0384; found: 332.0378. 
IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1628 (w), 1620 (vw), 1540 (w), 1520 (w), 1460 (w), 1382 (m), 
1373 (m), 1364 (m), 1326 (w), 1310 (m), 1276 (vs), 1237 (m), 1171 (s), 1123 (vs), 1110 (vs), 1043 (s), 
1012 (w), 905 (m), 884 (m), 848 (m), 815 (s), 768 (m), 722 (m), 705 (m), 684 (s). Mp (°C) = 97–101. 
2-(3,5-Bis(trifluoromethyl)phenyl)dibenzo[b,d]thiophene (3g) 
Using potassium dibenzo[b,d]thiophen-2-yltrifluoroborate (SM33) and a so-
lution of (3,5-bis(trifluoromethyl)phenyl)magnesium bromide in THF ac-
cording to general procedure Q (0.40 mmol scale), provided 3g (0.23 mmol, 
89 mg, 56%) as a colorless solid. Rf = 0.53 (hexane/EtOAc 100:0, UV, 
KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 8.32 (d, J = 1.6 Hz, 1H), 8.29 – 8.22 (m, 1H), 8.13 (s, 
2H), 7.96 (d, J = 8.3 Hz, 1H), 7.93 – 7.90 (m, 1H), 7.90 – 7.86 (m, 1H), 7.67 (dd, J = 8.3, 1.9 Hz, 1H), 
7.54 – 7.48 (m, 2H) ppm. 13C NMR (101 MHz, CDCl3) δ 143.4, 140.3, 140.1, 136.5, 135.2, 134.8, 132.4 
(q, J = 33.3 Hz), 127.5, 127.5, 125.8, 124.8, 123.7, 123.6 (q, J = 272.8 Hz), 123.1, 121.9, 121.0 (qq, J 
= 3.8 Hz), 120.2 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 396.0 (100), 326.0 (10), 258.0 (10), 198.0 
(14), 163.4 (12). HRMS (EI-Orbitrap): m/z calcd for C20H10F6S+: 396.0407; found: 396.0399. IR (Di-
amond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1717 (w), 1618 (w), 1459 (w), 1450 (w), 1434 (w), 1411 (w), 1374 (s), 
1326 (w), 1308 (w), 1273 (vs), 1246 (w), 1223 (m), 1170 (s), 1121 (vs), 1108 (s), 1072 (m), 1049 (s), 
1024 (m), 898 (m), 881 (m), 874 (m), 846 (m), 813 (m), 762 (s), 732 (m), 726 (m), 716 (w), 704 (m), 
692 (m), 682 (s). Mp (°C) = 119–124. 
4-(Dibenzo[b,d]thiophen-2-yl)-N,N-diisopropylbenzamide (3h) 
Using potassium dibenzo[b,d]thiophen-2-yltrifluoroborate (SM33) and 
a solution of (4-(diisopropylcarbamoyl)phenyl)zinc iodide in THF ac-
cording to general procedure Q (0.40 mmol scale), provided 3h 
(0.22 mmol, 85 mg, 56%) as a colorless oil. Rf = 0.35 (hexane/EtOAc 
80:20, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 8.34 (d, J = 1.5 Hz, 1H), 8.24 – 8.19 (m, 
1H), 7.90 (d, J = 8.3 Hz, 1H), 7.89 – 7.84 (m, 1H), 7.74 – 7.70 (m, 2H), 7.68 (dd, J = 8.3, 1.8 Hz, 1H), 
7.51 – 7.42 (m, 4H), 4.12 – 3.41 (m, 2H), 1.81 – 1.01 (m, 12H) ppm. 13C NMR (101 MHz, CDCl3) δ 
170.9, 141.6, 140.0, 138.9, 137.9, 137.2, 136.2, 135.5, 127.5, 127.0, 126.4, 126.1, 124.6, 123.2, 123.0, 
121.7, 120.1, 51.2, 46.3, 20.9 ppm. Signal splitting was observed, which was presumably caused by 
rotational barriers. LRMS (DEP/EI-Orbitrap): m/z (%): 387.2 (20), 344.1 (36), 287.1 (92), 258.1 (39), 
143.5 (11), 61.0 (15). HRMS (EI-Orbitrap): m/z calcd for C25H25NOS+: 387.1657; found: 387.1646. IR 
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(Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 2967 (w), 2930 (w), 2873 (w), 1610 (m), 1515 (w), 1466 (w), 1441 
(m), 1432 (m), 1378 (m), 1370 (m), 1340 (s), 1291 (w), 1252 (w), 1225 (w), 1212 (w), 1192 (w), 1159 
(w), 1136 (w), 1097 (w), 1082 (w), 1070 (w), 1037 (w), 1025 (w), 1017 (w), 1006 (w), 906 (s), 878 
(w), 852 (w), 838 (w), 822 (w), 811 (m), 763 (m), 725 (vs). 
2-Methoxy-5-(4-(trifluoromethyl)phenyl)pyridine (3i) 
Using potassium trifluoro(6-methoxypyridin-3-yl)borate and a solution of (4-
(trifluoromethyl)phenyl)magnesium bromide in THF according to general pro-
cedure Q (0.40 mmol scale), provided 3i (0.24 mmol, 60 mg, 59%) as a color-
less solid. Rf = 0.37 (hexane/EtOAc 95:5, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 8.41 (dd, 
J = 2.6, 0.8 Hz, 1H), 7.80 (dd, J = 8.6, 2.6 Hz, 1H), 7.72 – 7.67 (m, 2H), 7.65 – 7.60 (m, 2H), 6.85 (dd, 
J = 8.6, 0.8 Hz, 1H), 3.99 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 164.3, 145.4, 141.6, 137.6, 129.5 
(q, J = 32.5 Hz), 128.8, 127.0, 126.1 (q, J = 3.8 Hz), 124.3 (q, J = 271.9 Hz), 111.3, 53.8 ppm. LRMS 
(DEP/EI-Orbitrap): m/z (%): 252.1 (100), 224.1 (42), 222.1 (28), 202.0 (13), 183.0 (10), 154.1 (17). 
HRMS (EI-Orbitrap): m/z calcd for C13H10F3NO+: 253.0714; found: 253.0712. IR (Diamond-ATR, 
neat) 𝜈𝑚𝑎𝑥 (cm
- 1): 3058 (w), 3019 (w), 2980 (w), 2947 (w), 2905 (w), 1617 (w), 1608 (m), 1582 (w), 
1566 (w), 1529 (w), 1490 (m), 1460 (w), 1444 (w), 1438 (w), 1418 (m), 1374 (m), 1334 (s), 1327 (s), 
1314 (m), 1293 (s), 1280 (m), 1252 (m), 1196 (w), 1178 (w), 1161 (s), 1145 (m), 1108 (vs), 1073 (s), 
1042 (m), 1016 (s), 999 (m), 972 (w), 959 (w), 939 (w), 853 (w), 831 (s), 714 (m). Mp (°C) = 54–58. 
5-(3,5-Bis(trifluoromethyl)phenyl)-2-methoxypyridine (3j) 
Using potassium trifluoro(6-methoxypyridin-3-yl)borate and a solution of (3,5-
bis(trifluoromethyl)phenyl)magnesium bromide in THF according to general 
procedure Q (0.50 mmol scale), provided 3j (0.24 mmol, 77 mg, 48%) as a col-
orless oil. Rf = 0.46 (hexane/EtOAc 95:5, UV, KMnO4, PAA). 1H NMR 
(400 MHz, CDCl3) δ 8.41 (dd, J = 2.6, 0.8 Hz, 1H), 7.94 (s, 2H), 7.85 (s, 1H), 7.81 (dd, J = 8.6, 2.6 Hz, 
1H), 6.87 (dd, J = 8.7, 0.8 Hz, 1H), 4.00 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 164.7, 145.6, 
140.3, 137.4, 132.5 (q, J = 33.3 Hz), 127.4, 126.8, 123.4 (q, J = 272.8 Hz), 121.1 (qq, J = 3.8 Hz), 
111.6, 53.9 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 320.1 (100), 302.1 (14), 292.1 (47), 270.0 (24), 
222.1 (12), 202.0 (14), 182.1 (11). HRMS (EI-Orbitrap): m/z calcd for C14H9F6NO+: 321.0588; found: 
321.0578. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1604 (m), 1568 (w), 1504 (m), 1466 (m), 1455 (w), 
1436 (w), 1383 (m), 1368 (s), 1314 (w), 1274 (vs), 1171 (s), 1123 (vs), 1108 (s), 1062 (s), 1021 (s), 
1012 (m), 894 (s), 846 (m), 830 (s), 798 (w), 760 (w), 717 (m), 704 (s), 682 (s). 
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2-Methyl-6-(4-(trifluoromethyl)phenyl)quinoline (3k) 
Using potassium trifluoro(2-methylquinolin-6-yl)borate (SM34) and a so-
lution of (4-(trifluoromethyl)phenyl)magnesium bromide in THF according 
to general procedure Q (0.40 mmol scale), provided 3k (0.21 mmol, 60 mg, 
52%) as a colorless solid. Rf = 0.15 (hexane/EtOAc 90:10, UV, KMnO4, PAA). 1H NMR (400 MHz, 
CDCl3) δ 8.10 (dd, J = 8.5, 4.9 Hz, 2H), 7.96 (d, J = 2.0 Hz, 1H), 7.92 (dd, J = 8.7, 2.1 Hz, 1H), 7.79 
(d, J = 7.9 Hz, 2H), 7.73 (d, J = 8.3 Hz, 2H), 7.33 (d, J = 8.4 Hz, 1H), 2.77 (s, 3H) ppm. 13C NMR 
(101 MHz, CDCl3) δ 159.8, 147.6, 144.1, 137.0, 136.6, 130.0 (d, J = 32.5 Hz), 129.5, 128.9, 127.7, 
126.7, 126.0 (q, J = 3.7 Hz), 126.0, 124.4 (q, J = 272.0 Hz), 122.8, 25.6 ppm. LRMS (DEP/EI-Or-
bitrap): m/z (%): 287.1 (100), 268.1 (8), 217.1 (7), 176.0 (8), 143.5 (9), 118.5 (9). HRMS (EI-Orbitrap): 
m/z calcd for C17H12F3N+: 287.0922; found: 287.0917. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1615 (m), 
1600 (m), 1576 (w), 1494 (m), 1439 (w), 1415 (w), 1389 (w), 1371 (vw), 1322 (s), 1284 (m), 1258 (m), 
1225 (m), 1166 (s), 1158 (s), 1104 (vs), 1067 (s), 1028 (m), 1014 (m), 984 (w), 964 (m), 950 (m), 904 
(m), 892 (m), 850 (m), 826 (s), 775 (w), 736 (m). Mp (°C) = 117–121. 
5-(3,5-Bis(trifluoromethyl)phenyl)quinoline (3l) 
Using potassium trifluoro(quinolin-5-yl)borate (SM26) and a solution of (3,5-
bis(trifluoromethyl)phenyl)magnesium bromide in THF according to general pro-
cedure Q (0.40 mmol scale), provided 3l (0.16 mmol, 54 mg, 41%) as a colorless 
solid. Rf = 0.34 (hexane/EtOAc 80:20, UV, KMnO4, PAA). 1H NMR (400 MHz, 
CDCl3) δ 8.99 (dd, J = 4.2, 1.7 Hz, 1H), 8.22 (dt, J = 8.6, 1.0 Hz, 1H), 8.05 (dt, J = 8.5, 1.2 Hz, 1H), 
7.99 (s, 1H), 7.94 (s, 2H), 7.81 (dd, J = 8.6, 7.1 Hz, 1H), 7.54 (dd, J = 7.1, 1.2 Hz, 1H), 7.45 (dd, J = 
8.6, 4.2 Hz, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 150.9, 148.6, 141.6, 137.2, 133.2, 132.1 (q, J = 
33.4 Hz), 130.7, 130.2, 129.1, 128.0, 126.3, 123.4 (q, J = 272.9 Hz), 122.1, 121.8 (qq, J = 3.8 Hz) ppm. 
LRMS (DEP/EI-Orbitrap): m/z (%): 341.1 (100), 272.1 (47), 252.1 (10), 225.1 (11), 203.1 (10). HRMS 
(EI-Orbitrap): m/z calcd for C17H9F6N+: 341.0639; found: 341.0632. IR (Diamond-ATR, neat) 
𝜈𝑚𝑎𝑥 (cm
- 1): 1505 (w), 1374 (m), 1360 (w), 1285 (s), 1204 (w), 1170 (s), 1115 (vs), 1062 (w), 1042 (w), 
902 (m), 873 (w), 848 (w), 828 (w), 803 (m), 714 (m), 706 (m), 688 (m). Mp (°C) = 119–121. 
2-Methoxy-5-(4-(trifluoromethyl)phenyl)pyrimidine (3m) 
Using potassium trifluoro(2-methoxypyrimidin-5-yl)borate and a solution of 
(4-(trifluoromethyl)phenyl)magnesium bromide in THF according to general 
procedure Q (0.40 mmol scale), provided 3m (0.15 mmol, 37 mg, 37%) as a 
colorless solid. Rf = 0.20 (hexane/EtOAc 90:10, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 
8.74 (s, 2H), 7.74 (d, J = 7.8 Hz, 2H), 7.64 (d, J = 7.5 Hz, 2H), 4.08 (s, 3H) ppm. 13C NMR (101 MHz, 
CDCl3) δ 165.7, 157.6, 138.2, 130.5 (q, J = 32.7 Hz), 127.1, 127.0, 126.4 (q, J = 3.8 Hz), 124.1 (q, J = 
272.2 Hz), 55.4 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 254.1 (68), 225.1 (100), 198.1 (27), 169.0 
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(12), 155.1 (43), 151.0 (14). HRMS (EI-Orbitrap): m/z calcd for C12H9F3N2O+: 254.0667; found: 
254.0662. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1750 (w), 1710 (vs), 1619 (w), 1598 (w), 1551 (w), 
1525 (w), 1475 (m), 1436 (w), 1419 (m), 1361 (s), 1326 (s), 1304 (m), 1278 (w), 1221 (s), 1204 (w), 
1167 (m), 1156 (m), 1126 (m), 1115 (m), 1098 (m), 1080 (m), 1065 (m), 1034 (m), 1020 (w), 999 (w), 
901 (w), 853 (w), 838 (m), 798 (w), 716 (w). Mp (°C) = 103–107. 
2-(3,5-Bis(trifluoromethyl)phenyl)furan (3n) 
Using potassium trifluoro(furan-2-yl)borate and a solution of (3,5-bis(trifluorome-
thyl)phenyl)magnesium bromide in THF according to general procedure Q 
(0.50 mmol scale), provided 3n (0.13 mmol, 35 mg, 25%) as a colorless solid. (Note: 
This product could only be isolated in 70% purity, as no separation from the undesired homocoupled 
product was possible.) Rf = 0.58 (hexane/EtOAc 100:0, UV, KMnO4, PAA). 1H NMR (400 MHz, 
CDCl3) δ 8.07 (s, 2H), 7.73 (s, 1H), 7.55 (dd, J = 1.9, 0.7 Hz, 1H), 6.85 (dd, J = 3.4, 0.7 Hz, 1H), 6.55 
(dd, J = 3.5, 1.8 Hz, 1H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 280.0 (100), 261.0 (17), 251.0 (39), 
183.0 (35), 133.0 (10). Analytical data in accordance to literature.257 
2-(4-Phenoxyphenyl)dibenzo[b,d]furan (3o) 
Using potassium trifluoro(4-phenoxyphenyl)borate and a solution of 
dibenzo[b,d]furan-2-ylmagnesium bromide in THF according to general pro-
cedure Q (0.40 mmol scale), provided 3o (0.26 mmol, 88 mg, 66%) as a color-
less solid. Rf = 0.51 (hexane/EtOAc 98:2, UV, KMnO4, PAA). 1H NMR 
(400 MHz, CDCl3) δ 8.12 (dd, J = 1.9, 0.7 Hz, 1H), 8.00 (ddd, J = 7.7, 1.4, 0.7 Hz, 1H), 7.68 – 7.58 (m, 
5H), 7.48 (ddd, J = 8.4, 7.3, 1.4 Hz, 1H), 7.40 – 7.34 (m, 3H), 7.16 – 7.06 (m, 5H) ppm. 13C NMR 
(101 MHz, CDCl3) δ 157.4, 156.8, 156.8, 155.8, 136.6, 135.9, 130.0, 128.9, 127.5, 126.6, 124.9, 124.4, 
123.5, 123.0, 120.9, 119.4, 119.1, 112.0 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 336.1 (100), 259.1 
(10), 231.1 (14), 202.1 (10), 77.1 (9). HRMS (EI-Orbitrap): m/z calcd for C24H16O2+: 336.1150; found: 
336.1145. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1750 (w), 1734 (w), 1710 (s), 1684 (w), 1654 (w), 
1559 (w), 1540 (w), 1508 (w), 1489 (w), 1473 (w), 1466 (w), 1457 (w), 1447 (w), 1436 (w), 1430 (w), 
1419 (w), 1361 (m), 1221 (m), 1197 (w), 1092 (w), 915 (m), 842 (w), 814 (w), 728 (vs). Mp (°C) = 
140–145.  
4'-Phenoxy-[1,1'-biphenyl]-4-carbonitrile (4a) 
Using potassium trifluoro(4-phenoxyphenyl)borate and a solution of (4-cyano-
phenyl)zinc iodide in THF according to general procedure Q (0.50 mmol scale), 
provided 4a (0.23 mmol, 62 mg, 46%) as a colorless oil. Rf = 0.14 (hex-
ane/EtOAc 98:2, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.74 – 7.69 (m, 2H), 7.68 – 7.63 
 
257 G. E. Morton, A. G. M. Barrett, J. Org. Chem. 2005, 70, 3525–3529. 
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(m, 2H), 7.58 – 7.52 (m, 2H), 7.41 – 7.35 (m, 2H), 7.16 (ddt, J = 8.5, 7.2, 1.1 Hz, 1H), 7.12 – 7.05 (m, 
4H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 271.1 (100), 242.1 (12), 207.0 (86), 190.9 (12), 166.1 
(17), 140.1 (19), 77.0 (36). Analytical data in accordance to literature.258 
4-(Benzo[d][1,3]dioxol-5-yl)benzonitrile (4b) 
Using potassium benzo[d][1,3]dioxol-5-yltrifluoroborate and a solution of (4-cy-
anophenyl)zinc iodide in THF according to general procedure Q (0.50 mmol 
scale), provided 4b (0.19 mmol, 42 mg, 38%) as a colorless oil. Rf = 0.30 (hex-
ane/EtOAc 98:2, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.72 – 7.66 (m, 2H), 7.63 – 7.58 
(m, 2H), 7.09 – 7.04 (m, 2H), 6.91 (d, J = 7.9 Hz, 1H), 6.03 (s, 2H) ppm. LRMS (DEP/EI-Orbitrap): 
m/z (%): 223.0 (100), 164.0 (43), 138.0 (17), 111.2 (18). Analytical data in accordance to literature.259 
3',5'-Bis(trifluoromethyl)-[1,1'-biphenyl]-4-carbonitrile (4c) 
Using potassium trifluoro(4-benzonitrile)borate and a solution of (3,5-bis(tri-
fluoromethyl)phenyl)magnesium bromide in THF according to general proce-
dure Q (0.40 mmol scale), provided 4c (0.21 mmol, 66 mg, 66%) as a colorless 
solid. Rf = 0.33 (hexane/EtOAc 98:2, UV, KMnO4, PAA). 1H NMR (400 MHz, 
CDCl3) δ 8.02 (s, 2H), 7.94 (s, 1H), 7.85 – 7.78 (m, 2H), 7.77 – 7.69 (m, 2H) ppm. LRMS (DEP/EI-
Orbitrap): m/z (%): 315.0 (100), 296.0 (19), 226.0 (22), 177.0 (15). Analytical data in accordance to 
literature.260 
3-Bromo-9-phenyl-6-(4-(trifluoromethyl)phenyl)-9H-carbazole (4d) 
Using potassium (6-bromo-9-phenyl-9H-carbazol-3-yl)trifluoroborate 
(SM32) and a solution of (4-(trifluoromethyl)phenyl)magnesium bromide 
in THF according to general procedure Q (0.40 mmol scale), provided 4d 
(0.26 mmol, 120 mg, 64%) as a colorless solid. Rf = 0.50 (hexane/EtOAc 
98:2, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 8.33 – 8.29 (m, 2H), 7.80 (d, J = 8.4 Hz, 2H), 
7.73 (d, J = 8.3 Hz, 2H), 7.69 – 7.61 (m, 3H), 7.57 – 7.49 (m, 4H), 7.47 (d, J = 8.6 Hz, 1H), 7.30 (d, J 
= 8.7 Hz, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 145.3, 141.2, 140.2, 137.1, 132.4, 130.3, 129.2, 
128.9 (q, J = 32.4 Hz), 128.2, 127.6, 127.1, 126.2, 125.9 (q, J = 3.8 Hz), 125.1, 124.6 (q, J = 271.9 Hz), 
123.3, 123.0, 119.3, 113.2, 111.7, 110.7 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 467.0 (100), 465.0 
(97), 385.1 (18), 233.5 (10), 43.1 (35). HRMS (EI-Orbitrap): m/z calcd for C25H15BrF3N+: 465.0340; 
found: 465.0339. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1716 (w), 1700 (w), 1684 (w), 1616 (m), 1598 
(m), 1559 (w), 1541 (w), 1522 (w), 1500 (s), 1478 (m), 1456 (w), 1439 (m), 1420 (w), 1404 (w), 1363 
(m), 1323 (vs), 1286 (m), 1252 (w), 1234 (m), 1193 (w), 1164 (m), 1120 (s), 1111 (s), 1070 (s), 1059 
 
258 S. Yang, C. Wu, H. Zhou, Y. Yang, Y. Zhao, C. Wang, W. Yang, J. Xu, Adv. Synth. Catal. 2013, 355, 53–58. 
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(w), 1028 (w), 1018 (w), 1012 (w), 941 (w), 871 (w), 848 (m), 809 (m), 761 (m), 710 (w), 698 (m). 
Mp (°C) = 138–141. 
3-Bromo-6-(3,5-difluorophenyl)-9-phenyl-9H-carbazole (4e) 
Using potassium (6-bromo-9-phenyl-9H-carbazol-3-yl)trifluoroborate 
(SM32) and a solution of (3,5-difluorophenyl)magnesium bromide in THF 
according to general procedure Q (0.40 mmol scale), provided 4e (0.18 mmol, 
80 mg, 46%) as a colorless solid. Rf = 0.40 (hexane/EtOAc 98:2, UV, KMnO4, 
PAA). 1H NMR (400 MHz, CDCl3) δ 8.30 (d, J = 1.9 Hz, 1H), 8.25 (d, J = 1.8 Hz, 1H), 7.67 – 7.59 
(m, 3H), 7.56 – 7.49 (m, 4H), 7.44 (d, J = 8.5 Hz, 1H), 7.29 (d, J = 8.7 Hz, 1H), 7.24 – 7.17 (m, 2H), 
6.79 (tt, J = 8.9, 2.3 Hz, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 163.5 (dd, J = 247.6, 13.3 Hz), 145.1 
(t, J = 9.6 Hz), 141.3, 140.2, 137.1, 131.5 (t, J = 2.5 Hz), 130.2, 129.3, 128.2, 127.1, 125.9, 125.1, 
123.3, 123.0, 119.1, 113.2, 111.7, 110.6, 110.0 (dd, J = 18.2, 6.6 Hz), 102.0 (t, J = 25.5 Hz) ppm. 
LRMS (DEP/EI-Orbitrap): m/z (%): 435.0 (100), 433.0 (97), 353.1 (23), 216.5 (12), 166.5 (10), 123.0 
(12), 74.1 (75), 59.0 (91). HRMS (EI-Orbitrap): m/z calcd for C24H14BrF2N+: 433.0278; found: 
433.0272. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1750 (w), 1734 (w), 1717 (m), 1700 (w), 1684 (w), 
1654 (m), 1647 (w), 1635 (m), 1619 (s), 1592 (s), 1576 (m), 1570 (w), 1559 (m), 1541 (m), 1522 (w), 
1501 (vs), 1472 (m), 1465 (s), 1457 (s), 1436 (m), 1420 (w), 1363 (m), 1339 (w), 1321 (w), 1283 (m), 
1266 (m), 1234 (m), 1196 (m), 1173 (w), 1116 (s), 1063 (w), 1056 (w), 1026 (w), 988 (m), 937 (vw), 
905 (w), 857 (m), 835 (w), 810 (m), 790 (w), 761 (m), 699 (m). Mp (°C) = 174–178. 
4'-Chloro-3,5-bis(trifluoromethyl)-1,1'-biphenyl (4f) 
Using potassium trifluoro(4-chlorophenyl)borate and a solution of (3,5-bis(tri-
fluoromethyl)phenyl)magnesium bromide in THF according to general proce-
dure Q (0.40 mmol scale), provided 4f (0.32 mmol, 104 mg, 80%) as a colorless 
oil. (Note: This product could only be isolated in 90% purity, as no separation 
from the undesired homocoupled product was possible.) Rf = 0.67 (hexane/EtOAc 100:0, UV, KMnO4, 
PAA). 1H NMR (400 MHz, CDCl3) δ 7.98 (s, 2H), 7.88 (s, 1H), 7.58 – 7.52 (m, 2H), 7.51 – 7.45 (m, 
2H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 324.0 (100), 305.0 (15), 269.0 (25), 220.1 (26). Analyt-
ical data in accordance to literature.261 
4'-Bromo-3,5-bis(trifluoromethyl)-1,1'-biphenyl (4g) 
Using potassium (4-bromophenyl)trifluoroborate and a solution of (3,5-bis(tri-
fluoromethyl)phenyl)magnesium bromide in THF according to general proce-
dure Q (0.50 mmol scale), provided 4g (0.25 mmol, 90 mg, 49%) as a colorless 
oil. (Note: This product could only be isolated in 80% purity, as no separation 
 
261 Y.-N. Wang, X.-Q. Guo, X.-H. Zhu, R. Zhong, L.-H. Cai, X.-F. Huo, Chem. Commun. 2012, 48, 10437–10439. 
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from the undesired homocoupled product was possible.) Rf = 0.62 (hexane/EtOAc 100:0, UV, KMnO4, 
PAA). 1H NMR (400 MHz, CDCl3) δ 7.98 (s, 2H), 7.88 (s, 1H), 7.68 – 7.61 (m, 2H), 7.53 – 7.45 (m, 
2H) ppm. 13C NMR (101 MHz, CDCl3) δ 142.3, 137.2, 132.6, 133.7 (q, J = 33.3 Hz), 128.9, 127.2 – 
127.1 (m), 123.6, 123.4 (q, J = 272.8 Hz), 121.4 (qq, J = 3.8 Hz) ppm. LRMS (DEP/EI-Orbitrap): 
m/z (%): 370.0 (76), 368.0 (77), 269.0 (100), 219.0 (56), 201.1 (19), 199.0 (13), 170.1 (11). HRMS 
(EI-Orbitrap): m/z calcd for C14H7BrF6+: 367.9635; found: 367.9630. IR (Diamond-ATR, neat) 
𝜈𝑚𝑎𝑥 (cm
-1): 1465 (w), 1381 (s), 1349 (m), 1274 (vs), 1258 (s), 1170 (s), 1125 (vs), 1107 (s), 1076 (s), 
1052 (s), 1010 (m), 898 (s), 847 (m), 821 (s), 728 (m), 716 (w), 704 (s), 682 (s). 
4'-Iodo-3,5-bis(trifluoromethyl)-1,1'-biphenyl (4h) 
Using potassium trifluoro(4-iodophenyl)borate and a solution of (3,5-bis(trifluo-
romethyl)phenyl)magnesium bromide in THF according to general procedure Q 
(0.40 mmol scale), provided 4h (0.31 mmol, 129 mg, 78%) as a colorless solid. 
Rf = 0.75 (hexane/EtOAc 100:0, UV, KMnO4, PAA). 1H NMR (400 MHz, 
CDCl3) δ 7.97 (s, 2H), 7.87 (s, 1H), 7.86 – 7.82 (m, 2H), 7.37 – 7.32 (m, 2H) ppm. 13C NMR (101 MHz, 
CDCl3) δ 142.4, 138.6, 137.8, 132.5 (q, J = 33.4 Hz), 129.1, 127.1 (q, J = 2.8 Hz), 123.4 (q, J = 
272.9 Hz), 121.5 (dt, J = 7.7, 3.8 Hz), 95.2 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 416.0 (100), 397.0 
(10), 269.0 (59), 220.0 (34), 201.0 (12). HRMS (EI-Orbitrap): m/z calcd for C14H7F6I+: 415.9497; 
found: 415.9492. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1381 (m), 1273 (s), 1195 (m), 1186 (m), 1166 
(m), 1128 (vs), 1111 (m), 1051 (w), 1005 (w), 902 (m), 846 (w), 823 (s), 727 (w), 704 (m), 682 (m). 
Mp (°C) = 68–70. 
3-Chloro-4'-phenoxy-1,1'-biphenyl (4i) 
Using potassium trifluoro(4-phenoxyphenyl)borate and a solution of (3-chloro-
phenyl)magnesium bromide in THF according to general procedure Q 
(0.40 mmol scale), provided 4i (0.31 mmol, 87 mg, 77%) as a colorless solid. Rf 
= 0.18 (hexane/EtOAc 100:0, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.57 (t, J = 1.8 Hz, 
1H), 7.56 – 7.51 (m, 2H), 7.45 (dt, J = 7.6, 1.5 Hz, 1H), 7.42 – 7.34 (m, 3H), 7.34 – 7.29 (m, 1H), 7.19 
– 7.13 (m, 1H), 7.12 – 7.06 (m, 4H) ppm. 13C NMR (101 MHz, CDCl3) δ 157.5, 157.0, 142.5, 134.82, 
134.79, 130.1, 130.0, 128.6, 127.1, 125.1, 123.7, 119.3, 119.1 ppm. One carbon signal could not be 
detected. LRMS (DEP/EI-Orbitrap): m/z (%): 280.1 (100), 252.1 (11), 217.1 (14), 207.0 (22), 152.1 
(13). HRMS (EI-Orbitrap): m/z calcd for C18H13ClO+: 280.0655; found: 280.0650. IR (Diamond-ATR, 
neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3066 (w), 3037 (w), 1607 (w), 1594 (m), 1588 (s), 1563 (w), 1539 (w), 1510 (s), 
1488 (vs), 1473 (s), 1430 (w), 1419 (vw), 1394 (w), 1332 (w), 1303 (w), 1279 (w), 1233 (vs), 1202 (m), 
1169 (m), 1099 (m), 1081 (w), 1071 (w), 1036 (w), 1023 (w), 1011 (w), 1004 (w), 997 (w), 870 (m), 
837 (m), 805 (w), 782 (s), 746 (s), 731 (w), 724 (w), 691 (s), 673 (w). Mp (°C) = 46–48. 
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3-Iodo-4'-phenoxy-1,1'-biphenyl (4j) 
Using potassium trifluoro(4-phenoxyphenyl)borate and a solution of (3-iodo-
phenyl)magnesium iodide in THF according to general procedure Q (0.40 mmol 
scale), provided 4j (0.24 mmol, 88 mg, 60%) as a colorless solid. Rf = 0.28 (hex-
ane/EtOAc 100:0, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.93 (t, J = 1.8 Hz, 1H), 7.67 
(dt, J = 7.8, 1.3 Hz, 1H), 7.55 – 7.49 (m, 3H), 7.41 – 7.34 (m, 2H), 7.20 – 7.12 (m, 2H), 7.12 – 7.04 (m, 
4H) ppm. 13C NMR (101 MHz, CDCl3) δ 157.5, 157.0, 142.9, 136.0, 134.7, 130.6, 130.0, 128.6, 126.3, 
123.7, 119.3, 119.1, 95.0 ppm. One carbon signal could not be detected. LRMS (DEP/EI-Orbitrap): 
m/z (%): 372.0 (100), 207.0 (14), 152.1 (48), 139.1 (14). HRMS (EI-Orbitrap): m/z calcd for C18H13IO+: 
372.0011; found: 372.0005. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 3036 (w), 1610 (w), 1587 (s), 1554 
(m), 1509 (s), 1487 (vs), 1468 (s), 1455 (m), 1425 (w), 1389 (w), 1332 (w), 1303 (w), 1278 (w), 1232 
(vs), 1201 (m), 1166 (m), 1108 (w), 1070 (w), 1025 (w), 1010 (w), 992 (m), 907 (w), 903 (w), 870 (m), 
837 (m), 801 (w), 780 (s), 757 (m), 745 (w), 731 (m), 719 (w), 690 (s), 654 (m). Mp (°C) = 75–77. 
3-(4-(Trifluoromethyl)phenyl)-3-deoxyestrone (6a) 
Using potassium 3-deoxyestrone-3-trifluoroborate (SM27) and a solu-
tion of (4-(trifluoromethyl)phenyl)zinc iodide in THF according to gen-
eral procedure Q (0.40 mmol scale), provided 6a (0.26 mmol, 103 mg, 
65%) as a colorless solid. Rf = 0.17 (hexane/EtOAc 95:5, UV, KMnO4, 
PAA). 1H NMR (400 MHz, CDCl3) δ 7.68 (s, 4H), 7.42 – 7.40 (m, 2H), 
7.35 (s, 1H), 3.05 – 2.98 (m, 2H), 2.58 – 2.44 (m, 2H), 2.37 (td, J = 10.9, 4.1 Hz, 1H), 2.23 – 2.14 (m, 
1H), 2.14 – 2.04 (m, 2H), 2.01 (dt, J = 12.5, 2.9 Hz, 1H), 1.72 – 1.45 (m, 6H), 0.94 (s, 3H) ppm. 13C 
NMR (101 MHz, CDCl3) δ 221.0, 144.7, 140.1, 137.4, 137.4, 129.3 (q, J = 32.4 Hz), 128.0, 127.3, 
126.2, 125.8 (q, J = 3.8 Hz), 124.8, 127.2 (q, J = 270.8 Hz), 50.7, 48.1, 44.5, 38.3, 36.0, 31.7, 29.7, 
26.6, 25.9, 21.8, 14.0 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 398.2 (100), 365.2 (11), 354.2 (36), 
341.2 (29), 300.1 (26), 288.1 (25), 274.1 (22), 207.0 (47). HRMS (EI-Orbitrap): m/z calcd for 
C25H25F3O+: 398.1858; found: 398.1850. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 2940 (w), 2924 (w), 
1736 (s), 1615 (m), 1320 (vs), 1258 (m), 1163 (s), 1126 (s), 1114 (s), 1108 (s), 1088 (m), 1068 (s), 1056 
(s), 1042 (m), 1014 (m), 1007 (m), 958 (w), 865 (w), 850 (m), 842 (m), 824 (s), 800 (m). Mp (°C) = 
170–175. 
3-(4-(Ethoxycarbonyl)phenyl))-3-deoxyestrone (6b) 
Using potassium 3-deoxyestrone-3-trifluoroborate (SM27) and a solu-
tion of (4-(ethoxycarbonyl)phenyl)zinc iodide in THF according to 
general procedure Q (0.40 mmol scale), provided 6b (0.22 mmol, 
89 mg, 55%) as a colorless solid. Rf = 0.51 (hexane/EtOAc 80:20, UV, 
KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 8.12 – 8.06 (m, 2H), 
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7.68 – 7.61 (m, 2H), 7.45 – 7.33 (m, 3H), 4.40 (q, J = 7.1 Hz, 2H), 3.03 – 2.98 (m, 2H), 2.57 – 2.44 (m, 
2H), 2.36 (td, J = 10.8, 4.0 Hz, 1H), 2.22 – 2.13 (m, 1H), 2.13 – 2.04 (m, 2H), 2.03 – 1.96 (m, 1H), 1.72 
– 1.46 (m, 6H), 1.41 (t, J = 7.1 Hz, 3H), 0.93 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 220.9, 166.7, 
145.5, 140.1, 137.7, 137.3, 130.2, 129.2, 128.0, 126.9, 126.2, 124.8, 61.1, 50.7, 48.1, 44.5, 38.3, 36.0, 
31.7, 29.7, 26.6, 25.9, 21.8, 14.5, 14.0 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 402.2 (100), 357.2 
(10), 345.2 (10), 304.1 (8), 278.1 (7). HRMS (EI-Orbitrap): m/z calcd for C27H30O3+: 402.2195; found: 
402.2189. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 2979 (w), 2931 (m), 2872 (w), 1737 (s), 1710 (vs), 
1608 (m), 1576 (w), 1492 (w), 1473 (w), 1465 (w), 1454 (m), 1424 (w), 1405 (w), 1395 (m), 1367 (m), 
1338 (w), 1313 (w), 1270 (vs), 1218 (w), 1177 (m), 1102 (s), 1086 (m), 1057 (m), 1042 (w), 1020 (m), 
1009 (m), 965 (w), 910 (m), 894 (w), 860 (m), 847 (m), 822 (m), 768 (s), 730 (s), 703 (m). Mp (°C) = 
155–159. 
3-(4-(N,N-Diisopropylbenzamide)-3-deoxyestrone (6c) 
Using potassium 3-deoxyestrone-3-trifluoroborate (SM27) and a 
solution of (4-(diisopropylcarbamoyl)phenyl)zinc iodide in THF 
according to general procedure Q (0.40 mmol scale), provided 6c 
(0.19 mmol, 84 mg, 47%) as a colorless solid. Rf = 0.25 (hex-
ane/EtOAc 80:20, UV, KMnO4, PAA). 1H NMR (400 MHz, 
CDCl3) δ 7.58 (d, J = 8.2 Hz, 2H), 7.40 – 7.37 (m, 3H), 7.35 (d, J = 7.9 Hz, 2H), 4.07 – 3.39 (m, br, 
2H), 2.99 (dd, J = 9.2, 4.2 Hz, 2H), 2.57 – 2.43 (m, 2H), 2.36 (td, J = 10.8, 4.0 Hz, 1H), 2.22 – 2.13 (m, 
1H), 2.11 – 2.03 (m, 2H), 2.02 – 1.96 (m, 1H), 1.73 – 1.43 (m, 6H), 1.74 – 1.04 (m, 12H), 0.93 (s, 
3H) ppm. 13C NMR (101 MHz, CDCl3) δ 220.9, 171.0, 141.4, 139.4, 138.1, 137.6, 137.1, 127.8, 127.1, 
126.2, 126.0, 124.6, 51.1, 50.6, 48.1, 46.3, 44.5, 38.3, 36.0, 31.7, 29.6, 26.6, 25.9, 21.7, 20.9, 13.9 ppm. 
Signal splitting was observed, which was presumably caused by rotational barriers. LRMS (DEP/EI-
Orbitrap): m/z (%): 457.3 (17), 414.2 (62), 357.2 (100), 165.1 (12). HRMS (EI-Orbitrap): m/z calcd for 
C31H39NO2+: 457.2981; found: 457.2983. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 2962 (w), 2925 (w), 
2873 (w), 1736 (s), 1621 (vs), 1468 (m), 1437 (m), 1369 (m), 1338 (s), 1294 (w), 1260 (w), 1254 (w), 
1212 (m), 1203 (w), 1161 (m), 1153 (m), 1136 (w), 1083 (w), 1039 (m), 1013 (m), 963 (w), 917 (w), 
856 (w), 844 (m), 832 (m), 821 (vs), 785 (w), 763 (s). Mp (°C) = 275–280 (decomposition). 
5-(p-Tolyl)-1-(4'-(trifluoromethoxy)-[1,1'-biphenyl]-4-yl)-3-(trifluoromethyl)-1H-pyrazole (8a) 
Using potassium trifluoro(4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyra-
zol-1-yl)phenyl)borate (SM35) and a solution of (4-(trifluorometh-
oxy)phenyl)magnesium bromide in THF according to general proce-
dure Q (0.40 mmol scale), provided 8a (0.22 mmol, 100 mg, 54%) as 
a colorless oil. Rf = 0.23 (hexane/EtOAc 98:2, UV, KMnO4, PAA). 1H 
NMR (400 MHz, CDCl3) δ 7.62 – 7.57 (m, 2H), 7.57 – 7.52 (m, 2H), 
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7.43 – 7.37 (m, 2H), 7.32 – 7.27 (m, 2H), 7.16 (s, 4H), 6.74 (s, 1H), 2.37 (s, 3H) ppm. 13C NMR 
(101 MHz, CDCl3) δ 149.1 (q, J = 1.8 Hz), 144.9, 143.5 (q, J = 38.3 Hz), 139.8, 139.4, 138.9, 138.7, 
129.6, 128.9, 128.6, 127.8, 126.4, 125.9, 121.5, 121.4 (q, J = 269.0 Hz), 120.6 (q, J = 257.4 Hz), 105.7 
(q, J = 2.2 Hz), 21.5 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 462.1 (100), 441.1 (13), 178.1 (12), 
139.1 (15), 57.1 (11), 44.0 (49). HRMS (EI-Orbitrap): m/z calcd for C24H16F6N2O+: 462.1167; found: 
462.1662. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1498 (m), 1473 (m), 1448 (w), 1377 (m), 1259 (vs), 
1236 (vs), 1212 (s), 1161 (vs), 1134 (s), 1097 (m), 1008 (w), 978 (m), 922 (w), 859 (w), 836 (m), 826 
(m), 808 (m).  
1-(3',5'-Bis(trifluoromethyl)-[1,1'-biphenyl]-4-yl)-5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazole 
(8b) 
Using potassium trifluoro(4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyra-
zol-1-yl)phenyl)borate (SM35) and a solution of (3,5-bis(trifluorome-
thyl)phenyl)magnesium bromide in THF according to general procedure 
Q (0.40 mmol scale), provided 8b (0.22 mmol, 110 mg, 55%) as a col-
orless oil. Rf = 0.48 (hexane/EtOAc 98:2, UV, KMnO4, PAA). 1H NMR 
(400 MHz, CDCl3) δ 8.01 (s, 2H), 7.89 (s, 1H), 7.64 – 7.59 (m, 2H), 
7.50 – 7.44 (m, 2H), 7.20 – 7.14 (m, 4H), 6.75 (s, 1H), 2.38 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) 
δ 145.1, 143.7 (q, J = 38.4 Hz), 142.0, 139.9, 139.6, 138.1, 132.4 (q, J = 33.3 Hz), 129.7, 128.9, 123.0, 
127.3, 126.0, 126.1, 123.4 (q, J = 272.8 Hz), 121.6 (qq, J = 3.8 Hz), 121.4 (q, J = 269.0 Hz), 106.0 (q, 
J = 2.0 Hz), 21.5 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 514.1 (100), 499.1 (12), 493.1 (36), 479.1 
(13), 301.1 (10), 237.1 (11). HRMS (EI-Orbitrap): m/z calcd for C25H15F9N2+: 514.1092; found: 
514.1086. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥 (cm
-1): 1525 (w), 1513 (w), 1472 (m), 1448 (w), 1408 (w), 
1384 (s), 1278 (vs), 1262 (m), 1237 (m), 1164 (s), 1131 (vs), 1110 (m), 1097 (m), 1071 (w), 1053 (w), 
977 (m), 900 (w), 850 (w), 838 (m), 808 (w), 751 (w), 733 (w), 705 (w), 682 (m). 
5.5.5 Synthesis of compound 9a 
(E)-1-Fluoro-4-styrylbenzene (9a) 
A 25 mL Schlenk flask was charged with (E/Z)-trifluoro(styryl)borate (0.4 mmol, 
1.0 equiv) and 2 mL of THF were added. The mixture was cooled to 0 °C and the 
desired aryl Grignard reagent (1.20 mmol, 3.0 equiv) was added dropwise over 30 min via syringe 
pump. The reaction was quenched after 5 min with 5 mL of sat. aq. K2CO3 solution and extracted with 
EtOAc (3 × 40 mL). The combined organic phases were filtered and concentrated under reduced pres-
sure. The crude product was then dissolved in 8 mL of HPLC-grade MeCN and transferred into a 10 mL 
IKA glass vial. The reaction was started using the IKA ElectraSyn 2.0 with RVC as working and counter 
electrode (5 mA, 3.0 F, 700 rpm stirring). The crude was then treated with water and extracted with 
diethyl ether (3 × 15 mL). The combined organic phases were dried over MgSO4, filtered and 
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concentrated under reduced pressure. The crude product was purified by column chromatography on 
silica gel to yield the desired product 9a. Using potassium (E)-trifluoro(styryl)borate and a solution of 
(4-fluorophenyl)magnesium bromide in THF according to the procedure mentioned above, provided 9a 
(0.27 mmol, 54 mg, 68%, E/Z = 99:1) as colorless solid. Using potassium (Z)-trifluoro(styryl)borate 
(SM28) and a solution of (4-fluorophenyl)magnesium bromide in THF according to the procedure men-
tioned above, provided 9a (0.22 mmol, 44 mg, 55%, E/Z = 98:2) as colorless solid. 1H NMR (400 MHz, 
CDCl3) δ 7.46-7.35 (m, 4H), 7.27 (t, J = 7.7 Hz, 2H), 7.21-7.13 (m, 1H), 7.03-6.92 (m, 4H) ppm. LRMS 
(DEP/EI-Orbitrap): m/z (%): 198.0 (100), 183.0 (45), 177.0 (20). Analytical data in accordance to liter-
ature.262 
4'-Fluoro-3-methoxy-1,1'-biphenyl (10a) 
Using potassium trifluoro(3-methoxyphenyl)borate and a solution of (4-fluoro-
phenyl)magnesium bromide in THF according to general procedure P 
(0.40 mmol scale), provided 10a (0.18 mmol, 36 mg, 46%) as a colorless solid. 
Rf = 0.46 (hexane/EtOAc 98:2, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.58 – 7.52 (m, 
2H), 7.36 (t, J = 7.9 Hz, 1H), 7.18 – 7.06 (m, 4H), 6.91 (ddd, J = 8.3, 2.6, 1.0 Hz, 1H), 3.87 (s, 3H) ppm. 
LRMS (DEP/EI-Orbitrap): m/z (%): 202.1 (100), 172.1 (24), 159.1 (35), 133.1 (30). Analytical data in 
accordance to literature.263 
4'-Fluoro-2-methoxy-1,1'-biphenyl (10b) 
Using potassium trifluoro(2-methoxyphenyl)borate and a solution of (4-fluoro-
phenyl)magnesium bromide in THF according to general procedure P (0.40 mmol 
scale), provided 10b (0.07 mmol, 14 mg, 18%) as a colorless solid. Rf = 0.21 (hex-
ane/EtOAc 99:1, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.54 – 7.43 (m, 2H), 7.37 – 7.27 
(m, 2H), 7.19 – 7.08 (m, 2H), 7.06 – 6.97 (m, 2H), 3.82 (s, 3H) ppm. LRMS (DEP/EI-Orbitrap): m/z 
(%): 202.0 (100), 187.0 (58), 170.0 (13), 159.0 (54), 133.0 (46). Analytical data in accordance to liter-
ature.264 
3-Methoxy-4'-(trifluoromethyl)-1,1'-biphenyl (10c) 
Using potassium trifluoro(3-methoxyphenyl)borate and a solution of (4-(tri-
fluoromethyl)phenyl)magnesium bromide in THF according to general proce-
dure P (0.40 mmol scale), provided 10c (0.28 mmol, 70 mg, 70%) as a color-
less solid. Rf = 0.36 (hexane/EtOAc 98:2, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.69 (s, 
4H), 7.40 (t, J = 7.9 Hz, 1H), 7.19 (d, J = 7.7 Hz, 1H), 7.15 – 7.11 (m, 1H), 6.96 (dd, J = 8.2, 2.0 Hz, 
 
262 A. L. Isfahani, I. Mohammadpoor-Baltork, V. Mirkhani, A. R. Khosropour, M. Moghadam, S. Tangesta-
ninejad, R. Kia, Adv. Synth. Catal. 2013, 355, 957–972. 
263 J.-F. Soule, H. Miyamura, S. Kobayashi, J. Am. Chem. Soc. 2013, 11, 7899–7906. 
264 Q. Simpson, M. J. G. Sinclair, D. W. Lupton, A. B. Chaplin, J. F. Hooper, Org. Lett. 2018, 20, 5537–5540. 
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1H), 3.88 (s, 3H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 252.1 (100), 222.0 (21), 209.0 (24), 183.0 
(16), 152.0 (10), 139.0 (11). Analytical data in accordance to literature.265 
4-Fluoro-4'-phenoxy-1,1'-biphenyl (10d) 
Using potassium trifluoro(4-phenoxyphenyl)borate and a solution of (4-fluoro-
phenyl)magnesium bromide in THF according to general procedure P 
(0.35 mmol scale), provided 10d (0.24 mmol, 63 mg, 67%) as a colorless solid. 
Rf = 0.34 (hexane/EtOAc 98:2, UV, KMnO4, PAA). 1H NMR (400 MHz, CDCl3) δ 7.55 – 7.48 (m, 
4H), 7.40 – 7.33 (m, 2H), 7.16 – 7.10 (m, 3H), 7.10 – 7.04 (m, 4H) ppm. LRMS (DEP/EI-Orbitrap): 
m/z (%): 264.1 (100), 187.0 (10), 170.0 (17), 159.0 (18), 133.0 (16), 77.0 (13). Analytical data in ac-
cordance to literature.170c 
4'-Fluoro-3,4,5-trimethoxy-1,1'-biphenyl (10e) 
Using potassium trifluoro(3,4,5-trimethoxyphenyl)borate (SM22) and a solution 
of (4-fluorophenyl)magnesium bromide in THF according to general proce-
dure P (0.40 mmol scale), provided 10e (0.27 mmol, 70 mg, 67%) as a colorless 
solid. Rf = 0.25 (hexane/EtOAc 98:2, UV, KMnO4, PAA). 1H NMR (400 MHz, 
CDCl3) δ 7.54 – 7.47 (m, 2H), 7.15 – 7.08 (m, 2H), 6.72 (s, 2H), 3.92 (s, 6H), 3.89 (s, 3H) ppm. LRMS 
(DEP/EI-Orbitrap): m/z (%): 262.1 (93), 247.0 (82), 219.0 (36), 189.0 (36), 159.0 (30), 133.0 (100). 
Analytical data in accordance to literature.251 
5.6 Decagram Scale Reaction of 2a 
Figure 28 shows a pictorial guide toward the synthesis of product 2a on a decagram scale. First, a round 
bottom flask was charged with 75 mmol potassium trifluoro(4-methoxyphenyl)borate, 400 mL THF, a 
sufficiently powerful stirring bar and topped with a dropping funnel containing 237 mmol of freshly 
prepared 4-fluorophenyl magnesium bromide (approximately 1 M). The solution was cooled down to 0 
°C and the Grignard was added dropwise over 4 h (A). After warming to room temperature and stirring 
for additional two hours, a colorless solid was formed (B). The typical workup (see General Procedures) 
yielded crude TAB salt 1a (C), which was then dissolved in 650 mL ethanol and transferred into a 
1000 mL plastic beaker with respective RVC electrodes (7.0 x 8.0 x 0.5 cm). The reaction was electri-
fied using an Atlas 0931 Potentiostat in a simple two-electrode setup at 60 mA current until 3 F were 
reached (D). The solvent was then removed, and the crude mixture filtrated through a silica plug using 
hexanes/EtOAc (98:2) as eluent (E), which – after solvent evaporation – yielded pure compound 2a (F). 
After a simple wash with 1 M HCl, water and acetone, the RVC electrodes were easily recovered (G). 
  
 
265 V. Salamanca, A. Toledo, A. C. Albéniz, J. Am. Chem. Soc. 2018, 140, 6959–6963. 
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Figure 28: Pictorial guide toward the synthesis of product 2a on a decagram scale. 
5.7 Cyclic Voltammetry 
The oxidation potentials were determined in acetonitrile on a CH Instruments 630E electrochemical 
analyzer using a 2 mm diameter platinum working electrode, a platinum wire counter electrode and an 
Ag wire pseudo-reference electrode applying a scan rate of 0.1 V/s. Cyclic voltammetry measurements 
were performed in acetonitrile containing 0.1 M NBu4ClO4 with the TAB salts (1a−g) (c ≈ 3.4 × 10−4 M) 
and ferrocene (c = 3.8 × 10−4 M) as an internal standard. The E1/2(fc+/fc in MeCN) = +0.382 V was used 
to calibrate EpOx (in MeCN) vs. SCE. The results are summarized in Table 11 and Figure 29. 
  
A 
E F 
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Table 11:  Determined oxidation potentials of TAB salts 1a−g vs. SCE. 
TAB salt TAB structure EpOx vs. SCE / V 
1a 
 
0.84 
1b 
 
1.01 
1c 
 
0.90 
1d 
 
1.24 
1e 
 
0.94 
1f 
 
0.83 
1g 
 
0.62 
KB((p-F)phenyl)4 reference 
 
1.08 
 
 
Figure 29: Graphical summary of measured EpOx vs. SCE of TAB salts 1a–g. 
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5.8 Calculations266 
Calculations were performed at the equation-of-motion ionization potential coupled-cluster singles and 
doubles (EOM-IP-CCSD) level of theory and using density functional theory (DFT) with the ω B97X-
D3 functional. The 6-31G* basis set was used in all calculations if not indicated otherwise. (EOM-IP)-
CCSD calculations (Table 12) were performed for isolated molecules in gas phase, DFT calculations 
were performed in gas phase (Table 13) and additionally taking into account the solvent (acetonitrile) 
by means of the polarizable continuum (PCM) approach (Table 14 and Table 15).267 Non-equilibrium 
solvent effects upon ionization were either disregarded (Table 14) or taken into account by means of 
the state-specific approach (Table 15).268 Molecular structures of the TAB anions were optimized at the 
ω B97X-D3/6-31G*/PCM level of theory.269 Core electrons were frozen in all CCSD and EOM-IP-
CCSD calculations.270 All calculations were performed with the Q-Chem program package, release 
5.0.271 The energy differences shown in Table 12−Table 15 confirm most of the trends observed in 
experiment. For the three isomers 1a−c, all calculations agree with cyclic voltammetry measurements 
(see Section 5.7) that the species with the methoxy group in meta-position has the highest oxidation 
potential while that with the methoxy group in para-position has the lowest oxidation potential. All 
calculations also agree with experiment that molecule 1g is easier to oxidize than the three preceding 
species and that molecule 1d is harder to oxidize. However, experiment and theory disagree about the 
oxidation potential of molecules 1e and 1f. Notably, solvent effects make a sizable impact, especially 
on the oxidation potential of molecule 1e, but no theoretical approach reproduces the trends measured 
for these two species. To characterize the change in the electronic structure upon oxidation of the TAB 
anions, spin and charge densities (Table 16 and Table 17) were computed based on Mulliken population 
analysis.272 Since this approach is known to suffer from a heavy basis-set dependence, partial charges 
were additionally computed using the ChElPG (Charges from the electrostatic potential on a grid) ap-
proach (Table 18).273 These results illustrate that the single electron-rich aromatic ring is selectively 
oxidized in all cases while the charge and spin densities of the other aromatic rings change only insig-
nificantly. This fact is also visualized in Figure 30 by means of the spin density of molecule 1a. The 
sole exception is again molecule 1e, where all approaches agree on an unselective oxidation to which 
 
266 Calculations were performed by Dr. Thomas Jagau, Department of Chemistry, LMU Munich. 
267 J. Tomasi, B. Mennucci, R. Cammi, Chem. Rev. 2005, 105, 2999–3094. 
268 a) M. Cossi, V. Barone, J. Phys. Chem. A 2000, 104, 10614–10622. b) Z.-Q. You, J.-M. Mewes, A. Dreuw, J. 
M. Herbert, J. Chem. Phys. 2015, 143, 204104. 
269 a) J.-D. Chai, M. Head-Gordon, J. Chem. Phys. 2008, 128, 084106. b) J.-D. Chai, M. Head-Gordon, Phys. 
Chem. Chem. Phys. 2008, 10, 6615–6620. c) S. Grimme, J. Antony, S. Ehrlich, H. Krieg, J. Chem. Phys. 2010, 
132, 154104. 
270 I. Shavitt, R. J. Bartlett, Many Body Methods in Chemistry and Physics. MBPT and Coupled-Cluster Theory, 
Cambridge University Press, Cambridge, UK, 2009. 
271 Y. Shao, et al., Mol. Phys. 2015, 113, 184–215. 
272 F. Jensen, Introduction to Computational Chemistry, Wiley, New York, USA, 1994. 
273 a) C. M. Breneman, K. B. Wiberg, J. Comput. Chem. 1990, 11, 361–373. b) J. M. Herbert, L.D. Jacobson, K. 
U. Lao, M. A. Rohrdanz, Phys. Chem. Chem. Phys. 2012, 14, 7679–7699. 
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all four rings contribute equally. However, additional ω B97X-D3 calculations with the larger 6-
311G** basis set call this result into question: Here, Mulliken population analysis and the ChElPG 
approach agree that neither of the four aromatic rings connected to the boron atom is oxidized but 
instead the remote phenoxy unit. This points to the possibility that the oxidation of molecule 1e proceeds 
through a different mechanism than that of the other species and may also be related to the disagreement 
between theory and experiment about the oxidation potential of molecule 1e. Notably, results do not 
change significantly for all other molecules when going from 6-31G* to 6-311G**. 
Table 12: Total energies (in atomic units) of closed-shell TAB anions (1a−g) and the corresponding neutral rad-
icals computed at the CCSD/6-31G* and EOM-IP-CCSD/6-31G* levels of theory, respectively. Energy differ-
ences (in eV) are also shown. 
TAB salt Et(Anionic) (a.u.) Et(Radical) (a.u.) E (eV) 
KBPh4 reference -948.477575 -948.3275427 4.08 
1a -1359.736341 -1359.587152 4.06 
1b -1359.739393 -1359.580906 4.31 
1c -1359.734564 -1359.581572 4.16 
1d -2071.475102 -2071.305966 4.60 
1e -1550.895685 -1550.729427 4.52 
1f -1588.125960 -1587.970440 4.23 
1g -1176.874745 -1176.734463 3.82 
 
Table 13: Total energies (in atomic units) of closed-shell TAB anions (1a−g) and the corresponding neutral rad-
icals computed at the ω B97X-D3/6-31G* level of theory. Energy differences (in eV) are also shown. 
TAB salt Et(Anionic) (a.u.) Et(Radical) (a.u.) E (eV) 
KBPh4 reference -951.253221 -951.094822 4.31 
1a -1363.38385 -1363.227497 4.26 
1b -1363.38719 -1363.221982 4.50 
1c -1363.38271 -1363.222669 4.36 
1d -2076.64802 -2076.472911 4.77 
1e -1555.07616 -1554.903011 4.71 
1f -1592.35686 -1592.195301 4.40 
1g -1180.23428 -1180.083084 4.11 
 
Table 14: Total energies (in atomic units) of closed-shell TAB anions (1a−g) and the corresponding neutral rad-
icals computed at the ω B97X-D3/6-31G*/PCM level of theory. The solvent reaction field is equilibrated in all 
calculations. Energy differences (in eV) are also shown. 
TAB salt Et(Anionic) (a.u.) Et(Radical) (a.u.) E (eV) 
KBPh4 reference -951.325714 -951.104965 6.01 
1a -1363.451318 -1363.252960 5.40 
1b -1363.453315 -1363.248214 5.58 
1c -1363.451734 -1363.250999 5.46 
1d -2076.708309 -2076.501594 5.63 
1e -1555.141062 -1554.916474 6.11 
1f -1592.427566 -1592.223624 5.55 
1g -1180.311780 -1180.114435 5.37 
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Table 15: Total energies (in atomic units) of closed-shell TAB anions (1a−g) and the corresponding neutral rad-
icals computed at the ω B97X-D3/6-31G*/PCM level of theory. The state-specific approach is used to describe 
non-equilibrium solvent effects upon ionization. Energy differences (in eV) are also shown. 
TAB salt Et(Anionic) (a.u.) Et(Radical) (a.u.) E (eV) 
KBPh4 reference -951.325714 -951.075570 6.81 
1a -1363.451318 -1363.218253 6.34 
1b -1363.453315 -1363.211345 6.58 
1c -1363.451734 -1363.215351 6.43 
1d -2076.708309 -2076.465110 6.62 
1e -1555.141062 -1554.890363 6.82 
1f -1592.427566 -1592.189655 6.47 
1g -1180.311780 -1180.079829 6.31 
 
Table 16: Spin densities of neutral TAB radicals computed from Mulliken population analysis at the ω B97X-
D3/6-31G*/PCM level of theory. The values represent the sums of the spin densities associated with the carbon 
atoms of the four aromatic rings. 
TAB salt Spin density e-poor Ar1 Spin density e-rich Ar2 
KBPh4 reference 0.27/0.24/0.24/0.26 - 
1a 0.01/0.03/0.05 0.78 
1b 0.00/0.01/0.02 0.82 
1c 0.00/0.02/0.02 0.78 
1d 0.00/0.01/0.01 0.82 
1e 0.21/0.25/0.29 0.25 
1f 0.01/0.01/0.03 0.79 
1g 0.01/0.04 0.05/0.79 
 
Table 17: Differences in charge density between TAB anions and neutral radicals computed from Mulliken pop-
ulation analysis at the ω B97X-D3/6-31G*/PCM level of theory. The values represent the sums of the charge 
density differences associated with the carbon atoms of the four aromatic rings. 
TAB salt Charge density e-poor Ar1 Charge density e-rich Ar2 
KBPh4 reference 0.09/0.09/0.09/0.10 - 
1a 0.01/0.02/0.02 0.33 
1b 0.00/0.01/0.02 0.35 
1c 0.01/0.01/0.02 0.34 
1d 0.00/0.01/0.01 0.35 
1e 0.09/0.10/0.12 0.11 
1f 0.00/0.01/0.03 0.38 
1g 0.01/0.01 0.03/0.33 
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Table 18: Differences in charge density between TAB anions and neutral radicals computed from charges from 
the electrostatic potential on a grid (ChElPG) at the ω B97X-D3/6-31G*/PCM level of theory. The values repre-
sent the sums of the charge density differences associated with the carbon atoms of the four aromatic rings. 
TAB salt Charge density e-poor Ar1 Charge density e-rich Ar2 
KBPh4 reference -0.21, -0.20, -0.20, -0.19 - 
1a -0.03, -0.04, -0.06 -0.60 
1b -0.02, -0.02, -0.03 -0.63 
1c -0.03, -0.03, -0.04 -0.61 
1d -0.02, -0.03, -0.03 -0.63 
1e -0.19, -0.21, -0.20 -0.17 
1f -0.02, -0.03, -0.04 -0.59 
1g -0.03, -0.03 -0.04, -0.60 
 
 
Figure 30: Spin density for the neutral TAB radical (from 1a) computed at the ω B97X-D3/6-31G*/PCM level 
of theory and plotted at an isovalue of 0.015. 
5.9 Single X-Ray Diffraction 
Supporting Information available: Crystallographic data have been deposited with the Cambridge 
Crystallographic Data Centre: CCDC-1954369 for 1g, CCDC-1964338 for 1h. Copies of the data can 
be obtained free of charge: https://www.ccdc.cam.ac.uk/structures/. 
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Table 19: Crystallographic data for compound 1g.274 
 
Compound 1g 
net formula C26H24BKO2 absorption correction Multi-Scan 
Mr/g mol−1 418.36 transmission factor range 0.93–0.99 
crystal size/mm 0.100 × 0.040 × 0.040 refls. measured 19433 
T/K 109.(2) Rint 0.0359 
radiation MoKα mean σ(I)/I 0.0321 
diffractometer 'Bruker D8 Venture TXS' θ range 2.649–27.101 
crystal system monoclinic observed refls. 4348 
space group 'P 1 21 1' x, y (weighting scheme) 0.0300, 0.3433 
a/Å 7.8292(3) hydrogen refinement constr 
b/Å 11.0341(4) Flack parameter 0.21(4) 
c/Å 12.7149(6) refls in refinement 4734 
α/° 90 parameters 274 
β/° 100.8430(10) restraints 6 
γ/° 90 R(Fobs) 0.0312 
V/Å3 1078.81(8) Rw(F2) 0.0746 
Z 2 S 1.040 
calc. density/g cm−3 1.288 shift/errormax 0.001 
μ/mm−1 0.266 max electron density/e Å−3 0.273 
net formula C26H24BKO2 min electron density/e Å−3 −0.189 
 
274 Refined as inversion twin, BASF 0.21. 
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Table 20: Crystallographic data for compound 1h.275 
 
Compound 1h 
net formula C26H21.56BF3KO1.28 absorption correction Multi-Scan 
Mr/g mol−1 461.42 transmission factor range 0.96–0.99 
crystal size/mm 0.070 × 0.050 × 0.030 refls. measured 19826 
T/K 102.(2) Rint 0.0309 
radiation MoKα mean σ(I)/I 0.0293 
diffractometer 'Bruker D8 Venture TXS' θ range 2.887–27.101 
crystal system triclinic observed refls. 4217 
space group 'P -1' x, y (weighting scheme) 0.0605, 1.4236 
a/Å 9.8924(4) hydrogen refinement mixed 
b/Å 10.0377(4) refls in refinement 4955 
c/Å 11.5787(4) parameters 302 
α/° 82.5670(10) restraints 0 
β/° 81.2960(10) R(Fobs) 0.0566 
γ/° 88.2120(10) Rw(F2) 0.1499 
V/Å3 1126.86(7) S 1.054 
Z 2 shift/errormax 0.001 
calc. density/g cm−3 1.360 max electron density/e Å−3 1.214 
μ/mm−1 0.278 min electron density/e Å−3 −1.115 
 
  
 
275 H(C) constr, H(O1) refall, H(O2) not considered in refinement The sof of O2 has been refined freely and results 
in a value of 0.28. The hydrogen atoms bound to this O could not be located and have not been considered in the 
refinement. This water-O-atom is not depicted in the table above. 
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5.10 Unsuccessful Transformations and Limitations 
 
Scheme 45: Substitution effects on heterocoupling selectivity. 
As seen in Scheme 45, the yields generally increase from o- to m- to p-substitution on the more electron-
rich aromatic, presumably due to steric interactions. This trend is inversed when substituting the more 
electron-poor aromatics, as o-substituted systems give the best yield. In addition, best heterocoupling 
selectivity is obtained for TABs with great difference in electronic structure (Scheme 46), meaning that 
aromatics with donating groups (EDG, highlighted blue) are most selectively coupled with aromatics 
with electron-withdrawing groups (EWG, highlighted green).  
Couplings with unsubstituted heteroaromatics such as pyrroles, thiophenes and furans are challenging, 
mainly due to polymerization side reactions. Lastly, pyridyl patterns as electron-poor coupling partners 
were not tolerated, as TAB salt formation was never observed with pyridyl organometallics. This was 
attributed to preferred coordination of the pyridine moiety to the potassium aryl trifluoroborate salt, 
which results in the inhibition of its reactivity. 
 
Scheme 46: Electronic effects on heterocoupling selectivity. 
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5.11 Representative NMR Spectra 
 
Figure 31: 1H NMR (400 MHz, CDCl3) and 13C NMR (101 MHz, CDCl3) for 3-Bromo-6-(3,5-difluorophenyl)-
9-phenyl-9H-carbazole (4e). 
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6 Electro-Olefination – a Catalyst Free Stereoconvergent Strategy for the 
Functionalization of Alkenes276 
6.1 General Procedures  
For the synthesis of aryl Grignard and arylzinc reagents, see chapter 5.1.1 and 5.1.2 of the experimental 
part.  
6.1.1 General Procedure R: Preparation of Potassium Alkenyl Trifluoroborate Salts  
 
Adapted from a previously reported procedure,238 5.0 mmol (1.0 equiv) of commercially available 
alkenyl boronic pinacol esters and boronic acids were dissolved in 15 mL of a 4:1 (v/v) mixture of 
MeOH and H2O. The mixture was cooled to 0 °C and KHF2 (20 mmol, 4.0 equiv) was added neat. The 
mixture was vigorously stirred at room temperature overnight and then concentrated under reduced 
pressure. The remaining solids were extracted with boiling acetone (2 × 50 mL) and twice with acetone 
at room temperature (2 × 50 mL). The acetone was removed under reduced pressure, the remaining 
solid was dissolved in a minimum amount of boiling acetone and precipitated by the addition of diethyl 
ether. The colorless solids were filtered, washed with diethyl ether and dried in vacuo to yield potassium 
alkenyl trifluoroborate salts SM28 and SM36–47. (Note: Literature known potassium alkenyl tri-
fluoroborate salts were synthesized according to the same procedure and used without further purifica-
tion, see Figure 32). 
 
Figure 32: Literature known trifluoroborate salts. Analytical data in accordance to literature for SM36277,  
SM37278, SM38279, SM39280, SM28243, SM40277. 
 
276 The full supporting information can be found under the following link: 
https://doi.org/10.1002/chem.202001394. This project was conducted in equal contribution with A. N. Baumann. 
277 M. Presset, D. Oehlrich, F. Rombouts, G. A. Molander, J. Org. Chem. 2013, 78, 12837–12843. 
278 B. Gopula, C.-W. Chiang, W.-Z. Lee, T.-S. Kuo, P.-Y. Wu, J. P. Henschke, H.-L. Wu, Org. Lett. 2014, 16, 
632–635. 
279 J. J. Molloy, J. B. Metternich, C. G. Daniliuc, A. J. B. Watson, R. Gilmour, Angew. Chem. Int. Ed. 2018, 57, 
3168–3172. 
280 C. Feng, H. Wang, L. Xu, P. Li, Org. Biomol. Chem. 2015, 13, 7136–7139. 
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6.1.2 General Procedure S: Two-pot Procedure for the Synthesis of Functionalized Alkenes start-
ing from Potassium Alkenyl Trifluoroborate Salts 
 
A 25 mL Schlenk flask was charged with the corresponding potassium trifluoroborate salt (0.4 mmol, 
1.0 equiv) and 2 mL of THF were added. The mixture was cooled to 0 °C and a solution of the aryl 
Grignard reagent A in THF (1.16 mmol, 2.9 equiv) was added dropwise over 30 min via syringe pump. 
After addition, the reaction mixture was allowed to stir for further 10 min at 0 °C and was then quenched 
with 5 mL of H2O and extracted with EtOAc (3 × 40 mL). If no phase separation was observed, 5 mL 
of sat. aq. K2CO3 solution was added. The combined organic phases were filtered and concentrated 
under reduced pressure (no higher temperature than 40 °C). The crude tetraorganoborate was then dis-
solved in 8 mL of HPLC-grade MeCN and transferred into a 10 mL IKA glass vial. The reaction was 
started using the IKA ElectraSyn 2.0 with GCE (glassy carbon electrodes) as working and counter elec-
trodes (5 mA, 2.0 F, 1.3 mA/cm2, 700 rpm stirring). The crude mixture was then treated with water and 
extracted with diethyl ether (3 × 15 mL). The combined organic phases were dried over MgSO4, filtered, 
concentrated under reduced pressure and purified by flash-column chromatography on silica gel with 
the appropriate solvent mixture to obtain pure 3a–b, 3d–k, 3m–s/4a–r/5a–c. 
a) Adaptation for the use of arylzinc reagents 
After addition of a solution of the arylzinc species in THF (instead of the aryl Grignard reagent as 
described above) via syringe pump, the reaction was heated to 40 °C for 16 hours to ensure full conver-
sion of the potassium trifluoroborate salt into the desired ATB salt. General Procedure S was then fol-
lowed to give products 3c and 3l. 
6.1.3 General Procedure T: Procedure for the Isolation of Functionalized ATB Salts starting from 
Potassium Alkenyl Trifluoroborate Salts 
 
A 50 mL Schlenk flask was charged with (E)-trifluoro(styryl)borate (3.0 mmol, 1.0 equiv) and 9 mL of 
THF were added. The mixture was cooled to 0 °C and the corresponding solution of the aryl Grignard 
reagent A in THF (9.0 mmol, 3.0 equiv) was added dropwise over 30 min via syringe pump. After 
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addition, the reaction mixture was allowed to stir for further 10 min at 0 °C and was then quenched with 
5 mL of H2O and extracted with EtOAc (3 × 40 mL). If no phase separation was observed, 5 mL of sat. 
aq. K2CO3 solution was added. The combined organic phases were filtered and concentrated under re-
duced pressure (no higher temperature than 40 °C). The resulting oil was then layered with hexane (20 
mL) and sonicated at 0 °C for 10 min. The hexane was decanted, and the process repeated two more 
times, until a colorless solid was obtained. (Note: ATB salts are highly soluble in EtOAc and therefore 
solidification can be challenging.) The solids were then again sonicated in hexane, the fine white pow-
der was then filtered and washed with hexanes (2 × 10 mL) and dried in vacuo to yield ATB salts 2a–
b. 
6.2 Formation of ATB salt 2a by 11B NMR 
 
Figure 33: 11B NMR analysis of the TAB salt formation to yield 2a. 
As depicted in Figure 33, a smooth transformation of the starting (E)-trifluoro(styryl)borate into the 
desired ATB salt 2a was observed in the crude 11B NMR, which was measured as a 1:1 THF:CD3CN 
mixture following general procedure T. 
6.3 Optimizations 
Conversion rates into (E)-1-fluoro-4-styrylbenzene (3a) were assessed by hydrolysis and GC analysis 
with n-undecane as an internal standard. As seen in Table 21, the oxidation process can be performed 
with different carbon electrode setups, resulting in good conversion and selectivity ratios. In addition, 
the oxidation process can also be performed in environmentally friendly solvents such as ethanol with 
only marginal conversion loss. 
  
Following General Procedure T  
at 0 °C after 30 min 
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Table 21: Screening of different electrode materials, solvents and conditions. 
 
Anode || Cathode Solvent Conditions 
T 
(°C) 
conv. (%) 3a:3ab:3ac 
Graphite || Graphite MeCN Open to air no Electrolyte 25 77:5:2 
RVC || RVC MeCN Open to air no Electrolyte 25 80:10:3 
GCE || GCE MeCN Open to air no Electrolyte 25 82:5:5 (isolated 75%) 
GCE || GCE MeCN N2-atmosphere no Electrolyte 25 65:2:3 
GCE || GCE MeCN O2-atmosphere no Electrolyte 25 30:37:4 
GCE || GCE MeCN Open to air with LiClO4 [0.1 M] 25 75:4:3 
GCE || GCE EtOH Open to air no Electrolyte 25 78:5:5 
RVC || RVC EtOH Open to air no Electrolyte 25 73:9:1 
 
6.4 Experimental Data 
6.4.1 Synthesis of Potassium Alkenyl Trifluoroborates 
Potassium (Z)-trifluoro(2-(6-methoxynaphthalen-2-yl)vinyl)borate (SM41) 
Using (Z)-2-(2-(6-methoxynaphthalen-2-yl)vinyl)-4,4,5,5-tetramethyl-1,3,2-dioxabo-
rolane according to general procedure R, provided SM41 (4.09 mmol, 1.186 g, 48%) 
as brownish solid. 1H NMR (400 MHz, CD3CN) δ 7.97 (dd, J = 8.6, 1.7 Hz, 1H), 7.81 
(s, 1H), 7.66 (dd, J = 18.2, 8.8 Hz, 2H), 7.19 (d, J = 2.6 Hz, 1H), 7.07 (dd, J = 8.9, 
2.6 Hz, 1H), 6.73 (d, J = 15.0 Hz, 1H), 5.70 (dq, J = 15.2, 6.6 Hz, 1H), 3.88 (s, 3H) ppm. 
13C NMR (101 MHz, CD3CN) δ 158.1, 137.9, 136.7, 134.2, 130.2, 129.8, 128.8, 127.7, 126.5, 119.0, 
106.6, 55.9 ppm. The signal for the carbon atom adjacent to the boron center was not observed. 11B 
NMR (128 MHz, CD3CN) δ 2.43 (q, J = 54.7 Hz) ppm. HRMS (ESI-Quadrupole): m/z calcd for 
C13H11OBF3KNa+ [M+Na]+: 313.0390; found: 313.0385. IR (Diamond-ATR, neat)  𝜈𝑚𝑎𝑥 (cm
-1): 1686 
(m), 1680 (m), 1623 (m), 1605 (m), 1482 (m), 1390 (m), 1292 (w), 1268 (m), 1258 (m), 1210 (m), 1196 
(m), 1186 (m), 1164 (s), 1118 (m), 1108 (m), 1090 (s), 1084 (s), 1067 (s), 1060 (s), 1050 (s), 1030 (vs), 
990 (s), 982 (s), 966 (s), 958 (s), 950 (s), 934 (s), 881 (m), 860 (s), 854 (s), 834 (m), 804 (s), 780 (m), 
768 (m), 758 (m). Mp (°C) = 160–182 (decomposition). 
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Potassium cyclopent-1-en-1-yltrifluoroborate (SM42) 
Using 2-(cyclopent-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane according to general 
procedure R, provided SM42 (3.76 mmol, 658 mg, 84%) as colorless solid. 1H NMR 
(400 MHz, CD3CN) δ 5.48 (s, 1H), 2.25 – 2.19 (m, 2H), 1.94 (quint, J = 2.5 Hz, 2H), 1.69 
(quint, J = 7.5 Hz, 2H) ppm. 13C NMR (101 MHz, CD3CN) δ 128.8, 36.2, 34.5, 24.8 ppm. The signal 
for the carbon atom adjacent to the boron center was not observed. 11B NMR (128 MHz, CD3CN) δ 
2.71 (q, J = 57.1 Hz) ppm. HRMS (ESI-Quadrupole): m/z calcd for C5H7BF3- [M-K]-: 135.0593; found: 
135.0597. IR (Diamond-ATR, neat)  𝜈𝑚𝑎𝑥 (cm
-1): 2948 (w), 2843 (w), 1620 (w), 1291 (w), 1224 (w), 
1152 (m), 1038 (m), 1021 (m), 980 (m), 949 (s), 916 (vs), 885 (s), 840 (m), 806 (m). Mp (°C) = 200–
210 (decomposition). 
Potassium (3,6-dihydro-2H-pyran-4-yl)trifluoroborate (SM43) 
Using 2-(3,6-dihydro-2H-pyran-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane according to 
general procedure R, provided SM43 (6.84 mmol, 1.30 g, 68%) as colorless solid. 1H NMR 
(400 MHz, CD3CN) δ 5.55 (s, 1H), 3.96 (qd, J = 2.6, 1.3 Hz, 2H), 3.61 (t, J = 5.5 Hz, 2H), 2.00 
(dq, J = 5.6, 2.8 Hz, 2H) ppm. 13C NMR (101 MHz, CD3CN) δ 123.8, 66.6, 65.7, 27.8 ppm. The signal 
for the carbon atom adjacent to the boron center was not observed. 11B NMR (128 MHz, CD3CN) δ 
2.49 (q, J = 56.0 Hz) ppm. HRMS (ESI-Quadrupole): m/z calcd for C5H7OBF3- [M-K]-: 151.0542; 
found: 151.0547. IR (Diamond-ATR, neat)  𝜈𝑚𝑎𝑥 (cm
-1): 1239 (m), 1211 (m), 1176 (s), 1114 (m), 1066 
(m), 1035 (s), 1005 (s), 989 (s), 965 (s), 939 (vs), 919 (vs), 841 (s), 813 (m), 760 (m). Mp (°C) = 190–
192. 
Potassium (3,6-dihydro-2H-thiopyran-4-yl)trifluoroborate (SM44) 
Using 2-(3,6-dihydro-2H-thiopyran-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane according 
to general procedure R, provided SM44 (3.49 mmol, 718 mg, 84%) as colorless solid. 1H 
NMR (400 MHz, CD3CN) δ 5.79 (s, 1H), 3.06 – 2.97 (m, 2H), 2.60 (t, J = 5.8 Hz, 2H), 2.22 – 
2.17 (m, 2H) ppm. 13C NMR (101 MHz, CD3CN) δ 120.7, 27.3, 26.1, 25.9 ppm. The signal for the 
carbon atom adjacent to the boron center was not observed. 11B NMR (128 MHz, CD3CN) n. d. HRMS 
(ESI-Quadrupole): m/z calcd for C5H7SBF3- [M-K]-: 167.0314; found: 167.0318. IR (Diamond-ATR, 
neat)  𝜈𝑚𝑎𝑥 (cm
-1): n.d. 
Potassium trifluoro(1,4-dioxaspiro[4.5]dec-7-en-8-yl)borate (SM45) 
Using 4,4,5,5-tetramethyl-2-(1,4-dioxaspiro[4.5]dec-7-en-8-yl)-1,3,2-dioxaborolane accord-
ing to general procedure R, provided SM45 (3.43 mmol, 843 mg, 59%) as colorless solid. 1H 
NMR (400 MHz, CD3CN) δ 5.47 (s, 1H), 3.88 (s, 4H), 2.14 – 2.07 (m, 4H), 1.58 (t, J = 6.4 Hz, 
2H) ppm. 13C NMR (101 MHz, CD3CN) δ 121.9, 109.6, 64.6, 37.0, 32.2, 27.1 ppm. The signal 
for the carbon atom adjacent to the boron center was not observed. 11B NMR (128 MHz, CD3CN) δ 
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2.61 (q, J = 56.4 Hz) ppm. HRMS (ESI-Quadrupole): m/z calcd for C8H11O2BF3- [M-K]-: 207.0804; 
found: 207.0809. IR (Diamond-ATR, neat)  𝜈𝑚𝑎𝑥 (cm
-1): 1693 (w), 1209 (w), 1201 (w), 1170 (w), 1150 
(m), 1128 (m), 1108 (m), 1058 (m), 1048 (m), 1010 (s), 941 (vs), 894 (s), 857 (m), 816 (w), 812 (w), 
789 (m). Mp (°C) = 185–188.  
6.4.2 Experimental Procedures for the Synthesis of SM46 
 
3-TBS-5-DHEA was prepared according to Pérez et al.281 To a suspension of 5-dehydroepiandrosterone 
(15.0 mmol, 4.33 g) in DCM (50 mL) was added imidazole (72.0 mmol, 4.90 g). When a clear solution 
had formed, TBSCl (21.0 mmol, 3.16 g, 1.4 equiv) was added. The mixture was stirred at room tem-
perature for 2 h and then concentrated in vacuo. The crude product was dissolved in DCM (50 mL) and 
washed with 1 M HCl (2 × 50 mL) and water (2 × 50 mL). The organic phase was dried over MgSO4 
and evaporated in vacuo. The colorless solid was dried under high vacuum at 60 °C to obtain the pure 
product in 90% yield (13.5 mmol, 5.4 g), which was used without further purification for the following 
step. 
 
3-TBS-5-DHEA triflate was prepared according to procedures from Lopez et al.282 A solution of LDA 
was freshly prepared by dropwise addition of a solution of n-BuLi in hexanes (11.5 mmol, 4.64 mL, 
2.47 M, 2.3 equiv) to a solution of DIPA (12.5 mmol, 1.26 g, 1.75 mL, 2.5 equiv) in THF at –78 °C. To 
this solution, a suspension of 3-TBS-5-DHEA (5.00 mmol, 2.01 g) in THF (25 mL) was added dropwise 
at –78 °C. After stirring for 1 h, a solution of PyN(Tf)2 (9.00 mmol, 3.22 g, 1.8 equiv) in THF (12.5 mL) 
was added dropwise at –78 °C. The reaction mixture was stirred at room temperature overnight and 
then filtered over silica gel and washed with DCM (2 × 50 mL). The filtrate was concentrated in vacuo. 
The resulting colorless solid was purified via flash-column chromatography (hexanes/EtOAc 98:2) to 
give the product in 80% yield (4.0 mmol, 2.13 g), which was directly engaged in the next step. 
 
281 A. Pérez Encabo, J. A. Turiel Hernandez, F. J. Gallo Nieto, A. Lorente Bonde-Larsen, C. M. Sandoval 
Rodríguez, C07J 41/00, 2013. 
282 B. López-Pérez, M. A. Maestro, A. Mourino, Chem. Commun. 2017, 53, 8144–8147. 
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3-TBS-5-DHEA alkenylboronic acid pinacol ester was prepared according to procedures from Tagaki et 
al.283 A dried flask was charged with 3-TBS-5-DHEA alkenyl triflate (1.24 mmol, 661 mg), 
PdCl2(PPh3)2 (0.037 mmol, 26 mg, 3 mol%), PPh3 (0.074 mmol, 19 mg, 6 mol%), B2pin2 (1.36 mmol, 
345 mg, 1.1 equiv) and toluene (7.5 mL). After adding KOAc (1.85 mmol, 182 mg, 1.5 equiv), the flask 
was flushed with nitrogen, sealed and stirred at 50 °C for 24 h. The mixture was filtered over MgSO4, 
washed with THF (20 mL) and concentrated in vacuo. The resulting colorless solid was purified via 
flash-column chromatography (hexanes/EtOAc 95:5) to give the product in SM46-Bpin 86% yield 
(1.0 mmol, 512 mg). Rf = 0.60 (hexane/EtOAc 95:5, UV, KMnO4). 1H NMR (400 MHz, CDCl3) δ 6.50 
(dd, J = 3.1, 1.6 Hz, 1H), 5.35 – 5.31 (m, 1H), 3.48 (tt, J = 10.9, 4.7 Hz, 1H), 2.34 – 2.22 (m, 1H), 2.22 
– 2.05 (m, 3H), 2.05 – 1.89 (m, 2H), 1.81 (dt, J = 13.4, 3.6 Hz, 1H), 1.76 – 1.45 (m, 8H), 1.41 – 1.27 
(m, 3H), 1.25 (s, 12H), 1.03 (s, 3H), 0.89 (s, 9H), 0.06 (s, 6H) ppm. 13C NMR (101 MHz, CDCl3) δ 
146.1, 142.1, 121.2, 82.8, 72.8, 57.0, 53.6, 51.0, 47.8, 43.0, 37.5, 37.0, 35.9, 33.8, 32.2, 30.8, 26.1, 25.0, 
24.9, 21.0, 19.5, 18.5, 16.8, −4.5 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 455.3 (100) [M-t-Bu]+. 
Potassium ((3S,9S,10R,13S,14S)-3-((tert-butyldimethylsilyl)oxy)-10,13-dimethyl-
2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)trifluorobo-
rate (SM46) 
Using tert-butyl(((3S,9S,10R,13S,14S)-10,13-dimethyl-17-(4,4,5,5-tetra-
methyl-1,3,2-dioxaborolan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahy-
dro-1H-cyclopenta[a]phenanthren-3-yl)oxy)dimethylsilane according to 
general procedure R, provided SM46 (0.5 mmol, 246 mg, 50%) as colorless 
solid. Due to high insolubility in many different deuterated solvents like CDCl3, DMSO-d6, (CD3)2CO, 
C6D6, and CD3CN, NMR spectral analysis was not enough to determine the exact proton shifts and 
couplings. 11B NMR (128 MHz, CD3CN) δ 2.09 (br, s) ppm. HRMS (ESI-Quadrupole): m/z calcd for 
C25H41BF3OSi- [M-K]-: 453.2977; found: 453.2981. IR (Diamond-ATR, neat)  𝜈𝑚𝑎𝑥 (cm
-1): 2970 (w), 
2960 (w), 2949 (w), 2930 (m), 2897 (w), 2857 (w), 2828 (w), 1608 (w), 1584 (w), 1470 (w), 1459 (w), 
1437 (w), 1381 (w), 1368 (w), 1270 (w), 1250 (w), 1206 (w), 1195 (w), 1165 (w), 1146 (w), 1133 (w), 
1087 (s), 1044 (w), 1004 (m), 993 (m), 982 (m), 952 (s), 945 (s), 930 (s), 919 (s), 908 (m), 887 (m), 
874 (m), 863 (s), 838 (vs), 820 (m), 803 (m), 776 (s), 738 (m), 715 (w), 689 (w), 674 (w).Mp (°C) >300. 
 
283 J. Takagi, K. Takahashi, T. Ishiyama, N. Miyaura, J. Am. Chem. Soc. 2002, 124, 8001–8006. 
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6.4.3 Synthesis of Potassium difluorobis(4-fluorophenyl) borate (SM47) 
Adapted from a previously reported procedure,244 15.0 mL of (4-fluoro-
phenyl)magnesium bromide (0.7 M, 10.5 mmol, 2.1 equiv) were cooled to 0 °C. 
Triisopropyl borate (5.0 mmol, 1.0 equiv, 1.15 mL) was slowly added via syringe 
pump over 30 min. The mixture was allowed to reach room temperature and stirred overnight. The 
slurry was then quenched with 2 mL of 2 M HCl and extracted with EtOAc (3 × 30 mL). The organic 
phases were combined, dried over MgSO4 and concentrated in vacuo. After column chromatography in 
DCM (Rf = 0.60) the corresponding borinic acid was isolated as an orange oil. The crude product was 
then directly redissolved in MeOH (20 mL) and KHF2 (15.0 mmol, 1.17 g) was added in one portion at 
0 °C. The reaction was stirred at room temperature overnight and the solvent removed afterwards. The 
solids were extracted with boiling acetone (4 x 20 mL) and the combined organic phases were dried in 
vacuo. The colorless solid was then filtered off and washed with diethyl ether (3 × 20 mL) to yield the 
desired product SM47 (3.12 mmol, 867 mg, 62%). 1H NMR (400 MHz, CD3CN) δ 7.44 – 7.34 (m, 
2H), 6.90 – 6.81 (m, 2H) ppm. 13C NMR (101 MHz, CD3CN) δ 162.2 (d, J = 237.8 Hz), 133.8 (dt, J = 
6.9, 3.6 Hz), 113.7 (d, J = 18.6 Hz) ppm. The signals for the carbon atoms adjacent to the boron center 
were not observed. 11B NMR (128 MHz, CD3CN) δ 6.84 (t, J = 71.4 Hz) ppm. HRMS (ESI-Quadru-
pole): m/z calcd for C12H8BF4- [M-K]-: 239.0655; found: 239.0660. IR (Diamond-ATR, neat)  𝜈𝑚𝑎𝑥 
(cm-1): 1594 (m), 1499 (w), 1389 (vw), 1301 (w), 1270 (w), 1228 (m), 1207 (m), 1193 (m), 1166 (m), 
1158 (m), 1152 (m), 1090 (w), 1018 (w), 961 (w), 929 (m), 911 (m), 894 (s), 872 (m), 832 (s), 822 (vs), 
800 (m), 715 (w). Mp (°C) = 193–196. 
6.4.4 Characterization of ATB Salts 
(E)-Tris(4-fluorophenyl)(styryl)borate (2a) 
Using potassium (E)-trifluoro(styryl)borate and a solution of (4-fluoro-
phenyl)magnesium bromide in THF according to general procedure T, provided 
2a (2.61 mmol, 1.14 g, 87%) as colorless solid. 1H NMR (400 MHz, (CD3)2CO) 
δ 7.59 (d, J = 17.8 Hz, 1H), 7.34 – 7.28 (m, 2H), 7.24 – 7.13 (m, 8H), 7.01 – 6.92 (m, 1H), 6.76 – 6.68 
(m, 6H), 6.13 (ddd, J = 17.8, 6.9, 3.3 Hz, 1H)  ppm. 13C NMR (101 MHz, (CD3)2CO) δ 160.9 (d, J = 
236.1 Hz), 160.1 (d, J = 3.4 Hz), 159.6 (d, J = 3.4 Hz), 159.1 (d, J = 4.0 Hz), 158.6 (d, J = 4.3 Hz), 
158.0, 157.5, 143.7 (dd, J = 8.6, 4.3 Hz), 137.0 (ddd, J = 5.5, 3.5, 1.6 Hz), 131.6, 128.7, 126.0, 125.0, 
112.5 (ddd, J = 17.7, 6.1, 2.9 Hz) ppm. The signals for the carbon atoms adjacent to the boron center 
were not observed. 11B NMR (128 MHz, CD3CN) δ -9.49 ppm. HRMS (ESI-Quadrupole): m/z calcd 
for C26H19BF3- [M-K]-: 399.1532; found: 399.1538. IR (Diamond-ATR, neat)  𝜈𝑚𝑎𝑥 (cm
-1): 1579 (m), 
1487 (s), 1218 (s), 1157 (s), 1086 (w), 1012 (m), 966 (w), 827 (s), 817 (vs), 782 (w), 744 (m), 722 (m), 
696 (m). Mp (°C) = 279–282 (decomposition). 
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 (E)-Tris(phenyl)(styryl)borate (2b) 
Using potassium (E)-trifluoro(styryl)borate and a solution of phenylmagnesium 
bromide in THF according to general procedure T, provided 2b (2.47 mmol, 
949 mg, 82%) as colorless powder. 1H NMR (400 MHz, (CD3)2CO) δ 7.71 (d, J = 
17.8 Hz, 1H), 7.34 – 7.27 (m, 8H), 7.18 – 7.11 (m, 2H), 6.99 – 6.92 (m, 7H), 6.83 – 6.77 (m, 3H), 6.20 
(ddd, J = 17.8, 6.7, 3.3 Hz, 1H)  ppm. 13C NMR (101 MHz, (CD3)2CO) δ 165.5, 165.0, 164.5, 164.1, 
160.4, 159.9, 159.4, 158.9, 144.2 (dd, J = 8.5, 4.1 Hz), 136.4 (dd, J = 2.9, 1.4 Hz), 131.2, 128.7, 126.2 
(dd, J = 5.6, 2.7 Hz), 125.9, 124.6, 122.4 ppm. The signals for the carbon atoms adjacent to the boron 
center were not observed. 11B NMR (128 MHz, CD3CN) δ -8.75 ppm. HRMS (ESI-Quadrupole): m/z 
calcd for C26H22B- [M-K]-: 345.1815; found: 345.1824. IR (Diamond-ATR, neat)  𝜈𝑚𝑎𝑥 (cm
-1): 1742 
(w), 1596 (w), 1578 (w), 1493 (w), 1477 (w), 1444 (w), 1428 (w), 1261 (w), 1236 (w), 1185 (w), 1152 
(w), 1070 (w), 1030 (w), 1011 (w), 1006 (w), 958 (w), 912 (w), 874 (w), 818 (w), 768 (m), 756 (m), 
739 (s), 723 (m), 712 (vs), 696 (s). Mp (°C) >300. 
6.4.5 Characterization of Olefinated (Hetero)Arenes 
(E)-1-Fluoro-4-styrylbenzene (3a/3m) 
Using potassium (E)-trifluoro(styryl)borate and a solution of (4-fluorophenyl)magnesium 
bromide in THF according to general procedure S, provided 3a (0.27 mmol, 54 mg, 68%, E/Z 
= 99:1) as colorless solid. Using potassium (Z)-trifluoro(styryl)borate (SM28) and a solution 
of (4-fluorophenyl)magnesium bromide in THF according to general procedure S, provided 
3m (0.22 mmol, 44 mg, 55%, E/Z = 98:2) as a colorless solid. Using the purified tetraor-
ganoborate 2a under the optimized conditions for the electrochemical transformation, 3a 
(0.30 mmol, 59 mg, 75%, E/Z = 99:1) was provided as a colorless solid. Zweifel Olefination: A 25 mL 
Schlenk flask was charged with the (Z)-trifluoro(styryl)borate (SM28) (0.2 mmol, 1.0 equiv, 42 mg) 
and 1 mL of THF was added. The mixture was cooled to 0 °C and a solution of (4-fluorophenyl)mag-
nesium bromide in THF (0.6 mmol, 3.0 equiv) was added dropwise over 30 min via syringe pump. 
After addition, the reaction mixture was allowed to stir for further 10 min at 0 °C, after which 1.2 mL 
of NaOMe (0.5 M in MeOH, 0.6 mmol, 3.0 equiv) were added. Iodine (0.3 mmol, 1.5 equiv, 76 mg) 
was dissolved in 1 mL THF and added dropwise to the mixture, which was then further stirred at 0 °C 
for 30 min. The slurry was then quenched with sat. aq. Na2S2O3 solution (2 mL) and extracted with 
EtOAc (3 × 10 mL). The combined organic phases were dried over MgSO4, filtered, concentrated under 
reduced pressure and purified by flash-column chromatography on silica gel in hexane (Rf = 0.37 (hex-
ane/EtOAc 100:0, UV, KMnO4)) to yield product 3a (0.22 mmol, 44 mg, 55%, E/Z = 99:1) as colorless 
solid. 1H NMR (400 MHz, CDCl3) δ 7.46 – 7.35 (m, 4H), 7.27 (t, J = 7.7 Hz, 2H), 7.21 – 7.13 (m, 1H), 
7.03 – 6.92 (m, 4H)  ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 198.0 (100), 183.0 (45), 177.0 (20).  
Analytical data in accordance to literature.262 
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(Z)-1-Fluoro-4-styrylbenzene ((Z)-3a) 
Zweifel Olefination: A 25 mL Schlenk flask was charged with (E)-Tris(4-fluoro-
phenyl)(styryl)borate 2a (0.2 mmol, 1.0 equiv, 88 mg) and 1 mL of THF was added. 
1.2 mL of NaOMe (0.5 M in MeOH, 0.6 mmol, 3.0 equiv) were added in one portion. 
Iodine (0.3 mmol, 1.5 equiv, 76 mg) was dissolved in 1 mL THF and added dropwise to 
the mixture, which was then further stirred at 0 °C for 30 min. The slurry was then quenched with sat. 
aq. Na2S2O3 solution (2 mL) and extracted with EtOAc (3 × 10 mL). The combined organic phases were 
dried over MgSO4, filtered, concentrated under reduced pressure and purified by flash-column chroma-
tography on silica gel in hexane (Rf = 0.37 (hexane/EtOAc 100:0, UV, KMnO4)) to yield product (Z)-
3a (0.17 mmol, 34 mg, 86%, E/Z = 1:99) as colorless solid. 1H NMR (400 MHz, CDCl3) δ 7.28 – 7.16 
(m, 7H), 6.95 – 6.87 (m, 2H), 6.60 (d, J = 12.2 Hz, 1H), 6.55 (d, J = 12.2 Hz, 1H) ppm. LRMS (DEP/EI-
Orbitrap): m/z (%): 198.0 (100), 183.0 (45), 177.0 (20). Analytical data in accordance to literature.284 
trans-2-(4-fluorophenyl)-3-phenyloxirane (3ab)* 
Using potassium (E)-trifluoro(styryl)borate and a solution of (4-fluorophenyl)magnesium 
bromide in THF according to general procedure S under O2 atmosphere, provided 3ab 
(0.15 mmol, 32 mg, 37%) as yellowish oil. Rf = 0.21 (hexane/EtOAc 100:0, UV, KMnO4, 
PAA). 1H NMR (400 MHz, CDCl3) δ 7.44 – 7.28 (m, 7H), 7.08 (tt, J = 8.8, 2.5 Hz, 2H), 3.86 
(d, J = 1.8 Hz, 1H), 3.84 (d, J = 1.8 Hz, 1H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 214.0 
(20), 196.0 (20), 185.0 (100), 165.0 (70). Analytical data in accordance to literature.285 
(E)-1-Styryl-4-(trifluoromethyl)benzene (3b)* 
Using potassium (E)-trifluoro(styryl)borate and a solution of (4-(trifluoromethyl)phenyl)mag-
nesium bromide in THF according to general procedure S, provided 3b (0.28 mmol, 68 mg, 
69%, E/Z = 99:1) as colorless solid. 1H NMR (400 MHz, CDCl3) δ 7.61 (s, 4H), 7.56 – 7.52 
(m, 2H), 7.43 – 7.37 (m, 2H), 7.33 – 7.27 (m, 1H), 7.20 (d, J = 16.4 Hz, 1H), 7.12 (d, J = 16.4 
Hz, 1H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 248.0 (100), 233.0 (15), 227.0 (25). Ana-
lytical data in accordance to literature.286 
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(E)-4-Styrylbenzonitrile (3c) 
Using potassium (E)-trifluoro(styryl)borate and a solution of (4-cyanophenyl)zinc(II) iodide 
in THF according to general procedure S, provided 3c (0.12 mmol, 24 mg, 29%, E/Z = 99:1) 
as colorless solid. 1H NMR (400 MHz, CDCl3) δ 7.69 – 7.61 (m, 2H), 7.61 – 7.57 (m, 2H), 
7.56 – 7.52 (m, 2H), 7.43 – 7.37 (m, 2H), 7.36 – 7.29 (m, 1H), 7.22 (d, J = 16.3 Hz, 1H), 
7.09  (d, J = 16.3 Hz, 1H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 205.1 (100), 190.0 (50), 
176.0 (20). Analytical data in accordance to literature.287 
(E)-1,3-Dimethoxy-5-styrylbenzene (3d) 
Using potassium (E)-(styryl)trifluoroborate and a solution of (3,5-dimethoxy-
phenyl)magnesium bromide in THF according to general procedure S, provided 3d 
(0.21 mmol, 50 mg, 42%) as colorless solid. Rf = 0.50 (hexane/EtOAc 9:1, UV, 
KMnO4). 1H NMR (400 MHz, CDCl3) δ 7.54 – 7.49 (m, 2H), 7.39 – 7.34 (m, 2H), 
7.30 – 7.24 (m, 1H), 7.10 (d, J = 16.3 Hz, 1H), 7.04 (d, J = 16.3 Hz, 1H), 6.68 (d, J 
= 2.3 Hz, 2H), 6.40 (t, J = 2.3 Hz, 1H), 3.84 (s, 6H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 240.1 
(100), 224.0 (10), 209.0 (20). HRMS (EI-Orbitrap): m/z calcd. for C16H16O2+: 240.1150; found: 
240.1143. Analytical data in accordance to literature.288  
(E)-1-Styrylnaphthalene (3e/3q) 
Using potassium (E)-trifluoro(styryl)borate and a solution of naphthalen-1-ylmagnesium 
bromide in THF according to general procedure S, provided 3e (0.30 mmol, 68 mg, 74%, 
E/Z = 99:1) as colorless solid. Using potassium (Z)-trifluoro(styryl)borate (SM28) and a 
solution of naphthalen-1-ylmagnesium bromide in THF according to general procedure S, 
provided 3q (0.17 mmol, 37 mg, 43%, E/Z = 93:7) as colorless solid. 1H NMR (400 MHz, 
CDCl3) δ 8.23 (d, J = 8.0 Hz, 1H), 7.93 – 7.86 (m, 2H), 7.82 (d, J = 8.2 Hz, 1H), 7.76 (d, J = 6.1 Hz, 
1H), 7.65 – 7.60 (m, 2H), 7.58 – 7.48 (m, 3H), 7.42 (t, J = 7.7 Hz, 2H), 7.34 – 7.29 (m, 1H), 7.17 (d, J 
= 16.0 Hz, 1H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 229.1 (100), 215.1 (15), 202.1 (10). Analyt-
ical data in accordance to literature.284 
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(E)-4-(4-Fluorostyryl)-1,1'-biphenyl (3f)* 
Using potassium (E)-(2-([1,1'-biphenyl]-4-yl)vinyl)trifluoroborate (SM36) and a solution of 
(4-fluorophenyl)magnesium bromide in THF according to general procedure S, provided 3f 
(0.28 mmol, 78 mg, 71%, E/Z = 99:1) as colorless solid. 1H NMR (400 MHz, CDCl3) δ 7.69 
– 7.55 (m, 6H), 7.55 – 7.42 (m, 4H), 7.40 – 7.31 (m, 1H), 7.15 – 7.00 (m, 4H) ppm. LRMS 
(DEP/EI-Orbitrap): m/z (%): 274.1 (100), 259.0 (10), 252.1 (15). Analytical data in accord-
ance to literature.289 
(E)-2-Chloro-1-fluoro-4-(4-fluorostyryl)benzene (3g) 
Using potassium (E)-trifluoro(4-fluorostyryl)borate (SM37) and a solution of (3-chloro-4-
fluorophenyl)magnesium bromide in THF according to general procedure S, provided 3g 
(0.22 mmol, 55 mg, 55%, E/Z = 99:1) as colorless oil. Rf = 0.40 (hexane, UV, KMnO4). 
1H NMR (400 MHz, CDCl3) δ 7.53 (dd, J = 7.0, 2.2 Hz, 1H), 7.48 – 7.43 (m, 2H), 7.33 
(ddd, J = 8.6, 4.6, 2.2 Hz, 1H), 7.12 (t, J = 8.7 Hz, 1H), 7.06 (t, J = 8.7 Hz, 2H), 6.99 (d, J 
= 16.3 Hz, 1H), 6.90 (d, J = 16.3 Hz, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 162.7 (d, 
J = 247.8 Hz), 157.6 (d, J = 249.8 Hz), 134.7 (d, J = 3.9 Hz), 133.0 (d, J = 3.4 Hz), 128.7 (d, J = 2.4 Hz), 
128.3, 128.2, 126.2 (d, J = 7.0 Hz), 126.1 (t, J = 2.1 Hz), 121.5 (d, J = 18.1 Hz), 116.9 (d, J = 21.5 Hz), 
115.9 (d, J = 21.7 Hz) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 250.0 (95), 235.0 (15), 214.1 (100), 
195.1 (30). HRMS (EI-Orbitrap): m/z calcd. for C14H9ClF2+: 250.0361; found: 250.0354. IR (Diamond-
ATR, neat)  𝜈𝑚𝑎𝑥 (cm
-1): 2942 (vs), 2929 (vs), 2892 (s), 2866 (vs), 1502 (vs), 1463 (s), 1254 (m), 1202 
(s), 1148 (m), 1096 (s), 1059 (m), 1037 (s), 1017 (s), 1004 (s), 993 (s), 981 (s), 942 (m), 931 (m), 919 
(m), 906 (m), 884 (s), 863 (m), 830 (s), 810 (m), 804 (m), 775 (m), 739 (m), 709 (m), 677 (s), 668 (s), 
662 (s).  
(E)-5-Styrylbenzofuran (3h) 
Using potassium (E)-trifluoro(styryl)borate and a solution of benzofuran-5-ylmagnesium 
bromide in THF according to general procedure S, provided 3h (0.25 mmol, 55 mg, 63%, 
E/Z = 99:1) as colorless oil. Rf = 0.30 (hexane, UV, PAA, KMnO4). 1H NMR (400 MHz, 
CDCl3) δ 7.72 (s, 1H), 7.62 (d, J = 2.2 Hz, 1H), 7.55 – 7.47 (m, 4H), 7.37 (t, J = 7.7 Hz, 
2H), 7.31 – 7.19 (m, 2H), 7.10 (d, J = 16.3 Hz, 1H), 6.78 (d, J = 2.2 Hz, 1H) ppm. 13C NMR 
(101 MHz, CDCl3) δ 154.8, 145.7, 137.6, 132.6, 129.1, 128.8, 128.0, 127.8, 127.5, 126.5, 
123.1, 119.4, 111.7, 106.8 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 220.0 (100), 204.9 (10), 191.0 
(60).  HRMS (EI-Orbitrap): m/z calcd. for C16H12O+: 220.0888; found: 220.0882. IR (Diamond-ATR, 
neat)  𝜈𝑚𝑎𝑥 (cm
-1): 1464 (w), 1450 (w), 1253 (w), 1197 (w), 1125 (m), 1105 (m), 1028 (m), 967 (m), 
887 (m), 809 (s), 769 (s), 736 (vs), 693 (s). 
 
289 Y. Liu, P. Liu, Y. Wei, Chin. J. Chem. 2017, 35, 1141–1148. 
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(E)-2-Styryldibenzo[b,d]furan (3i/3s)* 
Using potassium (E)-trifluoro(styryl)borate and a solution of dibenzo[b,d]furan-2-
ylmagnesium bromide in THF according to general procedure S, provided 3i 
(0.23 mmol, 62 mg, 57%, E/Z = 99:1) as colorless solid. Using potassium (Z)-tri-
fluoro(styryl)borate (SM28) and a solution of dibenzo[b,d]furan-2-ylmagnesium bro-
mide in THF according to general procedure S, provided 3s (0.24 mmol, 65 mg, 60%, 
E/Z = 96:4) as colorless solid. 1H NMR (400 MHz, CDCl3) δ 8.09 (d, J = 1.8 Hz, 1H), 
7.99 (dd, J = 7.8, 1.3 Hz, 1H), 7.64 (dd, J = 8.5, 1.8 Hz, 1H), 7.61 – 7.53 (m, 4H), 7.48 (ddd, J = 8.4, 
7.3, 1.4 Hz, 1H), 7.43 – 7.35 (m, 3H), 7.32 – 7.25 (m, 2H), 7.17 (d, J = 16.3 Hz, 1H) ppm. LRMS 
(DEP/EI-Orbitrap): m/z (%): 270.1 (100), 255.0 (10), 239.0 (20). Analytical data in accordance to liter-
ature.290 
(E)-2-(4-Fluorostyryl)dibenzo[b,d]furan (3j) 
Using potassium (E)-trifluoro(4-fluorostyryl)borate (SM37) and a solution of 
dibenzo[b,d]furan-2-ylmagnesium bromide in THF according to general procedure S, 
provided 3j (0.27 mmol, 78 mg, 68%, E/Z = 99:1) as colorless oil. Rf = 0.30 (hexane, 
UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 8.07 (d, J = 1.8 Hz, 1H), 7.98 (d, J 
= 6.9 Hz, 1H), 7.62 (dd, J = 8.6, 1.8 Hz, 1H), 7.60 – 7.45 (m, 5H), 7.37 (td, J = 7.5, 
1.0 Hz, 1H), 7.18 (d, J = 16.3 Hz, 1H), 7.14 – 7.05 (m, 3H) ppm. 13C NMR (101 MHz, 
CDCl3) δ 162.40 (d, J = 246.9 Hz), 156.8, 156.0, 133.74 (d, J = 3.3 Hz), 132.4, 128.53 
(d, J = 2.5 Hz), 128.00 (d, J = 7.8 Hz), 127.5, 126.9, 126.0, 124.9, 124.2, 123.0, 120.8, 118.5, 115.8 (d, 
J = 21.6 Hz), 112.0, 111.9 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 288.1 (100), 273.0 (5), 257.1 (30). 
HRMS (EI-Orbitrap): m/z calcd. for C20H13FO+: 288.0950; found: 288.0945. IR (Diamond-ATR, neat) 
 𝜈𝑚𝑎𝑥 (cm
- 1): 3041 (w), 1710 (m), 1601 (m), 1508 (s), 1473 (m), 1450 (s), 1431 (m), 1414 (m), 1360 
(m), 1349 (m), 1329 (w), 1304 (w), 1296 (w), 1261 (w), 1226 (s), 1210 (m), 1196 (s), 1168 (m), 1159 
(m), 1141 (m), 1122 (m), 1100 (m), 1022 (m), 1004 (w), 972 (m), 961 (s), 940 (m), 926 (m), 908 (w), 
893 (m), 857 (m), 841 (m), 824 (vs), 812 (s), 790 (m), 766 (m), 752 (s), 741 (vs), 726 (s), 710 (m), 683 
(w), 665 (w), 656 (w). 
(E)-1,3-Difluoro-5-(2-phenylprop-1-en-1-yl)benzene (3k) 
Using potassium (E)-trifluoro(2-phenylprop-1-en-1-yl)borate (SM38) and a solution of 
(3,5-difluorophenyl)magnesium bromide in THF according to general procedure S, pro-
vided 3k (0.28 mmol, 64 mg, 70%, E/Z = 99:1) as colorless oil. Rf = 0.60 (hexane, UV, 
PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 7.56 – 7.46 (m, 2H), 7.43 – 7.36 (m, 2H), 
7.35 – 7.29 (m, 1H), 6.94 – 6.83 (m, 2H), 6.74 – 6.66 (m, 2H), 2.28 (d, J = 1.4 Hz, 
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3H) ppm. 13C NMR (101 MHz, CDCl3) δ 162.97 (dd, J = 247.4, 13.2 Hz), 143.4, 141.62 (t, J = 9.7 Hz), 
140.1, 128.6, 127.9, 126.2, 125.80 (t, J = 2.6 Hz), 112.21 – 111.70 (m), 102.01 (t, J = 25.5 Hz), 
17.8 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 230.1 (100), 215.1 (80), 195.1 (20). HRMS (EI-Or-
bitrap): m/z calcd. for C14H15FO2+: 230.0907; found: 230.0896. IR (Diamond-ATR, neat)  𝜈𝑚𝑎𝑥 (cm
-1): 
n.d. 
Ethyl (E)-3-(pyridin-3-yl)acrylate (3l) 
Using potassium (E)-(3-ethoxy-3-oxoprop-1-en-1-yl)trifluoroborate (SM39) and a solu-
tion of pyridin-3-ylzinc(II) iodide in THF according to general procedure S, provided 3l 
(0.10 mmol, 18 mg, 25%, E/Z = 99:1) as colorless oil. Rf = 0.25 (hexane/EtOAc 6:4, UV, 
PAA). 1H NMR (400 MHz, CDCl3) δ 8.75 (d, J = 2.2 Hz, 1H), 8.61 (dd, J = 4.8, 1.6 Hz, 
1H), 7.84 (dt, J = 7.9, 2.0 Hz, 1H), 7.67 (d, J = 16.1 Hz, 1H), 7.37 – 7.31 (m, 1H), 6.51 (d, J = 16.1 Hz, 
1H), 4.28 (q, J = 7.1 Hz, 2H), 1.35 (t, J = 7.1 Hz, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 166.5, 
151.1, 149.9, 141.0, 134.3, 130.4, 123.9, 120.6, 61.0, 14.4 ppm. HRMS (EI-Orbitrap): m/z calcd. for 
C10H11NO2+: 177.0790; found: 177.0782. IR (Diamond-ATR, neat)  𝜈𝑚𝑎𝑥 (cm
-1): 2963 (m), 2956 (m), 
2926 (m), 2853 (m), 1717 (vs), 1685 (w), 1653 (w), 1642 (m), 1508 (m), 1472 (m), 1465 (m), 1457 (m), 
1418 (m), 1388 (w), 1367 (m), 1312 (m), 1278 (m), 1262 (s), 1218 (m), 1184 (s), 1127 (m), 1120 (m), 
1096 (m), 1074 (m), 1066 (m), 1043 (m), 1026 (m), 983 (m), 806 (m), 718 (w), 712 (w), 700 (m), 668 
(w), 662 (w). 
(E)-1,3-difluoro-5-styrylbenzene (3n)* 
Using potassium (Z)-trifluoro(styryl)borate (SM28) and a solution of (3,5-difluoro-
phenyl)magnesium bromide in THF according to general procedure S, provided 3n 
(0.26 mmol, 56 mg, 65%, E/Z = 90:10) as colorless solid. 1H NMR (400 MHz, CDCl3) δ 
7.56 – 7.48 (m, 2H), 7.43 – 7.35 (m, 2H), 7.35 – 7.28 (m, 1H), 7.11 (d, J = 16.2 Hz, 1H), 
7.05 – 6.97 (m, 3H), 6.71 (tt, J = 8.8, 2.3 Hz, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 
163.41 (dd, J = 247.5, 13.2 Hz), 140.88 (t, J = 9.6 Hz), 136.4, 131.4, 129.0, 128.5, 126.9, 126.62 (t, J 
= 2.9 Hz), 109.46 – 108.89 (m), 102.85 (t, J = 25.7 Hz) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 216.1 
(100), 201.1 (50), 195.1 (30). Analytical data in accordance to literature.291 
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(E)-1-Styryl-4-(trifluoromethoxy)benzene (3o) 
Using potassium (Z)-trifluoro(styryl)borate (SM28) and a solution of (4-(trifluorometh-
oxy)phenyl)magnesium bromide in THF according to general procedure S, provided 3o 
(0.24 mmol, 64 mg, 60%, E/Z = 97:3) as colorless solid. 1H NMR (400 MHz, CDCl3) δ 7.57 
– 7.49 (m, 4H), 7.42 – 7.34 (m, 2H), 7.33 – 7.27 (m, 1H), 7.24 – 7.19 (m, 2H), 7.09 (s, 2H) 
ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 264.1 (100), 249.0 (10), 179.1 (50). Analytical 
data in accordance to literature.292 
(E)-1-Styryl-3,5-bis(trifluoromethyl)benzene (3p) 
Using potassium (Z)-trifluoro(styryl)borate (SM28) and a solution of (3,5-bis(trifluo-
romethyl)phenyl)magnesium bromide in THF according to general procedure S, pro-
vided 3p (0.24 mmol, 76 mg, 60%, E/Z = 90:10) as colorless solid. 1H NMR 
(400 MHz, CDCl3) δ 7.92 (s, 2H), 7.75 (s, 1H), 7.59 – 7.53 (m, 2H), 7.46 – 7.38 (m, 
2H), 7.38 – 7.31 (m, 1H), 7.25 (d, J = 16.4 Hz, 1H), 7.13 (d, J = 16.4 Hz, 1H) ppm. 
LRMS (DEP/EI-Orbitrap): m/z (%): 316.1 (100), 301.1 (15), 275.1 (10). Analytical data in accordance 
to literature.293 
(E)-2-(3,5-Bis(trifluoromethyl)styryl)-6-methoxynaphthalene (3r) 
Using potassium (Z)-trifluoro(2-(6-methoxynaphthalen-2-yl)vinyl)borate (SM41) and 
a solution of (3,5-bis(trifluoromethyl)phenyl)magnesium bromide in THF according 
to general procedure S, provided 3r (0.22 mmol, 89 mg, 56%, E/Z = 84:16) as color-
less oil. Rf = 0.25 (hexane, UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 7.94 
(s, 2H), 7.85 (s, 1H), 7.77 – 7.68 (m, 4H), 7.38 (d, J = 16.3 Hz, 1H), 7.24 (d, J = 
15.1 Hz, 1H), 7.19 – 7.12 (m, 2H), 3.94 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 
158.4, 139.8, 134.9, 132.8, 132.13 (q, J = 33.1 Hz), 131.5, 129.9, 129.1, 127.8, 127.6, 
126.2, 124.8, 123.9, 122.2, 120.7 (qq, J = 3.9 Hz), 119.5, 106.1, 55.5 ppm. LRMS (DEP/EI-Orbitrap): 
m/z (%): 396.1 (100), 381.0 (5), 353.0 (10), 333.0 (5). HRMS (EI-Orbitrap): m/z calcd. for C21H14F6O2+: 
396.0949; found: 396.0949. IR (Diamond-ATR, neat)  𝜈𝑚𝑎𝑥 (cm
-1): 1626 (m), 1611 (m), 1602 (m), 
1484 (m), 1467 (w), 1392 (m), 1373 (s), 1274 (vs), 1248 (m), 1218 (w), 1204 (m), 1170 (s), 1123 (vs), 
1107 (s), 1032 (m), 1000 (w), 957 (m), 943 (m), 888 (s), 853 (m), 844 (m), 810 (m), 699 (m), 682 (s), 
666 (m). 
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1-Methoxy-4-(prop-1-en-2-yl)benzene (4a)* 
Using potassium trifluoro(prop-1-en-2-yl)borate and a solution of (4-methoxyphenyl)magne-
sium bromide in THF according to general procedure S, provided 4a (0.16 mmol, 24 mg, 41%) 
as colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.45 – 7.37 (m, 2H), 6.91 – 6.82 (m, 2H), 5.29 
(dd, J = 1.6, 0.8 Hz, 1H), 5.04 – 4.96 (m, 1H), 3.82 (s, 3H), 2.13 (dd, J = 1.5, 0.8 Hz, 3H) ppm. 
LRMS (DEP/EI-Orbitrap): m/z (%): 148.0 (100), 133.0 (80), 127.8 (5). Analytical data in accordance 
to literature.211 
1-(Cyclopent-1-en-1-yl)-3,5-bis(trifluoromethyl)benzene (4b) 
Using potassium cyclopent-1-en-1-yltrifluoroborate (SM42) and a solution of (3,5-
bis(trifluoromethyl)phenyl)magnesium bromide in THF according to general proce-
dure S, provided 4b (0.21 mmol, 58 mg, 52%) as colorless oil. Rf = 0.60 (hexane, UV, 
PAA). 1H NMR (400 MHz, CDCl3) δ 7.81 (s, 2H), 7.70 (s, 1H), 6.39 (td, J = 2.7, 
1.4 Hz, 1H), 2.78 – 2.71 (m, 2H), 2.62 – 2.56 (m, 2H), 2.08 (quint, J = 7.6 Hz, 2H) ppm. 13C NMR 
(101 MHz, CDCl3) δ 140.3, 138.9, 131.6 (q, J = 32.9 Hz), 130.7, 125.5, 123.5 (q, J = 272.5 Hz), 120.3 
(q, J = 3.9 Hz), 33.7, 33.2, 23.4 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 280.1 (100), 261.1 (50), 
245.1 (40), 211.1 (100), 191.1 (45), 142.1 (25). HRMS (EI-Orbitrap): m/z calcd. for C13H10F6+: 
280.0687; found: 280.0680. IR (Diamond-ATR, neat)  𝜈𝑚𝑎𝑥 (cm
-1): 2959 (vw), 2929 (vw), 2852 (vw), 
1703 (vw), 1626 (vw), 1468 (w), 1384 (m), 1331 (w), 1277 (vs), 1171 (s), 1129 (vs), 1108 (m), 1046 
(w), 1016 (w), 994 (w), 960 (w), 945 (vw), 895 (m), 888 (m), 843 (w), 770 (vw), 758 (vw), 700 (m), 
682 (m). 
4'-Methoxy-2,3,4,5-tetrahydro-1,1'-biphenyl (4c) 
Using potassium cyclohex-1-en-1-yltrifluoroborate and a solution of (4-methoxyphenyl)mag-
nesium bromide in THF according to general procedure S, provided 4c (0.28 mmol, 53 mg, 
71%) as colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.36 – 7.29 (m, 2H), 6.90 – 6.82 (m, 2H), 
6.03 (tt, J = 3.9, 1.7 Hz, 1H), 3.81 (s, 3H), 2.38 (dtd, J = 6.1, 3.2, 2.6, 1.4 Hz, 2H), 2.19 (dddd, 
J = 8.7, 6.3, 4.4, 2.5 Hz, 2H), 1.82 – 1.72 (m, 2H), 1.68 – 1.61 (m, 2H) ppm. LRMS (DEP/EI-Orbitrap): 
m/z (%): 188.1 (100), 184.0 (5), 173.1 (15), 159.0 (50). Analytical data in accordance to literature.294 
3',4'-Dichloro-2,3,4,5-tetrahydro-1,1'-biphenyl (4d) 
Using potassium cyclohex-1-en-1-yltrifluoroborate and a solution of (3,4-dichloro-
phenyl)magnesium bromide in THF according to general procedure S, provided 4d 
(0.21 mmol, 48 mg, 53%) as colorless oil. Rf = 0.80 (hexane, UV, PAA, KMnO4). 1H NMR 
(400 MHz, CDCl3) δ 7.44 (d, J = 2.2 Hz, 1H), 7.35 (d, J = 8.4 Hz, 1H), 7.20 (dd, J = 8.4, 
 
294 M. O. Ganiu, A.-H. Cleveland, J. L. Paul, R. Kartika, Org. Lett. 2019, 21, 5611–5615. 
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2.2 Hz, 1H), 6.13 (td, J = 4.0, 1.9 Hz, 1H), 2.33 (tdd, J = 6.2, 2.5, 1.7 Hz, 2H), 2.20 (dddd, J = 9.2, 6.7, 
4.7, 2.7 Hz, 2H), 1.82 – 1.72 (m, 2H), 1.70 – 1.58 (m, 2H) ppm. 13C NMR (101 MHz, CDCl3) δ 142.0, 
134.8, 132.3, 130.2, 130.1, 127.0, 126.7, 123.5, 27.3, 26.0, 23.0, 22.0 ppm. LRMS (DEP/EI-Orbitrap): 
m/z (%): 226.0 (70), 211.0 (20), 191.0 (60), 163.0 (100). HRMS (EI-Orbitrap): m/z calcd. for 
C12H12Cl2+: 226.0316; found: 226.0309. IR (Diamond-ATR, neat)  𝜈𝑚𝑎𝑥 (cm
-1): 2927 (w), 2848 (w), 
1724 (w), 1627 (w), 1463 (w), 1447 (w), 1425 (w), 1384 (w), 1363 (w), 1353 (w), 1311 (w), 1279 (w), 
1261 (w), 1236 (m), 1128 (vs), 1076 (w), 1042 (m), 969 (m), 947 (m), 916 (w), 904 (m), 863 (w), 844 
(m), 802 (w), 773 (w), 762 (w), 746 (w). 
4'-Fluoro-2,3,4,5-tetrahydro-1,1'-biphenyl (4e) 
Using potassium cyclohex-1-en-1-yltrifluoroborate and a solution of (4-fluorophenyl)magne-
sium bromide in THF according to general procedure, provided 4e (0.30 mmol, 53 mg, 75%) as 
colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.41 – 7.29 (m, 2H), 7.03 – 6.92 (m, 2H), 6.06 (tt, 
J = 3.9, 1.8 Hz, 1H), 2.37 (ddq, J = 6.3, 4.3, 2.2 Hz, 2H), 2.20 (dtt, J = 8.8, 6.1, 2.6 Hz, 2H), 
1.85 – 1.74 (m, 2H), 1.70 – 1.60 (m, 2H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 176.1 (100), 161.0 
(50), 147.0 (100). Analytical data in accordance to literature.295 
N,N-dimethyl-2',3',4',5'-tetrahydro-[1,1'-biphenyl]-4-amine (4f)* 
Using potassium cyclohex-1-en-1-yltrifluoroborate and a solution of (4-(dimethylamino)phe-
nyl)magnesium bromide in THF according to general procedure S, provided 4f (0.20 mmol, 
40 mg, 70%) as colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.34 – 7.27 (m, 2H), 6.74 – 6.65 
(m, 2H), 6.00 (tt, J = 4.0, 1.7 Hz, 1H), 2.94 (s, 6H), 2.38 (ddt, J = 6.2, 3.9, 2.0 Hz, 2H), 2.19 
(dtd, J = 8.2, 4.0, 2.2 Hz, 2H), 1.82 – 1.72 (m, 2H), 1.69 – 1.59 (m, 2H) ppm. LRMS (DEP/EI-Orbitrap): 
m/z (%): 201.1 (100), 197.1 (40), 186.1 (5). Analytical data in accordance to literature.296 
4-Phenyl-3,6-dihydro-2H-pyran (4g) 
Using potassium (3,6-dihydro-2H-pyran-4-yl)trifluoroborate (SM43) and a solution of phenyl-
magnesium bromide in THF according to general procedure S, provided 4g (0.24 mmol, 38 mg, 
60%) as colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.42 – 7.38 (m, 2H), 7.37 – 7.32 (m, 2H), 
7.30 – 7.24 (m, 1H), 6.13 (tt, J = 3.0, 1.6 Hz, 1H), 4.33 (q, J = 2.8 Hz, 2H), 3.94 (t, J = 5.5 Hz, 
2H), 2.74 – 2.34 (m, 2H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 160.1 (100), 145.1 (10), 131.1 
(100). Analytical data in accordance to literature.297 
  
 
295 K. Ishizuka, H. Seike, T. Hatakeyama, M. Nakamura, J. Am. Chem. Soc. 2010, 132, 13117–13119. 
296 W. D. Oosterbaan, P. C. M. van Gerven, C. A. van Walree, M. Koeberg, J. J. Piet, R. W. A. Havenith, J. W. 
Zwikker, L. W. Jenneskens, R. Gleiter, Eur. J. Org. Chem. 2003, 3117–3130. 
297 B. Guo, G. Schwarzwalder, J. T. Njardarson, Angew. Chem. Int. Ed. 2012, 51, 5675–5678. 
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4-(3,5-Bis(trifluoromethyl)phenyl)-3,6-dihydro-2H-pyran (4h) 
Using potassium (3,6-dihydro-2H-pyran-4-yl)trifluoroborate (SM43) and a solution of 
(3,5-bis(trifluoromethyl)phenyl)magnesium bromide in THF according to general pro-
cedure S, provided 4h (0.22 mmol, 64 mg, 54%) as colorless oil. Rf = 0.30 (hex-
ane/EtOAc 9:1, UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 7.80 (s, 2H), 7.76 
(s, 1H), 6.31 (tt, J = 3.0, 1.6 Hz, 1H), 4.36 (q, J = 2.9 Hz, 2H), 3.96 (t, J = 5.4 Hz, 2H), 2.59 – 2.51 (m, 
2H) ppm. 13C NMR (101 MHz, CDCl3) δ 142.3, 132.3, 131.89 (q, J = 33.1 Hz), 126.3, 125.05 – 124.76 
(m), 123.51 (d, J = 271.9 Hz), 121.09 – 120.83 (m), 65.8, 64.2, 27.1 ppm. LRMS (DEP/EI-Orbitrap): 
m/z (%): 296.1 (100), 278.1 (70), 267.1 (80), 254.1 (20). HRMS (EI-Orbitrap): m/z calcd. for C13H10F6+: 
296.0636; found: 296.0628. IR (Diamond-ATR, neat)  𝜈𝑚𝑎𝑥 (cm
-1): 1710 (m), 1621 (vw), 1470 (vw), 
1356 (m), 1275 (vs), 1224 (w), 1171 (s), 1123 (vs), 1053 (m), 1021 (m), 963 (w), 940 (m), 899 (m), 
879 (w), 844 (m), 810 (w), 725 (w), 701 (m), 681 (s). 
4-(3,5-Dimethylphenyl)-3,6-dihydro-2H-pyran (4i) 
Using potassium (3,6-dihydro-2H-pyran-4-yl)trifluoroborate (SM43) and a solution of 
(3,5-dimethylphenyl)magnesium bromide in THF according to general procedure S, 
provided 4i (0.22 mmol, 64 mg, 54%) as colorless oil. Rf = 0.35 (hexane/EtOAc 98:2, 
UV, KMnO4). 1H NMR (400 MHz, CDCl3) δ 7.02 (s, 2H), 6.92 (s, 1H), 6.09 (tt, J = 
3.1, 1.6 Hz, 1H), 4.32 (q, J = 2.8 Hz, 2H), 3.93 (t, J = 5.5 Hz, 2H), 2.54 – 2.48 (m, 2H), 2.33 (s, 6H) ppm. 
13C NMR (101 MHz, CDCl3) δ 140.5, 138.0, 134.4, 129.1, 122.8, 122.2, 66.0, 64.7, 27.5, 21.5 ppm. 
LRMS (DEP/EI-Orbitrap): m/z (%): 188.1 (100), 173.1 (90), 159.1 (35), 145.1 (100). HRMS (EI-Or-
bitrap): m/z calcd. for C13H16O+: 188.1201; found: 188.1206. IR (Diamond-ATR, neat)  𝜈𝑚𝑎𝑥 (cm
-1): 
2948 (m), 2920 (s), 2894 (m), 1722 (s), 1685 (m), 1602 (s), 1464 (m), 1450 (m), 1444 (m), 1423 (m), 
1385 (m), 1363 (m), 1309 (m), 1295 (m), 1280 (m), 1269 (m), 1260 (m), 1242 (m), 1223 (m), 1183 (m), 
1160 (m), 1137 (vs), 1084 (s), 1060 (s), 1044 (s), 1017 (m), 995 (m), 974 (m), 966 (m), 951 (s), 881 
(m), 849 (s), 818 (m), 699 (m), 688 (m). 
4-(Benzo[b]thiophen-5-yl)-3,6-dihydro-2H-pyran (4j)* 
Using potassium (3,6-dihydro-2H-pyran-4-yl)trifluoroborate (SM43) and a solution of 
benzo[b]thiophen-5-ylmagnesium bromide in THF according to general procedure S, provided 
4j (0.09 mmol, 20 mg, 23%) as colorless oil. Rf = 0.60 (hexane/EtOAc 98:2, UV, PAA, 
KMnO4). 1H NMR (400 MHz, CDCl3) δ 7.74 – 7.68 (m, 2H), 7.37 – 7.29 (m, 2H), 7.23 (d, J 
= 5.5 Hz, 1H), 6.09 (tt, J = 3.0, 1.6 Hz, 1H), 4.26 (q, J = 2.8 Hz, 2H), 3.88 (t, J = 5.5 Hz, 2H), 2.59 – 
2.46 (m, 2H) ppm. 13C NMR (101 MHz, CDCl3) δ 140.8, 140.0, 138.7, 136.9, 134.3, 124.2, 122.6, 
122.4, 121.7, 119.7, 66.1, 64.7, 27.7 ppm. HRMS (EI-Orbitrap): m/z calcd. for C13H12OS+: 216.0609; 
found: 216.0604. IR (Diamond-ATR, neat)  𝜈𝑚𝑎𝑥 (cm
-1): 3253 (w), 3099 (w), 2922 (m), 2853 (m), 1596 
(m), 1565 (w), 1503 (w), 1415 (m), 1340 (s), 1328 (s), 1303 (m), 1253 (s), 1231 (m), 1188 (m), 1183 
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(m), 1146 (m), 1140 (m), 1089 (s), 1046 (s), 1017 (m), 944 (m), 917 (m), 906 (m), 900 (m), 889 (m), 
862 (m), 849 (m), 830 (s), 803 (s), 768 (m), 748 (s), 737 (s), 723 (s), 690 (vs). 
5-(3,6-Dihydro-2H-pyran-4-yl)-2,2-difluorobenzo[d][1,3]dioxole (4k) 
Using potassium (3,6-dihydro-2H-pyran-4-yl)trifluoroborate (SM43) and a solution of (2,2-
difluorobenzo[d][1,3]dioxol-5-yl)magnesium bromide in THF according to general proce-
dure S, provided 4k (0.12 mmol, 27 mg, 29%) as colorless oil. Rf = 0.30 (hexane/EtOAc 
98:2, UV, PAA). 1H NMR (400 MHz, CDCl3) δ 7.11 – 7.06 (m, 2H), 7.03 – 6.99 (m, 1H), 
6.06 (tt, J = 3.0, 1.6 Hz, 1H), 4.31 (q, J = 2.8 Hz, 2H), 3.93 (t, J = 5.4 Hz, 2H), 2.47 (ttd, J 
= 5.5, 2.7, 1.6 Hz, 2H) ppm. 13C NMR (101 MHz, CDCl3) δ 144.2, 143.0, 137.1, 133.3, 131.8 (t, J = 
255.1 Hz), 123.3, 120.1, 109.3, 106.3, 65.9, 64.5, 27.6 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 240.0 
(70), 222.0 (20), 196.9 (25), 158.0 (50). HRMS (EI-Orbitrap): m/z calcd. for C12H10F2O3+: 240.0598; 
found: 240.0592. IR (Diamond-ATR, neat)  𝜈𝑚𝑎𝑥 (cm
-1): 3248 (w), 3099 (w), 2961 (w), 2923 (w), 2853 
(w), 1597 (m), 1565 (m), 1502 (m), 1451 (w), 1421 (m), 1346 (s), 1328 (m), 1303 (m), 1261 (s), 1238 
(vs), 1183 (s), 1145 (s), 1088 (s), 1046 (s), 1035 (s), 944 (m), 916 (m), 908 (m), 889 (m), 862 (m), 849 
(m), 830 (s), 810 (s), 803 (s), 767 (m), 748 (s), 737 (m), 723 (s), 690 (vs). 
4-(4-Methoxyphenyl)-3,6-dihydro-2H-thiopyran (4l) 
Using potassium (3,6-dihydro-2H-thiopyran-4-yl)trifluoroborate (SM44) and a solution of (4-
methoxyphenyl)magnesium bromide in THF according to general procedure S, provided 4l 
(0.31 mmol, 63 mg, 77%) as colorless oil. The yield was calculated by 1H NMR analysis since 
the hydrolysis product of (4-methoxyphenyl)magnesium bromide (anisole) was not separable 
from the olefinic product via column chromatography. Rf = 0.50 (hexane/EtOAc 98:2, UV, 
PAA). 1H NMR (400 MHz, CDCl3) δ 7.30 – 7.25 (m, 2H), 6.89 – 6.84 (m, 2H), 6.12 – 6.08 (m, 1H), 
3.81 (s, 3H), 3.33 (dt, J = 4.5, 2.3 Hz, 2H), 2.88 (t, J = 5.8 Hz, 2H), 2.70 – 2.64 (m, 2H) ppm. 13C NMR 
(101 MHz, CDCl3) δ 159.0, 137.7, 135.6, 126.7, 120.3, 113.8, 55.4, 28.8, 26.4, 25.3 ppm. LRMS 
(DEP/EI-Orbitrap): m/z (%): 206.1 (100), 191.0 (5), 177.0 (60), 147.1 (75). HRMS (EI-Orbitrap): m/z 
calcd. for C12H14OS+: 206.0765; found: 240.0592. IR (Diamond-ATR, neat)  𝜈𝑚𝑎𝑥 (cm
-1): 3248 (w), 
2999 (w), 2934 (w), 2835 (w), 1601 (w), 1578 (w), 1511 (vs), 1493 (m), 1463 (m), 1453 (m), 1443 (m), 
1414 (m), 1340 (w), 1322 (w), 1309 (w), 1252 (vs), 1229 (vs), 1179 (m), 1134 (s), 1086 (w), 1071 (vw), 
1026 (s), 926 (w), 895 (w), 862 (m), 814 (m), 800 (w), 779 (s), 765 (m), 738 (w), 698 (m), 656 (w). 
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tert-Butyl 4-(4-methoxyphenyl)-3,6-dihydropyridine-1(2H)-carboxylate (4m)* 
Using potassium (1-(tert-butoxycarbonyl)-1,2,3,6-tetrahydropyridin-4-yl)trifluoroborate 
(SM40) and a solution of (4-methoxyphenyl)magnesium bromide in THF according to general 
procedure S, provided 4m (0.21 mmol, 60 mg, 52%) as colorless oil. 1H NMR (400 MHz, 
CDCl3) δ 7.35 – 7.29 (m, 2H), 6.93 – 6.83 (m, 2H), 6.00 – 5.88 (m, 1H), 4.08 – 4.03 (m, 2H), 
3.81 (s, 3H), 3.63 (t, J = 5.7 Hz, 2H), 2.53 – 2.45 (m, 2H), 1.49 (s, 9H) ppm. LRMS (DEP/EI-
Orbitrap): m/z (%): 232.1 (100), 202.1 (15), 188.1 (34), 160.0 (16). Analytical data in accordance to 
literature.298 
tert-Butyl 4-(4-fluorophenyl)-3,6-dihydropyridine-1(2H)-carboxylate (4n)* 
Using potassium (1-(tert-butoxycarbonyl)-1,2,3,6-tetrahydropyridin-4-yl)trifluoroborate 
(SM40) and a solution of (4-fluorophenyl)magnesium bromide in THF according to general 
procedure S, provided 4n (0.22 mmol, 62 mg, 56%) as colorless oil. 1H NMR (400 MHz, 
CDCl3) δ 7.37 – 7.29 (m, 2H), 7.06 – 6.98 (m, 2H), 6.02 – 5.91 (m, 1H), 4.09 – 4.02 (m, 2H), 
3.63 (t, J = 5.7 Hz, 2H), 2.53 – 2.44 (m, 2H), 1.49 (s, 9H) ppm. LRMS (DEP/EI-Orbitrap): m/z 
(%): 220.1 (100), 204.1 (15), 177.1 (70). Analytical data in accordance to literature.299 
tert-Butyl 4-(4-(trifluoromethyl)phenyl)-3,6-dihydropyridine-1(2H)-carboxylate (4o) 
Using potassium (1-(tert-butoxycarbonyl)-1,2,3,6-tetrahydropyridin-4-yl)trifluoroborate 
(SM40) and a solution of (4-(trifluoromethyl)phenyl)magnesium bromide in THF according to 
general procedure S, provided 4o (0.17 mmol, 56 mg, 43%) as colorless oil. 1H NMR 
(400 MHz, CDCl3) δ 7.58 (d, J = 8.7 Hz, 2H), 7.46 (d, J = 8.1 Hz, 2H), 6.15 – 6.08 (m, 1H), 
4.15 – 4.00 (m, 2H), 3.65 (t, J = 5.7 Hz, 2H), 2.58 – 2.50 (m, 2H), 1.49 (s, 9H) ppm. LRMS 
(DEP/EI-Orbitrap): m/z (%): 271.1 (100), 254.1 (15), 227.1 (90). Analytical data in accordance to liter-
ature.300 
8-(4-Methoxyphenyl)-1,4-dioxaspiro[4.5]dec-7-ene (4p) 
Using potassium trifluoro(1,4-dioxaspiro[4.5]dec-7-en-8-yl)borate (SM45) and a solution of 
(4-methoxyphenyl)magnesium bromide in THF according to general procedure S, provided 4p 
(0.35 mmol, 86 mg, 87%) as colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.35 – 7.31 (m, 2H), 
6.88 – 6.81 (m, 2H), 5.90 (td, J = 3.9, 2.0 Hz, 1H), 4.02 (s, 4H), 3.80 (s, 3H), 2.66 – 2.60 (m, 
2H), 2.51 – 2.42 (m, 2H), 1.92 (t, J = 6.5 Hz, 2H) ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 
246.1 (40), 231.0 (2). 160.1 (100). Analytical data in accordance to literature.301 
 
298 The full characterization can be found in chapter 4.4 of the experimental part (molecule 6d). 
299 D. J. Wustrow, L. D. Wise, Synthesis 1991, 11, 993–995. 
300 Merck & Co., US6303593, 2001, B1. 
301 A. J. Pearson, I. C. Richards, D. V. Gardner, J. Org. Chem. 1984, 49, 3887–3891. 
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8-(3,5-Difluorophenyl)-1,4-dioxaspiro[4.5]dec-7-ene (4q) 
Using potassium trifluoro(1,4-dioxaspiro[4.5]dec-7-en-8-yl)borate (SM45) and a solution 
of (3,5-difluorophenyl)magnesium bromide in THF according to general procedure S, pro-
vided 4q (0.16 mmol, 40 mg, 40%) as colorless oil. Rf = 0.10 (hexane/EtOAc 98:2, UV, 
PAA). 1H NMR (400 MHz, CDCl3) δ 6.95 – 6.85 (m, 2H), 6.66 (tt, J = 8.8, 2.3 Hz, 1H), 
6.05 (tt, J = 4.0, 1.6 Hz, 1H), 4.02 (s, 4H), 2.63 – 2.56 (m, 2H), 2.49 – 2.44 (m, 2H), 1.91 
(t, J = 6.6 Hz, 2H) ppm. 13C NMR (101 MHz, CDCl3) δ 163.1 (dd, J = 246.8, 13.3 Hz), 144.9 (t, J = 
9.2 Hz), 134.6 (t, J = 2.6 Hz), 124.0, 108.3 – 107.9 (m), 107.6, 102.1 (t, J = 25.6 Hz), 64.7, 36.2, 31.3, 
26.6 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 252.1 (35), 237.0 (5) 164.0 (15), 151.0 (15), 86.0 (100). 
HRMS (EI-Orbitrap): m/z calcd. for C14H14F2O2+: 252.0962; found: 252.0956. IR (Diamond-ATR, 
neat)  𝜈𝑚𝑎𝑥 (cm
-1): 2942 (vs), 2929 (vs), 2892 (s), 2866 (vs), 1502 (vs), 1463 (s), 1254 (m), 1202 (s), 
1148 (m), 1096 (s), 1059 (m), 1037 (s), 1017 (s), 1004 (s), 993 (s), 981 (s), 942 (m), 931 (m), 919 (m), 
884 (s), 863 (m), 830 (s), 810 (m), 804 (m), 775 (m), 709 (m), 677 (s), 668 (s), 662 (s). 
8-(4-Fluorophenyl)-1,4-dioxaspiro[4.5]dec-7-ene (4r)* 
Using potassium trifluoro(1,4-dioxaspiro[4.5]dec-7-en-8-yl)borate (SM45) and a solution of 
(4-fluorophenyl)magnesium bromide in THF according to general procedure S, provided 4r 
(0.34 mmol, 80 mg, 86%) as colorless oil. Rf = 0.15 (hexane/EtOAc 98:2, UV, PAA). 1H NMR 
(400 MHz, CDCl3) δ 7.38 – 7.31 (m, 2H), 7.02 – 6.95 (m, 2H), 5.93 (tt, J = 3.9, 1.6 Hz, 1H), 
4.02 (s, 4H), 2.63 (tq, J = 6.4, 2.1 Hz, 2H), 2.48 – 2.44 (m, 2H), 1.92 (t, J = 6.5 Hz, 2H) ppm. 
13C NMR (101 MHz, CDCl3) δ 162.1 (d, J = 245.4 Hz), 137.7 (d, J = 3.2 Hz), 135.5, 126.8 (d, J = 
7.8 Hz), 121.6 (d, J = 1.4 Hz), 115.1 (d, J = 21.2 Hz), 107.8, 64.6, 36.2, 31.4, 27.1 ppm. LRMS 
(DEP/EI-Orbitrap): m/z (%): 234.1 (25), 219.1 (5), 146.0 (20), 133.0 (20), 86.0 (100). HRMS (EI-
Orbitrap): m/z calcd. for C14H15FO2+: 234.1056; found: 234.1049. IR (Diamond-ATR, neat)  𝜈𝑚𝑎𝑥 (cm
-
1): 3406 (w), 2925 (w), 1709 (s), 1599 (m), 1509 (m), 1500 (m), 1412 (m), 1360 (s), 1277 (m), 1261 
(m), 1221 (vs), 1158 (s), 1092 (s), 1031 (s), 1014 (s), 946 (m), 931 (m), 900 (m), 881 (m), 828 (s), 811 
(s), 748 (m), 682 (m), 668 (m). 
tert-Butyl(((3S,8R,9S,10R,13S,14S)-17-(4-fluorophenyl)-10,13-dimethyl-
2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)dime-
thylsilane (5a) 
Using potassium ((3S,8S,9S,10R,13S,14S)-3-((tert-butyldimethylsilyl)oxy)-
10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclo-
penta[a]phenanthren-17-yl)trifluoroborate (SM46) and a solution of (4-
fluorophenyl)magnesium bromide in THF according to general procedure S, 
provided 5a (0.25 mmol, 121mg, 63%) as colorless oil. Rf = 0.20 (hex-
ane/EtOAc 98:2, UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 7.32 (dd, J = 8.7, 5.5 Hz, 2H), 
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7.01 – 6.95 (m, 2H), 5.85 (dd, J = 3.4, 1.8 Hz, 1H), 5.38 – 5.33 (m, 1H), 3.50 (tt, J = 11.0, 4.7 Hz, 1H), 
2.34 – 2.15 (m, 3H), 2.09 – 1.96 (m, 3H), 1.85 – 1.41 (m, 10H), 1.33 – 1.20 (m, 1H), 1.06 (s, 3H), 1.03 
(s, 3H), 0.90 (s, 9H), 0.07 (s, 6H) ppm. 13C NMR (101 MHz, CDCl3) δ 161.9 (d, J = 245.4 Hz), 153.8, 
141.9, 133.4 (d, J = 3.5 Hz), 128.2 (d, J = 7.7 Hz), 127.1, 120.9, 114.9 (d, J = 21.0 Hz), 72.6, 57.7, 50.5, 
50.4, 47.2, 42.9, 37.3, 36.8, 35.4, 32.1, 31.6, 30.5, 26.0, 20.9, 19.4, 18.3, 16.6, -4.4 ppm. LRMS 
(DEP/EI-Orbitrap): m/z (%): 423.3 (50), 348.2 (5), 207.0 (100). HRMS (EI-Orbitrap): m/z calcd. for 
C31H45FOSi+: 480.3224; found: 480.3211. IR (Diamond-ATR, neat)  𝜈𝑚𝑎𝑥 (cm
-1): 2929 (m), 2900 (m), 
2855 (m), 1714 (w), 1600 (w), 1507 (m), 1471 (w), 1462 (m), 1437 (w), 1408 (w), 1380 (w), 1371 (w), 
1361 (w), 1294 (w), 1250 (m), 1227 (m), 1159 (m), 1089 (s), 1006 (m), 959 (w), 938 (w), 925 (w), 888 
(m), 870 (m), 835 (vs), 806 (s), 774 (s), 736 (w), 718 (w), 668 (m). 
tert-Butyl(((3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(4-(trifluoromethoxy)phenyl)-
2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)dime-
thylsilane (5b) 
Using potassium ((3S,8S,9S,10R,13S,14S)-3-((tert-butyldimethylsi-
lyl)oxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-
1H-cyclopenta[a]phenanthren-17-yl)trifluoroborate (SM46) and a solu-
tion of (4-fluorophenyl)magnesium bromide in THF according to general 
procedure S, provided 5b (0.28 mmol, 153 mg, 70%) as colorless oil. Rf 
= 0.30 (hexane/EtOAc 98:2, UV, PAA, KMnO4). 1H NMR (400 MHz, CDCl3) δ 7.42 – 7.35 (m, 2H), 
7.16 – 7.09 (m, 2H), 5.92 (dd, J = 3.3, 1.8 Hz, 1H), 5.38 – 5.33 (m, 1H), 3.49 (tt, J = 11.0, 4.7 Hz, 1H), 
2.35 – 2.16 (m, 3H), 2.09 – 1.97 (m, 3H), 1.87 – 1.41 (m, 10H), 1.30 – 1.21 (m, 1H), 1.06 (s, 3H), 1.04 
(s, 3H), 0.89 (s, 9H), 0.06 (s, 6H) ppm. 13C NMR (101 MHz, CDCl3) δ 153.7, 148.1, 142.0, 136.2, 
128.4, 128.0, 121.0, 120.8, 120.6 (q, J = 256.7 Hz), 77.2, 72.7, 57.8, 50.6, 47.4, 43.0, 37.4, 36.9, 35.5, 
32.2, 31.7, 30.6, 26.1, 21.0, 19.5, 18.4, 16.7, -4.4 ppm. LRMS (DEP/EI-Orbitrap): m/z (%): 489.2 (100), 
413.1 (5), 329.1 (10). HRMS (EI-Orbitrap): m/z calcd. for C32H45F3O2Si+: 546.3141; found: 546.3138. 
IR (Diamond-ATR, neat)  𝜈𝑚𝑎𝑥 (cm
-1): 2959 (w), 2936 (w), 2930 (w), 2897 (w), 2857 (w), 1749 (w), 
1712 (s), 1602 (w), 1507 (w), 1470 (w), 1458 (w), 1437 (w), 1428 (w), 1382 (m), 1361 (s), 1257 (s), 
1220 (vs), 1166 (m), 1085 (s), 1062 (m), 1048 (m), 1019 (m), 1003 (m), 957 (m), 937 (m), 922 (m), 
911 (m), 888 (s), 869 (s), 838 (s), 815 (m), 802 (m), 771 (m), 734 (m), 672 (m). 
(E)-5-Styrylbenzene-1,3-diol (pinosylvin) (5c) 
Using potassium (E)-trifluoro(styryl)borate and a solution of (3,5-dimethoxy-
phenyl)magnesium bromide in THF according to general procedure S, provided (E)-
1,3-dimethoxy-5-styrylbenzene. For deprotection of the alcohol, the crude compound 
was dissolved in CH2Cl2 (4 mL) after electrochemical oxidation, cooled down to –20 °C 
and treated with a solution of BBr3 (1.6 mmol, 4.0 equiv) dissolved in 1 mL CH2Cl2. 
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The reaction was allowed to reach room temperature. After completion, the reaction was treated with 
water and extracted with dichloromethane (3 × 10 mL) and washed with a solution of sat. aq. NaCl 
(1 × 10 mL). The combined organic phases were dried over MgSO4, filtered and concentrated in vacuo. 
The crude was purified by flash-column chromatography with appropriate solvent mixture to provide 
5c (0.23 mmol, 62 mg, 57%, E/Z = 99:1) as colorless solid. 1H NMR (400 MHz, CDCl3) δ 7.51 – 7.46 
(m, 2H), 7.39 – 7.33 (m, 2H), 7.29 – 7.26 (m, 1H), 7.05 (d, J = 16.3 Hz, 1H), 6.96 (d, J = 16.3 Hz, 1H), 
6.58 (d, J = 2.2 Hz, 2H), 6.28 (t, J = 2.2 Hz, 1H), 4.76 (s, 2H, OH) ppm. HRMS (EI-Orbitrap): m/z 
calcd. for C14H12O2+: 212.0837; found: 212.0830. Analytical data in accordance to literature.288 
6.5 Cyclic Voltammetry  
Table 22: Determined Oxidation potentials of ATB salts 2a–b vs. SCE. 
ATB salt ATB structure EpOx vs. SCE / V 
2a 
 
0.81 
2b 
 
0.67 
NaBPh4 reference (2c) 
 
0.82 
 
The results of cyclovoltammetry experiments are summarized in Table 22 and Figure 34. The oxidation 
potentials were determined in acetonitrile on a CH Instruments 630E electrochemical analyzer using a 
2 mm diameter platinum working electrode, a platinum wire counter electrode and an Ag wire pseudo-
reference electrode applying a scan rate of 0.1 V/s. Cyclic voltammetry measurements were performed 
in acetonitrile containing 0.1 M NBu4ClO4 with the ATB salts (2a–b) (c ≈ 3.4 × 10−4 M) and ferrocene 
(c = 3.8 × 10−4 M) as an internal standard. The E1/2(fc+/fc in MeCN) = +0.382 V was used to calibrate 
EpOx (in MeCN) vs. SCE. 
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Figure 34: Graphical summary of measured EpOx vs. SCE of ATB salts 2a–b and NaBPh4 reference. 
6.6 Calculations266 
Calculations were performed at the equation-of-motion ionization potential coupled-cluster singles and 
doubles (EOM-IP-CCSD) level of theory and using density functional theory (DFT) with the ω B97X-
D3 functional. The 6-31G* basis set was used in all calculations if not indicated otherwise. (EOM-IP)-
CCSD calculations (Table 23) were performed for isolated molecules in gas phase, DFT calculations 
were performed in gas phase (Table 24) and additionally taking into account the solvent (acetonitrile) 
by means of the polarizable continuum (PCM) approach (Table 25 and Table 26).267 Non-equilibrium 
solvent effects upon ionization were either disregarded (Table 25) or taken into account by means of 
the state-specific approach (Table 26).268 Molecular structures of the ATB anions were optimized at the 
ω B97X-D3/6-31G*/PCM level of theory.269 Core electrons were frozen in all CCSD and EOM-IP-
CCSD calculations.270 All calculations were performed with the Q-Chem program package, release 
5.0.271 The energy differences shown in Table 23−Table 26 support most of the trends observed in 
experiments. For the both ATB salts 2a−b, the calculations agree with cyclic voltammetry measure-
ments (see Section 4) that the species with the styryl group (2b) shows a lower oxidation potential than 
the tetraphenylborate anion.  This effect is however nullified, when the phenyl substituents are ex-
changed for more electron-deficient p-fluorophenyl residues (2a), which results in a higher oxidation 
potential for this ATB salt compared to 2b and an almost identical oxidation potential as the tetraphenyl-
borate anion. To characterize the change in the electronic structure upon oxidation of the ATB anions, 
spin and charge densities (Table 27 and Table 28) were computed based on Mulliken population anal-
ysis.272 Since this approach is known to suffer from a heavy basis-set dependence, partial charges were 
additionally computed using the ChElPG (Charges from the electrostatic potential on a grid) approach 
(Table 29).273 These results illustrate that the single styryl moiety is selectively oxidized in all cases 
while the charge and spin densities of the other aromatic rings change only insignificantly. This fact is 
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also visualized in Figure 35 and by means of the spin densities of molecules 2a–b. Notably, results do 
not change significantly for all other molecules when going from 6-31G* to 6-311G**. 
Table 23: Total energies (in atomic units) of closed-shell ATB anions (2a–b) and NaBPh4 reference and the 
corresponding neutral radicals computed at the CCSD/6-31G* and EOM-IP-CCSD/6-31G* levels of theory, re-
spectively. Energy differences (in eV) are also shown. 
ATB salt Et(Anionic) (a.u.) Et(Radical) (a.u.) E (eV) 
NaBPh4 reference -948.477575 -948.3275427 4.08 
2a -1322.690426 -1322.534683 4.24 
2b -1025.630332 -1025.484670 3.96 
 
Table 24: Total energies (in atomic units) of closed-shell ATB anions (2a–b) and NaBPh4 reference and the 
corresponding neutral radicals computed at the ω B97X-D3/6-31G* level of theory. Energy differences (in eV) 
are also shown. 
ATB salt Et(Anionic) (a.u.) Et(Radical) (a.u.) E (eV) 
KBPh4 reference -951.253221 -951.094822 4.31 
2a -1326.271536 -1326.112552 4.33 
2b -1028.631710 -1028.481268 4.09 
 
Table 25: Total energies (in atomic units) of closed-shell ATB anions (2a–b) and NaBPh4 reference and the 
corresponding neutral radicals computed at the ω B97X-D3/6-31G*/PCM level of theory. The solvent reaction 
field is equilibrated in all calculations. Energy differences (in eV) are also shown. 
ATB salt Et(Anionic) (a.u.) Et(Radical) (a.u.) E (eV) 
KBPh4 reference -951.325714 -951.104965 6.01 
2a -1326.336968 -1326.136995 5.44 
2b -1028.704321 -1028.505684 5.41 
 
Table 26: Total energies (in atomic units) of closed-shell ATB anions (2a–b) and NaBPh4 reference and the 
corresponding neutral radicals computed at the ω B97X-D3/6-31G*/PCM level of theory. The state-specific ap-
proach is used to describe non-equilibrium solvent effects upon ionization. Energy differences (in eV) are also 
shown. 
ATB salt Et(Anionic) (a.u.) Et(Radical) (a.u.) E (eV) 
KBPh4 reference -951.325714 -951.075570 6.81 
2a -1326.336968 -1326.103329 6.36 
2b -1028.704321 -1028.472163 6.32 
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Table 27: Spin densities of neutral ATB (2a–b) and NaBPh4 reference radicals computed from Mulliken popula-
tion analysis at the ω B97X-D3/6-31G*/PCM level of theory. The values represent the sums of the spin densities 
associated with the carbon atoms of the four aromatic rings. 
ATB salt Spin densities Ar1 Spin density Ar2/vinyl 
KBPh4 reference 0.27/0.24/0.24/0.26 - 
2a 0.00/0.03/0.06 0.37/0.61 
2b 0.00/0.03/0.07 0.33/0.62 
 
Table 28: Differences in charge density between ATB (2a–b) and NaBPh4 reference anions and neutral radicals 
computed from Mulliken population analysis at the ω B97X-D3/6-31G*/PCM level of theory. The values repre-
sent the sums of the charge density differences associated with the carbon atoms of the four aromatic rings. 
ATB salt Charge density Ar1  Charge density Ar2/vinyl 
KBPh4 reference 0.09/0.09/0.09/0.10 - 
2a 0.02/0.01/0.04 0.19/0.17 
2b 0.02/0.01/0.03 0.18/0.17 
 
Table 29: Differences in charge density between ATB (2a–b) and NaBPh4 reference anions and neutral radicals 
computed from charges from the electrostatic potential on a grid (ChElPG) at the ω B97X-D3/6-31G*/PCM level 
of theory. The values represent the sums of the charge density differences associated with the carbon atoms of the 
four aromatic rings. 
ATB salt Charge density Ar1 Charge density Ar2/vinyl 
KBPh4 reference -0.21, -0.20, -0.20, -0.19 - 
2a -0.02/-0.01/-0.05, -0.29/-0.56 
2b -0.03/-0.01/-0.06 -0.28/-0.47 
 
 
Figure 35: Spin density of the neutral ATB radical for 2a (left) and 2b (right) computed at the ω B97X-D3/6-
31G*/PCM level of theory and plotted at an isovalue of 0.015. 
6.7 Single Crystal X-Ray Diffraction 
The structure determination of compound 2a was already presented and can be found in chapter 5.9 of 
the experimental part. 
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6.8 Representative NMR Spectra 
 
Figure 36: 1H NMR (400 MHz, CDCl3) and 13C NMR (101 MHz, CDCl3) for (E)-2-(4-
Fluorostyryl)dibenzo[b,d]furan (3j). 
